This electronic thesis or dissertation has been
downloaded from the King’s Research Portal at
https://kclpure.kcl.ac.uk/portal/
Take down policy
If you believe that this document breaches copyright please contact [email protected] providing
details, and we will remove access to the work immediately and investigate your claim.
END USER LICENCE AGREEMENT
Unless another licence is stated on the immediately following page this work is licensed
under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
licence. https://creativecommons.org/licenses/by-nc-nd/4.0/
You are free to copy, distribute and transmit the work
Under the following conditions:
Attribution: You must attribute the work in the manner specified by the author (but not in anyway that suggests that they endorse you or your use of the work).
Non Commercial: You may not use this work for commercial purposes.
No Derivative Works - You may not alter, transform, or build upon this work.
Any of these conditions can be waived if you receive permission from the author. Your fair dealings and
other rights are in no way affected by the above.
The copyright of this thesis rests with the author and no quotation from it or information derived from it
may be published without proper acknowledgement.
A Study of Raised Intra-abdominal Pressure and the Abdominal CompartmentSyndrome in Liver Intensive Care
Cresswell, Ben
Awarding institution:King's College London
Download date: 01. Sep. 2020
This electronic theses or dissertation has been
downloaded from the King’s Research Portal at
https://kclpure.kcl.ac.uk/portal/
The copyright of this thesis rests with the author and no quotation from it or information
derived from it may be published without proper acknowledgement.
Take down policy
If you believe that this document breaches copyright please contact [email protected]
providing details, and we will remove access to the work immediately and investigate your claim.
END USER LICENSE AGREEMENT
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0
Unported License. http://creativecommons.org/licenses/by-nc-nd/3.0/
You are free to:
Share: to copy, distribute and transmit the work Under the following conditions:
Attribution: You must attribute the work in the manner specified by the author (but not in any way that suggests that they endorse you or your use of the work).
Non Commercial: You may not use this work for commercial purposes.
No Derivative Works - You may not alter, transform, or build upon this work.
Any of these conditions can be waived if you receive permission from the author. Your fair dealings
and other rights are in no way affected by the above.
Title:A Study of Raised Intra-abdominal Pressure and the Abdominal CompartmentSyndrome in Liver Intensive Care
Author:Ben Cresswell
A Study of Raised Intra-abdominal Pressure and the Abdominal Compartment Syndrome in Liver
Intensive Care
Adrian B Cresswell MB ChB, FRCS
Submitted for degree of; MD(Res)
King’s College London
1
Acknowledgments
For my wife, Clodagh
With gratitude to my supervisors, Professor Julia Wendon and Mr Matthew Bowles
With acknowledgment of the assistance of the intensive care and surgical staff and patients at the Institute for Liver Studies at King’s College Hospital, London – especially Drs William Bernal,
Georg Auzinger and Pauline Kane
2
Contents
Page Number Abstract 6 Lists of Tables & Figures 8
Chapter
1 Introduction 12 1.1 What is Intra-abdominal Pressure 13 1.2 Historical Background 16 1.3 Definitions and Terminology 19 1.4 Epidemiology of IAH / ACS 25 1.5 Measurement of IAP 30 1.5.1 Techniques for Measurement of IAP 33 1.5.2 Screening Criteria 42 1.6 IAP and the Liver 45 1.7 IAP and the other Organ Systems 56 1.7.1 IAP and the Cardiovascular System 56 1.7.2 IAP and the Respiratory System 60 1.7.3 IAP and the Renal System 61 1.7.4 IAP and the Central Nervous System 62 1.8 Overview of Areas of Study 63 1.9 Considerations Regarding Study Design, 66
Data Collection and Analysis
2 Attitudes and Practice of Intra-abdominal Pressure 70 in the UK
2.1 Introduction – Previous Questionnaires and Surveys 71 2.2 Design of Questionnaire 80 2.3 Results 85 2.4 Discussion 95 2.5 Summary and Conclusions 98
3 Invitro & Invivo Evaluation of the Foley 99 Manometer Device for the Measurement of IAP
3.1 Introduction – Techniques available for the Measurement of 100 Intra-abdominal Pressure
3.2 Invitro Evaluation of the Foley Manometer 108 3.3 Comparison of Foley Manometer to Directly Transduced 115
Intra-peritoneal Pressure Recordings 3.4 Comparison of Foley Manometer to AbViser Device 122 3.5 Summary and Conclusions 126
3
4 Sources of Error in the Use of the 127 Foley Manometer
4.1 Introduction 128 4.2 Determining the Ideal Zero-Reference Point for the Measurement 130
of IAP 4.3 The Effect of Body Position on Measured IAP 141
4.4 The Effect of Priming Volume on Measured IAP 150 4.5 Vapour Lock 160 4.6 Discussion 161 4.7 Summary and Conclusions 165
5 An Observational Cohort Study of the Incidence 166
and Effects of Raised Intra-abdominal Pressure in the Liver Intensive Care Unit
5.1 Introduction and definitions 167 5.2 Methods 169 5.3 Results 174 5.3.1 Patient Demographics 174 5.3.2 Incidence of IAH & ACS 177 5.3.3 Association of Raised IAP with Length of Stay, Complications & Liver 178
Function 5.3.4 Factors Predicting Peak IAP 186 5.4 Discussion 191 5.5 Summary and Conclusions 197
6 Regional IAP Following Liver Transplantation 198 6.1 Introduction 199 6.2 Methods 202 6.3 Results 206 6.3.1 Compartmental Pressure Measurement & the effect of Body Position 210 6.3.2 Continuous Compartment Pressure Measurement 212 6.4 Discussion 215 6.5 Summary & Conclusion 221
7 Summary, Limitations and Conclusions 222
Bibliography 237
4
Appendix 250
1. i. IAP Questionnaire – Surgeons 252
ii. IAP Questionnaire – Anaesthetists 254
2. Peer-reviewed publications arising from thesis 256
i. Hepatic function and non-invasive hepatosplanchnic monitoring in patients with abdominal hypertension. Cresswell AB, Wendon JA. Acta Clin Belg. 2007;(1):113-8.
ii. The effect of different reference transducer positions on
intra-abdominal pressure measurement: a multicenter analysis. De Waele JJ, De Laet I, De Keulenaer B, Widder S, Kirkpatrick AW, Cresswell AB, Malbrain M, Bodnar Z, Mejia-Mantilla JH, Reis R, Parr M, Schulze R, Compano S, Cheatham M. Intensive Care Med. 2008 Jul;34(7):1299-303. 2008 Apr 4.
iii. The impact of body position on intra-abdominal pressure
measurement: a multicenter analysis. Cheatham ML, De Waele JJ, De Laet I, De Keulenaer B, Widder S, Kirkpatrick AW, Cresswell AB, Malbrain M, Bodnar Z, Mejia-Mantilla JH, Reis R, Parr M, Schulze R, Puig S; World Society of the Abdominal Compartment Syndrome (WSACS) Clinical Trials Working Group. Crit Care Med. 2009 Jul;37(7):2187-90.
iv. The effect of body position on compartmental intra-
abdominal pressure following liver transplantation. Cresswell AB, Jassem W, Srinivasan P, Prachalias AA, Sizer E, Burnal W, Auzinger G, Muiesan P, Rela M, Heaton ND, Bowles MJ, Wendon JA Annals of Intensive Care. 2012 5(2):S12
5
Abstract
Introduction
Interest in intra-abdominal pressure (IAP) measurement has increased significantly, with
evidence of its deleterious effects demonstrated on every organ. Despite the volume of
publications – several assumptions relating to the measurement of IAP remain unproven and
there is a paucity of data relating to patients in a specialised liver Intensive Therapy Unit (ITU).
Methods
This thesis encompasses a survey of the available literature and national attitudes / practice with
several clinical experiments;
Generic Questions
1. IAP measurement technique – validation of current gold-standard against alternatives
2. Identification of potential sources of error in measurement of IAP
3. Impact of body position and zero-reference point on IAP
Specialty Specific Questions
1. Incidence of raised IAP in specialised liver ITU and its link to complications / length of stay
2. Identification of early predictors of raised IAP
3. Study of regional abdominal compartmental variation in IAP
6
Results & Conclusions
• IAP is widely accepted by UK anaesthetists and surgeons, especially amongst those
more recently graduated. Knowledge and practice is variable however and requires
better education
• The Foley Catheter Manometer represents a reliable and valid tool for the measurement
of IAP, with excellent agreement to measurements obtained by other devices and directly
transduced intra-peritoneal pressure
• Body-position and bladder priming volumes both introduce significant clinical error in the
measurement of IAP
• Patients in liver ITU are at higher risk of developing elevated IAP than those in a general
ITU. Within this patient cohort, complications are associated with elevated IAP and IAP
is a better predictor of length of stay than other severity scores. A normal Day 1 IAP
reliably predicts that abdominal compartment syndrome will not occur during the
admission
• Significant variation in upper and lower IAP occurs following liver transplantation and this
regional variation can be manipulated by body positioning
7
List of Tables Chapter Table
Number Title Page
Number
1.1 WSACS Consensus Definitions 23 1.2 Summary of Studies Looking at the Incidence / Prevalence of IAH 28 1.3 The Richmond Agitation-Sedation Scale 67
1
1.4 WSACS Criteria for clinical equivalence of IAP measurement techniques
68
2.1 Summary of previous surveys of knowledge and practice relating to
IAP 72
2.2 Views regarding the existence of ACS reported by UK anaesthetists with or without an ITU practice
86
2.3 Views regarding the existence of ACS reported by UK general surgeons (further divided by sub-specialty interest)
87
2.4 Table summarising knowledge and practice relating to measurement of IAP
90
2.5 Table summarising practice relating to decompressive laparostomy 91 2.6 Comparison of intra-operative factors reported as making
laparostomy more likely 92
2.7 Comparison of post-operative factors making laparostomy more likely
93
2
2.8 Ranking of factors making laparostomy more likely, in order of importance, reported by surgeons and anaesthetists in the current study compared to the original research
94
3.1 Ideal characteristics for a system to measure IAP 100 3.2 Summary of the relative merits for various techniques used for the
measurement of IAP 106
3.3 Results of an in-vitro study of inter-observer variability in the use of the Holtech FoleyManometer
112
3.4 Results of comparison of IAP measurements made using the Holtech FoleyManometer and via direct transduction of pelvic intra-peritoneal pressure
119
3
3.5 Results of the comparison of IAP measured using the Holtech FoleyManometer and AbViser systems
124
4.1 Mean and standard deviation of distance (mm) between bony
landmarks and catheter balloon (bladder neck) 133
4.2 Comparison of IAP measured at symphysis pubis and iliac crest zero-reference points – local and multi-centre data presented
137
4.3 The effect of body position on measured IAP - local data and results of multi-centre study
145
4.4 Summary of the effects of bladder priming volume on the measured IAP expressed as bias over measurement obtained with a 25ml priming volume
152
4.5 Effect of different priming volumes on measured IAP over a standard minimum volume of 10mls
156
4
4.6 Comparison of observed bias in IAP measurement observed with various different devices
163
8
5.1 Measured end-points and definitions of summary measures
examined during epidemiological study of IAP in Liver ITU 171
5.2 Demographic details of patients recruited with a diagnosis of Acute Hepatic Dysfunction
174
5.3 Demographic details of patients recruited following HPB Surgery 175 5.4 Demographic details of patients recruited following Liver
Transplantation 175
5.5 Mean Peak IAP, Mean D1 IAP and Incidence of IAH & ACS for each of the study groups
177
5.6 Summary of length of stay observed amongst patients with normal (<12 mmHg) and elevated (> 12 mmHg) IAP
178
5.7 Variables included in the regression model to determine significant predictors of length of stay
179
5.8 Variables found to significantly contribute to a regression model to predict length of stay (all diagnoses)
179
5.9 Variables found to significantly contribute to a regression model to predict length of stay (HPB Surgery)
180
5.10 Variables found to significantly contribute to a regression model to predict length of stay (Liver Transplantation)
180
5.11 Relationship between the presence of IAH and the incidence of complications within the study groups
181
5.12 Summary of correlations between IAP and liver function – Pearson’s Product Moment Correlation Co-efficient
185
5.13 Volume of early fluid administration within the study groups 189
5
5.14 Regression analysis of the effect of early resuscitation volumes for predicting IAP
190
6.1 Comparison of compartmental IAP measured at supine and 30o
head of bed positions 206
6.2 Summary of compartmental pressure differences in subjects divided by whether the upper or lower compartment concealed the higher pressure
213
6
6.3 Summary of WSACS study of the effect of body position on IAP 218
9
List of Figures
Chapter Figure
Number Title Page
Number
1.1 Technique for measurement of IAP described by Kron 35 1.2 Technique for measurement of IAP described by Malbrain 36 1.3 AbViser device for the measurement of IAP 37 1.4 The Holtech FolyManometer System for the measurement of IAP 39 1.5 IAH / ACS Management Algorithm 44
1
1.6 Example of a Bland and Altman Plot of Agreement 68 2 2.1 A summary of volume of publications relating to IAP per year (1982
– 2006) 79
3.1 Set-up and use of the FoleyManometer system to measure IAP 108 3.2 Manufacturers instructions supplied with the Holtech
FoleyManometer 111
3.3 Experimental apparatus constructed to simulate measurement of IAP (visual screen to shield view of the cylinder from the subject omitted for clarity)
111
3.4 Measured simulated IAP using Foley Manometer (actual IAP = 18 mmHg). Bland and Altman absolute bias and limits of agreement marked by horizontal lines
113
3.5 Bland and Altman Plot to compare intra-vesical pressure (IBP) to lower intra-abdominal pressure (LIAP) at both 0o and 30o head of bed angles
120
3.6 Bland and Altman Plot to compare intra-vesical pressure (IBP) to intra-abdominal pressure (LIAP) at 0o (supine) head of bed angle
120
3.7 Bland and Altman Plot to compare intra-vesical pressure (IBP) to lower intra-abdominal pressure (LIAP) at 30o head of bed angle
121
3.8 The AbViser system to measure intra-vesical pressure 122
3
3.9 Bland and Altman Plot to compare IAP measured using the Holtech FoleyManometer and Abviser systems
124
4.1 Distance was measured from the centre of the catheter balloon to
the bony landmark (in the case of the iliac crest the catheter tip and landmark were identified on different slices)
132
4.2 Mean distance between bony landmarks and catheter balloon (bladder neck) overall and split by gender (Median, Inter-quartile Range and Range)
134
4.3 Bland and Altman Plots comparing symphysis pubis and iliac crest zero-reference points for the measurement of IAP from multi-centre data (left) and local study (right)
138
4.4 Bland and Altman Plot comparing IAP measured with a supine body position and a 15o head of bed angle (local data)
146
4.5 Bland and Altman Plot comparing IAP measured with a supine body position and a 30o head of bed angle (local data)
146
4.6 Bland and Altman Plot comparing IAP measurements made with bladder priming volumes of 10 & 50mls
157
4
4.7 Bland and Altman Plot comparing IAP measurements made with bladder priming volumes of 10 & 100mls
157
10
4.8 Bland and Altman Plot comparing IAP measurements made with bladder priming volumes of 10 & 200mls
158
4.9 Overall increase in median IAP observed with increasing bladder priming volumes
159
4.10 Individual increases in IAP observed with increasing bladder priming volumes
159
4.11 The problem of “vapour-lock” identified in the use of the Holtech FoleyManometer
160
5.1 There was a strong negative correlation between Peak IAP and Day
1 ICG Clearance 182
5.2 There was a strong negative correlation between Day 1 IAP and Day 1 ICG Clearance
183
5.3 There was a non-significant negative correlation between Peak IAP and Peak INR
184
5.4 There was a significant negative correlation between Day 1 IAP and Peak INR
185
5.5 Correlation between Day 1 and Peak IAP 186 5.6 No patient with a normal Day 1 IAP (green box) went on to develop
ACS during the period of their ITU admission 187
5.7 Day of diagnosis of IAH based on stage of admission 188
5
5.8 Day of ITU admission when Peak IAP reached 189
6.1 The experimental apparatus for measurement IAP by direct transduction of intra-peritoneal pressure at the liver and bladder and measurement of intra-vesical pressure using the Holtech FoleyManometer
203
6.2 Use of the Holtech FoleyManometer for the measurement of IAP 204 6.3 Bland and Altman Plot of agreement between intra-vesical pressure
(IBP) and lower intra-peritoneal pressure (LIAP) measurements made at all bed positions
207
6.4 Bland and Altman Plot of agreement between intra-vesical pressure (IBP) and lower intra-peritoneal pressure (LIAP) measurements with a supine body position – showing excellent agreement between the two
208
6.5 Bland and Altman Plot of agreement between intra-vesical pressure (IBP) and lower intra-peritoneal pressure (LIAP) measurements with a 30o head of bed angle – showing excellent agreement between the two
209
6.6 Bland and Altman Plot of agreement between intra-vesical pressure (IBP) and upper intra-peritoneal pressure (UIAP) measurements – showing poor agreement between the two
210
6
6.7 Bland and Altman Plot of agreement between lower (LIAP) and upper intra-peritoneal pressure (UIAP) measurements – showing poor agreement between the two
211
11
Chapter 1
Introduction
12
1 Introduction
1.1 What is Intra-abdominal Pressure?
The term intra-abdominal pressure (IAP) refers to the dynamic pressure generated within the
closed compartment of the abdomen and pelvis, and is a function of the interaction between the
pressure exerted by the abdominal contents and the mechanical properties of the abdominal wall
itself. The contents of the abdomen can be divided into those which are absolute, i.e. the
minimum volume occupied by the abdominal viscera and associated tissues and those which are
variable – by either gaseous distension or the accumulation of fluid in the form of visceral
oedema, ileus or ascites. It is alterations in these variable components, acting against the semi-
rigid constraints of the abdominal wall (the compliance of which may vary with pathology), which
leads to the problem of an acute rise in intra-abdominal pressure during a critical illness.
The concept of the anatomical compartment is well-established in terms of intracranial[1] and
muscle compartment monitoring[2]. Here, an increase in the volume of the compartment
contents results in a measurable increase in intra-compartmental pressure, which can lead to
damage to the organs of the compartment. The situation is relatively straightforward in these
cases because the compartment walls, bone in the case of the skull and rigid fascia in the case of
muscle compartments, represent a fixed and non-distensible vessel. An expansion within the
contents can lead to a reduction in blood flow and a direct pressure effect within the compartment
which is both clinically evident, in terms of reducing conscious level or limb pain and measurable
using intracranial or intra-fascial pressure transducers. The magnitude, and rate of pressure
change are important however and chronic conditions such as hydrocephalus[3], benign
intracranial hypertension[4] and chronic compartment syndrome of the limbs[5] are well described
13
and associated with less physiological upset. In this setting however it is normally easy to
differentiate between acute and chronic onset compartment syndromes.
The situation within the abdomen is similar in some respects but rather more complex.
The abdominal compartment is enclosed by both non-distensible (the bony pelvis, the posterior
wall and the intra-thoracic portion) and distensible (the lateral and anterior abdominal wall)
components, the contents of which are homogenous and contain fluid, gas and the abdominal
viscera (including the retroperitoneal structures). End organ function in this context is much more
difficult to define and elevated pressures can have variable effects on the cardiovascular,
respiratory, renal, G. I. and endocrine systems, along with transmitted pressure effects on the
respiratory and central nervous systems[6]. In this context the various organ systems, although
all demonstrably affected by raised intra-abdominal pressure, vary in their actual susceptibility
and defining critical levels for each system is difficult - especially so as damage may result from
direct pressure effects, indirect effects such as release of endotoxins or a combination of both[7].
Causes of raised intra-abdominal pressure are Catholic, and have been categorised as being
either primary (associated with injury or disease in the abdominopelvic region), secondary
(associated with conditions that do not originate from the abdomen such as sepsis, burns and
massive fluid resuscitation) and tertiary, or recurrent (ACS developing after treatment for primary
or secondary ACS)[8]. As such, individual causes are in no way confined to surgical or traumatic
injuries and diseases, so practically all critically ill patients remain at risk of developing this
condition.
In common with the other compartment syndromes a chronic form of the abdominal condition
exists and has been described in cases of morbid obesity[9] and ascites[10]
14
For these reasons, cause and effect have been difficult to separate[11], and defining threshold
values for abdominal pressure which impact on organ function has remained contentious for
several decades and only as recently as 2006 have standardised consensus definitions been
agreed[12]. Whilst there remains a lack of absolute consensus throughout the medical
community that raised intra-abdominal pressure represents a distinct clinical entity that requires
treatment, however there is a general acceptance that the phenomenon exists and that in some
patients, its treatment may be beneficial.
15
1.2 Historical Background.
Mention of intra-abdominal pressure has been noted as early as the middle of the 19th century.
The earliest references refer to the normal physiological changes in abdominal pressure related
to respiration and pregnancy but, according to the historical summary of a 1911 publication in the
Archives of Internal Medicine[13], a German named Wendt[14] in 1873, was the first to consider
the effects of raised abdominal pressure on organ function and noted a deterioration in urinary
output.
Emerson, went on to describe a series of elaborate physiological experiments involving the effect
of induced abdominal compartment syndrome on the organ systems of various mammals and
specifically considered effects on the cardiovascular and respiratory systems. The conclusion of
these experiments, namely that “excessive pressure artificially produced within the peritoneal
cavity, causes death from cardiac failure…” was one of the first to describe a clear link between
mortality and intra-abdominal pressure and has since been confirmed by numerous modern
studies[15-17].
Abdominal Compartment Syndrome as a surgical entity, was first noted by military surgeons, and
Gross in 1940, was reported as describing a “…continual battle, often somewhat brutal, while try
to pack intestinal loops into a cavity which was too small to receive them”. He went on to
associate this situation with respiratory failure, impaired venous return and intestinal
obstruction[18]. In the same year, a British Surgeon named Ogilvie, was the first to describe the
use of a laparostomy (leaving the abdomen open with a temporary dressing) following traumatic
wounds with subsequent skin grafting[19].
16
In the context of more elective surgery, Baggot, an Irish anaesthetist, in 1951 reported a high
mortality rate associated with cases of abdominal closure performed under great tension[20]. He
described both paediatric and adult cases but concluded that the underlying problem was an
excess of air trapped in the peritoneal cavity at the time of closure. He did, however, suggest that
the condition could be avoided by leaving the abdomen open.
The modern term of abdominal compartment syndrome, in the majority of recent review articles,
is most commonly attributed to Kron[6] and his colleagues in Charlottesville, Virginia in the 1980s.
In fact his paper, “The measurement of intra-abdominal pressure as a criterion for re-exploration”,
makes no mention of the term, although it is the first modern clinical paper to link oliguria in post-
operative patients with IAPs of >30 mmHg.
Abdominal compartment syndrome as a term, actually seems to have first been used by
Fietsam[21] who described a series of four cases of abdominal aortic aneurysm repair
complicated by an “intra-abdominal compartment syndrome”. All four cases had received
massive fluid resuscitation (more than 25 L of crystalloid) and the raised intra-abdominal pressure
was attributed to interstitial and retroperitoneal swelling with no evidence of active bleeding.
In 1984 Kron had described a series of 11 postoperative patients undergoing an acute elevation
of intra-abdominal pressure (above 30 mm Hg)[22]. This was the first modern description of the
measurement of intra-abdominal pressure via a transvesical route and built-on his previous
laboratory research showing that raised intra-abdominal pressure in dogs resulted in a significant
reduction in glomerular filtration rate[23].
In this clinical series an abdominal pressure of greater than 25 mmHg was considered criteria for
re-exploration of the abdomen. Seven patients underwent re-exploration for either haemostasis
or evacuation of blood clot and all displayed an improved diuresis postoperatively. Four patients
17
with an intra-abdominal pressure of greater than 25 mmHg who did not go undergo exploration
died.
This is a landmark paper, in that it described the first surgical intervention for abdominal
compartment syndrome showing an improved clinical outcome, and identified the correct
underlying mechanism for the improvement in respiratory function reported by Baggot in 1951 in
patients with open abdomens[20].
Since the 1990s more confirmation of the deleterious effects of raised intra-abdominal pressure
has appeared, both within the clinical setting and in various animal models. As interest and
acceptance of the concept grew, the number of studies considering the incidence, prevalence
and specific effects on organ function has also increased exponentially[24]. These, more recent
studies, will be discussed in context later in this chapter.
18
1.3 Definitions and Terminology
The study of raised intra-abdominal pressure has been hampered by many factors, some of
which will be expanded upon elsewhere in this thesis. One of the main problems has been a lack
of continuity in terminology between various reporters, and it was only within the last decade
(2004) that the initial consensus definitions were produced at the inaugural meeting of the World
Society of the Abdominal Compartment Syndrome (WSACS)[8]. The final versions of these
definitions were eventually agreed and published in 2006 [12]. It is these definitions that will be
used throughout the text of the thesis and a summary of the important terminology is provided in
the table below.
Normal intra-abdominal Pressure
Normal intra-abdominal pressure within healthy individuals is difficult to define with certainty, as
even indirect measurements of abdominal pressure are invasive to some degree. Only two
studies to consider the intra-abdominal pressure in normal, healthy humans appear to have been
performed[25, 26].
In the first, the investigators recruited 20 healthy subjects between the age of 18 and 30 years
(mean 22.7 years) with a BMI less than 30, and measured intra-abdominal pressure indirectly via
the urinary bladder. The mean pressure whilst supine and relaxed was 1.8 mm Hg (SD 2.2) and
this rose to 20 mm Hg on standing (highlighting the importance of posture on IAP measurement –
presumably due to a shift in the vertical weight of the abdominal organs on the bladder). The
investigators went on to study the effect of 13 physical manoeuvres on intra-abdominal pressure.
Interestingly, coughing and jumping lead to a far greater increase than performing abdominal
crunches or weightlifting.
A larger study was performed by an Egyptian group, to consider the effect of straining on the
perineal muscles. Here, 46 healthy volunteers with an age range of 28 to 32 years (mean 30.4
19
years) were studied and intra-abdominal pressure was measured via a rectal transducer. In this
study mean rectal pressure was found to be 7.2 cm H2O (SD 1.2) – equating to 5.3 mmHg. The
role of rectal pressure in the assessment of intra-abdominal pressure is less well-established
however, and really the only validation study for the technique comes from the same group[27].
In this study the authors compare rectal pressure to intra-abdominal pressure measured directly
by the insertion of a veress needle into the peritoneal cavity. Thirty subjects were recruited, only
11 were normal individuals, the remainder having some form of intra-abdominal pathology. The
validity of generalising from rectal pressure to intra-abdominal pressure has not been clearly
established.
A third study aspiring to address the question “What is normal intra-abdominal pressure” was
published in 2001, but this considered patients already hospitalised rather than healthy
volunteers[28]. In this study of 77 patients (mean age 67.7) mean intra-abdominal pressure was
6.5 mm Hg (range 0.2 to 16.2 mm Hg) and was found to be positively correlated to both Body
Mass Index and recent abdominal surgery. This, of course, represents a small epidemiological
study considering the incidence and associations of IAP within the general hospitalised
population rather than useful information on the normal value.
Beyond these three human studies data on normal values has been derived from animal
experiments. Perhaps the most extensive, yet historical study to address the issue of normal
intra-abdominal pressure was performed in 1911. Several species were examined with
individuals ranging from “feeble and emaciated” to “unusually muscular” cats. The author found
that the resting intra-abdominal pressure for small dogs was sub-atmospheric (-4cm H2O), cats
around 1 cm H2O and rabbits 2.5 cm H2O. The absolute values mean very little in the human
20
context but the variation between species is interesting and may represent actual
anthropomorphic differences, or perhaps just measurement artefact.
From a practical point of view, the consensus definitions produced by the World Society for the
Abdominal Compartment Syndrome suggest that “ intra-abdominal pressures greater than 12
mmHg (measured in a supine position) may exert adverse physiological sequalae[8]” and 5-7
mmHg is suggested as a normal value in critically ill adults[12].
21
Raised Intra-abdominal Pressure
The concept that pressures greater than 12 mm Hg are associated with impaired organ function
and poor outcome is based on systematic review of various reports, and the consensus opinion of
an assembled panel of experts[8]. Table 1.1. The obvious difficulty arises in that a true
randomised controlled trial based on human subjects is not possible, and so conclusions are
based on a series of observational human studies, where cause and effect is notoriously difficult
to ascribe, and animal studies which inevitably are contrived with artificially accomplished acute
rises in abdominal pressure or induced pathological states such as hypovolaemia and
septicaemia.
From a practical point of view, although artificial critical levels have been created, the problem of
elevated intra-abdominal pressure should be considered as a continuous spectrum and the
presence or absence of co-morbid conditions may well lower or raise the critical thresholds for
physiological upset in individual cases. Perhaps absolute values are of less importance
compared to firstly, a low threshold for suspicion of the condition and secondly a sensible
approach to the screening and monitoring the evolving trend of pressures in high risk patients –
with timely intervention in order to protect organ function.
22
Table 1.1. WSACS Consensus Definitions
Term Final Definition (2007) IAP The steady-state pressure concealed within the
abdominal cavity. IAP should be expressed in mmHg and measured at end expiration in the completely supine position.
Abdominal Perfusion Pressure Mean arterial pressure minus intra-abdominal pressure
Indirect IAP Measurement The reference standard for intermittent IAP measurement is via the bladder with a maximal installation volume of 25 ml of sterile saline
Normal IAP Normal IAP is approximately 5 to 7 mmHg in critically ill adults
Intra-Abdominal Hypertension IAH is defined by a sustained or repeated pathologic elevation of IAP greater than 12 mmHg
IAH Grading Grade 1: IAP 12 to 15 mmHg Grade 2: IAP 16 to 20 mmHg Grade 3: IAP 21 to 25 mmHg Grade 4: IAP greater than 25 mmHg
Abdominal Compartment Syndrome ACS is defined as a sustained IAP greater than 20 mmHg (with or without an abdominal perfusion pressure less than 60 mmHg) that is associated with new organ failure or dysfunction
Chronic IAH IAH lasting months or years (2005 definitions) Acute IAH IAH developing within hours (2005 definitions) Subacute IAH IAH developing within days (2005 definitions) Hyperacute IAH IAH that only lasts for seconds or minutes (2005
definitions) Primary ACS A condition associated with injury or disease in the
abdomino-pelvic region are frequently requires early surgical or radiological intervention
Secondary ACS ACS secondary to conditions that do not originate from the abdomino-pelvic region
Recurrent ACS ACS redeveloping following previous surgical or medical treatment of primary or secondary ACS
Indication for IAP Monitoring 1) if two or more risk factors for IAH/ACS present, baseline IAP measurement should be obtained and
2) if IAH is present, serial IAP measurements should be performed throughout the patient's critical illness
IAP Measurement Studies should adopt the standardised IAP measurement method recommended by the consensus definitions or provide sufficient detail of the technique utilised to allow accurate interpretation of the IAP data presented
Epidemiology Incidence and prevalence estimates of IAH/ACS should be based upon the consensus definitions and mean, median and maximal IAP values should be provided both on admission and during the study period
23
Medical treatment of IAH/ACS APP should be maintained above 50 to 60 mmHg in patients with IAH/ACS. As no prospective trials have yet been performed evaluating the benefits and risks of sedation and analgesia, no recommendations can be made. A brief trial of neuromuscular blockade may be considered in selected patients with mild to moderate IAH while other interventions performed to reduce IAP. The potential contribution of body position in elevating IAP should be considered in patients with moderate to severe IAH or ACS. No prospective trials have been performed to confirm the benefits of nasogastric/colonic decompression and prokinetic motility agents so no recommendations can be made at this time.
Temporary Abdominal Closure (TAC) Surgical decompression should be performed in patients with ACS that is refractory to other treatment options and presumptive decompression should be considered at the time of laparotomy in patients who demonstrate multiple risk factors for IAH/ACS. Recommendation for the type of temporary abdominal closure cannot be made at this time.
The data contained in this table is a direct summary of selected definitions presented in 2006 by the expert
working party of the World Society of the Abdominal Compartment Syndrome[12].
24
1.4 Epidemiology of Intra-Abdominal Hypertension & the Abdominal Compartment
Syndrome
Several factors have hampered the clear definition of the extent of the problems caused by raised
intra-abdominal pressure.
Firstly, as mentioned above and probably most importantly, a previous lack of a consensus
definition for the use of the terms “Intra-abdominal Hypertension” and the “Abdominal
Compartment Syndrome” has made it very difficult to compare the epidemiological data
presented in previous studies. The consensus definitions presented in 2006[12], provided they
are adhered to, will go some way to overcoming this problem in future studies.
Beyond the variable definitions and use of terminology the multitude of causes of raised IAP has
also presented difficulty, with different rates observed depending of the sub-group of patients
studied.
In general – the published literature considering the incidence and prevalence of intra-abdominal
hypertension and the abdominal compartment syndrome is challenging to interpret, as there is
great variation in the diagnostic criteria reported. This has improved somewhat subsequent to the
2006 consensus definitions[12] and only studies complying to the WSACS criteria are outlined in
detail below.
One of the earliest studies designed with the express aim of identifying the prevalence of raised
intra-abdominal pressure within a general Intensive Care Unit population was conducted in 2004
[29]. This was a multi-centre trial involving 13 ICUs across Europe, Australia, Israel and South
America. A total of 97 patients were studied and intra-abdominal pressure was measured every 6
hours for a 24 hour period using a “direct needle puncture technique[30]” (described in detail in
the next section) to assess intravesical pressure. The researchers found that the mean IAP was
25
9.8mmHg and that the overall prevalence of IAH (defined as IAP > 12mmHg) was 52%. The
prevalence of ACS (IAP > 20mmHg with organ dysfunction) was 8%. The overall figures included
both medical (59%) and surgical (41%) patients and sub-group analysis showed a higher
prevalence in the surgical group (65% vs 54.4%). This important study would therefore suggest
that around half of the patients admitted to a general ITU could be expected to have a
significantly elevated intra-abdominal pressure (IAH) and that just fewer than 1 in 10 will have the
abdominal compartment syndrome.
The same group conducted a longer-term follow-up study a year later[31] to consider the
admission characteristics of intensive care patients. This study looked at 265 consecutive ICU
admissions over a 4 week period. The mean IAP was found to be 10 mmHg (+/- 4.8) with the
prevalence on the day of admission for IAH of 32% and for ACS of 4.2%. The conclusion of the
original paper noted that the cumulative incidence of IAH was high, but the actual value was not
provided in the text of the report. A subsequent review by the same authors reported that the
cumulative incidence of IAH after 1 week was 57%[32], suggesting that around a quarter of
admissions can be expected to develop IAH subsequent to the first 24 hours of measurement.
This finding has subsequently been replicated in a single centre Argentinean study of 83 mixed
critical care patients. Of the cohort, 31% met diagnostic criteria for IAH at the time of admission
and a further 33% subsequently during their ITU stay. The cumulative incidence of ACS in this
study was 12%[33].
Further contemporary evidence of the frequency of the diagnosis is provided by a study of 100
general ITU patients revealing an incidence of IAH of 42% and ACS of 4%[34]. A more focussed
study of just medical ITU patients who were deemed at “high risk” of IAH showed an incidence of
68% for IAH, though no cases of ACS[35]. Unfortunately, this study is significantly weakened by
26
the fact that they did not expand on the baseline IAP of the majority of admissions during the
study period who were not considered “high risk” for IAH.
In addition to these studies of general ITU populations, further research to consider the incidence
within specific sub-groups of patients with specific underlying diagnoses has been undertaken.
The incidence of raised IAP varies amongst the various sub-groups, however a significant burden
of IAH has been described for virtually all diagnoses. Severe acute pancreatitis has been shown
to carry an incidence of IAH of 40 – 60% and ACS of 10 – 56%[36, 37]. Septic shock would
appear to carry a particularly high risk of 83% IAH overall (93% in surgical patients and 73% in
medical), in a study of 81 patients[38].
Although not specifically designed as epidemiological studies, a significant prevalence and
cumulative incidence has also been reported within further specific sub-groups, all of which are
known to be at particularly high risk of developing elevated IAP. These studies can be roughly
divided as considering patients following trauma, major abdominal surgery and burns - the results
are summarised below. Table 1.2. It is apparent that the lack of uniformity in defining the end-
points of IAH and ACS prevent a meaningful combination of these studies, however each may be
evaluated on it’s own merits.
27
Table 1.2. Summary of Studies Looking at the Incidence / Prevalence of IAH
Author Year Country Sub-Group n Definition Incidence (%)
Meldrum[39] 1997 USA Trauma 145 > 20 mmHg + Organ
Dysfunction
14
Ivatury[40] 1998 USA Trauma 70 > 25 mmHg 32.9 Maxwell[41] 1999 USA Trauma 1216 Laparostomy 0.5
Kirkpatrick[42] 2000 Canada Trauma 42 > 10 mmHg 50 Ertel[43] 2000 Switzerland Trauma 311 Clinical * 5.5
Offner[44] 2001 USA Trauma 52 > 20 mmHg + Organ Dysfunction
33
Raeburn[45] 2002 USA Trauma 77 > 20 mmHg + Organ Dysfunction
36
Hong[46] 2002 USA Trauma 706 IAH > 20 mmHg ACS = IAH & MOF
IAH 2 ACS 1
Balogh[47] 2003 USA Trauma 156 IAH > 20 mmHg ACS > 25 mmHg + Organ Dysfunction
IAH 32 ACS 12.8
Balogh[48] 2003 USA Trauma 188 ACS > 25 mmHg + Organ Dysfunction
14
Sugrue[49] 1995 Australia Abd Surgery 88 > 20 mmHg 33 Sugrue[50] 1996 Australia Abd Surgery 73 > 20 mmHg 38.4 Sugrue[51] 1999 Australia Abd Surgery 263 > 18 mmHg 40.7
Biancofiore[52] 2003 Italy Liver Transplant 108 > 25 mmHg 31.5 Busani[53] 2006 Italy Emergency
Surgery 22 IAH > 12 mmHg
ACS > 20mmHg IAH 63.6 ACS 9
Djavani[54] 2006 Sweden AAA Repair 27 > 21 mmHg 29 Greenhalgh[55] 1994 USA Burns 30 > 30 mmHg 36.7
Ivy[56] 2000 USA Burns 10 IAH > 20 mmHg ACS = IAH & Organ
Dysfunction
IAH 70 ACS 20
Latenser[57] 2002 USA Burns 13 IAH > 25 mmHg ACS > 35 mmHg
IAH 69 ACS 31
Hobson[58] 2002 USA Burns 1014 Clinical ** 1 Oda[59] 2006 Japan Burns 48 > 25 mmHg 16
* Ertel[43] - “The ACS was defined as the development of significant respiratory compromise, including
elevated inspiratory pressure of >35 mbar, a decreased Horowitz quotient (PaO2:FiO2 ratio <150), renal
dysfunction (urine output, <30 mL/hr), hemodynamic instability necessitating catecholamines, and a rigid
or tense abdomen.”
** Hobson[58] – “ACS was suspected in any patient who presented with a clinically tense abdomen in
combination with either exceedingly high peak inspiratory pressures that compromised the ability to
ventilate the patient or oliguria despite aggressive fluid resuscitation” Bladder pressure was then
measured in such patients.
28
Data are extremely limited for the sub-group of patients with liver-related pathology. Only one
previous study has been identified that has looked specifically at the problem in patients
undergoing liver transplantation. Biancofiore et al looked prospectively at the incidence of raised
intra-abdominal pressure in 108 patients undergoing elective orthotopic liver transplantation in his
unit in Pisa, Italy[52]. IAH was defined as an IAP > 25mmHg (highlighting the difficulty with non-
standardised definitions) and found a cumulative incidence of 32% over the course of the ICU
admission. Under the current consensus definitions this would equate to the diagnosis of an
abdominal compartment syndrome (provided that the requirements for organ dysfunction were
also met), and appears to be significantly higher in this sub-group of patients than others.
In conclusion, these findings would seem to support the idea that elevated intra-abdominal
pressure is a significant problem in the critical care setting and even more common following liver
transplantation. Certainly patients with liver-related pathologies would seem to merit further
study.
29
1.5 The Measurement of Intra-abdominal Pressure
As interest in intra-abdominal hypertension and the abdominal compartment syndrome has
grown, several different methods for the measurement of intra-abdominal pressure have been
described. An accurate and reliable method for measuring intra-abdominal pressure is essential
in interpreting its effects in individual patients, and several studies have shown that both clinical
examination[42, 60, 61] and measurement of abdominal girth[62], are inaccurate methods of
diagnosing elevated IAP.
Techniques for measuring IAP have traditionally been described as either direct (performed via
an intra-peritoneal catheter) or indirect (an intra-luminal measurement, obtained via one of the
intra-abdominal viscera). The majority of clinical and research techniques have concentrated on
the intravesical method for IAP measurement and, indeed, this is regarded as the “reference
standard” for intermittent pressure measurement[12]. This section will present the evolution of
the various measurement systems for intra-abdominal pressure, along with the evidence of their
validity and reliability.
Intravesical Pressure Measurement – Two Key Assumptions
Although established as the gold standard, and certainly the most utilised in both clinical and
research practice, the intravesical technique is based on two key assumptions.
Firstly, in the first clinical description of the modern technique, by Kron et al in 1984, it was stated
that “The wall of the urinary bladder behaves as a passive diaphragm when the bladder volume is
between 50 and 100 ml.”[22] This means that the intravesical pressure can be used as a
surrogate marker for intra-abdominal pressure and forms the basis for most of the world literature
on aspects of IAP. It also assumes that the bladder wall musculature itself does not impart any
significant pressure load.
30
Only two human studies could be identified that compared directly measured pressure with that
inside the bladder. The first was performed on 14 children and the purpose was to determine the
ideal volume of instillate for paediatric intravesical pressure measurement[63]. It was found that
there was good agreement between direct IAP and intravesical pressure when 1ml/kg of saline
was instilled into the bladder prior to measurements.
In 1989 Iberti repeated an experiment he had previously performed on dogs[64], on 16 human
subjects[65]. IAP was measured directly, via an intra-peritoneal drain and also via the urinary
catheter using a technique similar to that described by Kron. He found good agreements
between the measurement techniques in both his canine and human studies.
Beyond these data only one further animal study, in a porcine model (18 animals) has utilised
both piezoresistive and air-capsule measurement probes to demonstrate good agreement
between intravesical and intra-abdominal pressure[66].
More recent experiments have also shown that the temperature of the bladder instillate is also
important and that the use of chilled saline may cause bladder spasm resulting in erroneously
high pressure readings – body or room temperature fluids do not produce this effect[67].
The second assumption was presented by Malbrain et al in 2004[68]. This was that “…the
abdomen and its contents can be considered as relatively non-compressive and primarily fluid in
character, subject to Pascal’s law, the IAP can be measured in nearly every part of the
abdomen.” This means that the pressure is assumed to be equal throughout the abdominal
cavity, and that the bladder pressure can be assumed to be the pressure applied to the whole of
the abdominal viscera.
The statement that the abdominal contents are primarily fluid in character may not be safe, and in
fact a good number of critically ill patients can be expected to be suffering from a degree of ileus
and gaseous distension, which is known to influence their IAP in itself. This raises the possibility
31
that pressure may not be transmitted throughout the cavity according to Pascal’s law and the
concept of a possible “regional compartment syndrome” will also be considered by the clinical
experiments described in this thesis.
The only prior study identified in this area was by Sugrue et al in 1994[69], who compared
bladder pressure measured at the time of elective laparoscopic cholecystectomy to intra-gastric
pressure in 9 subjects. It was found that the gastric pressure could be up to 4 mmHg higher or 3
mmHg lower than the bladder. Despite this seemingly wide variation within a small sample size,
the researchers concluded that the intra-gastric pressure was sufficiently accurate for clinical use.
32
1.5.1 Techniques for the Measurement of Intra-abdominal Pressure
Direct Measurement of Intra-abdominal Pressure
Direct measurement, by its very nature, is inevitably invasive and requires placement of an intra-
peritoneal catheter or pressure transducer. The majority of the reported studies have been
performed in animals or else in otherwise healthy humans undergoing elective laparoscopic
procedures in whom the laparoscopic insufflator provides a measurement of the intra-peritoneal
pressure.
One of the first descriptions of the technique came from Emerson in 1911[13] who “plunged” a
trocar “through one or other of the parts of the abdominal wall” of various small mammals and
connected the cannula to a water manometer to perform the detailed studies described above in
the historical overview.
As mentioned above Iberti has described a technique for the connection of intra-abdominal
drainage tubes to a pressure transducer in order to directly transduce intra-abdominal
pressure[64, 65]. This technique will be fully outlined in a later chapter.
Other than the instances described above, the direct technique has not been utilised widely, nor
for clinical or research purposes, in patients who are critically ill. The direct measurement of
intra-abdominal pressure has however been described and used to compare compartmental
pressures in a later chapter of this thesis.
Intravesical Pressure Measurement – Evolution of the Technique.
Kron’s original description of a “direct needle puncture” technique for measuring intravesical
pressure[22] via the bladder catheter and subsequent refinements has formed the basis for most
of the modern data relating to intra-abdominal pressures. The technique consists of firstly,
33
priming the bladder catheter tubing and proximal portion of the collection system by the injection
of 50mls of sterile saline. The collection tubing is then clamped just distal to the catheter
aspiration port ensuring that there is a continuous column of fluid along the urinary catheter up to
the level of the clamp. A hypodermic needle, connected to a transduced line (often the CVP
transducer is used), is then inserted through the catheter aspiration port. The current intra-
abdominal pressure may then be measured using a saline manometer or, with the use of an
electronic transducer, can be displayed on the ITU monitor in the same manner as the other
pressure traces, such as central venous pressure. Figure 1.1.
This technique obviously carries the drawback of providing only intermittent pressure
measurements and also the potential risks associated with repeated manipulation of the urinary
collection system (in terms of infection) and also a risk to the operator of transmission of viral
infections secondary to needle stick injury.
The technique was further refined by Cheatham in 1998[30], who suggested that a small
indwelling plastic cannula could be left in place within the aspiration port of the catheter between
measurements to reduce the risk of needle stick injury. In 2004 Malbrain described a further
improvement by the incorporation of a number of three-way taps in the urinary collection system,
which would allow for both the injection and aspiration of saline into the collecting system and
measurement of IAP without the need for either manipulation of the collection system or the use
of a hypodermic needle[68]. Figure 1.2. Commercially available electronic transduction systems
have since reached the marketplace and are based upon the same principles. The most popular
of these systems is probably the “AbViser” device produced by Wolfe Tory. Figure 1.3.
34
Figure 1.1.
Technique for measurement of IAP described by Kron[22]
35
Figure 1.2.
Technique for measurement of IAP described by Malbrain[68]
36
Figure 1.3.
AbViser device for the measurement of IAP – Figure taken from Wolf Tory Website
37
Alongside the development of electronic systems, which transduce the intra-abdominal pressure,
a water manometer system has also been developed. The idea of this system being that fluid,
either the patient's own urine or sterile saline injected into the system, can be used to estimate
intra-abdominal pressure using a mechanical manometer.
The first use of a rudimentary manometer system was described in 1998 by a critical care nurse
named Harrihill[70]. It was suggested that the patient’s urinary collection tubing could simply be
elevated vertically above the symphysis pubis and the height of the fluid column measured. The
drawback of this approach was that it provided a measurement in cm H2O which subsequently
needed to be converted to mmHg, and the lack of a distal air inlet valve led to vapour lock
preventing the fluid level from settling to its correct level, potentially producing an erroneously
high reading of the intra-abdominal pressure.
These drawbacks were addressed in the commercial production of a simple device which
incorporated both an air inlet valve and gradations marked on the manometer tubing, scaled to
mmHg. Figure 1.4.
The obvious advantages of the manometer system over electrical systems, being increased
simplicity leading to shorter setup and recording times, less scope for the introduction of error to
the system and potential financial savings. At this stage however, the manometer system has not
been validated against either an indirect electronic system or the direct measurement of intra-
abdominal pressure. For its simplicity and ease of use, the manometer system is favoured by our
institution. A full assessment of its reliability and validity for the measurement of intra-abdominal
pressure form a subsequent chapter of this thesis.
38
Figure 1.4.
The Holtech FolyManometer System for the measurement of IAP – Figure reproduced from
Holtech Website
39
Other Indirect Techniques for the Measurement of Intra-abdominal Pressure
Gastric Pressure
Measurement of the intragastric pressure via a standard nasogastric tube has been described,
which operates in much the same way as the measurement of intravesical pressure. In the
original description a standard pressure transducer was connected to be nasogastric tube along
with a syringe containing sterile saline via a standard three-way tap[71]. The technique has been
recommended for cases where the intravesical route is inappropriate, such as abnormal or
absent bladder and cases of pelvic injury and/or packing. For the technique to be accurate
however, all the air must be aspirated from the stomach prior to measurements, which is both
difficult to achieve and verify. The technique will also only allow for intermittent pressure
measurements and will inevitably interrupt enteral feeding regimens for significant periods.
The use of an air filled tonometer balloon was reported by Sugrue in 1994[69] and subsequently
by Malbrain in 2000[68]. The use of an air filled balloon obviates the requirement for complete
emptying of all air from the stomach and can be used in conjunction with continuous enteral
feeding. Specialized equipment is however required, and continuous measurement made difficult
due to the slow resorption of air from the balloon.
Dedicated, commercially available devices have been produced to overcome these problems
such as the Spiegelberg device and the newer CiMon unit. The Spiegelberg equipment consists
of a standard nasogastric tube with an air pouch at the tip, the attached IAP-monitor will
automatically both calibrate the device and refill the air balloon each hour[66]. The CiMon device
consists of a similar air filled balloon, but also a second balloon which lies within the thoracic
oesophagus so that both intrathoracic and intragastric pressures can be measured continuously.
Both of these devices offer fairly limited circumstances where their use would be advantageous
over the intravesical measurement technique. Their price and this limited role is likely to restrict
their clinical use.
40
Rectal Pressure
The measurement of rectal pressure is mentioned only for the sake of completeness. Its use in
both clinical and experimental settings is extremely limited due to the inevitable increase in
inconvenience with no real benefits to offer over the intravesical technique. The technique is
evolved from its routine use during urodynamic studies where the difference between the
intravesical and intra-abdominal pressure can be used to calculate transmural detrusor muscle
pressure[27].
41
1.5.2 Screening Criteria for the Recognition of Raised Intra-abdominal Pressure
Given that around 50% of critical care inpatients can be expected to have a raised intra-
abdominal pressure, based on previous epidemiological studies, it would not seem unreasonable
to suggest that all such patients should undergo routine measurement of intra-abdominal
pressure, along with their other routine physiological parameters. The converse argument to this
approach however, is that half of all the patients screened will have normal intra-abdominal
pressures and, depending on the technique used to measure IAP, this could lead to a potentially
significant cost both in terms of nursing time and increased risk to both patient and care worker,
due to needlestick injuries, supine position changes, and the theoretical risk of introduction of
urinary tract infection.
A rationalised approach has therefore been proposed by an international panel of experts seeking
to define a cohort of patients most at risk of developing complications due to raised intra-
abdominal pressure, and targeting surveillance to this group[72] with an algorithm forming a
strong recommendation based on moderate evidence[73]. Figure 1.5.
We have already seen that the underlying causes of raised intra-abdominal pressure are many
and varied, with primary (secondary to intra-abdominal causes), secondary (with no intra-
abdominal pathology), and tertiary (recurrent) variations of the condition having been
described[12]. There have been two large, prospective studies to identify independent risk
factors for the development of raised intra-abdominal pressure, and these will be considered in
some detail.
Malbrain’s 2005 study of the characteristics of 265 consecutive general ITU admissions, found
that independent predictors for the development of raised intra-abdominal pressure, present at
the time of admission were abdominal surgery, fluid resuscitation, ileus and liver dysfunction[31].
42
For the purpose of this study, massive fluid resuscitation was arbitrarily defined as more than 3.5
litres of colloid or crystalloid in 24 hours, ileus as the presence of abdominal distension, absence
of bowel sounds or the failure of enteral feeding and liver dysfunction as either compensated or
decompensated cirrhosis or other liver failure with the presence of ascites (such as
paraneoplastic, cardiac failure, portal vein thrombosis or ischaemic hepatitis).
The presence of intra-abdominal hypertension on the day of admission was not found to be an
independent predictor of mortality however such patients, did have a significantly higher sepsis
related organ failure assessment score and the development of intra-abdominal hypertension
during the intensive care stay was a predictor of mortality (relative risk 1.85 [95% CI 1.12 – 3.06]).
In 2003 Balogh studied 188 major torso trauma patients who had undergone standardised
resuscitation[48]. This study demonstrated that patients developing secondary abdominal
compartment syndrome had received significantly more crystalloid fluid over the first 24 hours
than those with primary ACS, and similarly the primary ACS group had received more crystalloid
than the non-ACS group (the majority of crystalloid infusion was received with in the emergency
department and for those developing ACS involved an infusion of > 5 L). The authors conclude
that secondary ACS is predictable in patients undergoing massive crystalloid resuscitation,
however, given that their resuscitation policy was protocol driven, it would seem more likely that
those receiving higher volumes of crystalloid in relation to packed red cells were simply those
patients with more severe extra-abdominal injuries. Nonetheless the paper does seem to support
the expected finding that large volume resuscitation is associated with a raised intra-abdominal
pressure.
At present, no specific recommendations exist in relation to screening “liver patients” for raised
intra-abdominal pressure. It is hoped that the findings of an epidemiological study set within a
43
dedicated liver intensive care unit, described in a later chapter of this thesis, will better inform the
decision to commence screening in this particular patient population.
Figure 1.5.
IAH / ACS Management Algorithm - Taken from Recommendation statement of
International Panel of Experts[74]
44
1.6 Intra-abdominal Pressure and the Liver
Intra-abdominal hypertension and the abdominal compartment syndrome have clearly been
shown to be important contributors to morbidity and mortality within the critical care patient
population[7, 75]. Despite a large volume of emerging evidence concerning cardiovascular,
respiratory and renal effects of elevated intra-abdominal pressure there is a relative paucity of
data relating specifically to liver blood flow and function, with most of that which is available
relating to animal studies or “healthy” subjects undergoing pneumoperitoneum for elective
procedures.
A better understanding of intra-abdominal hypertension with relation to the liver is vital to the
management of all forms of liver pathophysiology. Supporting good hepatic function within the
critically ill patient is important not only in maintaining synthetic function, but also in avoiding the
multi-organ complications of liver dysfunction.
Specific medical and surgical insults upon the liver are becoming increasingly common with a
rising incidence of both alcohol-related liver disease and non-alcoholic steato-hepatitis (NASH).
Surgical treatments of liver lesions such as metastatic colorectal carcinoma, cholangiocarcinoma
and hepatocellular carcinoma have become more aggressive, with the widespread use of pre-
operative portal vein embolisation, radiofrequency or microwave ablation and staged liver
resections in order to improve operability rates. In such cases pre and perioperative optimisation
of hepatic functional reserve has become vitally important and control of intra-abdominal pressure
appears to be important for hepatic regeneration[76].
The incidence of intra-abdominal hypertension following liver transplantation[52] and specifically
its effects on renal function[77] have been previously demonstrated. With a shrinking donor pool
45
and increasing use of marginal and split liver grafts, optimisation of support and minimisation of
extra-hepatic organ dysfunction within this group is obviously as important as ever.
Significant liver trauma, whether managed operatively or non-operatively, may be expected to
lead to an elevation of intra-abdominal pressure and for marginally ischaemic tissues,
optimisation of blood flow is obviously essential – though this must be balanced against the
tamponading effects of raised pressure.
The deleterious effects of increased intra-abdominal pressure may be considered in terms of the
hepatic circulation and the biochemical function of the hepatocyte. The basic physiology and
strategies for non-invasive assessment of these parameters will be discussed in some detail
below, with specific reference to the effects of raised intra-abdominal pressure.
Physiology of Liver Blood Flow
The liver receives it's blood supply from two main sources, the hepatic artery and portal vein and,
under normal conditions, will receive around one quarter of the total cardiac output, accounting
for approximately 20% of total body oxygen consumption. In health, the hepatic artery supplies
around 30 mls/min per 100 g of liver tissue, which equates to roughly 25% of the liver blood flow.
The portal vein supplies the remaining 75% at a rate of 70 mls/min per 100g[78], and drains blood
from the entire GI tract from the level of the distal oesophagus, including the spleen and pancreas
(the splanchnic circulation). Portal venous blood is obviously rich in nutrients, but also by virtue
of its large flow rate, is responsible for a significant proportion of the hepatic oxygen supply.
Normal portal pressure is between 5 and 8 mmHg. Hepatic vascular outflow is via the three
hepatic veins, which converge to drain into the inferior vena cava. Normal hepatic venous
pressure is around 1 to 2 mmHg.
46
Control of liver blood flow is complex and occurs at the level of the splanchnic and hepatic
arterioles and the portal and hepatic venules. Autoregulation is primarily achieved through
alterations in the hepatic arterial flow (known as the hepatic arterial buffer response[79]). In
health, it is the accumulation of adenosine[80, 81] within the liver that seems to be responsible for
the regulation of this buffer response. Control of liver blood flow in disease states depends on the
underlying pathology and cellular and biochemical mechanisms vary.
Measurement of Hepato-Splanchnic Blood Flow
Techniques for measuring hepatic and splanchnic blood flow can be broadly divided into
approaches which consider flow in single inflow vessels (such as the portal vein and hepatic /
mesenteric arteries), and those providing a more global indicator of organ perfusion and function.
By and large, most of the techniques described are employed mainly within the research setting
and routine clinical application is relatively limited.
For the invasive measurement of single vessels, doppler flowmetry is commonly employed with
flow probes surgically placed around the vessel of interest. Amongst other applications, this
technique has been successfully used to study the effects of pneumoperitoneum on the hepatic
blood flow in anaesthetised pigs[82]. More recent advances in microtechnology have allowed the
development of laser doppler flowmetry via a single fibre microprobe. Such probes illuminate the
liver tissue with a low powered laser in order to measure movement of red cells[83] and provide a
regional tissue measurement.
In the clinical setting, non-invasive ultrasound examination of the hepatic vessels has been
disappointing in quantitative terms[84]. The advent of colour flow Doppler however, has enabled
47
the direction of flow within the portal vein to be ascertained[85] and micro-bubble contrast has
been employed to measure hepatic vein transit times with apparent success[86].
More recently, magnetic resonance imaging has been used to estimate hepatic blood flow,
especially with respect to the diagnosis and grading of portal hypertension[87, 88].
The most commonly employed technique for the assessment of total liver blood flow is an
indicator clearance technique, usually employing indocyanine green (though sorbitol or galactose
can also be used). Indocyanine green is a tri-carbocyanine dye that is actively taken up by
hepatocytes and excreted exclusively into the bile. The elimination rate can be measured
invasively via an hepatic vein catheter following either a continuous infusion[89] or bolus
administration[90] of ICG or else non-invasively via a transcutaneous saturation probe[91]. The
rate of elimination, or plasma disappearance rate (PDR) is a composite measure of both total liver
blood flow and hepatocyte function which correlates to hepatosplanchnic blood flow[92] and is
sensitive in detecting subtle variations[93].
Data on ICG clearance may also be combined with hepatic vein, arterial and mixed venous
oxygen tensions in order to calculate hepato-splanchnic oxygen delivery[89]. In addition, ICG has
been used as a reliable indicator of liver graft function following transplantation[94] and as an
assessment of functional reserve after trauma[95] and prior to hepatectomy[96].
Methacetin and lignocaine clearance tests offer similar assessments of hepatic metabolism, but
are less commonly employed.
For the sake of completeness, two other invasive techniques for the measurement of global liver
blood flow are worthy of mention, however their use is limited exclusively to the experimental
setting. Fluorescent microscopy involves visualising individual sinusoids within the liver
48
substance and measuring the flow rate of injected contrast agent[97]. Coloured microspheres
have also been used to quantify global blood flow, however their used requires sacrifice of the
experimental subjects and digestion of the liver tissue, in order to count the individual
spheres[98]. Despite their obvious importance – reliable and valid tests of gut function remain
elusive within the clinical setting.
Intra-Abdominal Pressure and the Hepatosplanchnic Circulation
Elevated intra-abdominal pressure has been associated with deterioration in renal and gut
function which is likely, at least in part, to be due to reduced organ perfusion. An IAP of 20
mmHg can be expected to reduce glomerular filtration rate by up to 25%[99], and mesenteric
blood flow by 40 to 70%[100].
With specific reference to the hepatic circulation and function, clinical studies are lacking. The
data that are available clearly suggests that rising intra-abdominal pressure significantly impairs
hepatic blood flow, however a definite link between this reduction and subsequent organ
dysfunction has not been positively demonstrated.
In a relatively small animal study, in which intra-abdominal pressure was raised incrementally to
10, 20, 30 and 40 mmHg in five pigs, the effect on hepatic artery and portal vein blood flow was
measured using doppler flowmetry and the hepatic microvascular flow measured using laser
doppler flowmetry. At 20 mmHg arterial flow was found to be reduced to 45% of baseline, portal
venous flow to 65% and microvascular flow to 71%[100], despite maintenance of the baseline
mean arterial blood pressure by means of fluid infusion. It is interesting that the most profound
reduction in flow occurs in the relatively high pressure arterial system, compared to the portal
vein, and especially important given that the hepatic artery supplies proportionately more of the
49
liver’s oxygen requirement. The fact that this reduction occurs despite preservation of the MAP is
a highly significant finding for clinical practice in terms of routine monitoring strategies.
Similar results have been found in rats, where the calculated blood flow for the spleen, stomach
and total intestine (measured by a microsphere injection technique) was reduced in a near linear
fashion in the face of increasing IAP, although hepatic arterial flow was seen to be preserved at
an IAP of 20 mmHg. An observation that the authors attributed to the hepatic arterial buffer
response[97]. Similarly it was found that a pneumoperitoneum of 8 mmHg maintained for 90
minutes resulted in microcirculatory dysfunction (measured by fluorescent microscopy) and a
significant rise in transaminases[98].
In a further rat study, the effects of continuously raised intra-abdominal pressure, was compared
in healthy rats and in those with induced cirrhosis. As before, increased intra-abdominal pressure
was found to impair liver microcirculation (assessed by laser doppler flowmetry), however the
deterioration was significantly worse within the cirrhotic group. The authors also observed
increased levels of alkaline phosphatase, alanine aminotransferase and bilirubin concentrations,
although these changes did not reach significance[83]. The study does however, suggest that
patients with pre-existing liver disease may be more susceptible to the effects of raised intra-
abdominal pressure.
Impaired hepatic blood flow has been demonstrated in studies considering subjects undergoing
pneumoperitoneum for laparoscopy. In one human study of 18 patients undergoing laparoscopy
for cholecystectomy or appendicectomy significant impairment of blood flow to the stomach,
jejunum, colon and liver was observed by laser doppler flowmetry. Liver blood flow was reduced
by 39% following increase of the pneumoperitoneum from 10 mmHg to 15 mmHg[101]. In an
50
equivalent study utilising a rat model, portal vein flow measured by doppler flowmetry was
similarly seemed to reduce in a linear fashion with increasing IAP[102].
Only one study has specifically considered the influence of IAP on hepatocyte metabolism and
this considered 53 rabbits at intra-abdominal pressures of 20 mmHg and 30 mmHg. Hepatic
blood flow was measured using the ICG plasma disappearance rate (PDR) and was found to be
significantly impaired at both 20 and 30 mmHg. Hepatic mitochondrial redox status was also
evaluated and found to be unaffected at 20 mmHg. At 30 mmHg however, the mitochondrial
redox status was significantly decreased with a corresponding reduction in tissue energy level.
This has been the only study to consider isolated hepatocyte function in the face of raised IAP,
but unfortunately the results have not since been replicated and cannot, justifiably be generalised
to a human population.
The effect of reduced hepatosplanchnic blood flow on mucosal pH has been clearly demonstrated
in humans. One prospective study of 73 patients undergoing major abdominal surgery
demonstrated a significant association between raised IAP and abnormal intestinal mucosal pH
(pHi), with pressures greater than 20 mmHg being associated with an 11 fold increase in
abnormal pHi (< 7.32)[50]. Moreover an improvement in pHi has been demonstrated following
abdominal decompression[40].
From a clinical point of view, although we can clearly demonstrate that increasing IAP does
deleteriously effect hepatosplanchnic blood flow and gut mucosal pH, we are not yet at a stage to
say what level of either IAP or the resulting reduction in blood flow, will result in a significant
deterioration in liver function.
51
Intra-Abdominal Pressure in Acute Hepatic Dysfunction
Very little work has been published looking specifically at the effects of raised intra-abdominal
pressure in acute hepatic dysfunction, although the effects of IAH on the hepatic microcirculation
have been shown to be exaggerated in cirrhotic subjects[83]. A recent study, which was
designed to consider the association between abdominal hypertension and liver dysfunction,
found a correlation between intra-abdominal pressure and degree of hyper-bilirubinaemia but no
strict association between IAP and liver dysfunction[103]. This study however, set a threshold for
intra-abdominal hypertension at 10 mmHg and recruited very few patients with an IAP > 15
mmHg (the mean IAP was 10.7 mmHg).
Interim analysis of our own unpublished data, has shown that raised intra-abdominal pressure is
an extremely common finding in patients with acute hepatic dysfunction and a better independent
predictor of length of ITU stay than other contemporary scoring systems. 95% of patients were
found to have intra-abdominal hypertension (> 12 mmHg) and 60% would be classified as having
the abdominal compartment syndrome (> 20 mmHg).
In this subgroup of physiologically unstable patients, high intra-abdominal pressures can be
expected to exacerbate the other specific pathophysiological changes in associated organ
systems. Namely worsening the raised intracranial pressure and renal, respiratory and cardiac
dysfunction which usually accompany acute liver failure. The observed compressive effect of
high intra-abdominal pressure on the inferior vena cava[104] may lead to significant problems
with hepatic outflow resulting in further hepatic congestion.
Patients with large volume ascites are unusual in the general course of abdominal compartment
syndrome, in that the relatively minor intervention of paracentesis can be associated with a
52
significant increase in cardiac index, stroke volume and renal function[105]. In such patients, with
high intra-abdominal pressures and evidence of deteriorating organ function, limited paracentesis
should therefore be considered early. Paradoxically however, it is these patients who may
tolerate high intra-abdominal pressures the best, due to some degree of chronic intra-abdominal
hypertension and alteration of abdominal wall compliance. Individual pressure measurements
should therefore be interpreted in conjunction with the overall clinical picture and the individual
patient’s history of chronic illness.
Of particular importance in the subgroup of acute hepatic dysfunction patients with
decompensated cirrhosis, is the association of right atrial dysfunction. This can make the use of
traditional (though now super-ceded) indicators of volume loading such as central venous
pressure (CVP) or pulmonary artery wedge pressure (PAWP) unreliable. In this subgroup of
patients, as well as those with other causes of acute hepatic dysfunction, we have found that
continuous cardiac output monitoring provided the best correlation with stroke volume and
cardiac index[106] and that ICG clearance may also provide a useful adjunct in the assessment
of volume status.
Intra-Abdominal Pressure in Liver Transplant Recipients
Several facets of liver transplantation place recipients at risk of development of high intra-
abdominal pressures. Firstly it is not unusual for the transplanted graft to be an imperfect size
match, often with a greater volume than the native liver. This is particularly true of the shrunken
cirrhotic explanted liver. Liver transplantation is, by definition, a major and lengthy abdominal
surgery and the required disruption to mesenteric outflow will inevitably produce some visceral
oedema, which can be exacerbated if there is any impairment of flow at the portal vein
53
anastomosis. Finally, blood loss is unavoidable and large volume transfusion is not unusual,
even for elective procedures.
In the only prospective study of IAP in liver transplant recipients (beyond individual case reports)
the incidence of intra-abdominal hypertension (defined as > 25 mmHg) was 31.5%[52]. In our
own unpublished interim data, using cut-offs of 12 and 20 mmHg for IAH and ACS, we found an
incidence of 60% and 25% respectively. In the published study a significant difference in IAP was
noted in individuals subsequently developing acute renal failure and IAH was associated with a
relative risk for acute renal failure of 3.9 (95% CI 1.6 - 9.8)[77].
The evidence to date would therefore suggest that liver transplant recipients are at significant risk
of developing raised abdominal pressure and that the operating surgeon should perhaps have a
low threshold for the use of prophylactic temporary abdominal closures. Measurement of intra-
abdominal pressure in the postoperative period should be mandatory and in due course,
strategies to predict individual risk may aid in identification of particular patients requiring more
intensive observations.
Intra-Abdominal Pressure and Hepatopancreatobiliary Surgery
There are no data relating to the incidence of raised intra-abdominal pressure following major
hepatic or pancreatic resections. Interim analysis of our own unpublished data, suggest that 72%
of patients developed intra-abdominal hypertension (> 12 mmHg) and that the abdominal
compartment syndrome (> 20 mmHg) can be expected in 24%. The problem is therefore
significant and merits further research, especially as raised intra-abdominal pressure has been
54
shown to be associated with impaired liver regeneration following animal studies of
hepatectomy[76].
Conclusions
The resulting reduction in hepatosplanchnic blood flow observed with increasing intra-abdominal
pressure has been clearly documented and seen to be exaggerated in animals with established
liver disease. Unfortunately the tools required to measure this remain difficult to apply routinely in
the clinical setting and as such, goal directed therapy to specifically improve the
hepatosplanchnic circulation remains elusive.
Given the documented effects of IAP on hepatosplanchnic blood flow and the relatively high
incidence of intra-abdominal hypertension and the abdominal compartment syndrome within “liver
patients” as a whole, close attention to IAP and timely correction by appropriate medical or
surgical means would appear to be essential.
55
1.7 Intra-Abdominal Pressure and the Other Organ Systems
In order to maintain an overall prospective on the problem of raised intra-abdominal pressure in
the context of multiple organ dysfunction, a brief overview will be presented on the effects of intra-
abdominal hypertension and the abdominal compartment syndrome on the cardiovascular,
respiratory, renal and central nervous systems.
1.7.1 Intra-Abdominal Pressure and the Cardiovascular System
The interaction of intra-abdominal pressure and the cardiovascular system is arguably the most
important feature to consider in optimising the care of the critically ill patient with raised intra-
abdominal pressure. Intra-abdominal pressure has been shown categorically, to be directly
transmitted and exert an effect in terms of raised intra-thoracic pressure on the heart and
vascular system[13]. This results, not only in demonstrable mechanical changes in the properties
in function of the cardiac muscle, but also underpins the circulatory changes which manifest as
end organ dysfunction in terms of the respiratory, renal and hepatic systems.
In attempting to optimise cardiovascular function in these patients, it is also necessary to
understand the effect that raised intra-abdominal pressure will have upon the standard measures
of cardiovascular function, such as pulmonary artery occlusion pressure (PAOP) and central
venous pressure (CVP).
Direct Effects on the Cardiovascular System
Optimisation of cardiac function relies on not only the contractility of the heart muscle itself, but
also attention to the vascular inflow and outflow (preload and afterload), with these three features
inseparable in terms of function. Direct pressure effects have been shown to result in regional
56
wall motion abnormalities on echocardiological studies[107] and are known to result in altered
cardiac geometry[108].
It is the relatively thin walled right ventricle which seems most susceptible to acute intrathoracic
(pulmonary) pressure changes[109]. As pulmonary pressure increases (with direct compression
of the pulmonary parenchyma[110]), so does right ventricular afterload, which results in dilatation
of the right ventricle, leading to a reduction in ejection fraction and mechanical splinting of the left
ventricle with concomitant reduction in left heart function[111]. The clinical manifestation, being
low left ventricular end-diastolic volume, despite extremely high right ventricular and left atrial
pressures, which leads to reduced coronary and systemic blood flow.
Outside of the thoracic cavity, blood flow through the inferior vena cava (IVC) has been shown to
be inversely proportional to IAP in animal models[112, 113] and during laparoscopic surgery[114,
115] with direct transmission of intra-abdominal pressure to the IVC[116]. In addition, anatomical
changes in diaphragmatic morphology brought about by increases in intra-abdominal pressure
may lead to a mechanical reduction in flow. The resulting overall reduction in venous return can
be expected to affect myocardial contractility, according to the Frank Starling principle.
The inevitable results of suboptimal venous return and myocardial contractility, combine with
direct pressure effects on the aorta and systemic vasculature to produce an increase in systemic
vascular resistance (SVR), which can be extremely poorly tolerated in patients with raised intra-
abdominal pressure and marginal cardiovascular function[108].
The situation is further compounded in patients with liver dysfunction in addition to raised IAP with
the recognition of a condition labelled by Lee et al in 2003 as “cirrhotic cardiomyopathy”[117].
57
A number of cardiovascular changes are observed in patients with cirrhosis of the liver, with a
constellation of problems including a raised cardiac output, decreased systemic vascular
resistance and impaired ventricular contractility. The underlying cause for these abnormalities
seem to arise from both structural (poorly compliant ventricles with hypertrophy and diastolic
dysfunction[118]) and electrophysiological (prolonged QT interval[119]) factors. As almost all
patients with cirrhosis may be assumed to have a degree of diastolic dysfunction[119], accurate
and appropriate assessment of the cardiovascular system with optimisation of function, is of the
utmost importance in this patient group.
Cardiovascular Assessment in the Context of Raised Intra-Abdominal Pressure
The changes outlined above have the net result of increasing right heart pressure in conjunction
with a fall in left ventricular end-diastolic volume and hence reduced systemic perfusion. This
means that some standard assessments of volume loading will become unreliable, specifically
the measurement of right atrial pressure (CVP) and pulmonary artery wedge pressure (PAWP),
and may potentially lead to under-resuscitation. In these patients, volumetric studies rather than
the pressure measurements noted above, become more appropriate and their judicious use may
lead to more accurate volume resuscitation and the resultant optimisation of organ perfusion.
Appropriate options for monitoring might include the use of arterial pulse contour analysis (such
as PiCCO) or oesophageal doppler studies.
Proponents of the use of pulmonary artery catheters have demonstrated that right ventricular
end-diastolic volume index (RVEDVI) may be calculated from RVEF and the stroke volume
index(SVI) (RVEDVI = SVI / RVEF), to provide a useful measurement of preload[120]. No data
exist for the use of this technique in the context of raised IAP, however studies performed in
58
patients undergoing treatment with positive end expiratory pressures (PEEP) of up to 50 mmHg
have shown highly significant correlations to cardiac index (CI) in the face of an inversely
proportional relationship to changes in CVP and PAWP[121].
Arterial pulse contour analysis carries the immediate advantage of being less invasive than
pulmonary artery catheterisation, requiring the use of just a central arterial pressure line and CVP
catheter, both of which are usually present within the critical care setting. In addition, it allows
calculation of a number of physiological variables giving an estimation of left ventricular CI,
prediction of cardiac preload (global end-diastolic volume index and intra-thoracic blood volume)
and capillary leak (extra-vascular lung water)[122]. Beat to beat stroke volume variation may also
provide a prediction of likely response to fluid loading[123], though this will be limited in clinical
practice by the requirement for the patient to be sedated, in sinus rhythm and not breathing
spontaneously.
Unlike the use of pulmonary artery catheters, PiCCO has been studied in the context of raised
IAP and global end-diastolic volume index targeted resuscitation shown to be more useful than
CVP and PAWP in direct comparison[124].
59
1.7.2 Intra-abdominal Pressure and the Respiratory System
The intimate relationship between intra-abdominal pressure and thoracic pressure has been
clearly demonstrated since the earliest experiments with Emerson in 1911[13], and can be seen
in clinical practice, by the obvious respiratory variations in IAP observed with real-time monitoring
systems[125].
This increase in intrathoracic pressure with the concomitant reduction in chest wall compliance
leads to a vicious cycle whereby lung volume is demonstrably reduced[126] along with functional
residual capacity[127] leading to ventilation perfusion mismatch[128]. The loss of compliance
within the respiratory system inevitably requires increasing plateau and mean ventilatory
pressures, in order to maintain an adequate tidal volume and oxygenation[99]. Such high
pressures are known to induce barotrauma leading to an acute lung injury[129] and often adult
respiratory distress syndrome (ARDS), which may be compounded in the case of ACS by the
release of pro-inflammatory cytokines[130] and bacterial translocation secondary to
hepatosplanchnic hypoperfusion[131]. Early recognition and correction of IAH by surgical
abdominal decompression, which often leads to rapid and spectacular improvement in ventillatory
parameters[22, 75], may offer an opportunity to mitigate against this potential barotrauma.
60
1.7.3 Intra-Abdominal Pressure and the Renal System
Despite being one of the first complications to be attributed to raised intra-abdominal
pressure[14], the exact pathophysiology causing renal impairment in the presence of IAH is yet to
be clearly defined. In particular, recent research has shown that a degree of renal dysfunction
occurs at intra-abdominal pressures far lower than that previously recognized as being dangerous
and certainly lower than the definition for abdominal compartment syndrome[132].
Many historical, and non-prospective studies have described oliguria and reduced glomerular
filtration rate in patients with raised intra-abdominal pressure and have shown that both urine
output and renal function can be improved following decompressive laparostomy[111]. Problems
have existed with the available prospective data in that, in common with other studies considering
intra-abdominal pressure, a unifying definition has never been suggested as to what exactly
constitutes renal impairment and indeed, abnormal intra-abdominal pressure. As previously,
these difficulties make comparison between studies extremely difficult, there is however,
evidence from studies in both animal and human models to suggest that intra-renal blood flow is
reduced[133] and abnormal hormonal responses (increased ADH[134] and activation of the renin-
angiotensin-aldosterone system[135]) are provoked by raised intra-abdominal pressure
(>12mmHg).
The prospective data which is available however, have suggested that a lag time of around 2.5
days between the onset of intra-abdominal hypertension and renal injury can be expected[51] and
a recent study specifically addressing the problem of renal failure following liver transplantation,
has shown that the degree of renal dysfunction displayed in response to elevated intra-abdominal
pressure can be expected to be directly proportional to the degree of IAH[77]. This means, in
practical terms, that the physician must remain mindful to potential renal dangers of elevated
intra-abdominal pressure and reinforces the view that high risk populations should be screened
61
with early corrective measures undertaken, rather than waiting for the onset of signs of renal
dysfunction. Such an approach would certainly support the view that intra-abdominal
hypertension induced renal dysfunction is, at least in part, the result of acute kidney injury and
that an observed failure to reverse the renal dysfunction following delayed decompression in
some cases[136, 137] simply reflects the duration and hence degree of tubular necrosis[132].
1.7.4 Intra-abdominal Hypertension and the Central Nervous System
Elevated intra-abdominal pressure has been shown to be transmitted to the intracranial
compartment via the thoracic cavity and can be expected to increase ICP by reducing the venous
outflow from the brain and thus increasing the vascular component of the tissue mass[138, 139],
the net effect of these processes being a fall in cerebral perfusion pressure. This hypothesis was
supported by the observation that, in an open chest porcine model, elevations in intra-abdominal
pressure were not transmitted to the ICP[139].
In the only prospective clinical study of intra-abdominal pressure in patients with elevated ICP
following traumatic brain injury, it was found that decompressive laparostomy resulting in a
sustained reduction of ICP, was associated with a significantly better survival[140]. The value of
the study is limited by a sample size of only 17 patients, however it would seem reasonable to
assume that any pre-existing pathology leading to an elevated ICP, for example acute hepatic
failure, should be expected to be exacerbated by elevated intra-abdominal pressure. Certainly,
patients in whom ICP is being monitored should also undergo monitoring of their IAP, perhaps
with a lower threshold for decompression.
62
1.8 Overview of Areas of Study
Current Attitudes and Practice of IAP in the UK
Currently, the United Kingdom is conspicuous by its relatively minor contribution to world
literature on intra-abdominal pressure. The majority of studies and reviews originate from
elsewhere in Europe (with a preponderance to Belgium), the United States of America and
Australasia. It is possible that this discrepancy reflects reluctance amongst UK physicians to
accept and adopt the principles of intra-abdominal pressure monitoring and surgical
decompression for cases of the abdominal compartment syndrome. Only one previous postal
questionnaire of British anaesthetists has been performed in 2005, with 137 respondents. Data is
presented from an up-to-date survey of the attitudes and practices of British Intensive Care
Physicians and General Surgeons.
Measurement of IAP on LITU – The Foley Manometer
A multitude of techniques for the measurement of intra-abdominal pressure have been described
and most rely on the measurement of intravesical pressure. A urine manometer connected to the
Foley catheter has been adopted as the technique of choice in the host institution, however this
apparatus has never been evaluated or validated in the clinical setting. Data is presented to
demonstrate the reliability of the apparatus by means of an in vitro study and also the validity of
the pressure measurements by comparing the Foley manometer to both a commercially available
electronic device, which measures intravesical pressure, and also by comparison to directly
measured intra-abdominal pressure.
63
Sources of Error in the Use of the Foley Manometer
In considering how best to evaluate the Foley manometer system several essential sources of
error were identified, which have not been addressed previously in the world literature.
Contradiction exists between the manufacturer’s guidance for the ideal location of the zero
reference point and the current consensus advice provided by an international panel of experts.
An anatomical study is presented which considers the best bony landmark to correspond with the
tip of the intravesical pressure measurement device.
Current recommendations suggest that intra-abdominal pressure should be measured only with
the patient lying supine. For several reasons, patients are usually nursed in a head-up (30°)
position. A study was conducted to examine the effect of head-up positioning on the measured
intravesical pressure.
Recommendations suggest the use of low-volume bladder instillate for the measurement of
intravesical pressure, based on data obtained using an electronic measurement system. The
pressure volume relationship observed using the Foley manometer equipment was explored.
Finally, the problem of vapour lock was seen to be a common cause for spuriously high pressure
measurements. This phenomenon is described for the sake of completeness in this chapter.
The Epidemiology of IAP in a Specialised Liver ITU
Data relating to the problem of intra-abdominal pressure specifically within the liver failure,
transplant and HPB surgery population are extremely limited. Only one animal study has
considered the effects of raised intra-abdominal pressure on liver regeneration following resection
and a single clinical study following liver transplantation has been reported. No data exist on the
clinical problem of raised intra-abdominal pressure in patients with acute or acute on chronic liver
failure, within the intensive care unit setting. A prospective observational study was conducted
within a specialised liver intensive care unit to consider the role of intra-abdominal pressure in
64
three distinct patient subgroups: acute or acute on chronic liver failure, following major hepato-
pancreato-biliary resections and following liver transplantation. Data on incidence, association to
complications and length of ITU stay are presented, along with an evaluation of potential early
predictive indicators for the development of raised intra-abdominal pressure.
Regional IAP Following Liver Transplantation
Conventional dogma suggests that intra-abdominal pressure is consistent throughout all areas of
the abdomen. This is based on the assumption that the abdominal contents are fluid in nature, in
terms of their transmission of pressure. This is not absolutely true, in that bowel is usually gas
filled, to at least some degree and this can be quite pronounced in the presence of ileus which
often follows major abdominal surgery. A study was undertaken to measure intra-abdominal
pressure via a direct puncture technique in both the supra-colic and infra-colic compartments in
order to identify any cases of regional variation. Having identified a significant regional variation,
the effect of body position on the relative regional pressures was also studied.
65
1.9 Considerations regarding study design, reporting and analysis
The period of research predates any formal guidance on standards for reporting of observational
studies relating to intra-abdominal pressure. Since the data collection phase of the research was
completed, formal recommendations for research from the international panel of experts on intra-
abdominal hypertension and the abdominal compartment syndrome were produced[141].
In broad terms, this body of research falls into three categories of investigation – a major
questionnaire, comparative studies for technique of measurement of intra-abdominal pressure
and an observational epidemiological cohort study. All of the studies were reviewed and
approved by both independent Research Ethics Committees (St Mary’s Hospital or Woolwich
Hospital, London, UK) and King’s College Hospital, Research and Development Committee. All
data were anonymised and stored in accordance with the stipulations of the Research Ethics
Committees.
Where possible, this research has been analysed and is presented in alignment with the
subsequently published recommendations. In particular, studies considering the measurement of
IAP that have traditionally been analysed by way of parametric comparison of means and
correlation between recordings, have been re-analysed using the technique outlined below.
Certain elements, particularly data relating to body anthropomorphic considerations were not
collected during the studies and areas where the absence of this data may have produced
limitations in the research are outlined in the final summary of this work.
In line with the recommendations – clinical studies relating to the measurement of IAP were
performed at a range of body positions to eliminate the influence of body position on the
measurement device. No measurements were made in patients who were agitated, however
measurements were made in patients with a Richmond Agitation and Sedation Scale
66
(RASS)[142] score of 0 or less. Table 1.3. All IAP measurement sets met the stipulated
requirement that at least 50% of measurements should reveal an elevated IAP (>12 mmHg).
Table 1.3.
The Richmond Agitation-Sedation Scale[142]
Statistical analysis of different measurement techniques or regional pressure data were
compared using a technique described by Bland and Altman, which allows for comparisons
between the mean difference in measurements, whilst eliminating inter and intra-individual
variations. For the purpose of reporting – the bias is defined as the mean difference between
measurements, the precision as the standard deviation of the bias and the limits of agreement,
the bias plus or minus twice the precision. This data is also presented graphically as a “Bland
and Altman Plot” of the difference between two measurements plotted as the mean of the two
techniques. The plot is then marked with the bias and limits of agreement as horizontal lines as
below. Figure 1.6.
67
Figure 1.6.
Example of a Bland and Altman Plot of Agreement
Based on the published expert opinion (level D data), for two sets of measurements to be
considered as clinically equivalent, the following criteria should have been met. Table 1.4.
Table 1.4.
WSACS Criteria for clinical equivalence of IAP measurement techniques
Criteria Requirement
Minimum Subjects At least 20
IAP > 12 mmHg At least 50%
Bias <1 mmHg
Precision (SD of bias) <2 mmHg
Limits of Agreement +/- 4 mmHg
The epidemiological component of this research (Chapter 5) has been conducted and presented
with reference to the STROBE statement[143].
68
There were no financial, nor commercial relationships between the researcher, his supervisors
nor the unit in which the studies were undertaken and the manufacturers of any of the devices
described for the measurement of IAP.
69
Chapter 2
Attitudes and Practice of Intra-Abdominal Pressure
in the United Kingdom
70
2.1 Introduction - Previous Questionnaires and Surveys A MEDLINE search was performed using the terms intra-abdominal hypertension or abdominal
compartment syndrome and survey or questionnaire, limited to English-language publications.
Seven publications were identified, two from Canada[144, 145], two from the USA[146, 147], one
from Australasia[148] and two from the UK[149, 150]. In addition a review article outlining clinical
awareness of intra-abdominal hypertension was identified, which originated from the USA and
was published in 2007[151].
Of the published surveys, four focused on anaesthetists and intensive care physicians[147-150]
and the other two on trauma surgeons[144-146], and these are summarised below. Table 2.1.
Although these surveys are drawn from a highly heterogenous group of respondents and differ
significantly in their content, several features are striking. Despite a seemingly good level of
familiarity with the problem of raised intra-abdominal pressure, significant proportions of the
respondents felt that they had not seen a case of ACS in the year prior to the survey. This is
despite a known prevalence for ACS of around 8% within the general ITU population (and 52%
for intra-abdominal hypertension)[29]. A striking theme amongst all of the surveys was that a
clear threshold value of IAP for the diagnosis of ACS appears to be lacking and indeed it was not
until the publication of the consensus definitions in 2007[152] (post-dating all of the surveys) that
a universally agreed level had been disseminated at all.
The other significant observation of the existing surveys was that, despite the increasing interest
in the ACS, routine measurement of IAP was not commonly undertaken. The highest level of
routine measurement was amongst the Canadian trauma surgeons[145] and occurred in 52% of
patients. This may explain the apparent lack of appreciation of measured IAP as an important
consideration in the decision to surgically decompress a tight abdomen.
71
Table 2.1. Summary of previous surveys of knowledge and practice relating to IAP
Author Kirkpatrick Kimball Tiwari Nagappan Ravishankar Mayberry Year 2006[144,
145] 2006[147] 2006[150] 2005[148] 2005[149] 1999[146]
Country Canada USA UK Australia UK USA Target Trauma Sx Trauma Sx ITU ITU ITU Trauma Sx Response Rate
84% (86/102)
35.7% (1622/4538)
57.2% (127/222)
90% (36/40)
66.2% (137/207)
70% (331/473)
Diagnosed ACS
- - 84% - 98.5% -
No ACS in Last Year
- 17% 15% - - 14%
Threshold for Diagnosis
25mmHg 20 -27mmHg
11 – 50mmHg
- 25mmHg 30mmHg
Routine IAP Monitoring
52% - - 0% 3.8% * 6%
Commonest Cause for ACS
- Trauma and Bleeding
GI or Vascular Surgery
- - -
Commonest Indication for Laparostomy
Subjectively “too tight” to
close
- - - - CVS Instability “On-table”
* Routine IAP monitoring only following emergency surgery
The worldwide literature, including countries where surgeons are more heavily involved with
critical care units, suggests a large degree of variability in practice and each of the studies
identified will be outlined in more detail.
In 2005 Ravishankar and Hunter published the results of a postal questionnaire targeted at
United Kingdom Intensivists, aimed to outline current practice in intra-abdominal pressure
measurement and attitudes towards the abdominal compartment syndrome[149]. A short postal
questionnaire was sent out addressed to “ Lead Clinician, Intensive Care Unit”, at 207 hospitals
identified as having four or more general surgeons on staff and the response rate was 66.2%
(137 out of 207). The questionnaires were sent as a single hit, with no follow up of non-
responders.
72
98.5% of respondents reported prior knowledge of ACS and 75.9% had measured IAP on at least
one previous occasion, all via the transvesical route. In the majority of units (93.9%), IAP was
only measured in cases where there was a clinical suspicion of raised intra-abdominal pressure.
Of those measuring IAP 26.9% (the majority), made measurements at four to eight hourly
intervals. A small number of units (3.8%), reported a practice of measuring the IAP on all patients
following emergency laparotomy, but no units measured IAP routinely in all admissions.
In terms of requesting laparostomy as treatment for raised intra-abdominal pressure, 64% would
request surgical decompression if the IAP exceeded 25 mmHg and was accompanied by signs of
organ dysfunction and a further 6.7% would request decompression at this level even if organ
dysfunction was not present. 2% of respondents considered an IAP of more than 20 mmHg
without sign of organ dysfunction sufficient criteria for decompression.
Of the respondents who never measure intra-abdominal pressure (33) 27% did not know how to,
36% thought the practice futile and 33% did not know how to interpret results. One respondent
felt that he did not admit any patients with intra-abdominal hypertension.
The survey was published before the current versions of the consensus definitions from the World
Society of the Abdominal Compartment Syndrome[152], but after previous versions of these
guidelines. Although it is encouraging that the vast majority of respondents were aware of the
concept of ACS, it would be useful to know the proportion of these respondents who actually
believe in the diagnosis as a distinct clinical entity. A significant proportion of respondents did not
measure intra-abdominal pressure on any occasion and, even discounting those who think the
practice is futile, there appears to be a clear indication for increasing education in terms of
measurement techniques and interpretation of results.
In interpreting the results of this survey, one must remain mindful of its limitations. The response
rate of 66%, although not uncommon, raises the possibility of selection bias with the potential
73
proportion of “non believers” possibly being much higher. The simple manoeuvre of issuing a
reminder letter may have significantly improved response rate. The fact that the survey was sent
only to the clinical lead of the individual intensive care units may also have produced a bias in the
results.
Tiwari and colleagues published a second survey of intensive care doctors the following year.
This survey was sent to the clinical directors of 222 general intensive care units and produced
response rate of 57.2% following a reminder letter sent to non-responders.
Responses were stratified according to practise within teaching hospitals and district general
hospitals and comparisons made between the two types of units. The report of a clinical
suspicion of an abdominal compartment syndrome was high in both teaching units and district
general hospitals and was associated with the presence of abdominal distension, oliguria,
increased ventilatory support and hypotension. The clinical suspicion was however confirmed by
measurement of IAP more often within the teaching hospitals (94% vs 74%) and this was
achieved most often using the transvesical method (90%).
The only significant difference between the conditions associated with the ACS within the two
types of unit were the identification of the problem following hepatobiliary surgery in the teaching
hospitals - simply reflecting centralisation of this tertiary practice. Overall, the most common
associations were gastrointestinal and vascular surgery and trauma.
Following the diagnosis of ACS, the number of patients who proceeded to surgical
decompression was universally low (less than 50% for the majority of units), though the outcome
for those not undergoing decompression is unknown. There was no statistical difference in
laparostomy rates between the teaching hospitals and district general units.
74
A larger survey of intensive care physicians in the USA was performed by Kimball et al in
2006[147]. A 10 question postal survey was sent to 4538 members of the Society of Critical Care
Medicine produced 1622 responses (35.7%). The stated aims were to assess current
understanding and clinical management of intra-abdominal hypertension and the abdominal
compartment syndrome.
Although aimed at intensive care physicians, due to differences in training groups seen in the
USA, 35% had primary training in surgery, 31.5% in medicine and only 10% in anaesthesia (the
remainder having trained as “intensivists”. Of the respondents, the majority saw either 1-3 cases
per year (38.5%) or 4-7 cases (26.5%). Interestingly, 17% reported that they had not see any
cases of raised intra-abdominal pressure in the year prior to the survey. 70% of respondents felt
that a combination of clinical picture and bladder pressure was required to make the diagnosis of
IAH, however 20% felt that this was a clinical diagnosis only. Of those who did measure bladder
pressure, the majority believe that a value of between 20-27 mmHg was the cut off range to
cause physiological compromise.
When asked about the commonest cause of intra-abdominal hypertension in their clinical
practice, the majority chose abdominal trauma and bleeding with large volume resuscitation as
the main underlying problem.
Decompressive laparostomy was identified as the most frequently used intervention and
worsening oliguria and increasing ventilator pressures were selected as having the most
significant effects on the decision to proceed to surgery. 20% of respondents were willing to
surgically decompress an abdomen based on IAP measurements alone.
The authors concluded that there was a significant variance in the approach to diagnosis and
management of raised intra-abdominal pressure. This is especially true amongst the medical and
75
paediatric intensivists. The authors saw better education and the availability of clear guidelines
as the solution to this problem.
The third survey to target intensive care physicians was published by Nagappan and colleagues
in 2005[148]. This was a written questionnaire handed to 40 Australasian intensive care trainees,
which was completed by 36 (90%). Although 92% of the trainees had used IAP in their clinical
practice, measurements were not being performed routinely. Overall, 22% were unsure of the
thresholds recommended for the instigation of therapy for raised intra-abdominal pressure and
this, along with the fact that the majority of trainees had a poor understanding of the clinical
sequalae of retroperitoneal conditions such as pancreatitis, were the main conclusions from this
small study. The usefulness of the study is limited by its small sample size and the fact that the
authors used their own threshold values for ACS. It did however highlight the recurring themes
that education and competence in the management of raised intra-abdominal pressure seems to
be lacking within the intensive care community.
A survey targeting trauma surgeons was published by Mayberry and colleagues in 1999[146].
Surveys were posted to 473 members of the American Association for the Surgery of Trauma and
the response rate was 70%. The stated aim was to assess the proportion of surgeons
recognizing ACS. The structure of the questionnaires differed from other published surveys in
that it was developed in consultation with a statistician and used a five point Likert scale to
determine the willingness of the surgeon to close the abdomen at the end of a trauma laparotomy
and also willingness for subsequent decompression. The survey was conducted over a four
month period and initial non-responders were sent a reminder questionnaire on a second
occasion.
76
There was a significant variation in reported exposure to ACS with 14% of the respondents not
having diagnosed any cases of raised intra-abdominal pressure in the previous year and 33%
having been involved with six or more cases. Bladder pressure measurements were the
diagnostic tool of choice and were used selectively by 59% of respondents - at either end of the
spectrum, 34% had never or rarely measured IAP and 6% measured routinely in all patients.
The main factors identified which would make the surgeon less likely to perform primary closure
of the abdomen, were the presence of haemodynamic or pulmonary instability or deterioration
and a subjective feelings of a “ tight closure”.
The final two publications, from a Canadian trauma unit, report the results of the same
survey[144, 145]. This was a combined postal and internet questionnaire, which was sent out to
102 members of the Trauma Association of Canada and returned an 84% response rate. Of the
86 responders however, only 20 performed more than 25 trauma laparotomies within the previous
year and were drawn from a relatively young cohort, with a median year of practice entry being
1997 (within 9 years of the survey).
The aim of the first publication was to present the perceptions of the Trauma Association
members regarding the open abdomen and the abdominal compartment syndrome.
90% of respondents had left an abdomen open following a trauma laparotomy on at least one
occasion, and 24% reported doing so often. The main indications for leaving the abdomen open
were either being physically unable to close (87%) or planned reoperation (80%). Airway and
bladder pressure measurements were utilised in the decision making process in 41% and 39% of
the time respectively.
84% of respondents reported that they had re-opened an abdomen because of the abdominal
compartment syndrome on at least one occasion. Ventilatory status, specific bladder pressure
77
measurements and overall haemodynamic status were the three commonest indications for
decompression (75%, 71% and 67% respectively), although 66% reported having also performed
surgical decompression based on a subjective feelings of tightness on physical examination
alone.
Routine screening of intra-abdominal pressure was reported in 52% of units, with the transvesical
route used in 95% of cases and gastric pressure monitoring in 3%. Secondary abdominal
compartment syndrome (occurring without primary intra-abdominal pathology) was encountered
by 46% of respondents and tertiary (ACS occurring in a previously decompressed abdomen) by
28%.
The second publication to arise from the same survey explored in more detail, the factors
affecting the decision to close primarily an abdomen at the time of trauma laparotomy. This
paper was based on a section of the questionnaire in which respondents were presented with
four clinical scenarios and asked about their likely decision making in each.
When presented with a 45-year-old male following laparotomy for massive haemoperitoneum
secondary to splenic injury, 42% of respondents opted for a primary fascial closure provided the
patient was normothermic, haemodynamically stable and non-coagulopathic, even if the fascial
closure was subjectively “ extremely tight”. In more unstable patients with the same scenario,
25% said that they would still persist with a primary fascial closure. These interesting comments
illustrate well that despite having a high level of awareness of the problems posed by raised intra-
abdominal pressure, varying management decisions will still be encountered relatively frequently.
78
In summarising the current clinical awareness of intra-abdominal hypertension and the abdominal
compartment syndrome, in an invited review paper for the second world Congress of the
abdominal compartment syndrome in 2007, Kimball and colleagues[151] have elegantly shown
that the number of publications relating to this subject has risen from less than 10 per year in the
early 90s to more than 60 per year in 2006. Figure 2.1. In this review, the authors point out that,
to add some perspective the problem of intra-abdominal hypertension has been repeatedly
shown to affect more patients within the critical care setting than sepsis[151], and that the time
has now come to push forward with multicentre outcome trials for abdominal compartment
syndrome interventions.
Figure 2.1.
A summary of volume of publications relating to IAP per year (1982 – 2006)
Kimball et al. Acta Clinica Belgica. Volume 62, Supplement 1, 2007.
79
The previous surveys have demonstrated some marked variation amongst reported practice and
there have not been any surveys to poll attitudes since the publication of the 2007 consensus
guidelines. Additionally there has not been any previous work looking at the attitudes and
practice of United Kingdom surgeons, nor any surveys which directly compare surgeons and
intensivists.
2.2 Design of Questionnaire
Background
In the United Kingdom, the management of the Intensive Care Unit is by and large, the domain of
the anaesthetist or specifically trained intensive care clinicians (physicians and anaesthetists
predominantly). There has been an anecdotally perceived “battle” in the UK, between intensivists
who believe passionately in the deleterious effects of raised intra-abdominal pressure and who
struggle to convince their surgical colleagues of the merits of surgical decompression. The
attitudes and practice of General Surgeons in relation to this condition has never been assessed
however, and with a growing body of evidence to support the importance of recognising IAH, an
alignment of the views of the surgeons with their intensive care colleagues would seem to be
desirable.
General Aims
1. To delineate current attitudes and practice in relationship to the problem of raised intra-
abdominal pressure in the UK.
2. To compare the attitudes and practices of general surgeons to intensive care doctors and
anaesthetists in the UK.
3. To identify any specific clinical areas of common ground and also areas where beliefs
may differ between the two specialities.
80
Specific Questions to be Answered
1. Are there any differences in responses from surgeons and intensivists?
2. Are there are any differences in responses from anaesthetists who undertake intensive
care work and those who do not?
3. Are there any differences in response according to the number of years in consultant
practice?
4. Are there any differences in response from surgeons working in the various general
surgical subspecialties?
5. To assess the perceived threshold level for intra-abdominal hypertension and for the
abdominal compartment syndrome.
6. To identify the perceived number of cases of abdominal compartment syndrome dealt
with in the previous year.
7. To identify the proportion of cases that were surgical, traumatic or medical.
8. To identify the proportion of units measuring intra-abdominal pressure, the regularity with
which this is measured and to identify factors which influence the decision to measure
IAP.
9. To assess the number of patients undergoing surgical decompression of an abdominal
compartment syndrome in the year prior to the survey.
10. To identify the most important clinical features, at the time of surgery, which would make
a surgeon more likely to leave the abdomen open, or which would make the intensivist
expect that the abdomen would have been left open.
11. To identify the most important clinical features, occurring in the postoperative surgical
patient, which would influence the decision to perform or request a surgical
decompression.
81
Design Considerations
Pilot Questionnaire
In order to optimise the response rate, it was felt essential to make the questionnaire as
compact and easy to answer as possible, whilst obtaining sufficient data to satisfactory
answer all the questions identified in the design phase. For this reason, the length of the
questionnaire was limited so that it would not extend beyond a single two-sided page and the
majority of questions were closed, to aid both responses and data collection / analysis.
Following the gathering of initial demographic data, care was taken to ensure that
subsequent questions were not leading in their context and that the respondents were free to
dismiss the concept of intra-abdominal pressure, as they felt appropriate. Wording was made
as simple and direct as possible to ensure face validity and some data equivalent to previous
surveys were included to ensure content validity. Internal reliability was not anticipated to be
a problem and therefore, for the sake of brevity, repetition of data acquisition for the sake of
testing internal consistency was not attempted.
In order to compare differences in clinical approaches to the problem of raised intra-
abdominal pressure between anaesthetists and surgeons, it was felt that the clinical
scenarios presented by Mayberry in 1999[146] remained highly appropriate. These
scenarios were therefore included with their Likert-type scale responses and this added
criterion validity to the survey.
The initial questionnaire was piloted locally amongst general surgeons and intensive care
physicians (10 of each) in the host institution, in order to identify any areas of ambiguity and
also to gauge a feel for the time burden incurred by responding to the questions. The pilot
resulted in the removal of an ambiguous question, the identification of a spelling mistake and
82
confirmed that the questionnaire could be completed in less than 10 minutes. Responders
were also asked to gauge their “satisfaction” in completing the survey as a score of 1 – 10,
with 1 being completely dissatisfied and 10 being completely satisfied. The mean satisfaction
score was 8 with a range of 6 – 10. The final questionnaire is included in Appendix 1.
Target Population
The survey was limited to consultants working in mainland UK NHS hospitals undertaking
General Surgical interventions and with a high likelihood of providing acute surgical services
(i.e. those with Accident & Emergency departments). It was felt that a national survey was
more appropriate than a targeted regional approach, in order to avoid any potential for
location bias. This decision was made in the knowledge that seeking responses from the
larger geographical area was likely to result in a lower response rate.
Method of Selection
The questionnaire was administered by a commercial medical mailing and research company
(InTime Data LTD, Edinburgh), who were in possession of an up to date personnel list of UK
NHS hospitals. 400 Anaesthetists and 400 General Surgical consultants were randomly
selected from the database using a commercial random selection tool utilising a system
based on atmospheric static (there being no separate list of intensive care clinicians). The
sample size was based on previous studies and assumed a response rate of 50% to achieve
the largest UK study and the second largest worldwide survey. Financial constraints for
mailing and data collection were also a consideration.
83
Management of Responses
Questionnaires were anonymous and uncoded and were dispatched with a covering letter to
explain the purpose of the survey and a paid response envelope. The mailing company
received responses, which were entered onto a spreadsheet pre-designed by the researcher.
It was not possible to log individual responders in a financially viable manner and so all
participants were sent a second mailing of the questionnaire after two weeks, with a reminder
letter and an apology to those who had already responded, in order to maximise the
response rate. Responses were collected for a total of 6 weeks (2 weeks following the initial
mailing and 4 weeks following the reminder), with the initial mailing despatched on 14th June
2010.
Data were collected in an Excel spreadsheet (Microsoft, WA, USA). Results are presented
as descriptive statistics of absolute numbers, with the exception of the Likert type scores,
which were normally distributed on Kolmogorov Smirnov testing and therefore mean score
differences between surgeons and anaesthetists were compared by way of t-test.
84
2.3 Results
Response Rate
The overall response rate was 44% (354 responders), consisting of 226 (57%) surgeons and
128 (32%) anaesthetists. Table 2.2. & 2.3.
There were responses from 82 anaesthetists who also undertook work in ITU and from 46
who did not. Amongst those who undertook ITU work a roughly equal age spread was seen,
however there was a slight predilection to more junior consultants in the non-ITU group.
There were more responses from the more junior surgical consultants, though all age groups
were adequately represented and there was roughly equal responses from the three major
specialty groups of Upper and Lower GI and Vascular Surgery.
Attitudes Towards the Abdominal Compartment Syndrome
Respondents were asked to state whether or not they believed that the abdominal
compartment syndrome was a real clinical entity. The majority (around 90% in each group)
did believe in the diagnosis. Interestingly most of the non-believers were more senior
consultants in each specialty and most of the consultants appointed within the last decade
agreed that ACS did exist. Table 2.2. & 2.3.
85
Table 2.2.
Views regarding the existence of ACS reported by UK anaesthetists with or without an
ITU practice. Data presented as absolute numbers and %.
Years in Consultant
Practice
ACS Exists (%)
ACS Does Not Exist (%)
Overall (n = 128)
116 (91)
12 (9)
Anaesthetics & ITU
(n = 82)
81 (99)
1 (1)
Anaesthetics, No ITU (n = 46)
35 (76)
11 (24)
0 – 5
(n = 22) 22
(100) 0
(0) 6 – 10
(n = 20) 20
(100) 0
(0) 11 – 15 (n = 20)
19 (95)
1 (5)
Anaesthetics & ITU
(n = 82)
16 + (n = 20)
20 (100)
0 (0)
0 – 5
(n = 18) 15
(83) 3
(17) 6 – 10
(n = 12) 12
(100) 0
(0) 11 – 15 (n = 6)
6 (100)
0 (0)
Anaesthetics, No ITU
(n = 46)
16 + (n = 10)
2 (20)
8 (80)
86
Table 2.3.
Views regarding the existence of ACS reported by UK general surgeons (further divided by
sub-specialty interest) Data presented as absolute numbers and %.
Years in Consultant
Practice
ACS Exists (%)
ACS Does Not Exist (%)
Overall (n = 226)
202 (89)
24 (11)
0 – 5 (n = 78)
78 (100)
0 (0)
6 – 10 (n = 54)
50 (93)
4 (7)
11 – 15 (n = 50)
40 (80)
10 (20)
Surgeons
16 + (n = 42)
34 (81)
8 (19)
Responses by Sub-Specialty Interest
Breast (n = 24)
24 (100)
0 (0)
Colorectal (n = 48)
46 (92)
4 (8)
UGI (n = 42)
42 (100)
0 (0)
Vasc (n = 58)
50 (86)
8 (14)
Not Given (n = 52)
40 (77)
12 (23)
87
IAP and Clinical Practice / Knowledge (Table 2.4. & 2.5.)
There was no difference between groups in reports of how often IAP was measured within ITU
patients, with both surgeons and anaesthetists suggesting that is usually performed “sometimes”
(66 & 70% respectively). In both groups, 23% of respondents reported that it was never
measured however.
44% of surgeons knew that IAH was associated with an IAP of 12-20mmHg as opposed to only
27% of anaesthetists. A significant proportion in each group provided higher estimates however
and 43% of anaesthetists over-estimated in their response. The majority of respondents were
aware that ACS was defined by an IAP >20 mmHg, however there were a significant number in
each group who believed that the diagnostic cut-off was far higher than this.
The chief factors reported to provoke the selective measurement of IAP was a clinical suspicion
of ACS within the context of multi-organ failure, or an acute deterioration in condition without
other obvious cause. Clinical examination was cited as a stimulus for measurement in only 5% of
surgeons, but in 15% of anaesthetists.
The mean number of cases of ACS treated within the last 12 months was around two for both
groups, although 16% of anaesthetists and 19% of surgeons had not seen a case in the last year.
48 (38%) Anaesthetists reported a perceived “surgical reluctance” to perform laparostomies on
patients which they thought had an ACS.
In both groups, the majority of laparostomies performed were reported as being in postoperative
patients and the commonest indications were either the operative findings or a postoperative
88
deterioration with a high measured IAP reported as being a major indication by only 14 and 17%
of respondents.
89
Table 2.4.
Table summarising knowledge and practice relating to measurement of IAP
Surgeons (%) Anaesthetists (%) X2 p Always 24
(11) 10 (7)
Sometimes 140 (66)
96 (70)
How often is IAP Measured
Never 48 (23)
32 (23)
0.667
< 10 mmHg 4
(3) 2
(2) 10 – 11 mmHg 12
(10) 2
(2) 12 – 20 mmHg 52
(44) 34
(27) >20 mmHg 46
(39) 26
(21) >30 mmHg 4
(3) 6
(5)
Which IAP Corresponds to IAH
Don’t Know 0 (0)
54 (43)
0.244
<20 mmHg 16
(10) 4
(4) 20 mmHg 18
(12) 18
(16) >21 mmHg 78
(51) 56
(50) >30 mmHg 34
(22) 24
(21)
Which IAP Corresponds to ACS
>40 mmHg 8 (5)
10 (9)
0.220
Clinical suspicion in multi-organ failure
52 (33)
30 (33)
Acute deterioration without other cause
34 (21)
28 (31)
Purely ITU decision 14 (9)
1 (1)
Raised risk due to specific operation
8 (5)
4 (4)
Presence of risk factors
8 (5)
2 (2)
Surgeons request 10 (6)
1 (1)
Clinical examination 12 (7)
14 (15)
Chief Factor to Influence Selective
Measurement of IAP
Don’t know 22 (14)
12 (13)
0.297
90
Table 2.5.
Table summarising practice relating to decompressive laparostomy
Surgeons Anaesthetists p Number of Laparostomies
Performed / Treated in last 12 Months
Mean (SD)
1.9
(2.6)
2.2
(2.7)
0.233 (t-test)
Proportion of cases that were; (%)
Postoperative 87 80 Trauma Related 6 7
Non-Surgical 7 13
0.338 (X2)
Proportion of cases performed for; (%)
High Measured IAP 14 17 Operative Findings 45 46
Postoperative Deterioration 35 33 Other Reason 6 4
0.473 (X2)
91
Intraoperative and Postoperative Clinical Factors Making Laparostomy More Likely
(Table 2.6. & 2.7.)
The only statistically significant difference between surgeons and anaesthetists in the ranking of
intra-operative findings which would make formation of a laparostomy more likely, was the
subjective feeling of a “tight closure” and paradoxically, this factor was ranked higher by the
anaesthetists than the surgeons (4.0 vs 3.3 – p=0.03). All other responses were broadly similar,
with ventilatory instability being the single most important factor amongst the surgeons and a
planned 2nd look or high measured IAP ranking most highly for the anaesthetists. Massive blood
transfusion was classed as the least important factor by both groups.
There were no statistically significant differences in the ranking of the postoperative factors by the
two groups, with very similar rankings for all.
Table 2.6.
Comparison of intra-operative factors reported as making laparostomy more likely
(Data presented as mean and standard deviation)
Mean Score for Intra-operative Factors Making Laparostomy More Likely (0-5) Surgeons
(SD) Anaesthetists
(SD) p
Faecal Soiling 3.3 (1.6) 3.6 (1.2) 0.37 Massive Transfusion 2.8 (1.3) 2.7 (1.3) 0.25
Poly-trauma 3.5 (1.6) 3.3 (0.8) 0.51 Acidosis 2.9 (1.4) 3.0 (1.0) 0.81
Elevated Lactate 3.0 (1.4) 3.1 (1.0) 0.73 Haemodynamic
Instability 3.4 (1.7) 3.1 (1.1) 0.64
Ventilatory Instability
4.0 (1.7) 3.4 (1.2) 0.62
Planned 2nd Look 3.3 (1.1) 4.4 (0.7) 0.19 Subjectively “Tight” 3.3 (1.6) 4.0 (0.8) 0.03 High Measured IAP 3.2 (2.1) 4.3 (0.7) 0.06
92
Table 2.7.
Comparison of post-operative factors making laparostomy more likely
(Data presented as mean and standard deviation)
Mean Score for Post-operative Factors Making Laparostomy More Likely Surgeons
(SD) Anaesthetists
(SD) p
Increasing Acidosis 3.4 (1.4) 3.7 (0.7) 0.70 Increasing Lactate 2.6 (1.4) 3.8 (0.7) 0.30
Decreasing Cardiac Index
3.0 (1.3) 3.2 (0.9) 0.60
Decreasing Urine Output
3.4 (1.3) 3.8 (1.0) 0.52
Worsening LFTs 2.6 (1.1) 3.1 (0.8) 0.09 Increasing Creatinine 3.0 (1.5) 3.6 (1.0) 0.16 Increasing Oxygen
Requirements 3.2 (1.4) 3.2 (0.8) 0.34
Increasing Ventilatory Pressure
3.7 (1.7) 3.7 (1.2) 0.67
93
The order of the rankings differed both between our contemporary groups and the previous
findings from Mayberry’s original research in 1999, suggesting that surgeons and anaesthetists
place different emphasis on the various factors when deciding their order of importance. Table
2.8.
Table 2.8.
Ranking of factors making laparostomy more likely, in order of importance, reported by
surgeons and anaesthetists in the current study compared to the original research
Mayberry[146] Surgeons Anaesthetists
Order of Ranking of Intraoperative Factors 1st Ventilatory Instability Ventilatory Instability Planned 2nd Look 2nd Haemodynamic
Instability Poly-trauma Subjectively “Tight”
3rd Subjectively “Tight” Haemodynamic Instability
Faecal Soiling
4th Planned 2nd Look Subjectively “Tight” Ventilatory Instability 5th Acidosis Planned 2nd Look Poly-trauma 6th Poly-trauma Faecal Soiling Haemodynamic
Instability 7th Massive Transfusion Acidosis Acidosis 8th Faecal Soiling Massive Transfusion Massive Transfusion
Order of Ranking of Postoperative Factors
1st Decreasing Urine Output
Increasing Ventilatory Pressure
Decreasing Urine Output
2nd Increasing Ventilatory Pressure
Increasing Acidosis Increasing Ventilatory Pressure
3rd Increasing Acidosis Decreasing Urine Output
Increasing Acidosis
4th Decreasing Cardiac Index
Increasing Oxygen Requirements
Increasing Oxygen Requirements
5th Increasing Oxygen Requirements
Decreasing Cardiac Index
Decreasing Cardiac Index
94
2.4 Discussion
Despite a disappointing response rate in the anaesthetic arm the survey accrued a total of 354
responses, making it the largest UK survey on ACS, the third largest worldwide and the only
survey to directly compare responses from general surgeons and anaesthetists.
This survey was the first to ask directly whether respondents actually believed that ACS exists as
a diagnostic entity and it was reassuring that 90% felt that it did. This figure was broadly in
keeping with previous surveys, from the UK and elsewhere, that have asked whether
respondents had previously diagnosed ACS and for which responses ranged from 84 – 98%[145,
146, 149, 150]. Likewise, the number of cases reported as being treated within the last twelve
months was consistent from results from these other surveys, which had been published over the
last decade.
An interesting observation was that the vast majority of consultants across both specialties who
had been appointed in the last decade agreed that ACS exists and only three anaesthetists, who
did not work in ITU, felt that it did not. This may represent the more recent interest in the topic
and the fact that teaching on IAP and the ACS is gradually finding its way into many training
programmes. It was also interesting to see that overall, there appeared to be a large difference
between anaesthetists working in ITU and those who did not, where the rate for those believing in
ACS as a real clinical entity was 76 vs 99%. This may reflect the diverse range of clinical
interests amongst anaesthetic consultants and the fact that a significant proportion of those not
involved with intensive care sessions, may not come into routine contact with critically unwell
patients.
The threshold pressure for the diagnosis of ACS was highly variable in the previously reported
literature. Despite the wide dissemination of consensus definitions[152] and their subsequent
95
incorporation in many of the subsequent contemporary review articles[153-158], it was surprising
that this survey again revealed a wide variation in perceived thresholds that do not seem to have
been refined by the consensus publication. It would seem therefore that whereas awareness of
ACS as a diagnosis is increasing, factual knowledge of the topic may not be. More specifically –
the finding that more than a quarter of all respondents (27% surgeons and 30% anaesthetists)
believed that an IAP in excess of 30 mmHg was required for a diagnosis of ACS is a genuine
cause for concern. The implication being that potentially lifesaving abdominal decompressions
are being delayed and intra-abdominal pressures are being allowed to rise to levels far higher
than desirable. Clearly continued and focussed education as to the internationally agreed criteria
for diagnosis needs to be pursued further and incorporation of knowledge of the ACS and its
limits for treatment should form a core part of surgical and anaesthetic training in the UK.
Perhaps also there is a need for more simple core definitions for diagnosis and guidelines for
management.
More reassuringly, it was encouraging to see what appears to be a modest improvement in the
routine measurement of IAP from 0 – 6% in previous studies[146, 148, 149] to an overall level of
9% in this survey. A further 68% of respondents reported that IAP was measured selectively in
their practice – usually on the basis of clinical suspicion of ACS or a clinical deterioration.
Patients may benefit from a more proactive approach to the measurement of IAP and practice
may well be positively influenced if a fast, economical and reliable technique for measurement
could be established and perhaps a robust protocol for screening, which could be tailored to
specific patient groups based on more detailed epidemiological data.
Where an ACS has been identified on the basis of pressure measurement within the context of
worsening organ failure, most cases will require surgical decompression by way of a
96
laparostomy[152]. Whilst the reported experience of laparostomy in this series is equivalent with
previous studies, it falls far short of what could be expected from the previous finding that 8% of
all ITU patients (medical or surgical) will have an intra-abdominal pressure greater than 20 mmHg
at any point in time[159] – whether this reflects inaccuracies in measurement or a reluctance to
act on apparent results remains unclear. The anecdotally perceived battle between intensivists
and surgeons to achieve decompression is supported by the report of a “surgical reluctance” to
perform a laparostomy amongst 42% of anaesthetic respondents, although this apparent
discrepancy was not borne out by any discernable difference between surgeons and
anaesthetists in terms of actual attitudes and practice. Interestingly, the only significant
difference between intra-operative factors perceived as being important to make laparostomy
more likely, was a higher ranking of a subjectively “tight closure” amongst anaesthetists, despite
good evidence demonstrating that clinical examination is of no benefit in discerning elevated
IAP[160, 161]. There is, of course the possibility that the “perceived tight closure” by
anaesthetists is educated by an “observed and measured” increase in ventillatory pressures or
haemodynamic parameters that may not necessarily be readily accessible to the surgeon.
It was positive to see very little variation in the rankings of the various intraoperative and
postoperative factors making formation of a laparostomy more likely. Of course, all of these
factors are associated with elevated IAP and there was very little variation in the importance
afforded to each factor and also between groups of respondent. Whilst the actual rank orders for
the postoperative factors included from Mayberry’s original survey (a decade earlier) were fairly
consistent amongst our contemporary series, there was an interesting difference in ordering of
the intra-operative factors between the surgeons and anaesthetists. Anaesthetists ranked the
“surgical factors” of a planned second look, a subjectively tight closure and degree of peritoneal
contamination highest, whereas the surgeons ranked the more “critical care based” factors of
pulmonary and cardiovascular instability the highest. Table 2.8.
97
The survey has undoubtedly suffered from some bias introduced by the response rate and the
failure to collect data on the type of institution worked at was a missed opportunity to determine
whether any difference in practice exists between teaching hospital and DGH practice (though
this itself may be further confounded by a possible difference in case mix between the two types
of institution). It is possible that the lower anaesthetic response rate might reflect the fact that it
was not possible to separate those anaesthetists involved in ITU work from those with no role in
postoperative care and there may have been some element of self-selection based on this
distinction in anaesthetists who did choose to respond to the survey.
2.5 Summary and Conclusions
Whilst there does seem to be some improvement in awareness of ACS, willingness to measure
IAP and knowledge of factors predisposing to elevated IAP amongst younger generations of
consultants, there is still a significant knowledge gap of the threshold levels of IAP associated
with the diagnosis of IAH and ACS.
Continued education as to these threshold values is needed - possibly with clearer guidelines and
definitions. Clinical care may be improved by the development of a fast, cheap, safe and reliable
measurement system and either routine measurement of IAP or else evidence based screening
protocols.
98
Chapter 3
In-vitro and In-vivo Evaluation of the Foley Manometer Device for
the Measurement of Intra-abdominal Pressure
99
3.1 Introduction – Techniques available for the Measurement of Intra-abdominal
Pressure
Studies have shown that neither clinical examination nor measurement of the abdominal
perimeter, are precise in the diagnosis of raised intra-abdominal pressure[42, 60]. Some form of
objective measurement device is clearly required, especially if effective definitions and clinical
management guidelines are to be developed and instigated. As with other systems for
measurement of physiological parameters in clinical practice, certain characteristics are highly
desirable in order to optimise uptake and ensure accurate data acquisition. Such characteristics
are outlined in Table 3.1, and will be discussed in the context of the various methods that have
been described for the measurement of intra-abdominal pressure (See Chapter 1.5) and which
are currently available for clinical use.
Table 3.1.
Ideal characteristics for a system to measure IAP
Ideal Characteristics for a System to Measure Intra-abdominal Pressure
Safe – for patient and operator
Reliable (Reproducible)
Valid (Accurate & Precise)
Simple
Fast
Cost effective
100
Techniques for the Measurement of Intravesical (Urinary Bladder) Pressure
As outlined in chapter 1, the indirect measurement of IAP by via the urinary bladder remains the
commonest approach in both clinical and research settings. Various techniques exist to achieve
this measurement, all of which involve the instillation of some fluid (urine or external fluid) into the
bladder followed by electronic or mechanical measurement of pressure. This thesis deals solely
with measurement of IAP within an adult population and details of the various available
techniques are outline below. The various potential sources for error with each of the techniques,
such as volume or temperature of bladder instillate along with the effects of body positioning are
discussed in detail in chapter 4.
Direct Needle-Puncture Systems – Kron[22] & Cheatham[30]
Kron’s 1984 publication entitled “The measurement of intra-abdominal pressure as a criterion for
abdominal re-exploration” was the first to describe the popular direct needle puncture technique
for the measurement of IAP. The system was easily assembled from minor consumables that are
commonly available on the intensive care unit and has subsequently been shown in multiple trials
to be reliable and valid, probably becoming the commonest technique for the adhoc
measurement of IAP. The main drawback of the system is that it requires a separate needle
puncture of the urinary collection system for each pressure measurement, with each episode
carrying the potential for the introduction of urinary tract infection and the possibility of needle
stick injury to the operator. Although the system is simple to assemble, repeated measurements
are time consuming.
The system was modified by Cheatham in 1998[30] with replacement of the hypodermic needle
with the plastic sheath of an intravenous catheter. This sheath could be left in position, which
made subsequent pressure measurements faster to obtain, but the system still had the important
101
drawbacks of the risk of needle stick injury, the fact that the sheath could easily be dislodged and
the potential for the introduction of infection. The modified technique however, remained cost
effective and safer than the original Kron technique.
Malbrain System for Continuous Monitoring[68]
To overcome these important safety issues, Malbrain in 2004, described a system whereby a
series of three-way taps was connected between the urinary catheter and collection system. This
allowed for the addition of bladder instillate via a connected syringe and the transduction of
intravesical pressure. The system was validated by Malbrain's original study, but not
subsequently. Again the components are relatively cheap and available on the majority of
intensive care units, however the set-up is slightly more complicated and requires specific
training.
Ab-Viser System
This constitutes a commercially produced system for the measurement of intravesical pressure
and is produced by Wolfe Tory (Salt Lake City, Utah, USA). The equipment is a more refined
version of Malbrain’s concept and is supplied as a relatively straightforward package which
connects between the patient’s urinary catheter and collection bag and permits the unimpeded
flow of urine between measurements, which are gathered via a standard transducer. The inter
and intra-observer variability produced by the system have been tested and found to be low with
reported Pearson’s correlation coefficients of 0.93 and 0.95 respectively [162]. The major
disadvantages being that the system is fairly elaborate and costly and, in addition to the
componentry supplied, it also requires an electronic transducer, which further adds to costs.
102
Direct Urinary Manometry
Direct urine manometry carries the inherent advantage of simplicity and eliminates a potential
stage for the introduction of error, by doing away with the requirement for electronic transduction
devices. The pressure measured by such a system would be in cm of urine, however by
recalibration of the manometer tubing it is possible to convert the column of urine to mmHg
equivalent. A commercially produced system is available, which is relatively cheap and allows for
simple and rapid measurement of intra-abdominal pressure (FoleyManometer, Holtech Medical,
Denmark). The reliability and validity of this system has been tested previously in vitro, and found
to be good[163]. The only potential drawback of this system is a theoretical increase in risk of
urinary tract infection associated with the drainage of urine, trapped within the closed collection
system, back into the patient's bladder. This risk has been reported in only one clinical
paper[164] and the complication has never been described in relation to the measurement of
intra-abdominal pressure by this method. The commercially available device results in the return
of only a very small volume of urine with each pressure measurement (<10ml), which then drains
again from the bladder rapidly after measurement is complete.
This system represents our own method of choice for the measurement of intra-abdominal
pressure at the host institution, and this chapter describes a full clinical evaluation of the Holtech
system, with both in-vitro testing and in-vivo comparisons to the AbViser device and directly
transduced intraperitoneal pressure. Potential pitfalls of the device are also described.
103
Techniques for the Measurement of Intra-Gastric Pressure
Gastric Balloon Tipped Catheter Systems
Air or fluid filled gastric balloon systems are commercially available for the measurement of intra-
gastric pressure. Once in position, the systems are simple and quick to use, however the
drawbacks are the expense of the consumables and also the requirement for a dedicated monitor
and software system.
Direct Gastric Manometry
Some enthusiasts have reported success with fluid manometry performed via a nasogastric
tube[69, 71], with close correlation to intravesical pressure. The key to success however, is
ensuring that the stomach is completely empty of all gas prior to the instillation of the fluid
required to make the pressure measurement. Such a requirement inevitably interferes with
nasogastric feeding regimens to a degree dependant on the frequency of pressure
measurements and may also require the placement of a second nasogastric tube, with the
accompanying risks and discomfort. Finally, the agreement between intra-gastric pressure and
intra-vesical or directly transduced intra-peritoneal pressure is yet to be categorically proven.
This manoeuvre is therefore both extremely time-consuming and difficult to verify, meaning that
the reliability of the technique outside of the two reported papers is difficult to ensure.
104
Techniques for the Direct Measurement of Intra-peritoneal Pressure
Direct Intra-peritoneal Systems
A group from Israel have reported some success with the direct measurement of intraperitoneal
pressure via a PVC surgical drain. Both papers presented by the group involve the same patient
cohort and correlated the pressure transduced via a surgical drain against that measured by a
laparoscopic insufflator and by a transvesical technique respectively[165, 166]. Unfortunately the
statistical analysis of the papers is not robust, and is limited to simple correlation between the two
measurement techniques. Given that the correlation was between two different techniques for
measuring the same value (IAP), the correlation coefficient reported was excellent. This does
not, of course, provide any measure of the bias or agreement between the two measurement
methods and as such, the data presented is of very limited value.
A near identical technique for the direct transduction of intra-abdominal pressure via a surgical
drain was developed in the host institution during the work leading to this thesis, and the resulting
data is discussed in more detail elsewhere in this chapter.
A major limitation of this technique is of course, the requirement of an indwelling intra-peritoneal
drainage catheter and it is therefore limited, to all extents and purposes, to postoperative surgical
patients.
The relative merits of each of these techniques, in terms of the ideal characteristics are
summarised in Table 3.2.
105
Table 3.2.
Summary of the relative merits for various techniques used for the measurement of IAP
Safe Reliable Valid Simple Fast Economical Direct Needle Puncture (After Kron[22])
No Yes Yes Yes No Yes
Modified Kron Technique (Cheatham[30])
No Yes Yes Yes Yes Yes
Malbrain System for Continuous Monitoring[68]
Yes Yes Yes No Yes Yes
Ab-Viser Device[162]
Yes Yes Yes Yes Yes No
Foley Manometer[163]
Yes Yes Yes Yes Yes Yes
Gastric Balloon Tipped Catheter Systems[66]
Yes Yes Yes Yes Yes No
NG Tube Manometry[69]
Yes No No Yes No Yes
Direct Intra-peritoneal Catheter Systems[165, 166]
Possibly Not
Yes Yes No Yes Yes
Clinical Evaluation of 3 Systems Used for the Measurement of IAP
The host institution utilised a commercially available Foley catheter manometer
(FoleyManometer) for the measurement of intra-abdominal pressure. It was felt that, in line with
the recommendations provided by the world society of the abdominal compartment syndrome[72]
and previous research in the field[52, 77], the patients of the Liver Intensive Therapy Unit were at
particularly high risk of developing raised intra-abdominal pressure. As such, the unit wished to
promote the use of a simple and safe device, which could be used to monitor the intra-abdominal
pressure of all patients admitted to the unit. The foley manometer was felt to provide such
characteristics and was therefore adopted as the instrument of choice. The only previously
published data relating to this device is an in-vitro evaluation of its reliability and validity[163]. A
full clinical evaluation to check the validity of its measurement of both intra-vesical and intra-
abdominal pressure has not yet been performed. The remainder of this chapter therefore
106
addresses this problem, in three parts. Firstly a repeated in vitro evaluation is reported in order to
determine the reliability and validity of measurements made with the device. The Foley
Manometer is then evaluated clinically by comparing its performance to directly transduced
measures of intra-peritoneal pressure and also to the other main commercially produced device
for measurement of intravesical pressure – the AbViser. Finally, potential pitfalls of the device
are described.
107
3.2 In-vitro Evaluation of the Foley Manometer
Introduction
The Foley Manometer is a commercially produced water (urine) manometer which attaches
between the patient’s urinary catheter and the urine collection / measurement system. The
system permits free flow of urine to the collection bag between measurements and has a
calibrated scale to allow estimation of intravesical pressure by examination of a continuous
standing column of fluid from the bladder to the device. Figure 3.1.
Figure 3.1.
Set-up and use of the FoleyManometer system to measure IAP (reproduced with
permission of Holtech Ltd, Denmark)
108
A previous in-vitro analysis, which was performed around the same time as our own experiments,
has subsequently been published and has shown the device to be reliable and accurate[163]. In
this study, 15 observers (a mixture of nurses, doctors and medical students) were asked to
measure the pressure displayed by a Foley Manometer that had been connected to a standing
column of water in a plastic 3L cylinder. The measured values were compared to those obtained
from electronically transduced air filled balloon tip catheters mounted in the same device. The
bias was found to be just 0.5mmHg, with excellent limits of agreement suggesting that the device
was as accurate as the more expensive electronic systems.
Methods
An in-vitro testing system was assembled, which comprised of a Foley Manometer device set
within a 2L plastic cylinder, on which a calibrated scale was applied to convert cmH20 to mmHg.
The cylinder was filled to a set pressure (18 mmHg) and shielded behind a screen on which the
instructions for use supplied by the device’s manufacturer were mounted. Figure 3.2. & 3.3. A
block was mounted in front of the screen corresponding to the zero-reference point for the device
and this was labelled “symphysis pubis”.
A total of 40 subjects (all qualified intensive care nurses) were asked to measure the mock intra-
abdominal pressure using the experimental apparatus. Each were given the same verbal
introduction “Please read the printed instructions for the use of this device designed for the
measurement of intra-abdominal pressure and then use the apparatus to record the simulated
pressure. This is the simulated symphysis pubis to be used.” No further assistance or
instructions were given and the first response was recorded. 20 of the subjects worked in the
liver intensive care unit and were therefore familiar with the device, which had been in standard
use in that unit for around 12 months. The other 20 subjects worked in the general intensive care
109
unit of the same hospital, where IAH was not routinely measured. None of the general ITU
nurses had any prior experience of the Foley Manometer device.
Statistical Analysis
Reported IAP was collected in an excel spreadsheet (Microsoft, Washington, USA) and analysed
using SPSS (IBM, Chicago, USA).
Means were compared by way of a t test and bias / agreement, by way of Bland and Altman
analysis in line with recommendations for analysis from WSACS[141] which were described in
detail in Chapter 1.9.
110
Figure 3.2.
Manufacturers instructions supplied with the Holtech FoleyManometer (reproduced with
permission)
Figure 3.3.
Experimental apparatus constructed to simulate measurement of IAP (visual screen to
shield view of the cylinder from the subject omitted for clarity)
111
Results
All 40 subjects were able to complete the measurement successfully within 2 minutes, with only
the manufacturers instructions for guidance.
There was no difference between the mean IAP reported by either group, which was 17.9 mmHg
(p = 0.496). Table 3.3. The overall bias was 0.1 mmHg with limits of agreement of 17.5 – 18.3
mmHg. Figure 3.4. In terms of clinical significance – all reported measurements were within 0.5
mmHg of the actual simulated IAP.
Table 3.3.
Results of an in-vitro study of inter-observer variability in the use of the Holtech
FoleyManometer
n Mean Measured IAP mmHg (SD)
Absolute Bias Limits of Agreement
Liver ITU Nurse 20 17.9 (0.18)
0.1 17.5 – 18.3
General ITU Nurse
20 17.9 (0.24)
0.1 17.4 – 18.4
Overall Measurements
40 17.9 (0.21)
0.1 17.5 – 18.3
112
Figure 3.4.
Measured simulated IAP using Foley Manometer (actual IAP = 18 mmHg). Bland and Altman absolute bias and limits of agreement marked by horizontal lines. (Shade of circle reflects number of responses)
Number of Responses (Shade of circle reflects multiple identical responses)
113
Conclusion
The Foley Manometer is simple to use and requires minimal instruction / training for accurate
measurements. There is excellent agreement between measurements obtained by both
experienced and novice users and the device is accurate to within <0.5 mmHg.
114
3.3 Comparison of the Foley Manometer to Directly Transduced Intra-peritoneal
Pressure Recordings
Introduction
Whilst the measurement of intra-vesical pressure has been established as the “gold-standard”
technique for the assessment of IAP by an international panel of experts[12], this
recommendation is based on the previously unfounded assumption that the urinary bladder would
act as a passive diaphragm for the transmission of pressure, such that the pressure within the
bladder would correspond to that outside of the organ, within the peritoneal cavity. Subsequent
to the publication of the consensus definitions, it has been shown that there is good bias and
agreement between intra-peritoneal and intravesical pressure in a porcine model[167, 168],
however this data is not yet available in human subjects.
Given the acceptance and wide reporting of intravesical pressure in the diagnosis and
management of intra-abdominal hypertension and the abdominal compartment syndrome, its face
validity would seem to be assured. To be sure of the true content validity of using the Foley
Manometer to measure the intra-peritoneal pressure, we decided that its measurements should
be formally compared to pressures that were directly transduced from catheters lying within the
peritoneal cavity itself. We had developed a technique for this manoeuvre following on from the
care of a patient who had developed signs of an abdominal compartment syndrome following a
complex colorectal resection requiring a total cystectomy. The procedure had been complicated
by an anastamotic leak and with no urinary bladder available to measure intravesical pressure,
we transduced the IAP via a column of fluid “flushed” via the surgical tube drain. This revealed a
grossly elevated IAP and subsequent decompression resulted in a dramatic clinical improvement.
A near identical technique was subsequently described in Israel and we have further refined the
115
process such that small (3mm) “micro-drains” can be used to minimise risk to the patient, as the
smaller the drain tube the smaller the “dead space” that must be routinely flushed into the
peritoneal cavity, to facilitate IAP measurement.
Patients & Methods
Following approval of the study design by the local Research Ethics and Research &
Development Committees, a total of 20 patients undergoing orthotopic transplantation of a whole
liver for non-fulminant disease were recruited and gave their consent to be studied. All data were
collected during the subject’s stay on the Liver Intensive Care Unit, with aspects of postoperative
care, such as the administration of intra-venous fluids and the use of vaso-active agents, guided
by established unit protocol and individual clinician decisions. All subjects were nursed in a 30o
head of bed position to minimise the risk of respiratory complications, with the exception of short
periods (< 5 minutes) in order to measure supine IAP and all were calm and comfortable at the
time of measurement (Richmond Agitation and Sedation Scale – RASS of 0 or less)[142].
For each patient, intra-peritoneal IAP was recorded continuously via catheters placed in the
pelvis, at the time of operation (Minivac Drain, Unomedical, Worcestershire, UK). These
catheters were connected to a standard ICU monitor (Fakuda Denshi, Tokyo, Japan) via
electronic pressure transducers and were used solely for measurement of IAP and not for
drainage. Standard closed surgical drains were placed in the usual position to prevent
accumulation of body fluids.
The transducer was mounted to the patient by sutures at a point corresponding to the internal
position of the catheter tip on the lower abdominal wall – a position that was found to correspond
to the zero-reference point suggested by the WSACS, of the midaxillary line at the iliac crest
116
when supine. The transducers were flushed and zeroed twice daily and also following each
position change. The measured dead space of the catheter was <2ml and so a 4ml flush with
normal saline, from a sterile closed system, ensured a continuous column of fluid between the
intra-peritoneal catheter tip and the transducer which was maintained between flushes by
continuous low volume irrigation. The quality of the pressure waveform was checked hourly by
the “rapid oscillation test[68]”, whereby rapid and repeated palpation of the abdominal wall at the
level of the intra-peritoneal catheter tip was visible in real-time on the ICU monitor’s pressure
trace.
The catheters were left in place for a maximum of 72 hours, or until the point of discharge from
the Liver Intensive Care Unit, whichever came sooner.
Each patient was repositioned to lie supine at 6 hourly intervals (4 times per day) in order to
measure the supine IAP. The transducers were “re-zeroed” following each position change and
the pressure allowed to equilibrate for 5 minutes, prior to making each of these recordings. At the
same time points, the intravesical pressure was monitored by means of the Foley Manometer and
paired measurements recorded at both supine and 30o head of bed angles. All patients were
passing urine at the time of the measurements and, for the Foley Manometer device, urine was
used to measure IAP with no requirement for instillation of additional fluid.
117
Statistical Analysis
The data were recorded in a Microsoft Excel Spreadsheet (Microsoft, WA, USA) and analysed
using SPSS v15 (Chicago, IL, USA) in accordance with the recommendations for data analysis
published by the World Society for the Abdominal Compartment Syndrome[141] and described in
detail in Chapter 1.9. The normality of distribution of the pressure recordings was tested using a
Kolmogorov Smirnov test and, being parametric and normally distributed, means were compared
using a paired t-test.
The bias and agreement between the indirect and direct means of measuring pressure at the
urinary bladder were calculated using the Bland and Altman technique [169]. In accordance with
these recommendations – measurements were considered equivalent when the measure bias did
not exceed 1 mmHg, the precision 2 mmHg and the limits of agreement +/- 4 mmHg.
118
Results
A total of 169 paired pressure measurements were made at supine and 30o body positions.
Table 3.4. Figures 3.5, 3.6 & 3.7.
There was no clinically relevant difference between the mean measurements made via the pelvic
transducer and the FoleyManometer. The Bland and Altman analysis confirmed excellent
agreement between the two measures in both body positions, with a calculated bias and
precision of 0.06 mmHg and 0.6 when supine and 0.01 mmHg and 0.6 at 30o.
Table 3.4.
Results of comparison of IAP measurements made using the Holtech FoleyManometer and
via direct transduction of pelvic intra-peritoneal pressure
Comparisons n Mean IAP
Range IAP
Bias Precision Limits Of
Agreement All 338 9.43 0 - 19 0.03 0.59 -1.1 – 1.2
Supine 169 9.23 0.5 – 18 0.06 0.62 -1.2 – 1.3 30o 169 9.63 0 - 19 0.01 0.55 -1.1 – 1.1
(Results are presented in accordance with the WSACS guidelines for data analysis whereby the
bias represents the mean difference between measurements techniques, the precision is the
standard deviation of the bias and the limits of agreement the 95% confidence intervals of the
bias)
119
Figure 3.5.
Bland and Altman Plot to compare intra-vesical pressure (IBP) to lower intra-abdominal
pressure (LIAP) at both 0o and 30o head of bed angles
Figure 3.6.
Bland and Altman Plot to compare intra-vesical pressure (IBP) to intra-abdominal pressure
(LIAP) at 0o (supine) head of bed angle
120
Figure 3.7.
Bland and Altman Plot to compare intra-vesical pressure (IBP) to lower intra-abdominal
pressure (LIAP) at 30o head of bed angle
Conclusion
This experiment has shown that, in the absence of known intrinsic bladder pathology (no reported
bladder symptoms), there is no difference between the pressures measured within the urinary
bladder and immediately outside in the peritoneal cavity itself. This lends support to the
hypothesis that the bladder does indeed act as a passive diaphragm for the transmission of IAP
and supports the recommendation that the intravesical pressure may be considered the gold
standard for IAP monitoring.
121
3.4 Comparison of the Foley Manometer and AbViser Device
Introduction
Whilst the measurement of intravesical pressure has been proposed as the gold-standard for
clinical measurement of IAP, the ideal device has not been defined. We have shown that the
Foley Manometer is valid and reliable in the in-vitro environment and that it corresponds well to
IAP transduced directly from an intra-peritoneal catheter. This series of experiments were
intended to test its clinical performance against the main alternative commercial system produced
to measure intravesical pressure. The AbViser system consists of an electronic switch device
which lies within an extension to the urinary catheter collection tubing and which, when activated
by a manual fluid flush, temporarily diverts the catheter stream to an electronic pressure
transducer which displays the measured pressure exerted by the column of urine originating in
the bladder. Figure 3.8. The device has previously undergone in-vitro evaluation against a
standing column of water and found to be accurate to within 1 mmHg[170].
Figure 3.8.
The AbViser system to measure intra-vesical pressure (Wolfe Tory, Utah, USA)
122
Methods
Following approval of the study design by research ethics and local research and development
committees, 20 patients receiving postoperative critical care on the Liver Intensive Care Unit gave
consent to be studied.
The AbViser device was fitted to the urinary collection tubing in series with the Foley Manometer,
such that neither device would interfere with recordings made using the other. IAP was
measured at a range of body positions (0, 15 & 30 degrees), by the same investigator at 8 hourly
intervals for up to 72 hours following admission, or until discharge from ITU, depending on which
came sooner. All patients were calm and comfortable at the time of measurement, with a
Richmond Agitation and Sedation Scale (RASS) score of 0 or less[142].
Statistical Analysis
Data were recorded in an Excel (Microsoft, Washington, USA) spreadsheet and analysed by the
Bland and Altman technique in accordance with the recommendations for research published by
the WSACS[141]. All statistical analyses were performed using SPSS (IBM, Chicago, USA).
Results
Of the 20 patients studied, 12 had undergone elective orthotopic transplantation of a whole or
split liver graft, 6 had undergone pancreatoduodenectomy and 2 major liver resection. The mean
IAP was 12.6 mmHg across a range from 0 – 28. One of the patients required reoperation for
postoperative haemorrhage following liver transplantation, which was manifest through
haemodynamic instability and a rising IAP.
A total of 378 paired pressure measurements were recorded over the study period and no
measurements were missed due to patient agitation. Table 3.5. & Figure 3.9.
123
The agreement between the two measurement techniques was excellent with a calculated bias of
0.09 mmHg and all of the measurements fell within the required limits of agreement of +/- 4
mmHg.
Table 3.5.
Results of the comparison of IAP measured using the Holtech FoleyManometer and
AbViser systems
n Mean IAP (mmHg)
Range (mmHg)
Bias (mmHg)
Precision (mmHg)
LA (mmHg)
378 12.6 0 - 28 0.09 1.03 -1.97 – 2.15
Figure 3.9.
Bland and Altman Plot to compare IAP measured using the Holtech FoleyManometer and
Abviser systems
124
Conclusion
The Foley Manometer offers identical performance to the AbViser device for the measurement of
intra-vesical pressure. It carries the advantages of being substantially cheaper and simpler than
its competitor.
125
3.5 Summary and Conclusion
Measurement of the intravesical pressure for the assessment of IAP is now standard practice,
although there remain a variety of techniques available and no consensus as to which is best.
For the reasons outlined above, we favour the Foley Manometer as being the simplest, easiest
and safest device, whilst also offering good value for money.
Through the experiments outlined in this chapter, we have shown firstly that measurement of
intravesical pressure carries content validity to match its face validity in estimating IAP - in that
there is no clinical difference (as demonstrated by the Bland / Altman Analysis) between
pressures measured within and outside of the urinary bladder. Though this assumption has long
been accepted, our results add weight to the previous animal models to address this question
and represent the first human evidence that this is so.
We have demonstrated that the Foley Manometer is simple and quick to use and that, with
minimal instruction, accurate and consistent results may be obtained by experienced and novice
users alike. Finally the clinical validity of the device has been examined by its comparison to an
alternative and established commercially produced system. We have found that there is no
difference between these two devices in their ability to repeatedly and accurately measure
intravesical pressure. In conclusion therefore, we would suggest that the measurement of
intravesical pressure is indeed a valid and reliable clinical and research tool. Furthermore, we
would advocate the use of a Foley Manometer for this purpose in view of its simplicity, accuracy
and safety to both patient and clinician coupled with it representing the best economic value
against its commercial competitors.
126
Chapter 4
Sources of Error in the Use of the Foley Manometer for the
Measurement of Intra-abdominal Pressure
127
4.1 Introduction
Prior to the publication of the 2006 consensus definition statements[12] there was significant
variation in the reporting of data relating to intra-abdominal pressure. With specific reference to
the measurement of IAP, several potential sources for variation and error had been identified and
the consensus definitions used the best available evidence to make suggestions in order to
harmonise practice as far as possible.
There were three major points for deliberation;
1. The interchangeable use of the symphysis pubis, the phlebostatic axis and the anterior
superior iliac crest in the mid-axillary line as the ideal zero-reference point
2. The ideal volume that should be instilled into the bladder prior to pressure recording
3. The effects of body position on intra-abdominal pressure.
Data collection for this thesis began prior to publication of the consensus guidelines and
therefore, in view of the known deliberations, a series of experiments were planned to try to
determine more exactly the impact of these various factors on the performance of the Foley
Manometer device, in order to define and avoid any potential source of error.
Following discussions with other researchers at the 2nd meeting of the World Society for the
Abdominal Compartment Syndrome in 2007, it was agreed that further data collection should be
performed in these areas and be shared in the context of an agreed common protocol to produce
two international multi-centre studies. This chapter therefore addresses the issues of zero-
reference point and body position both from our own local data and in the context of two multi-
128
centre studies[171, 172] to which we contributed data (both of which are included in the appendix
– 2.iii & 2.iv).
In addition to the shared data a novel anatomical study of the ideal zero-reference position is
described and, for the sake of completeness, a note on the discovery of a problem of “vapour
lock”, which is particular to the Foley Manometer.
129
4.2 Determining the ideal zero-reference point for the measurement of IAP
Prior to the consensus definitions of 2006 there was a disparity in the zero-reference position
used for the measurement of IAP, with most researchers using the symphysis pubis (SP), some
the iliac crest in the mid-axillary line (IC) and a few using the same “phlebostatic axis” (PA) used
for right atrial pressure measurements. The ideal zero-reference point would of course
correspond with the external position of the tip of the measurement device – cf the transduction of
right atrial pressure. As this anatomical point was not known, the assumption was that the three
reference points detailed above would be interchangeable. This assumption was untested
however and the actual impact of the zero-reference point on the measured IAP was not known.
Our own experiments had begun prior to the publication of the consensus definitions and had
used the SP, in line with the manufacturers instructions supplied with the Foley Manometer
devices. Subsequently, the international panel of experts suggested that the iliac crest in the
mid-axillary line should be used, on the basis that it was more easily palpated.
In order to investigate the impact of the reference point we performed three sets of experiments;
1. The first was an anatomical study to ascertain the measured distance between the tip of
the urinary catheter (the theoretical ideal zero-reference point) and the bony landmarks of
SP and IC.
2. We compared the IAP measured using a Foley Manometer at the SP and IC in 20
patients.
3. Following discussions at the World Congress, we participated in an international multi-
centre study to compare IAP using the SP, IC and PA zero-reference points, using the
AbViser device - contributing 20 patients to a total of 132 studied (the 5th highest
contribution from a total of 12 centres).
130
An anatomical study of the potential zero-reference points for the measurement of IAP
Introduction
As previously stated, the ideal zero-reference point for the measurement of intra-vesical pressure
would be at a fixed and easily palpable bony landmark which corresponds to the location of the
tip of the urinary catheter (the tip of the measurement device). Following insertion, the catheter
can be expected to slip back until the balloon impacts upon the bladder neck. Thereafter, the
location of the catheter tip can be expected to remain consistent, and indeed this assumption
underlies the use of the urinary catheter for the measurement of IAP - this point can be identified
by locating the catheter balloon, on CT imaging of patients who had a urinary catheter in-situ.
This study therefore considered the variability of the distance between the balloon of the urinary
catheter and the bony landmarks of the symphysis pubis and the iliac crest.
Methods
Axial abdominal computed tomograms (CT) of 200 (100 male and 100 female) consecutive,
catheterised critical care patients were reviewed in conjunction with an experienced consultant GI
radiologist (PK). The distance between the centre of the inflated catheter balloon (equating to the
effective tip of the catheter) and the clear anatomical landmarks of the anterior surface of the
symphysis pubis and iliac crest were measured using the inbuilt measurement function of the
viewing software – accurate to 0.1mm (PACS, Phillips CE, England). Figure 4.1.
131
Figure 4.1.
Distance was measured from the centre of the catheter balloon to the bony landmark (in
the case of the iliac crest the catheter tip and landmark were identified on different slices)
Statistical Methods
The data were tested for normality of distribution, using a Kolmogorov Smirnov test and, having
been found to be normally distributed, means were compared using a related samples t-test.
Descriptive data is presented as means with standard deviations and box and whisker plots are
included to demonstrate the variance between the two landmarks – this non-parametric
presentation of the median, interquartile range and range provided the best graphical
representation of the observed variance.
132
Results
There was a statistically, though not clinically, significant difference between the mean distance
between the catheter tip and Symphysis Pubis (SP) and the catheter tip and the Iliac Crest (IC)
p=0.002. The mean measured distance from SP was 51.7mm (+/- 8.7) versus 49.3mm (+/- 13.3)
for IC.
Table 4.1.
Mean and standard deviation of distance (mm) between bony landmarks and catheter
balloon (bladder neck)
Group SP Distance +/- Standard (mm) Deviation
IC Distance +/- Standard (mm) Deviation
Males 53.0 9.0 48.7 12.8 Females 49.8 7.8 50.1 13.9 Overall 51.7 8.7 49.3 13.3
Similar results were seen for both males and females with no significant difference between
genders for either SP (p=0.74) or IC (p=0.18) distances – though an interesting gender difference
was observed with women exhibiting a shorter distance between SP and the catheter balloon and
a longer distance between the IC and the situation reversed in males. Again this was not
clinically significant.
In all cases, the observed individual variation in measured distance was greater when using the
IC reference point, compared to SP.
Figure 4.2.
133
Figure 4.2.
Median distance between bony landmarks and catheter balloon (bladder neck) overall and
split by gender (Median, Inter-quartile Range & Range)
134
The effect of different zero-reference transducer positions on the measurement of IAP
Patients & Methods
Two sets of experiments were performed, each recruiting 20 subjects locally and having been
approved by research ethics and local research and development committees.
Local Study
20 post-operative patients were recruited and consented to be studied. All of whom had
undergone liver transplantation of either a whole or split orthotopic graft. At the time of
measurement, all subjects were calm and comfortable with a Richmond Agitation and Sedation
Scale (RASS) score of 0 or less[142]. Intra-abdominal pressure was measured supine using a
Foley Manometer with both the bony symphysis pubis (SP) and the iliac crest in the mid-axillary
line (IC) as zero-reference points on 2 occasions for each patient at least 1 hour apart. A total of
40 paired pressure measurements were therefore recorded.
Statistics
The measurements were tested for normality of distribution by way of a Kolmogorov Smirnov test
and means compared by way of a paired t-test. Bland and Altman plots were constructed to
display agreement and bias calculated with corresponding limits of agreement.
Contribution to multi-centre study
An additional 20 patients were contributed to a multi-centre trial conducted by the World Society
for Abdominal Compartment Syndrome Clinical Trials Group. The study recruited patients
between 1st August and 31st December 2006 (subsequent to the local study described above).
My contribution was review of the study protocol, collection and submission of the local data and
135
editing of the final manuscript. The complete dataset was analysed by the first author in line with
the agreed protocol. The 20 patients submitted constituted 15% of the total study population.
The inclusion criteria selected patients aged more than 18 years, who were sedated and
mechanically ventilated, and demonstrated at least one risk factor for intra-abdominal
hypertension as proposed by the WSACS.
Of the 20 patients contributed to the study – 12 had undergone orthotopic liver transplantation of
either a whole or split graft and 8 were suffering from acute liver failure requiring sedation and
ventilation.
Three reference levels were identified and marked on the skin with the patient in the supine
position: the symphysis pubis (SP), the phlebostatic axis (PA) at one half of the patient’s
anteroposterior diameter below the sternal angle, and the midaxillary reference level at the iliac
crest (IC).
For each patient, three sets of IAP measurements were performed at least 4 hours apart after
instillation of 20ml of room-temperature saline using an AbViser device (Wolfe-Tory Medical,
Utah, USA).
Statistics
Statistical analysis was performed using Medcalc (Medcalc, Mariakerke, Belgium). IAP
measurements obtained at the different transducer levels were compared using a paired T-test
and agreement explored by means of the Bland and Altman technique.
In line with the WSACS recommendations, the difference was considered to be clinically non-
significant if the bias did not exceed 1mmHg (either positive or negative) and the precision was
not higher than 2mmHg.
136
Results
Data is presented from both studies relating to the SP and IC reference points. The findings from
both sets of experiments were similar with a mean difference between the SP and IC reference
points (absolute bias) of 3.3 mmHg for the local study and 3.8 mmHg for the multicentre study.
The IC IAP was always found to be higher than the SP IAP, and there was no clinically significant
difference in the overall bias between the two sets of subjects (Local vs Multi-centre). Table 4.2.
& Figure 4.3
Table 4.2.
Comparison of IAP measured at symphysis pubis and iliac crest zero-reference points –
local and multi-centre data presented
n
Range of IAP
(mm Hg)
Mean SP IAP
(mm Hg)
Mean IC IAP
(mm Hg)
Bias (mm Hg)
Precision Limits of Agreement
Local Study
20
1 – 18
7.7
11.0
3.3
0.83
-4.96 to
-1.64 Multi-centre Study
132
2 - 29
8.2
12.4
3.8
3.03
-2.16 to
9.71
137
Figure 4.3.
Bland and Altman Plots comparing symphysis pubis and iliac crest zero-reference points
for the measurement of IAP from multi-centre data (left) and local study (right)
Discussion
Accuracy and reproducibility of measurement is key to the successful management of patients
with raised intra-abdominal pressure (IAP) and improved acceptance of IAH / ACS as a concept.
Though the symphysis pubis (SP) has been the traditionally accepted reference point, this has
more recently been revised to the iliac crest in the mid-axillary line (IC), in order to overcome
perceived inaccuracies in locating the SP.
The current data represents the first anatomically based approach to locating the ideal reference
point for IAP measurement. The theoretical basis for a zero-reference point suggests that it
should represent the position of the tip of the measurement device, hence the phlebostatic axis,
which equates to the level of the aorta, right atrium and pulmonary artery, is used for
cardiovascular measurements. For the transvesical measurement of IAP therefore, the actual
zero-reference point should lie at a point equating to the tip of the urinary catheter within the
138
bladder. As this is clearly impalpable in the clinical setting a reliable anatomical landmark is
required to act as a surrogate reference point, and this should be as close to the actual catheter
tip as possible, with the minimum of variation between individual patients and genders.
Our data suggest that both the SP and IC are located around 4cm anterior to the tip of the urinary
catheter and although there is a statistical difference between the two landmarks in terms of their
distance to the catheter tip (2.4mm), this is not clinically relevant. There is a marked difference
however in the variance between individuals, of measurements between the two points, with a far
tighter range associated with the distance to the catheter tip from the SP than from the IC. This
observation holds true for subjects when considered as a whole and within the two separate
gender groups, meaning that the SP is far more consistent in terms of its anatomical relation to
the catheter tip.
Given the lack of a clinically significant difference in the anatomical distance of the two bony
landmarks from the catheter tip, it was interesting to see that there did appear to be a clinically
significant difference in IAP measured from each of these two zero-reference points. The fact
that the bias between measurements in the local 20 patient study and also the multi-centre 132
patient study was virtually identical (3.3 & 3.8 mmHg) is striking and clearly adds significant
credibility to the hypothesis that despite no demonstrable anatomical difference – these two
reference points can clearly not be considered as interchangeable. It is possible that the clinical
discrepancy results from difficulty in reliably locating one or either of the landmarks – though
neither of the studies described were designed to address this question.
The variation in measurements and limits of agreement were far tighter in the smaller local study,
which may reflect the fact that all of these measurements were performed by the same
investigator (ABC), or may reflect a genuinely wider distribution of measurements in the larger
139
sample size of the multi-centre study. Despite this possible evidence of some degree of inter-
observer variability, it was interesting that the limits of agreement for the measurements made
across 12 centres still fell within the clinically acceptable range, whilst the bias was greater than 2
mmHg.
The expert’s consensus decision to reject the SP in favour of the IC was made on the subjective
presumption that the IC was more readily palpable and that measurement at the SP could vary
depending on whether the bony landmark proper or the fat pad were used[74]. It is ironic
therefore that the SP appears to have a more consistent anatomical relationship to the bladder
neck and further research is needed to support the assertion that the bony SP is difficult to locate
leading to clinically significant inter-observer variability. The clear and convincing clinical
discrepancy between the two reference points and the anatomical variability between subjects
does however lend weight to the more contemporary view that it remains most important to use a
zero-reference point consistently and interpret IAP as a trend recording rather than an absolute
value.
140
4.3 The Effect of Body Position on Measured IAP Introduction
Most descriptions of techniques for the measurement of IAP suggest that the patient should be
positioned supine to conduct the measurements in order to reduce error and improve accuracy,
as a results, the majority of the clinical data available on measurement techniques is taken in the
supine position[22, 30, 65, 68, 70, 163, 173]. The expert recommendations recognised early,
unpublished work suggesting that IAP may be influenced by body position however and stated
that the effect of position should be taken into account in patients in whom IAP was borderline for
diagnostic criteria, when measured in the supine position[74]. This is a particularly important
topic given that the majority of critical care patients are now nursed in a “head-up” position to
reduce the incidence of respiratory complications[174] and therefore, returning them to a supine
position in order to measure IAP may result in an under-estimation of the bladder pressure
following repositioning. There are also a sub-group of patients in whom supine positioning may
be inherently troublesome – such as those patients who are conscious and in discomfort, or those
with elevated intra-cranial pressure, whose condition may be exacerbated by even brief changes
in bed position.
Two previous studies have examined the potential error induced by body positioning, suggesting
that a more upright position was associated with an increase in measured IAP over the supine
position - both studies were however unfortunately flawed in their methodology. One had used
an excessively large bladder priming volume[175], which is known to also artificially increase the
measured IAP (see section 4.4 of this chapter) and the second study used an unvalidated
continuous measurement system to acquire data[176].
141
Having completed a full in-vitro and clinical evaluation of the Foley Manometer system,
comparing it both to direct measures of IAP and another commercially available device (the
AbViser), we wished to examine the effect of body position on IAP measured using the Foley
Manometer and conducted a local study of 20 patients at various head of bed angles.
Having discussed our own unpublished preliminary data with the WSACS clinical trials working
group at a World Congress meeting, it was also decided to incorporate a study of the effect of
body-position into the protocol of the international multi-centre study of zero-reference position
using the AbViser device as described in the previous section of this chapter. Again therefore,
we present both the results of our own local study along with the multi-centre WSACS study
looking at the same issue. As previously, we contributed to the protocol design and review of the
multi-centre study and formed one of 12 centres supplying data.
142
Patients & Methods
Two sets of experiments were performed, each recruiting 20 subjects locally. Both studies had
been separately approved by research ethics and local research and development committees.
Local Study
20 post-operative patients were recruited – all of whom had undergone liver transplantation of
either a whole or split orthotopic graft. At the time of measurement, all subjects were calm and
comfortable with a Richmond Agitation and Sedation Scale (RASS) score of 0 or less[142]. Intra-
abdominal pressure was measured using a Foley Manometer with bed angles of 0, 15 and 300
(as indicated by the built in indicator on the ITU bed) on 2 occasions for each patient, at least 1
hour apart. The zero-reference position for measurements was the symphysis pubis. A total of
60 paired pressure measurements were therefore recorded.
Statistics
The measurements were tested for normality of distribution by way of a Kolmogorov Smirnov test
and means compared by way of a paired t-test. Bland and Altman plots were constructed to
display agreement and bias calculated with corresponding limits of agreement.
WSACS multi-centre study
20 patients were contributed to a multi-centre trial conducted by the World Society for Abdominal
Compartment Syndrome Clinical Trials Group. The study recruited patients between 1st August
and 31st December 2006 (subsequent to the local study described above) and my contribution
was review of the study protocol, collection and submission of the local data and editing of the
final manuscript. The complete dataset was analysed by the first author in line with the agreed
protocol.
143
Of the 20 patients contributed to the study – 12 had undergone orthotopic liver transplantation of
either a whole or split graft and 8 were suffering from acute liver failure requiring sedation and
ventilation.
For each patient, three sets of IAP measurements were performed at least 4 hours apart after
instillation of 20ml of room-temperature saline using an AbViser device (Wolfe-Tory Medical,
Utah, USA). Each set of triplicate measurements were made at head of bed angles of 0, 15 and
300, using the iliac crest at the mid-axillary line as the zero-reference position. For each patient,
this anatomical landmark was marked on the skin at the time of the first set of measurements to
ensure consistency of use for the subsequent sets.
Statistics
Statistical analysis was performed using Medcalc (Medcalc, Mariakerke, Belgium). Mean
differences between IAP measured in the standard supine position and the two experimental
head of bed positions (15 & 30o) were compared using a paired T-test and agreement between
the positions explored by means of the Bland and Altman technique.
In line with the WSACS recommendations, the difference was considered to be clinically non-
significant if the bias did not exceed 1mmHg (either positive or negative) and the precision was
not higher than 2mmHg.
144
Results
The findings from both sets of experiments were remarkably similar, despite each being from
different patient groups and using different measurement devices, with different zero-reference
points.
The mean measured IAP was similar and the absolute bias between measurements made at
supine and 15 or 300 head of bed positions was virtually identical in both studies, with a
significant difference between measured IAP at each of the body positions. Table 4.3. and
Figures 4.4. & 4.5.
Table 4.3
The effect of body position on measured IAP - local data and results of multi-centre study
Mean IAP (mmHg) Body Position Local Data Multi-centre Data
Supine (0o) 11.0 12.1 15o 12.4 13.6 30o 14.9 15.8
Body Position
Bias Precision Limits of Agreement t-test p
Local WSACS Local Local WSACS Local WSACS 0 – 15o 1.4 1.5 0.74 -0.1 – 2.9 -2.8 – 5.8 <0.001 <0.001 0 – 30o 3.9 3.7 1.12 -1.7 – 6.1 -2.2 – 9.6 <0.001 <0.001
145
Figure 4.4. Bland and Altman Plot comparing IAP measured with a supine body position and a 15o head of bed angle (local data)
Figure 4.5. Bland and Altman Plot comparing IAP measured with a supine body position and a 30o head of bed angle (local data)
146
Discussion
The fact that the data from our own small, preliminary study are so closely matched to that of a
much larger multi-centre study, add weight to the observation that increasingly upright patient
positioning seems to result in both statistically and clinically significant increases in measured IAP
at the bladder. This would suggest that body position is indeed a significant potential source of
error that must be standardised between measurements for both clinical and research purposes.
What is not clear from either set of data, is whether the increase in bladder pressure observed as
the head of bed angle is increased is simply an effect of gravity and increased compression of the
bladder by the other abdominal viscera or whether the change in body position does result in a
genuine increase in the intra-abdominal pressure. If the former then the recommendation should
remain, that IAP only be measured when the patient is supine in order to eliminate this potential
measurement artefact. If the latter however, there would be implications for cases of borderline
raised IAP in that measuring the pressure with the patient positioned supine may actually mask a
clinically significantly rise in IAP when the patient is returned to the standard 300 head of bed
nursing position. Lying such patients flat for a period, whilst conservative measures such as
drainage of collections, sedation or naso-gastric suctioning are implemented may then provide a
means for temporary relief in these borderline cases with the possibility of avoiding formal
decompression - though it is a weakness of the study that mean arterial blood pressure (MAP)
was not recorded at the time of the pressure measurements. Knowing the MAP in this context
would have allowed calculation of the abdominal perfusion pressure (APP) as it is likely that MAP
may have also changed with the change in position, with the potential to either protect, or more
likely, further impair the APP. With this in mind, it would also have been interesting to study any
difference between whole bed angulation, using the reverse trendelenberg position, over
“breaking” the head end of the bed to 30o.
147
Further study is required to consider the pressure within the upper and lower abdomen to firstly
determine whether any regional pressure differences exist and also, if they do, what the effects of
changes in body position are on each compartment.
Very limited data currently exits on the synchronous measurement of upper and lower IAP, with a
small study conducted in patients undergoing laparoscopic cholecystectomy where the IAP was
artificially elevated by a laparoscopic gas insufflator showing that there was a difference of
several mmHg between bladder and gastric pressure[69]. A further report of 2 patients with intra-
abdominal complications has suggested that a regional pressure difference may indicate and
indeed localise the source of intra-abdominal pathology[177]. Current data is therefore unclear
as to whether regional pressure differences are to be expected as a matter of routine, or whether
they may indicate the presence of a pathological process.
We have gone on to consider the effect of body position on compartmental intra-abdominal
pressure following liver transplantation in chapter 6, which provides further information on this
interesting phenomenon.
Finally – more recent interest has suggested that body anthropomorphics may have an impact on
the transmission and measurement of IAP[178]. It is possible therefore that specific constitutional
factors, such as body mass index (BMI) and perhaps even also anatomical considerations such
as abdominal AP to lateral diameter ratio, or the ratio of torso to limb length may also impact on
positional changes in IAP. Future studies must therefore seek to address these observed
changes in the context of both dynamic physiological and fixed anatomical variables, unique to
the individual.
148
Conclusion
In keeping with a larger multi-centre study to which we contributed, our local data confirms that
IAP is significantly altered by changes in body position. Further research is however required to
determine whether these differences are simply due to measurement artefact or whether they
have any clinical significance and whether they are reflected uniformly throughout the peritoneal
cavity. Future studies must be widened to collect more extensive physiological and anatomical
variables in order to aid the interpretation of the observed changes in IAP.
149
4.4 The Effect of Bladder Instillate (Priming) Volume on the Measurement of IAP
Introduction
Whilst intravesical pressure measurement is now well established, the most reliable technique
remains unclear and the volume of fluid to be instilled into the bladder prior to measurement
remains a topic for debate, with various volumes having been studied and described for use with
the mainstream measurement techniques. For technical success, there must be a continuous
column of fluid between the urinary bladder and the measurement device in order that the
pressure may be accurately transmitted.
In Kron’s first description of his popular technique[22] (needle transduction of IAP via the
aspiration port of urinary catheter), a bladder volume of 50 – 100mls was recommended and
subsequent authors, who have suggested further refinements of this technique, have proposed
anything from 50[30] – 250mls[64].
Accuracy and reproducibility are clearly the key concerns and the current recommendations[74]
favour a low volume of instillate, with 25mls suggested as the ideal. There is however, a lack of
concrete evidence for this volume and a number of studies, some from the same author, have
produced some conflicting results. It has certainly been shown that large bladder volumes
(>364mls) will stimulate contractions of the abdominal wall musculature[179], along with some
evidence that chilled water will result in spasm of the smooth muscle of the bladder itself[67].
There is a further concern however, that even much smaller increases in bladder volume will
produce changes in the mechanical properties of the bladder wall, either through passive
elasticity or through stimulation of detrusor contraction, that may lead to elevation of the
intravesical pressure to a level beyond the actual IAP.
150
It is possible that the ideal priming volume is dependant on the technique chosen and the variety
of published data may be a reflection of this. Whilst the priming volume has been studied for
many of the common measurement techniques, no data exist in relation to the Foley Manometer.
Priming Volume with Kron Technique
Kron’s initial description of the needle transduction technique in 1984 suggested that the urinary
bladder should be primed with 50 – 100mls of saline, in order to ensure a continuous column of
fluid. The effect of the volume of instillate on measurements made using the Kron technique has
been examined by two groups of researchers. In 2001, Fusco[173] and colleagues compared
IAP measured with instillate ranging in 50ml increments from 0 – 200mls in 37 patients
undergoing laparoscopic surgery and compared this to the pressure supplied by the gas
insufflator. They found that for IAPs < 25mmHg, the lowest bias was achieved with a priming
volume of 0ml (0.8 mmHg) and that the bias rose sequentially with increased instillate (3.5 mmHg
at 50mls, 4.6 at 100, 4.6 at 150 & 5.2 at 150). Unfortunately, the accuracy of laparoscopic
insufflators are insufficient to render the absolute measurements of bias as meaningful, however
the upward trend in bias with increasing priming volume is interesting.
With the apparent switch to minimal priming volumes, a more recent study by Hunt[180] in 2012,
recruiting 37 patients, showed no difference in IAP measured by the Kron technique with priming
volumes of 10 and 25mls. The absolute bias between these two volumes was 1.5 mmHg, which
the authors did not consider to be significant and their recommendation was for the smallest
volume of instillate required to fill the deadspace of the urinary catheter as far as the transducer.
151
Priming volume with the Malbrain technique
Malbrain’s modification for the addition of a series of 3-way taps to enable priming and
measurement of IAP via the urinary catheter without repeated puncture of the aspiration port has
been studied by two groups, with broadly similar results. In a series of experiments in 2006,
Malbrain documented a sequential increase in bias between measurements performed with
increasing priming volumes between 25 and 300mls[181] in 13 subjects. Table 4.4. It was
concluded that a priming volume of greater than 50mls leads to a clinically significant increase in
IAP reading.
Table 4.4.
Summary of the effects of bladder priming volume on the measured IAP expressed as bias
over measurement obtained with a 25ml priming volume (Malbrain[181])
Priming Volume Bias over 25mls Prime
50 1.5
100 2.5
150 5.5
300 11
These findings were confirmed a year later by Chiumello[182], who again studied 13 patients and
found that a difference in priming volume of 50 – 100mls resulted in a bias of 4.2 mmHg, which
although they did not find to be statistically significant (by 2-way ANOVA, rather than by Bland
and Altman analysis), could certainly be considered as a clinically significant difference. Also of
interest in this groups findings was that saline introduced at room temperature produced a
significantly higher IAP (average bias 1.2 mmHg) than that at body temperature, suggesting that
152
temperature as well as volume may influence measurements – most likely through alterations in
detrusor contractility.
Priming volume with the Cheatham technique
The Cheatham modification for an indwelling measurement cannula in the urinary catheter, was
first described with a priming volume of 50mls[30]. In 2006, De Waele studied the effect of
priming volumes between 0 and 100mls in 20 sedated and ventilated patients[67]. It was found
that a volume of 10mls was the minimum required to provide an accurate measurement and that
volumes of 50 and 100mls were associated with a measurement bias of 2.2 and 4.3 mmHg
respectively. These findings have leant further support to the use of minimal priming volumes.
Summary
Whilst it would seem that the various measurement techniques are susceptible to a greater or
lesser degree to induced error due to priming volume, it is apparent that the measured pressure
by all techniques is elevated as the volume of bladder instillate increases. The ideal
measurement device would therefore be that which is the least sensitive to such induced error
and comparative data for the Foley Manometer is therefore required.
153
Methods
20 Patients gave their consent to be studied, following orthotopic transplantation of a whole or
split liver graft. Measurements were recorded immediately on return to the Liver Intensive Care
Unit following the transplant procedure and whilst the patients were sedated and ventilated, with a
Richmond Agitation and Sedation Scale score of -4 or -5 (deeply sedated or unrousable)[142].
IAP was measured using the Foley Manometer in accordance with the manufacturers
instructions, with priming volumes of saline (at room temperature) from 0 – 200mls at 10ml
increments. All measurements were completed by a single researcher (ABC) allowing 2 minutes
for pressure to equilibrate following each instillation of additional fluid before each pressure was
recorded. The urine collection tubing distal to the Foley Manometer device was clamped
between each measurement to prevent drainage of the fluid added at each increment, but the
tubing was unclamped once the apparatus was elevated in order to ensure that each
measurement was complete accurately.
The typical bladder volume producing a desire to micturate in the conscious patient is around
200ml and the Research and Ethics Committee refused permission to study volumes greater than
200mls in unconscious patients, in order to avoid any possibility of inadvertent over-distension of
the bladder.
Statistical Analysis
Data were collected in an excel spreadsheet (Microsoft, Washington, USA) and analysed using
SPSS (IBM, New York, USA). The observed values for bias were tested for normality of
distribution by way of a Kolmogorov Smirnov test and were not found to be normally distributed.
Median IAP with priming volumes of 10, 50, 100 and 200mls were therefore compared using a
154
Wilcoxon signed rank sum test. Clinical differences between the IAP measurements with these
priming volumes were examined using the Bland and Altman technique.
In order to identify the threshold volume increase in priming fluid which produced an increase
(bias) in measured IAP of 1 mmHg over baseline, pressure / volume curves for both group means
and individual values of IAP were plotted.
155
Results
All measurements were completed in the 20 subjects resulting in a total of 420 pressure
recordings with a median baseline IAP with a 0mls priming volume (urine present in tubing only)
of 11.5 mmHg and ranging from 4 to 18 mmHg. When the maximum priming volume of 200mls
was reached, the median recorded IAP increased to 15.7 mmHg with a range of 7 – 22 mmHg.
The measured IAP at 0 and 10mls priming volume was identical in all subjects. Table 4.5. and
Figures 4.6, 4.7 & 4.8.
The measured bias at 50, 100 and 200mls was not normally distributed when examined using a
Kolmogorov-Smirnov test. Median IAP was statistically significantly different between priming
volumes of 10 and 50, 100 and 200mls (p = 0.014, <0.001 & <0.001 respectively). There was no
clinically significant difference between priming volumes of 10 and 50mls however, with an
observed absolute bias between measurements of just 0.29 mmHg and a precision of 0.46 –
falling well within the required range stipulated by the WSACS for equivalence of
measurements[141]. Priming volumes of 100 and 200mls did result in clinically significant
differences in measured IAP however.
Table 4.5. Effect of different priming volumes on measured IAP over a standard minimum volume of 10mls
Priming Volumes Difference (*p)
Bias (mmHg)
Precision Limits of Agreement
10 vs 50mls 0.014 0.29 0.46 -0.63 to 1.21 10 vs 100mls <0.001 1.33 0.73 -0.13 to 2.79 10 vs 200mls <0.001 4.19 1.25 1.69 to 6.69
* = Wilcoxon signed rank test
156
Figure 4.6. Bland and Altman Plot comparing IAP measurements made with bladder priming volumes of 10 & 50mls
Figure 4.7. Bland and Altman Plot comparing IAP measurements made with bladder priming volumes of 10 & 100mls
157
Figure 4.8. Bland and Altman Plot comparing IAP measurements made with bladder priming volumes of 10 & 200mls
When considered as a group, the first increase in median IAP occurred following instillation of
40mls of priming fluid, however there was not an increase of >1 mmHg until a total of 80mls had
been instilled. Figure 4.9. At the level of individual patients, an increase in measured IAP of 1
mmHg was observed at one patient following instillation of 40mls and a further patient at 50mls.
There was no increase in baseline IAP for priming volumes up to and including 30mls.
Figure 4.10.
158
Figure 4.9.
Overall increase in median IAP observed with increasing bladder priming volumes
Figure 4.10.
Individual increases in IAP observed with increasing bladder priming volumes
159
4.5 Vapour Lock
During the course of the experiments performed with the Foley Manometer, it became apparent
that, on occasion, an unusually high reading for IAP would be encountered. In such
circumstances, a frequent finding was that urine had tracked into the air inlet port of the Foley
Manometer. Figure 4.11. Although this was more frequently observed if the air inlet clamp had
been inadvertently left open following a pressure measurement, it did also occur at other times.
The effect of this situation was to prevent the ingress of air through the filter valve, which
prevented the column of fluid falling and settling to an accurate reading, i.e. it always produced an
over-estimation of IAP. The situation could be quickly rectified by flushing the inlet valve with
20mls of air via a standard syringe, forcing the fluid back into the collecting system. Such a
problem has not been described elsewhere, nor recognised by the device manufacturer. The
situation simply requires vigilance and local training to overcome and is mentioned in this chapter
for the sake of completeness. The device manufacturer has been notified of this potential error.
Figure 4.11.
The problem of “vapour-lock” identified in the use of the Holtech FoleyManometer
160
4.6 Discussion
Accurate and reproducible measurement of any physiological variable is essential and IAP should
be considered as “just another physiological variable” in this context. However, in many critical
care units there is quite a marked diversity of measurement techniques, and until / unless these
are homogenised it is difficult for IAP measurement to be accepted and action taken on given
values. A working knowledge of potential sources of error in measurement is important, both in
the overall setting and in relation to the specific technique being used – especially if these
potential sources can result in clinical error / variable management and / or research error.
Our data, presented in the previous chapter, has shown that the Foley Manometer is accurate,
reliable and simple to use within the clinical setting. In the series of experiments described in this
chapter we have demonstrated that, as with the other techniques available, this device is not
immune to the introduction of error and care must be taken to minimise this.
Our initial data showing that there is a clinically and statistically significant difference in IAP when
different anatomical zero-reference points for measurement are used, has been confirmed by a
subsequent and larger multi-centre trial. Based on both these sets of data, it is clear that the
symphysis pubis (SP) and the iliac crest (IC) should not be used interchangeably and that, for the
sake of reproducibility, a consensus technique is required. Opinion from an international panel of
experts has informed the WSACS decision to recommend that the iliac crest in the mid-axillary
line be used as the reference standard, despite much of the earlier (and indeed subsequent)
research data on the subject using the SP. Whilst our own anatomical study has shown that
there is less variation between the measured distance from the SP to the bladder neck than from
the IC, this improved consistency may well be mitigated against by the difficulty in palpating the
bony landmark at the SP and variations in measurement using either the bone or the fat pad at
the SP. It was interesting to see far tighter limits of agreement for measurement of IAP from both
161
landmarks in our own local data, rather than the multicentre study, despite near-identical bias
between the two studies. This may reflect the inevitable degree of variability introduced by
measurements performed by more than one investigator, or perhaps it demonstrates a genuine
increase in measurement variability revealed with the larger sample size – it is difficult to
distinguish which factor is actually at play. What is clear however is that within an individual
institution, practice must be standardised to whichever landmark is felt most appropriate and the
trend of IAP over time – measured consistently from the same land mark – is the most important
factor. From a research point of view, despite the recommendations for use of the IC as the zero-
reference point, the SP continues to be reported in some contemporary publications and the
small clinical difference from these two landmarks should be borne in mind – especially in
borderline cases where decompressive laparostomy is being considered. In such cases, the
trend of IAP measurement and overall clinical picture must remain the priority, rather than any
absolute measured value.
Likewise, the effect of body position on intra-abdominal pressure is significant with a tendency
towards higher bladder pressures exhibited as the patient is placed in a more erect position.
Again, our own local data has conformed with the findings of a larger multi-centre study almost
exactly and there is no doubt that body position needs to be standardised for both clinical and
research based measurements of IAP. Whether the observed rise in IAP on upright positioning
reflects a simple measurement artefact or a significant clinical phenomenon remains to be seen
and further data presented in chapter 6 will go some way to answering this question – though
future information as to the effect of posture on abdominal perfusion pressure and specific factors
relating to body anthropomorphism will be awaited with interest.
162
The issue of priming volume is relatively new and certainly, the original descriptions of
measurement techniques did not recognise this variable as a source of error. Our experiments
are the first to address this issue with the use of the Foley Manometer and suggest that whilst
priming volume is just as important an issue for this device as for the other techniques, our data
do suggest that the manometer carries the advantage of being slightly less prone to
measurement error at medium volumes. Table 4.6.
Table 4.6.
Comparison of observed bias in IAP measurement observed with various different devices
Measurement Technique Bias at 50mls Bias at 100mls
Kron[22, 173] 3.5 mmHg 4.6 mmHg
Cheatham[30, 67] 2.2 mmHg 4.3 mmHg
Malbrain[181, 182] 1.5 mmHg 2.5 mmHg
Foley Manometer 0.29 mmHg 1.3 mmHg
Despite this finding, examination of individual subject data did suggest that not all bladders
behave in the same way to filling and we demonstrated that there is a variation in responses with
some subjects increasing IBP over baseline with priming volumes as low as 40mls. This has
subsequently been confirmed by Malbrain[181] with a further series of 13 patients and lends
support to the call for the use of minimal priming volumes in order to mitigate against the potential
error from underlying detrusor hyper-sensitivity as very small priming volumes (10 – 20mls) seem
to have no effect on accuracy or reproducibility of measurements in our own and others series.
Finally, during the course of the experiments, we have identified a specific potential problem with
the use of the Foley Manometer in the form of “vapour lock”. Although this has not been subject
163
to (and indeed does not require) formal study, it is included as a description of a novel source of
error which could have a significant clinical impact.
164
4.7 Summary and Conclusion
All measurement devices are inherently prone to the introduction of error and our experiments
have shown that body position, zero-reference point and priming volume can all influence the
values obtained using the Foley Manometer. Whilst body position and zero-reference position
would seem to have a consistent effect, despite the device used, the Foley Manometer does
however seem to be genuinely less prone to error introduced by priming volume.
Our data would therefore support the following approaches;
1. The minimal possible priming volume should be used when measuring IAP using the
Foley Manometer (and certainly no error is introduced with the recommended 25mls).
2. A fixed zero-reference position is important for the reproducible measurement of IAP and
although the IC may be subject to a statistically larger variation in terms anatomical
relations to the bladder neck, it is probably more important that the global consensus
suggested by the WSACS be followed for future experiments and for clinical use.
3. In keeping with recommendations – all measurements of IAP should be made with the
patient positioned supine and even if the patient is being nursed routinely in a “head-up”
position, short changes to the supine position are essential for accurate IAP estimation.
4. Vapour lock is a simple and avoidable source of significant bias and that this should be
actively sought and eliminated when present.
165
Chapter 5
An Observational Cohort Study of the Incidence and Effects of
Raised Intra-abdominal Pressure in the Liver Intensive Care Unit
166
5.1 Introduction Previous studies have examined the incidence and prevalence of intra-abdominal hypertension
and the abdominal compartment syndrome within the critical care setting and have found both to
be encountered frequently, though something of a variation exists between the studies. Two
large, multicentre cohorts have suggested that the ITU prevalence at any given time is 52% for
intra-abdominal hypertension and 8% for the abdominal compartment syndrome[29, 31]. A
consistent finding within studies of mixed ITU populations however is that the cumulative
incidence of both conditions tends to rise during the course of an admission lasting longer than 24
hours, suggesting that continued monitoring is required for the duration of the critical care
admission[33, 157]. The incidence and severity of IAH does seem to be related to illness
severity, with correlation to others illness severity scores such as APACHE II and SOFA
scores[31, 33, 183]. It is also a consistent finding that conditions that are known to have profound
multi-system effects, such as severe acute pancreatitis and extensive burns are also associated
with significantly higher levels of IAH and ACS[36, 37, 59, 184].
Whilst raised intra-abdominal pressure has been shown to deleteriously influence hepatic
circulation[89, 101, 185] and hepatocyte function[186] in both in-vitro and in-vivo studies, only one
clinical study has addressed the magnitude of the problem in patients undergoing liver
transplantation[52], data from which also shows an association between IAP and renal function in
the post-operative period[77]. Unfortunately, the study predated any consensus definitions and
so is difficult to interpret. The authors used a cut-off IAP of > 25 mmHg to define IAH and, with
that definition, found an incidence of 32% amongst 108 patients undergoing transplantation.
Within this group of patients, a raised IAP was found to be associated with impaired renal
167
function, poor urine output and post-operative mortality. No other studies of IAP in patients with
liver dysfunction have been published.
The aims of the current study were therefore to ascertain whether raised IAP was indeed a
significant problem amongst our patient group and to define what impact IAP may have on clinical
course during the period of intensive care admission. Given that raised IAP has been shown to
be a significant problem in other critical care settings, we also wished to seek to identify any
possible early predictive factors that may suggest increased risk of IAH, in order to permit an
evidence based screening approach. We therefore also examined the relationship between Peak
IAP and admission variables such as Day 1 IAP, APACHE II and SOFA scores, along with early
resuscitation volumes (given an apparent relationship to volume and type of fluid resuscitation).
Finally, in light of the relationship between the mechanical properties of the abdominal wall and
the development of IAH[178], we have examined the relationship between postoperative IAP and
preoperative volume of ascites found at the time of liver transplantation, with the hypothesis that
prior distension of the abdominal wall with large volume ascites may protect against postoperative
IAH due to increased capacity of the abdominal cavity and / or altered compliance of the
abdominal wall.
168
5.2 Methods
An observational epidemiological cohort study was performed over an 18 month period in a
dedicated 15 bedded Liver Intensive Care Unit. Three major outcome measures were identified
relating to specific aspects of intra-abdominal hypertension and the abdominal compartment
syndrome.
1. The incidence of IAH & ACS
2. The clinical associations of IAH & ACS on;
a. Length of ITU stay
b. The onset of complications (Renal, Cardiovascular & Respiratory)
c. Early liver / graft function following liver failure or transplantation
3. The identification of early factors that might predict raised IAP
a. Relationship between Day 1 and Peak IAP
b. The temporal relations / natural course of IAP during the admission
c. The relationship between IAP and early resuscitation volumes
d. The relationship between IAP and volume of ascites at transplantation
Three major groups of patients were studied
i. Those undergoing liver transplantation
ii. Those undergoing major hepatopancreatobiliary surgery
iii. Those requiring critical care level support for an episode of acute hepatic dysfunction
with a variety of aetiologies
Patient recruitment was non-consecutive and assent to data collection was obtained in each case
from the patient or their next of kin. Any patients admitted with one of the three diagnoses
169
outlined above and with an expected duration of admission of at least 24 hours were invited to
participate and the study was purely observational with no departures from standard protocol
based care – which included the routine measurement and recording of IAP using a Foley
Manometer technique at 6 hourly intervals.
A pre-defined physiological dataset was collected in an excel spreadsheet (Microsoft,
Washington, USA) and anonymised in compliance with the stipulations of the St Mary’s Hospital,
Research Ethics Committee. The process required that all patient-identifiable data – name, date
of birth, hospital and ITU numbers – were removed following the period of admission when all
data fields had been filled or within a maximum of 6 weeks.
In order to address the stated aims of the study and to facilitate the processing of a large volume
of physiological and biochemical data, a summary measures approach was adopted. The
measured endpoints are listed and defined in Table 5.1.
170
Table 5.1.
Measured end-points and definitions of summary measures examined during
epidemiological study of IAP in Liver ITU
End-point Definition
Day 1 IAP Mean of first 4 IAP measurements performed over the 24hrs following admission
Peak IAP
Maximal IAP sustained for at least 3 recordings (i.e. 18 hours) Serum creatinine > 300 mmol/L Renal Impairment Requirement for haemofiltration / haemodialysis
Cardiovascular Failure The requirement for vasopressor / inotropic therapy to maintain Mean Arterial Pressure > 60mmHg
Onset of Complications
Respiratory Failure The requirement for an FiO2 > 0.6
Day 1 Indo-cyanine Green Clearance
Plasma disappearance rate measured within 24 hrs of admission
Liver / Graft Function (Acute Hepatic Dysfunction and Transplantation Groups Only)
Peak INR Peak International Normalised (Prothrombin) Ratio during admission
APACHE II[187] Acute Physiology & Chronic Health Evaluation v2
Day 1 and Peak Critical Illness Severity Scores SOFA[188] Sepsis-related Organ Failure
Assessment Score Length of ITU Stay Duration (in days) of ITU stay or to point that standard
discharge criteria have been met
Data were analysed using SPSS (IBM, Illinois, USA) according to a planned analysis strategy.
Length of stay was normally distributed and is therefore presented as a mean value.
Intra-abdominal hypertension (IAH) & the abdominal compartment syndrome (ACS) were
diagnosed in accordance with the standard definitions of the World Society for Abdominal
Compartment Syndrome (WSACS). IAH was defined as a sustained or repeated elevation of IAP
> 12 mmHg (for the purpose of this study – sustained across 2 separate measurements
171
performed at least 6 hours apart). ACS was defined as a sustained elevation of IAP > 20 mmHg
with associated new onset failure of at least one organ system (for the purpose of this study and
in line with existing unit protocol, an IAP >20 mmHg was re-measured at 4 hours and considered
to be diagnostic if sustained for this 4 hour period).
Abdominal Perfusion Pressure (APP) was defined as the mean arterial pressure (MAP) minus the
IAP.
The relationship between the presence of IAH or ACS and each of the complications (as defined
by the above summary measures system) was examined by way of a Chi-square test.
The correlation between Day 1 and Peak IAP and liver function (measured by ICG Clearance and
INR in the Acute Hepatic Dysfunction and Liver transplantation groups) was examined using
Pearson’s Product-moment Correlation Co-efficient and where a significant correlation was found,
the predictive relationship of these two variables to the measured end-points was tested using
stepwise regression with backwards elimination.
Following professional statistical advice received from the University College of London
department of biomedical statistics, stepwise hierarchical regression analysis with backwards
elimination was performed to examine variables that were thought to have face validity of being
predictive for length of stay using both Day1 and Peak measurements of standard ITU critical
illness severity scores (APACHE II & SOFA), IAP and APP – which were entered to the model as
blocks in this order with IAP and the composite measure of APP expected to contribute the most
to the predictive model.
The output of the regression models has been reported in tablular form using standard
conventions to include;
172
1. The R Square of the model – the variance explained by the overall model
2. The p value for the model as a whole – whether the model provides a significant
prediction of variance
3. The p value for each variable entered – whether each variable made any significant
contribution to the accuracy of the model
4. The Standardised Beta for each significant variable – the % variance that was
explained by each variable
Backwards elimination was used whereby variables were eliminated in order to improve the
accuracy of the model until no further improvement could be obtained.
In order to identify early factors that might be predictive of Peak IAP, the temporal onset of IAH
and Peak IAP were explored graphically and the relationship between Day 1 IAP and illness
severity scores, early resuscitation volumes and, in the case of transplantation, volume of ascites
to Peak IAP was again examined by way of stepwise regression with backwards elimination.
Early resuscitation volumes were defined as the volume of intra-venous fluid administered in the
first 24 hours of ITU admission (including peroperative fluids in the case of liver transplantation or
HPB surgery). The relationship between early resuscitation volume and peak IAP was examined
by further hierarchical regression modelling in each of the three sub-groups, with the variables of
Day 1 transfusion volumes of crystalloid and colloid entered. The results are again presented in
tabular form.
173
5.3 Results
5.3.1 Patient Demographics
A total of 183 patients participated in the study, with 54 admitted due to acute hepatic
dysfunction, 43 following major HPB surgery and 86 following orthotopic liver
transplantation of either a whole or split liver graft. Full details of patients included in each of the
3 groups are summarised in the tables below. In the case of patients with acute hepatic
dysfunction, the underlying diagnosis is identified. Patients in this group were acutely suffering
from a variety of haemorrhage, sepsis or encephalopathy.
Tables 5.2, 5.3 & 5.4.
Table 5.2. Demographic details of patients recruited with a diagnosis of Acute Hepatic Dysfunction
Diagnosis Number Proportion (%)
Acute Transplantation
Mortality (%)
Alcoholic Liver Disease
16 30 0 4 (25)
Paracetamol Overdose
12 22 3 0 (0)
Sero-neg Acute Liver Failure
10 18 3 3 (30)
Hepatitis C Virus
8 14 0 3 (38)
Non-alcoholic Steatohepatitis
2 4 0 1 (50)
Amyloid Disease
2 4 0 0 (0)
Auto-immune Hepatitis
2 4 0 1 (50)
Acute Hepatic Dysfunction
(n = 54)
Acute Fatty Liver of Pregnancy
2 4 0 0 (0)
174
Table 5.3. Demographic details of patients recruited following HPB Surgery
Operation Number Underlying Diagnosis
Number Proportion (%)
Mortality
Pancreato-duodenectomy
19 Pancreatic Carcinoma
19 44 1 (5)
Colorectal Metastases
9 21 0 (0)
Hepatocellular Carcinoma
8 18 1 (13)
Liver Resection
21
Cholangio-carinoma
4 10 1 (25)
Splenectomy 2 Colorectal Metastases
2 5 0 (0)
HPB Surgery (n = 43)
Cholecystectomy 1 Gallstones (Cirrhosis)
1 2 0 (0)
Table 5.4. Demographic details of patients recruited following Liver Transplantation
Diagnosis Number Proportion (%)
Alcoholic Liver Disease 27 32 Hepatitis C Virus 14 16
Primary Biliary Cirrhosis 13 15 Auto-immune Hepatitis 9 11 Cryptogenic Cirrhosis 5 6
Primary Sclerosing Cholangitis
5 6
Sub-acute Liver Failure* 4 5 Paracetamol Overdose* 3 3
Hepatitis B Virus 2 2 Drug Induced Hepatitis* 2 2
Chronic Rejection 1 1
Liver Transplantation (n = 86)
*Fulminant Disease
Non-alcoholic Steatohepatitis
1 1
The only significant number of deaths (22%) occurred in the acute hepatic dysfunction group, with
8 mortalities (67%) in those with acute on chronic disease (alcoholic liver disease, Hep C
infection & NASH) and 33% in those with acute liver failure (sero-negative acute liver failure &
auto-immune hepatitis). These mortalities were subject to further post-hoc analysis by Wilcoxon
Signed Rank Testing.
175
On comparison using a t-test there was found to be a significant difference in mean IAP [SD]
comparing survivors and non-survivors (20.4 [3.98] vs 14.5 [4.64] mmHg) p = 0.05, and a
significant difference in mean age (56 [10.46] vs 37 [11.02] years) p = 0.036. The absolute
mortality rate within the HPB Surgery group, was so low to render further analysis meaningless
and there were no deaths following Liver Transplantation within the study population.
All patients were considered to be critically unwell at the time of admission with an elevated mean
APACHE II score for patients admitted with acute hepatic dysfunction of 27 (18 – 39), following
HPB surgery 16.8 (10 – 29) and following liver transplantation 14.3 (7 – 25).
176
5.3.2 Incidence of IAH & ACS
As many patients with an IAP > 20 mmHg presented with this pressure at the time of admission
and in conjunction with often multiple organ failure, making it impossible to describe a temporal
relationship between IAP and the onset of organ failure – the pressure cut-off with the presence
of at least single organ failure was used to diagnose ACS for the purpose of the analysis. The
overall incidence of IAH and ACS was found to be very high at 81 and 38% respectively, with the
highest incidence of ACS in patients with acute hepatic dysfunction (64%). The precise incidence
for each group, along with other demographic details is summarised in Table 5.5.
Table 5.5.
Mean Peak IAP, Mean D1 IAP and Incidence of IAH & ACS for each of the study groups
Proportion
Group
n Male (%)
Female (%)
Median Age
(Range)
Mean Peak IAP [SD] (Range)
Mean D1 IAP [SD]
(Range)
Incidence IAH
Incidence ACS
Deaths (%)
Acute Liver Failure
54 49 51 44 (17 – 71)
18 [4.8] (14 – 30)
18 [4.2] (11 – 28)
97% 64% 12 (22)
HPB Surgery 43 69 31 63 (31 – 77)
16 [4.2] (10 – 25)
13 [3.4] (8 – 22)
91% 23% 3 (7)
Liver Transplant
86 65 35 53 (19 – 69)
15 [4.9] (8 – 28)
14.5 [3.8] (6 – 23)
65% 26% 0 (0)
Total
183 61 39 53 (17 – 77)
17 [5.3] (8 – 30)
15 [4.2] (5 – 25)
81% 38% 15 (8)
177
5.3.3 Associations of Raised Intra-abdominal Pressure with Length of Stay,
Complications and Liver Function
Length of Stay
There was a significant difference in mean length of stay in patients with a normal IAP (mean 3.8
days [SD 1.7] Range 1 - 10) and those with IAH (mean 11.4 days [SD 4.3] Range 1- 57) p =
0.002. Similar differences were seen on sub-group analysis for each of the three patient groups,
although given the very small absolute numbers with normal IAP in the Acute Hepatic Dysfunction
and HPB Surgery groups (2 and 4 patient respectively), this data has not been subject to further
statistical testing. Table 5.6.
Table 5.6.
Summary of length of stay observed amongst patients with normal (<12 mmHg) and
elevated (> 12 mmHg) IAP
Normal IAP (< 12 mmHg)
Length of Stay in Days
(Range)
n
Elevated IAP (> 12 mmHg)
Length of Stay in Days
(Range)
n
Acute Hepatic Dysfunction
4 (1 – 4)
2 12.4 (1 – 57)
52
HPB Surgery 3 (1 – 3)
4 5.9 (1 – 57)
39
Liver Transplant 3.6 (1 – 10)
30 9.9 (2 – 39)
56
Overall 3.8 (1 – 10)
66 11.4 (1 – 57)
147
The effect of IAP on length of ITU stay was further examined by comparing the predictive value of
Day 1 and Peak IAP with other ITU illness sevrity scores (APACHE II and SOFA), measured as
both Day 1 and Peak values. Table 5.7.
178
Table 5.7.
Variables included in the regression model to determine significant predictors of length of
stay
Variables Included in the Regression Model IAP IAP
APP* APACHE II APACHE II
Peak
SOFA
Day 1
SOFA * APP = Abdominal Perfusion Pressure (Mean Arterial Pressure – IAP)
When all three groups were considered together, Peak APACHE II and Day 1 APP were the only
variables to significantly contribute towards prediction of length of stay. Full details for the
regression models for each of the 4 groups are summarised below. Table 5.8, 5.9 & 5.10.
Table 5.8
Variables found to significantly contribute to a regression model to predict length of stay
(all diagnoses)
R2 Model p Model Sig Variables Beta p Variable Peak
APACHE II 0.029 < 0.001
0.67
< 0.001 Day 1 APP 0.022 0.015
Acute Hepatic Dysfunction
No significant model was produced. The last variable to be eliminated was Day 1 APP, however
the model remained non-significant (0.077).
179
Table 5.9
Variables found to significantly contribute to a regression model to predict length of stay
(Hepato Pancreato Biliary Surgery)
R2 Model p Model Sig Variables Beta p Variable Peak IAP 0.51 <0.001
Peak APACHE II
5.01 <0.001
Peak SOFA 5.83 <0.001 Day 1 IAP 0.23 0.02
Day 1 APACHE II
0.96 0.02
0.99
<0.001
Day 1 SOFA 0.86 0.04
Table 5.10
Variables found to significantly contribute to a regression model to predict length of stay
(Liver Transplantation)
R2 Model p Model Sig Variables Beta p Variable Peak IAP 0.96 <0.001
Peak SOFA 2.66 0.01
0.83
<0.001 Day 1 IAP 0.89 <0.001
180
Complications
There was a strong relationship between the presence of IAH and complications when explored
using a Chi-square test, with no complications occurring in patients having a normal IAP
throughout their stay. Table 5.11 All of the individual complications were strongly related to the
presence of IAH in all study groups, with elevated creatinine levels the most consistantly and
significantly so.
Table 5.11.
Relationship between the presence of IAH and the incidence of complications within the
study groups
Group Complication Incidence (%)
p (Chi-square)
Creat > 300 mmol/L 8.0 <0.001 Renal Replacement Therapy 24.0 <0.001
Hypotension Requiring Vasopressors / Inotropes
31.5 <0.001
Overall
Fi02 > 0.6 22.6 <0.001
Creat > 300 mmol/L 10.5 <0.001 Renal Replacement Therapy 43.0 0.04
Hypotension Requiring Vasopressors / Inotropes
54 0.01
Acute Hepatic
Dysfunction
Fi02 > 0.6 37 <0.001
Creat > 300 mmol/L 3.8 <0.001 Renal Replacement Therapy 11.5 <0.001
Hypotension Requiring Vasopressors / Inotropes
23 0.03
HPB
Surgery
Fi02 > 0.6 23 0.02
Creat > 300 mmol/L 9.8 0.002 Renal Replacement Therapy 17.6 0.02
Hypotension Requiring Vasopressors / Inotropes
17.6 0.05
Liver
Transplantation
Fi02 > 0.6 7.8 0.04
181
Liver / Graft Function
Day 1 Indo-cyanine Green Clearance (D1 ICG Cl) and Peak INR were used as summary
measures for liver / graft function within the acute liver failure and transplantation groups.
Overall, there was a strongly significant negative correlation between both Peak and Day 1 IAP
and D1 ICG Cl (p <0.001 & <0.001), (Figure 5.1 & 5.2.) however neither measures of IAP were
significant predictors for ICG Cl on regression modelling (R2 0.13, p = 0.07, D1 IAP p = 0.7 &
Peak IAP p = 0.89).
Figure 5.1.
There was a strong negative correlation between Peak IAP and Day 1 ICG Clearance
182
Figure 5.2.
There was a strong negative correlation between Day 1 IAP and Day 1 ICG Clearance
183
There was a significant negative correlation between Day 1 IAP and Peak INR (p <0.001), but no
relationship with Peak IAP (p = 0.13) nor was a significant model produced from these two
variables on regression modelling (R2 0.05, p = 0.07, D1 IAP p = 0.7, Peak IAP p = 0.22). Figure
5.3 & 5.4.
Figure 5.3.
There was a non-significant negative correlation between Peak IAP and Peak INR
184
Figure 5.4.
There was a significant negative correlation between Day 1 IAP and Peak INR
These trends in correlation were similar on sub-group analysis, though there was no significant
correlation between IAP and Peak INR following liver transplantation. Table 5.12.
Table 5.12.
Summary of correlations between IAP and liver function – Pearson’s Product Moment
Correlation Co-efficient
Correlation Overall Acute Hepatic Dysfunction
Liver Transplant
Day1 Indo-Cyanine Green Clearance Mean D1 ICG PDR
(Range) [SD] 12.2
(4.6 – 27.3) [6.5] 9.1
(4.6 – 15.6) [3.7] 20.5
(14.7 – 27.3) [4.7] Peak IAP P <0.001 P = 0.02 P = 0.02 Day 1 IAP P <0.001 P = 0.05 P <0.001
Peak Measured INR Mean Peak INR
(Range) [SD] 3.4
(1 – 13) [2.9] 4.2
(1 – 13) [4.6] 2.6
(1 – 6) [1.3] Peak IAP P = 0.13 P = 0.13 P = 0.97 Day 1 IAP P = 0.03 P = 0.03 P = 0.76
185
5.3.4 Factors Predicting Peak IAP
There was a strong positive correlation between mean Day 1 and Peak measured IAP (r = 0.83, p
<0.001). Suggesting that subjects with an elevated Day 1 IAP were most likely to have a higher
Peak IAP. Figure 5.5.
Figure 5.5.
Correlation between Day 1 and Peak IAP
A crucial relationship between Day 1 and Peak IAP was discovered such that, across all three
study groups, no patient with a normal mean IAP (<12 mmHg) on day 1 went on to develop an
abdominal compartment syndrome at any point during their admission (green box), whereas a
proportion of those with an elevated Day 1 IAP (>12 mmHg) did susequently develop ACS
(amber box). Figure 5.6.
186
Figure 5.6.
No patient with a normal Day 1 IAP (green box) went on to develop ACS during the period
of their ITU admission
187
More than 90% of patients who developed IAH did so within 48 hours of admission and indeed,
85% met diagnostic criteria based on their mean Day 1 IAP measurements. Figure 5.7.
Figure 5.7.
Day of diagnosis of IAH based on stage of admission
188
Likewise, there was a tendency for Peak IAP to be reached in the first few days following
admission. Figure 5.8.
Figure 5.8.
Day of ITU admission when Peak IAP reached
There was marked variation in the volumes of initial fluid resuscitation between the three groups
and, as a result, analysis was performed separately and not combined. Table 5.13.
Table 5.13.
Volume of early fluid administration within the study groups (Day of admission to LITU)
Group
Day 1 Crystalloid (L) (Range)
Day 1 Colloid (L)
(Range)
Intra-op Blood Transfusion (L) (Range)
Acute Hepatic Dysfunction
3.7 (2.1 – 6.3)
2 (0 – 7.8)
HPB Surgery
3.4 (2.3 – 6.0)
2.7 (0.75 – 7.2)
N/A
Liver Transplant
6.3 (2.3 – 12.6)
5.5 (1.25 – 16.2)
6.9 (2.2 – 25.5)
189
Early resuscitation volumes did not produce a significant model to predict Peak IAP in patients
with acute hepatic dysfunction or in those undergoing liver transplantation. A significant model did
emerge however for those undergoing elective HPB surgery and both Day 1 crystalloid and
colloid volumes both contributed significantly and equally to the model. Table 5.14.
Table 5.14.
Regression analysis of the effect of early resuscitation volumes for predicting Peak IAP
Group R2 Model p Model Variable B Variable p Variable Acute Hepatic Dysfunction
0.02 0.35 / / /
D1 Crystalloid 2.6 <0.001 HPB Surgery
0.86 <0.001 D1 Colloid 2.8 <0.001
Liver Transplant
0.55 0.34 / / /
Ascitic Volume and IAP
There was no difference between the mean measured volume of ascites present at the time of
transplantation (measured as the recorded suction volume at the time of opening the abdomen)
amongst patients with IAH and normal IAP (750ml vs 800mls p = 0.14), nor was there any
significant correlation between volume of ascites and peak measured IAP (r = 0.21, p = 0.36).
190
5.4 Discussion
Our series is the largest single centre study of the incidence and associations of raised intra-
abdominal pressure within a critical care setting, with only a single major multi-centre study
having recruited more patients (265) from 14 different units[31]. The current study is also the only
one to look specifically at sub-population of liver intensive care and the only to apply the WSACS
definitions to a population of patients following liver transplantation.
Our data, which was unselected and represents a typical case mix of the unit’s workload,
confirms that the incidence of intra-abdominal hypertension and the abdominal compartment
syndrome in this population is high. Furthermore, with an overall incidence of IAH of 81% and
ACS of 38% this appears to be a far more frequent problem than that encountered within a
general ITU cohort, where the equivalent rates are around 50 – 60% for IAH and 4 – 8% for
ACS[29, 31, 33, 34, 189] and also other high risk critical care groups such as severe acute
pancreatitis (40% & 10%)[37].
The incidence of raised intra-abdominal pressure within our cohort was highest in the group with
Acute Hepatic Dysfunction – corresponding to the same finding in other studies that level of IAP
does seem to be correlated to illness severity[31, 183] as the mean APACHE II score for patients
in our group of 27.0 (range 18 – 39) was significantly higher than the other two groups (HPB
Surgery – 16.8 (10 – 29) & Transplantation – 14.3 (7 – 25) ).
We have also demonstrated a similar, though more profound difference in IAP amongst Acute
Hepatic Dysfunction survivors and those who succumbed to their illness with mean IAP of 14.5
mmHg in survivors versus 20.4 in those who died. A similar finding was reported amongst a
general ITU population by Malbrain[31], however the contrast was far less marked (11.4 vs 9.5
191
mmHg).
Notwithstanding the different definitions used in our own study of IAP following liver
transplantation and that of Biancofiore[52], we do seem to have encountered a slightly lower
incidence of ACS in our series (26 vs 32%), despite a typical spread of underlying disease
processes within the transplant cohort and a broad age range of 19 – 69 years. (In our series,
ACS was defined as an IAP > 20 mmHg in the presence of organ dysfunction and for
Biancofiore’s data ACS was defined as an IAP > 25 mmHg). Unfortunately, the Italian study did
not include data on the incidence of IAH and so it is not possible to make any further comparisons
in this respect, however, it is possible that our lower observed incidence of ACS may represent
improvements in surgical and / or anaesthetic techniques in the intervening period.
In summary therefore, the problem of raised IAP within the Liver ITU population appears to be
significant, even more so than a general ITU population and IAP is associated to outcome, in so
much that patients who die from their illness have a significantly higher peak IAP than those who
survive.
Aside from mortality, which was relatively low in our study amongst patients undergoing elective
HPB surgery and liver transplantation, we have shown a significant relationship between IAP and
length of ITU stay – though the data for length of stay as a whole and in the Acute Hepatic
Dysfunction group specifically was significantly flawed by a failure to correct for the effects of
mortalities.
Whilst our data cannot show a cause and effect relationship between IAP and length of stay, we
have shown that IAP and especially Day 1 IAP or abdominal perfusion pressure can be used as a
significant predictive variable for admission duration following liver transplantation (where there
were no mortalities) and indeed, IAP is the only Day 1 predictor for length of stay following
192
elective HPB surgery. In terms of utility therefore as a surrogate illness severity score, IAP would
appear to be as useful or better than both APACHE II and SOFA scores in predicting length of
stay, though this preliminary finding was unexpected and would need to be confirmed in further
cohorts and in other centres. Whereas numerous previous studies have identified the
relationship between IAP and APACHE II / SOFA scores, our data is the first to demonstrate its
usefulness as a possible predictor of ITU length of stay and this finding deserves further
evaluation in a wider context with a more robust study design.
In keeping with other studies[7, 34, 38, 46, 49, 53, 77, 103, 108, 111, 125, 189-191], we have
demonstrated a significant relationship between IAP and complications in all organ systems,
which further supports or explains the observed link between IAP and length of stay. We also
saw a negative correlation between IAP and early graft function, measured by ICG clearance
following transplantation. We could not demonstrate a clear relationship between IAP and peak
INR within this patient group however. This is a novel finding which may be unique to
transplantation, as a previous study failed to show a correlation between IAP and ICG clearance
in non-transplant patients, despite showing a significant difference in IAP between survivors and
non-survivors (10.1 vs 24.5 mmHg)[186].
This probably reflects the difficulty that persists in accurately assessing the hepatosplanchnic
circulation within the clinical setting[192] and the significant number of confounding variables that
influence postoperative liver function – especially the INR. There is no doubt however that there
was a significant relationship between raised IAP and the incidence of complications and it was
interesting that we did not see any complications, defined by our summary measures technique,
amongst patients exhibiting a normal (< 12 mmHg) IAP during their admission.
A novel and interesting finding from our data was the observation that Peak IAP was so strongly
193
related to Day 1 IAP and that the peak incidence for the highest IAP for the admission was the
first 48 hours. In studies of general ITU populations, it would seem that around 50% of the
cumulative incidence for IAH occurs on Day 1, with a further 50% of cases developing
subsequently during the admission[29, 31, 33]. Our population seems different in that no patients
exhibiting a normal mean Day 1 IAP subsequently developed ACS and more than 95% of the
cases of IAH occurred within 48 hours of admission, with a very low incidence of onset
subsequent to this. The reasons for this observation is unclear, but it does seem that the Liver
ITU population does differ from a general ITU population, both in terms of the incidence and
natural course of raised IAP. Perhaps the most important determinants for the development of
ACS within this group are the admission factors and the disease process itself – rather than the
treatment or subsequent evolution of the pathology following admission? The important
implication of this finding therefore lies in the utility for screening as accurate measurement of IAP
over the first 48 hours seems to be key to identifying the cohort of patients who are at risk of
developing ACS during the admission and also for determining their risk stratification in terms of
length of stay.
Having seen that IAH and ACS in Liver ITU is both a common and “front-loaded” diagnosis with
significant implications, we were keen to know whether any actions or interventions prior to
elective admission could be shown to affect incidence. Previous studies have suggested that
high volume fluid resuscitation / transfusion and body anthropomorphics[178] are both predictors
of raised IAP. Cumulative intravenous infusion volumes have been shown to be a significant
independent predictor of IAH[47, 59, 189, 193] and a randomised controlled trial comparing
crystalloid versus colloid resuscitation following severe burns has identified large volume
crystalloid infusion especially, to be associated with a higher incidence of IAH[184].
194
Patients admitted to the Liver ITU carry many non-modifiable risk factors for the development of
IAH and ACS. Within the liver transplantation group especially, large volume intravenous fluid
therapy is very common whilst chronic changes in abdominal wall compliance, which could be
expected to have been brought about by chronic distension secondary to ascites associated with
underlying liver disease, could logically be considered as factors that could influence or predict
the onset of raised IAP. It was surprising therefore to see that despite massive mean
resuscitation volumes following transplantation, with mean Day 1 combined crystalloid, colloid
and blood volumes of around 18L (range 5.75 – 54.3L), there did not seem to be any correlation
to peak IAP. It may be that resuscitation and transfusion within this group is so accurately guided
by intensive invasive cardiac monitoring and thromboelastography, that despite the large absolute
volumes, accurate fluid replacement mitigates against the increased risk. It may be that the
presence of surgical drains to evacuate ascites or other fluids, and the previously postulated
changes in abdominal wall compliance may also have played a role. It was disappointing
however that the volume of measured ascites – a surrogate indicator of chronic distension and
abdominal wall compliance – did not show any relationship to peak IAP as this would have
provided a further simple predictor for subsequent risk within the transplantation group, although
this area probably needs to be revisited in more detail if an accurate means of measuring
abdominal wall compliance can be found.
It was interesting that the only group exhibiting a significant relationship between initial fluid
infusion volume and subsequent IAH were the elective HPB surgery patients. Two possible
explanations for this could be that these patients, by virtue of their admission to the Liver ITU
were deemed to be high risk – either due to their co-morbidity or extent of operation, or that they
had not been monitored as intensely as those undergoing transplantation. As a result therefore,
they may have been physiologically more sensitive to resuscitation volume or perhaps relatively
195
over-resuscitated.
Lead time bias could have played a significant role in the patients admitted with Acute Hepatic
Dysfunction as this group would inevitably have been transferred from other inpatient settings
(either external critical care units, emergency departments or medical wards) and prior fluid
administration volumes were not know. Further and better controlled studies would be required to
make any firm conclusions.
The very high incidence of raised IAP within the acute hepatic dysfunction group, identified by this
observational study is interesting and, given that this group in particular is often amenable to non-
surgical treatment by way of paracentesis further interventional studies are required. The
relationship between IAP and organ function is clearly more complex in the context of liver
impairment, with a recent study showing that the effects of decompression of ascites on cardiac
function is quite different in patients with acute Budd-chiari syndrome compared with controls
suffering from chronic liver disease[194] and this is likely to represent the tip of the iceberg in
unravelling this complex problem.
Whilst the current research has identified that raised IAP is a significant problem in the setting of
liver intensive care it is also apparent that the “hepatic dysfunction” group represents a very
disparate population and that individual cohorts within the group are likely to exhibit both variable
susceptibility to raised IAP and, very likely, quite different systemic and local organ responses to
its treatment.
196
5.5 Summary and Conclusions
The incidence of raised IAH is much higher within the Liver ITU than the general ITU population,
with virtually all patients admitted with acute hepatic dysfunction having IAH. The positive
association of IAH to the incidence of complications and length of stay means that measurement
of IAP within this patient group is important not only as a modifiable clinical parameter, but also
as a key prognostic variable.
The natural course of raised IAP in the Liver ITU seems to be different from other populations in
that it appears to be a “front-loaded” diagnosis and finding a normal mean Day 1 IAP is highly
significant in stratifying subsequent risk. Day 1 IAP measurement should therefore be considered
a vital, straightforward and cost-effective screening tool in this population. This observational
study has identified a number of further clinical questions that will merit more focussed
observation and interventional study.
197
Chapter 6
Regional Intra-abdominal Compartment Pressures Following Liver
Transplantation
198
6.1 Introduction
Interest in the measurement of IAP has grown steadily over the last decade and has been shown
to be a significant problem within the general Intensive Care Unit (ICU) population[29, 31], with
the deleterious effects of elevated IAP having been well described in numerous clinical studies
and reviews [24, 32, 75, 77, 83, 100, 108, 110, 132, 191, 195-198]. The culmination of the recent
increase in interest in this condition has been the creation, by an international panel of experts
(The World Society on Abdominal Compartment Syndrome – www.wsacs.org), of a consensus
document for reliable definitions [12] and suggested guidelines [74] for management.
Underpinning these recommendations however, is a requirement for the accurate and
reproducible measurement of IAP and, as previously discussed, several studies have shown that
there is no role for clinical estimation nor measurement of abdominal perimeter alone [42, 60,
161].
Numerous techniques for the measurement of IAP by both direct and indirect methods have been
described, with indirect approaches consisting of the measurement of the pressure concealed
within a hollow intra-abdominal viscus, most usually the urinary bladder (IBP) [68] or stomach
(IGP) [69] and intravesical pressure (IBP) measurement is now well established as the gold
standard. Direct methods for measuring IAP have been employed exclusively in the experimental
setting, whereby the IAP is transduced directly from the peritoneal cavity via a catheter containing
a continuous column of fluid [165], a balloon-tipped catheter [168] or via a laparoscopic gas
insufflation system [166]. The application of such techniques, are clearly limited by their
invasiveness and no advantage over indirect measurements have been demonstrated in terms of
accuracy in both the published literature and our own experiments described earlier in this thesis.
199
On the face of the available data therefore, a non-invasive technique such as the IBP or IGP
method, would seem more attractive for routine clinical use. This however relies on two unproven
assumptions regarding the transmission of pressure throughout the abdomen. The first is that the
bladder wall will act as a passive diaphragm for the transmission of pressure (tested in chapter 3)
and the second that IAP is transmitted uniformly throughout the abdominal cavity, such that the
measured pressure at any one position will be equally reflected elsewhere in the cavity.
The second assumption relies on the contents of the intra-abdominal cavity transmitting pressure
as a single compartment, which given the heterogeneous mix of contents and / or the effects of
previous surgery or inflammatory conditions, may not hold true. Such a regional variation in post-
operative patients would have important implications, both for the post-operative screening of IAP
following surgery and also for the potential of a localised effect on the regional organ systems that
may not be manifest by the measurement of the relatively remote IBP. This concept would be
synonymous with the poly-compartment syndrome which has previously been suggested to affect
the head, thorax, abdomen [199] and extremities.
It has been shown that IAP can be influenced by body position in both our own and others
published data, with an increase in bladder pressure of up to 7.5 mmHg with various “head-up”
positioning angles [176]. The effect of body position on the individual intra-abdominal
compartments has not previously been described however.
Liver transplantation was chosen for the study as a major intervention that has been shown to be
associated with a significant incidence of intra-abdominal hypertension (IAH) in both our own
epidemiological data presented in chapter 5, and in studies from other institutions [52]. The
surgical procedure itself is relatively standardised and mainly confined to a single intra-abdominal
200
compartment, which would make comparisons between individual subjects easier and logically
suggests that the chances of identifying a regional pressure phenomenon would be highest.
The two primary aims of the current study were to compare the IBP to that immediately outside,
within the intra-peritoneal pelvis and to establish whether there are any regional variations in IAP
between the upper and lower abdominal compartments (UIAP & LIAP) following liver
transplantation. A secondary endpoint was to examine the effect, if any, of body position on the
compartmental pressures.
201
6.2 Patients & Methods
Approval of the study design was obtained from the St Mary’s Hospital Research Ethics
Committee and the Local Research and development Committee.
A total of 20 patients undergoing orthotopic transplantation of a whole liver for non-fulminant
disease were recruited. All data were collected during the subject’s stay on the Liver Intensive
Care Unit, with aspects of postoperative care such as the administration of intra-venous fluids
and the use of vaso-active agents, guided by established unit protocol. All subjects were nursed
in a 30o head of bed position to minimise the risk of respiratory complications, with the exception
of short periods in order to measure supine IAP and all were calm and comfortable at the time of
measurement (Richmond Agitation-Sedation Scale of 0 or less).
For each patient, UIAP and LIAP were measured directly via catheters placed under the Left lobe
of the transplanted organ and in the pelvis, at the time of operation (Minivac Drain, Unomedical,
Worcestershire, UK). These catheters were connected to a standard ICU monitor (Fakuda
Denshi, Tokyo, Japan) via electronic pressure transducers and were used solely for
measurement of IAP and not for drainage. Standard closed surgical drains were placed in the
usual position to prevent accumulation of body fluids.
The transducers were mounted to the patient by sutures at a point corresponding to the internal
position of the catheter tips on the upper and lower abdominal wall – a position that was found to
correspond to the zero-reference point suggested by the WSACS, of the midaxillary line at the
iliac crest when supine. Figure 6.1. The transducers were flushed and zeroed twice daily and
also following each position change. The measured dead space of the catheter was <2ml and so
a 4ml flush with normal saline, from a sterile closed system, ensured a continuous column of fluid
between the intra-peritoneal catheter tip and the transducer which was maintained between
202
flushes by continuous low volume irrigation. The quality of the pressure waveform was checked
hourly by the “rapid oscillation test [68]”, whereby rapid and repeated palpation of the abdominal
wall at the level of the intra-peritoneal catheter tip was visible in real-time on the ICU monitor’s
pressure trace.
Figure 6.1.
The experimental apparatus for measurement IAP by direct transduction of intra-peritoneal
pressure at the liver and bladder and measurement of intra-vesical pressure using the
Holtech FoleyManometer
Compartmental IAP was transduced continuously via this equipment and the monitoring system
recorded paired measurement of UIAP and LIAP at 10 minute intervals. The catheters were left
in place for a maximum of 72 hours, or until the point of discharge from the Liver Intensive Care
Unit, whichever came sooner.
203
Each patient was repositioned to lie supine at 6 hourly intervals (4 times per day) in order to
measure the supine compartmental pressures. The transducers were “re-zeroed” following each
position change and the pressure allowed to equilibrate for 5 minutes, prior to making each of
these recordings.
In addition to the direct pressure measurements, IBP was also recorded at 6 hourly intervals with
the patient both in a 30o head-up and supine position using a Foley Manometer system (Holtech,
Charlottenlund, Denmark). Figure 6.2.
Figure 6.2.
Use of the Holtech FoleyManometer for the measurement of IAP
204
Statistical Analysis
The data were recorded in a Microsoft Excel Spreadsheet (Microsoft, WA, USA) and analysed
using SPSS v15 (Chicago, IL, USA) in accordance with the recommendations for data analysis
published by the World Society for the Abdominal Compartment Syndrome [141].
Data obtained at 6 hourly intervals (IBP, LIAP and UIAP at supine and 30o head of bed angles)
were compared by means of a Bland and Altman analysis [169]. The co-efficient of variance
(COVA) of IAP was defined as the mean divided by the standard deviation of IAP. Percentage
error of the measurement was defined as twice the precision divided by the mean IAP.
The normality of distribution of the continuous pressure recordings was tested using a
Kolmogorov Smirnov test and, being parametric and normally distributed, means were compared
using a paired t-test.
Following professional statistical advice and in order to perform both within and between
individual comparisons of the difference in compartmental pressures in subjects with differing
baseline IAP, the difference between the 2 compartmental recordings was converted to a
percentage of the mean of both compartments (Diff / (mean of UIAP + LIAP) X 100). This
eliminated the effect of the underlying baseline IAP and inter-individual variations. For the same
reason, the trend in compartmental pressure over time was expressed as the difference in each
subsequent pressure recording over the initial IAP. The differences in compartmental pressures
over time were normally distributed and therefore compared by linear Regression.
For the purpose of reporting, a difference between the compartments of 4 mmHg or greater was
considered to be clinically significant.
205
6.3 Results
Comparison of Direct and Indirect Measurement of Lower Intra-abdominal Pressure
As previously demonstrated, there was no clinically relevant difference between the mean
measurements made via the pelvic transducer and the Foley Manometer. Table 6.1. The Bland
and Altman plot confirmed excellent agreement between the two measures in all body positions,
with a calculated bias and precision of -0.06 and 0.6 when supine and 0.006 and 0.5 at 30o.
Figures 6.3, 6.4 & 6.5.
Table 6.1.
Comparison of compartmental IAP measured at supine and 30o head of bed positions
206
Figure 6.3. Bland and Altman Plot of agreement between intra-vesical pressure (IBP) and lower intra-
peritoneal pressure (LIAP) measurements made at all bed positions
207
Figure 6.4.
Bland and Altman Plot of agreement between intra-vesical pressure (IBP) and lower intra-
peritoneal pressure (LIAP) measurements with a supine body position – showing excellent
agreement between the two
208
Figure 6.5.
Bland and Altman Plot of agreement between intra-vesical pressure (IBP) and lower intra-
peritoneal pressure (LIAP) measurements with a 30o head of bed angle – showing
excellent agreement between the two
209
6.3.1 Compartmental Pressure Measurements & the effect of Body Position
A total of 169 synchronous measurements of IBP, LIAP and UIAP were made to obtain
compartmental pressure with subjects in a supine and 30o head of bed position at 6 hourly
intervals. In contrast to the excellent agreement between IBP and LIAP, comparisons of both IBP
and UIAP, and LIAP and UIAP revealed very poor agreement with a high measured bias,
precision and percentage error. Parameters for these comparisons fell well outside the
thresholds for agreement stated by the WSACS [141]. Table 6.1 and Figures 6.8 & 6.9.
Figure 6.6.
Bland and Altman Plot of agreement between intra-vesical pressure (IBP) and upper intra-
peritoneal pressure (UIAP) measurements – showing poor agreement between the two
210
Figure 6.7.
Bland and Altman Plot of agreement between lower (LIAP) and upper intra-peritoneal
pressure (UIAP) measurements – showing poor agreement between the two
The mean UIAP when supine was 11.7 mmHg, which was reduced to 9.6 mmHg with 30o head of
bed positioning (p=<0.001). Mean LIAP was 9.2 mmHg when supine and increased to 9.6 mmHg
with 30o head of bed (p=<0.001).
The increase in UIAP with a move to a supine position was observed in all patients irrespective of
which compartment contained the higher pressure. The observed magnitude of change in mean
UIAP was not different between subjects exhibiting a raised IAP (>12 mmHg) and those with a
normal IAP (2.4 and 1.8 mmHg change respectively p=0.5). Similarly, although there was a
suggestion that subjects with higher upper than lower compartmental pressures exhibited a larger
change in UIAP when moving to a supine position (2.4 and 1.1 mmHg change respectively), this
difference was not statistically significant (p=0.9).
211
6.3.2 Continuous Compartmental Pressure Measurements
A total of 5980 automated paired pressure measurements of direct LIAP and UIAP were
recorded, with an average of 299 per patient (range 212 – 461).
Of the 20 subjects, 12 revealed a higher mean pressure within the UIAP than the LIAP
compartment, with the greatest mean pressure difference for an individual being 5.3 mmHg.
When analysed as a whole, and as sub-groups with either higher UIAP or higher LIAP, the
difference between the compartmental pressures was highly statistically significant (p = <0.001,
<0.001 and 0.004 respectively). The range of differences between compartmental pressures in
the two groups also differed with those exhibiting a higher UIAP having a broader range (0 – 16
mmHg) than those with a higher LIAP (0 – 12 mmHg). The mean pressures observed in each
compartment for the subjects as a whole, and for the two sub-groups is displayed in Table 6.2.
212
Table 6.2. Summary of compartmental pressure differences in subjects divided by whether the upper or lower compartment concealed the higher pressure
Mean Compartmental IAP (mmHg) (SD)
Subject Group
UIAP
LIAP
Mean Difference Between
Compartments (SD)
*Mean Percentage Difference Between
Compartments Higher UIAP
10.5 (4.6)
8.3 (4.5)
2.2 (2.4)
23.4%
Higher LIAP
8.6 (3.8)
10.9 (5.6)
2.3 (3.2)
23.6%
Overall 9.7 (4.2)
9.5 (4.6)
0.3 (4.1)
3.1%
*Mean percentage difference between compartments = Mean difference between compartments / (Mean UIAP + Mean LIAP / 2) X100
The mean difference between the two compartments was similar whether it was the upper or
lower compartment that contained the higher pressure. Expressed as a percentage of the mean
of the two compartments, this equated to a clinically significant 23.4% difference when UIAP was
highest and 23.6% when LIAP was highest.
Individual analysis of each subject’s data confirmed the significant difference (p=<0.001) between
compartments for all but two patients. In two individuals the compartmental pressures did not
differ significantly (p = 0.349 and 0.122), however the mean IAPs for both patients and in both
compartments fell within normal, safe limits (7.1 and 7.3 mmHg and 11.4 and 12.0 mmHg).
Nine subjects displayed a continuous pressure >12 mmHg in one or other compartment for
greater than 1 hour. Of these 5 had higher mean UIAP and 4 higher LIAP. There was no
difference between the mean difference in compartmental pressures in subjects with a sustained
pressure of >12 mmHg compared to those without (2.3 and 2.1 mmHg respectively p=0.772).
213
In the higher UIAP group, a clinically significant difference of 4mm Hg or more between
compartmental pressures was observed during an average of 23% of the study period. This
proportion was higher in the higher LIAP group at 37% of the study duration, however these
differences were not statistically significant (p=0.666).
The direction of change in compartmental IAP over time correlated positively such that an overall
upward trend in UIAP was accompanied by an upward trend in LIAP (R2 = 0.582, p=<0.001,
n=5960).
214
6.4 Discussion
The recognition and treatment of IAH and the abdominal compartment syndrome (ACS) is clearly
reliant on an accurate and reliable system for the measurement of IAP. The technique for IBP
measurement has undergone much refinement over the last decade [68] and has now been
presented, by an international panel of experts, as the gold standard for intra-abdominal pressure
measurement [74]. In addition to the effects of gravity and sheer stress[200], the value of bladder
pressure, relies on two key assumptions, which have been widely accepted without direct
evidence of their validity.
The first assumption is that the bladder wall will act as a passive diaphragm to the transmission of
pressure, and therefore the pressure measured within the urinary bladder will accurately reflect
the pressure immediately outside within the peritoneal cavity. Several studies, in both animal and
human models, have shown good agreement between directly and indirectly measured intra-
abdominal pressure [27, 69, 133, 165]. All of these studies however, have measured direct IAP
at a site distant to the urinary bladder, and following artificial elevation of IAP by means of either
saline or gas insufflation or by insertion of a mechanical prosthesis. Our data (presented
previously in Chapter 3 of this thesis and repeated here for clarity) is the first to directly compare
the pressure measured at the intravesical and intraperitoneal sides of the bladder wall and
confirms that the pressure measured within the urinary bladder demonstrates excellent
agreement with the pressure to be measured within the pelvic peritoneal cavity.
The second assumption relates to the mechanical properties of the peritoneal contents. It has
been suggested that the abdominal contents are primarily fluid in composition and therefore that
pressure transmission can be expected to follow Pascal’s law, such that measurement of the IAP
at any point will reflect the pressure contained within the entire abdominal cavity[68]. In reality
215
however the abdominal contents remain a heterogeneous mix of solid, liquid and gaseous
components, with the exact composition influenced by several disease processes such as
paralytic ileus, visceral oedema, or the presence of ascites. Pressure transmission
characteristics are therefore likely to be rather more complex.
Regional IAP
The implications of a regional ACS are profound, with the gold-standard technique for pressure
measurement occurring at the lowest point in the abdominal cavity, whilst the organs that have
been shown to be most susceptible to raised IAP all lie in the upper abdomen. Separate studies
have all clearly shown the deleterious effects of raised IAP on the splanchnic circulation[50, 83,
100, 131, 198], cardiac[108, 111], respiratory[125, 127, 191], renal[77, 133, 135] and
neurological[197, 201] function in both human and animal models.
The possibility of a regional variation between the upper and lower IAP was identified, but not
explored in detail in 1994[69]. In this study, IGP was measured in nine patients undergoing
laparoscopic cholecystectomy, at a variety of different insufflation pressures. The study was
designed to validate the measurement of IGP against the pneumoperitoneum, but also showed
that IGP could also be up to 4mmHg higher or 3 mmHg lower than the measured IBP. A further
small study has identified differences in gastric and bladder pressure in 2 patients within a
general ICU population[177] and suggested that such a variation could provide clues as to any
underlying pathophysiological process.
Our study is the largest to compare the two compartmental pressures within a clinical setting,
without artificial manipulation of IAP. In keeping with the above study, we showed a significant
difference between compartmental pressures, but with a much broader and more clinically
216
significant range of variation, of up to 16 mmHg and a mean difference between the
compartments of around 20%, which equates to a maximal inter-compartmental mean difference
of 5.3 mmHg.
Clearly such a magnitude of variation, coupled with the observation that compartmental pressures
were seen to vary by 4 or more mmHg for an average of 23% of the time, means that relying on
the measurement of one compartmental pressure only, may lead to a significantly elevated
pressure in the other compartment being missed. The positive relationship that we have
demonstrated between compartmental pressures should mandate separate measurement of
UIAP in patients in whom the IBP is adopting an upwards trend.
It was interesting to observe that the range of variation in inter-compartmental pressure was
greater in those patients concealing a higher UIAP and this may be related to previous data which
suggests that upper abdominal incisions result in measurable changes to abdominal wall
contractile properties, which may contribute to the generation of a locally raised IAP[202].
217
Body Position and Regional IAP
Other clinical studies, including our own unpublished data from chapter 4, have considered the
influence of patient positioning on IAP. The largest[171] is a multicentre study of 132 ventilated
patients, to which we contributed data from 20 patients, equating to 15% of the total study
population, which was the 5th largest contribution from a total of 12 sites. Table 6.3. The mean
difference between supine and 30o IBP was 3.7 mmHg with a range of 3.4 – 4.0 mmHg, which
was considered to be clinically significant and confirmed that body position has a significant
impact on the measurement of IAP and mandates that pressure recordings should be carried out
in the supine position to ensure accuracy and reproducibility.
Table 6.3.
Summary of WSACS study of the effect of body position on IAP[171]
The largest reported difference in positional pressures was seen in a study of 37 patients at a
range of bed positions between 0 and 45°[176]. It was found that IBP increased with head-up tilt
with a mean increase of 5 mmHg at 30° and 7.4 mmHg at 45°.
In our post-transplantation group of patients our local data have also demonstrated a statistically
significant increase in the IBP with head-up positioning to 30°. This was however, a far smaller
increase of just 0.43 mmHg rather than the 5 mmHg seen in the other studies. This would lend
support to the theory that LIAP will increase as the result of a more upright posture[27]. The most
218
likely explanation for this being that an erect posture leads to an increase in the hydrostatic
weight exerted by the abdominal organs and body habitus pressing downwards on the bladder,
much in the same manner as increasing the height of a standing column of fluid would increase
the measurable pressure at the bottom of the column.
A more interesting observation in our own data however, is the fact that despite accurate re-
zeroing of a patient mounted transducer, UIAP was significantly increased in the supine position
compared to a 30° head-up tilt. The reason for this observation remains unclear, but may be
related to the repositioning of the more mobile hollow abdominal viscera along with both their fluid
contents and any free intra-peritoneal fluid with a more upright posture. This observation would
suggest that a simple change in posture could provide a clinically significant improvement in the
UIAP, which in turn may improve hepatic, renal and splanchnic blood flow, with only a modest
increase in LIAP observed in our own dataset. Such positive effects on organ perfusion would
need to be demonstrated by further specific studies, however it does raise the possibility that a
head-up position may be advantageous for reasons other than simple ventilatory mechanics in
spite of the expected modest increase in intravesical pressure. It is also particularly encouraging
to note that a larger reduction in UIAP can be expected in those patients with a higher upper,
rather than lower, baseline intra-abdominal pressure. The lack of collection of other body
anthropomorphic data to further examine these two groups is accepted to be an unfortunate
limitation of the study.
Clinical Application
The fact that it was impossible to predict which of the two compartments would conceal the higher
pressure suggests that, for this subgroup of patients, dual compartmental pressure monitoring
may be required, based upon the clinical condition of the patient. It remains unclear however,
219
whether the observed variation in inter-compartmental pressure is specific to the procedure of
liver transplantation, or whether the findings could be generalised to all upper abdominal surgery,
local inflammatory conditions such as severe acute pancreatitis, or indeed the measurement of
IAP in general. It is also a shortcoming that various anthropomorphic data and details of illness
severity scores were not collected, as these have been shown to impact on baseline IAP. None
the less, the data do suggest that in some cases, the measurement of bladder pressure alone
may lead to significant over or under-estimation of pressure within the upper abdomen and
perhaps indicates (particularly in this patient group) that dual-compartment pressure
measurement may be required before making a definite diagnosis of ACS.
Further study with a larger sample size, will be required to elucidate the relationship between the
location of the higher compartmental pressure, the magnitude of variation in compartmental
pressure and the duration for which there is a significant difference between compartments with
clinical outcome. Such a study, with higher numbers, may be facilitated by the recent introduction
of a commercially available, non-invasive device for the measurement of IGP (CiMON, Pulsion
Medical Systems, Munich, Germany). It would also be extremely interesting to measure the
retroperitoneal compartmental pressure within the upper abdomen, which very much contains the
“anatomical terminus” for the arrival and departure of the abdominal blood supply, as well as the
kidneys themselves.
220
6.5 Summary and Conclusion
It remains to be seen, and further research is certainly required, to discover whether the observed
effects are specific to patients undergoing liver transplantation and to define any effects on
clinical outcome. The current data do however demonstrate a significant variation in regional IAP
within the study group. It may well be that we need to consider regional IAP in more detail and
consider the different abdominal compartments, including the retroperitoneum, as more distinct
entities and that patient positioning may prove a useful utility for optimising compartmental
pressures and perfusion.
221
Chapter 7
Summary, Limitations and Conclusions
222
Survey of Attitudes and Practice
Our postal survey, with a total of 354 responses, was the largest UK study of attitudes and
practice in the problem of raised intra-abdominal pressure and the second largest study
worldwide. Despite an interval of 6 years since the last UK survey, practice surrounding intra-
abdominal pressure does not seem to have changed significantly, with similar reported numbers
of cases over the two surveys. We chose to ask directly whether the respondents believed in the
abdominal compartment syndrome as a real clinical entity, in the hope that those who did not
would be encouraged to return their survey and have the opinions noted. It was interesting that
overall, 90% did believe in the diagnosis, but especially interesting that there was a large
difference between anaesthetists engaged in ITU practice and those who were not (99 vs 76%).
The finding that most clinicians who did not believe in the abdominal compartment syndrome
tended to be more senior, having been in consultant practice for more than 10 years, supports the
observation that interest and publications in ACS have increased over more recent years and that
more contemporary training programmes were likely to include this topic.
Despite 43% of anaesthetic respondents reporting a “surgical reluctance” to perform
decompressive laparostomies, we could not demonstrate any significant differences in attitudes
and practice between surgeons and anaesthetists and the views of the two groups were
surprisingly well aligned.
There was perhaps a small increase in the rate of routine measurement of IAP within critical care
units, though this does not seem to have translated into any increase in the number of
laparostomies being performed. Perhaps the most striking finding was that fact that, despite the
increase in interest in IAP that has been demonstrated by the growing number of publications and
the consensus guidelines documents – factual knowledge of the threshold values for the
223
diagnosis of IAH and ACS remain poor, with most clinicians still over-estimating the cut-off for
diagnosis of these conditions. We have therefore identified an ongoing requirement for further
education and awareness of this important aspect of critical care.
The survey was designed to answer a series of specific research questions and was intentionally
structured to be as brief as possible, whilst still fulfilling these objectives. The pilot study ensured
that the questions were unambiguous and that the time taken to complete the questionnaire not
overly burdensome. Repeated questions were not included in order to keep the survey as short
as possible and so internal reliability could not be assessed.
The major limitation of the survey was the relatively low response rate. Whilst steps were taken
to maximise returns by designing a questionnaire that might appeal to respondents who did not
believe in abdominal compartment syndrome, minimising leading questions and by incorporating
a reminder notice after 2 weeks, the overall response rate was disappointing. The response rate
amongst physician targeted questionnaires is known to be lower than within the general
population of surveys published within medical journals and the mean response rate in a review
of 68 such studies was 54%[203]. It was found that the use of a written reminder including a
further copy of the questionnaire increased the rate by up to 16% and so our overall response
rate of 44% with such a reminder is unfortunate.
Whilst the major concern with lower response rates is response bias, specifically bias arising from
the missed opinion of non-responders, it was encouraging that our results did not significantly
differ from those of previous surveys with higher response rates. This is consistent with previous
studies suggesting that bias associated with a high proportion of non-responders tends to be
minimal in surveys conducted within the medical community[204] and, although clearly this
224
observation does not eliminate the possibility that our results have been influenced by response
bias, it does provide a degree of reassurance that our results and conclusions may be considered
valid and generalised to the wider UK population of anaesthetists and surgeons.
Evaluation of the Foley Manometer Device
The measurement of intravesical pressure as a surrogate for intra-abdominal pressure has
become well established in both the clinical and research setting and is reported as the “gold-
standard technique” by an international panel of experts. The assumption that the bladder wall
will act as a passive diaphragm to allow the free and complete transmission of the intra-
abdominal pressure such that the intravesical pressure would be equivalent, had previously been
tested in a porcine model, but remained untested in human subjects. We have shown for the first
time, that there is no clinically nor statistically significant difference between the pressure in the
urinary bladder and immediately outside, within the intra-peritoneal pelvis.
The experiments presented in this chapter also represent the first full in-vitro and in-vivo analysis
of the Foley Manometer device for the measurement of IAP. This has been vital to this thesis as
the device has been used throughout as the key tool for the measurement of IAP. The Foley
Manometer had previously been evaluated in-vitro amongst a small mixed population of 15
individuals – physicians, nurses and students, with a very low bias exhibited (0.5 mmHg). Our
experiments, with a larger study group of 40 critical care nurses have shown an even lower bias
(0.1 mmHg) and tighter limits of agreement. More importantly however, we have shown that
equivalent measurements can be obtained by novice users with minimal written instructions
compared with more experienced users of the system. The device therefore carries the
225
advantages of not only being extremely cost-effective, but also of being extremely simple, safe
and easy to use.
The Foley Manometer has also been compared to the other commercially available system for
the measurement of intravesical pressure – the AbViser system and has been shown to be
equivalent in terms of bias, precision and limits of agreement. The obvious advantages of the
Foley Manometer over the AbViser is simplicity of use and cost – not only of the device, but also
the additional consumables required to set-up the AbViser.
We have therefore confirmed that the Foley Manometer delivers all of the desirable qualities of a
clinical measurement tool – namely, safety, reliability (reproducibility), validity, simplicity, speed
and cost-effectiveness, whilst showing that it provides a true and accurate measure of intra-
abdominal pressure.
The experiments described have broadly conformed to the standards for research prescribed by
the World Society for the Abdominal Compartment Syndrome and were analysed in line with
there recommendations. Unfortunately the work did predate the guidelines and data on body
anthropomorphics were not recorded. Though the inclusion of this data may have been of
interest, given the very tight agreement between the various measurements, there is no
suggestion that the missing data would have any bearing on the outcome or conclusions of these
experiments in terms of the evaluation of the Foley Manometer device.
226
Sources of Error in the use of the Foley Manometer for the Measurement of IAP
Our previous data have demonstrated that the Foley Manometer is accurate, reliable and simple
to use in both the clinical and research setting. In keeping with other techniques however, the
device is not immune to the introduction of error and care must be exercised in its use.
Body position and the anatomical landmark used as the zero-reference point have both been
shown to impact significantly on the measurement of IAP – both from our own data and in other
published trials. The Foley Manometer would seem to be as susceptible to these errors as the
other reported devices and our data has highlighted the importance that the patient must be
positioned supine in order to accurately estimate the IAP, even if this requires a brief position
change for patients being nursed in a “head-up” position. Our anatomical study would suggest
that there is less variation amongst subjects between the bladder neck and the symphysis pubis
than to the iliac crest and that this might therefore be a more accurate landmark to use than the
WSACS suggestion of the iliac crest. This observation is however balanced against the fact that
there is a large variation in the size of the fat-pad overlying the symphysis pubis and
inconsistency in using the bony landmark or skin overlying the fat pad will probably mitigate the
reduced anatomical variability in distance between the bone and the bladder neck, such that
there is little clinical difference between the two landmarks. Further clinical research is required
to evaluate the true inter-observer variability with these landmarks and the fact that we saw near-
identical alterations in IAP following positional changes in our local experiments (using the
symphysis pubis as zero-reference) compared to the multi-centre WSACS trial (using the iliac
crest), reinforces the suggestion that consistency may be more important than the actual
landmark chosen.
227
Whilst we have confirmed the observations made with other devices that excessively large
priming volumes used prior to measurement will spuriously increase the IAP, our data suggests
that the Foley Manometer is actually less prone to this error than other techniques. So, in
addition to the other advantages of accuracy, reproducibility, simplicity and cost-effectiveness, the
Foley Manometer also seems to be less sensitive to error induced by priming volume, with no
concerns of artificially elevated IAP measurements within the recommended maximum priming
volume of 25mls.
The novel problem of “vapour lock” was identified during the course of the experiments and
clinicians simply need to remain mindful of this occurrence, especially if higher IAPs are
encountered.
The experiments described in this chapter were performed and analysed according to the
published guidelines for research from the World Society for the Abdominal Compartment
Syndrome. The sample size for each of the experiments complied with the minimum required by
these guidelines and were all larger than previous comparable single-centre studies of other
devices. Further reassurance as to the validity of the results obtained was provided by the finding
of near-identical levels of bias in the studies of the effect of body position and zero-reference
point on IAP between our own local study of 20 patients and the multi-centre studies which
recruited 132 patients.
228
Observational Cohort Study of IAP in Liver Intensive Care
Our study is the first to examine the incidence and effects of raised intra-abdominal pressure in a
dedicated Liver Intensive Care Unit, is the largest single-centre observational cohort study and
the second largest critical care study to be performed. We have demonstrated a significant
incidence of raised IAP within this patient group and the incidence of IAH (81%) and ACS (38%)
seems to be much higher within this selected population than a general ITU cohort, with the peak
incidence following admission due to acute liver failure (97% & 64%).
We have demonstrated that there is a significant difference in length of stay between patients
with a normal and elevated IAP, and Day 1 abdominal perfusion pressure (Mean Arterial
Pressure – IAP) has been shown to be the only Day 1 independent predictor of length of ITU stay
in all groups.
In keeping with previous ITU cohort studies, we have demonstrated a strong and statistically
significant relationship between the presence of IAH and the incidence of renal, cardiovascular
and respiratory complications and our data is unique in that no such complications were
encountered within the normal IAH group following liver transplantation. IAP may also offer a
more accurate prediction of length of stay than other illness severity scores (APACHE II & SOFA)
though this would require further study with far tighter control and better design to prove.
Our most novel and interesting finding was that the natural course of IAH and ACS within this
particular patient group seems to be very different from that described within the general ITU
population. The relationship between Day 1 and Peak IAP is such that no patient who was
admitted with a normal Day 1 IAP went on to develop ACS at any point during their admission.
This contrasts with previously published reports that suggest that around 50% of the cumulative
incidence of IAH in the general ITU population occurs in the first 24 hours, with the further 50% of
229
cases developing later during the admission period. It would therefore seem that IAH and ACS
are both “front-loaded” diagnoses within our patient cohort, with in excess of 90% of cases of IAH
diagnosed within the first 48 hours following admission and 85% of patients with IAH reaching
diagnostic criteria on Day 1. The combination of the above factors means that though a very
significant proportion of patients admitted to the Liver Intensive Care Unit may be expected to
develop IAH, the vast majority will do so early in the course of their admission, which is therefore
where screening needs to be focussed. It is also reassuring to know that if, following liver
transplantation, the patient’s IAP is normal on Day 1 there were no subsequent cases of ACS and
no complications within this group.
We were not able to demonstrate any early predictive features that might suggest an increased
risk of IAH prior to admission to the intensive care unit following liver transplantation. Specifically,
despite the large volume intra-operative resuscitation involved with liver transplantation, there
was no relationship to subsequent peak IAP. Similarly, chronic abdominal distension associated
with large volume ascites prior to transplantation did not provide any protective effect in
preventing raised IAP post-operatively, though it is probably necessary to seek a way to directly
measure and quantify changes in abdominal wall compliance in patients with significant volume
ascites.
The major limitation of this cohort study was that it recruited non-consecutive patients and there
are several other significant sources of avoidable bias and instances of missing data that should
have been collected. The lack of consecutive sampling was due to a failure of all patients or their
relatives assenting to be studied and also a lack of availability of the researcher at all times. This
last factor combined with stringent requirements of the research ethics committee for early
anonymisation of the data led to a number of patients being missed for the study and also to
230
several incomplete datasets, which could not then be retrospectively filled and were therefore
excluded from the analysis. This difficulty could be overcome in any future studies by better
researcher collaboration and better negotiation with the research ethics committee for a secure
coding system to allow sufficient identification of subjects to permit retrospective collection of
missed data. The implications of this limitation is, of course, that the true incidence of IAH and
ACS may not have been captured, however by inference from the relatively low mortality rate
captured amongst the transplantation group – it is likely that the true incidence is as high or
higher than the rates presented. It is also likely that the largest number of refusals to participate
were from the relatives of the most critically ill patients, such that this also would have presented
a positive bias, if anything, to the results.
Whilst it is unit protocol to admit all patients to the Liver Intensive Care Unit following
transplantation, admission following HPB surgery or due to acute hepatic dysfunction is selective.
Whilst this policy ensures the maximum robustness of data following transplantation, it does
present the opportunity for selection bias in the other two groups. The incidence of IAH & ACS
was very high indeed following admission for acute hepatic dysfunction, but this of course reflects
the incidence within the very sickest cohort of patients with the condition – those requiring
admission for organ support and therefore, by definition, those with demonstrable organ
dysfunction. Similar bias exists within the HPB surgery group in that only those patients with
severe co-morbidity or significant intra-operative difficulties were admitted to the ITU
postoperatively, which again could be expected to skew the observed incidence of both IAH and
complications.
Whilst we have demonstrated a significant incidence of raised IAP within this patient group and
shown a strong relationship of IAH to complications, we cannot ascribe cause and effect to the
231
relationship. It is quite possible, and indeed we have demonstrated, that IAP acts well as an
illness severity marker, but IAH per se may not be responsible for the observed rate of
complications. Further targeted and well-controlled studies of the effects of abdominal
decompression on organ function are required in this patient population to examine this
relationship. Likewise we have identified a negative correlation between IAP and early liver graft
function as measured by ICG clearance, but further repeated measurements of ICG over the
course of admission and the subsequent effects of abdominal decompression for elevated IAP on
ICG clearance are warranted and may show an even more significant relationship.
In retrospect, there were several other areas of the study design that were sub-optimal and failure
to collect a number of additional variables has significantly limited the value of this work. The
value of collecting body anthropomorphic data has been discussed previously and the lack of this
data in the thesis reflects the timing of the experiments in relation to more recent interest in these
factors. Future studies should also examine physiological factors, such as cardiac output
measures in more detail and the patient groups clearly need to be better defined – particularly
those with acute hepatic dysfunction. For this group especially, lead time bias was not addressed
and treatments administered prior to admission to the LITU could not be reviewed. Within the
liver transplantation group, failure to collect more robust data surrounding the indications (and
urgency) of transplant along with some basic data concerning the graft to recipient size ratio,
gender mismatch, mode of organ retrieval, cold ischaemic time and steatosis scores all represent
missed opportunities to enrich the quality of the data.
For all groups, failure to statistically correct for mortalities will have skewed the length of stay data
and limits the value of the analyses for the acute hepatic dysfunction and HPB surgery groups
(there were no deaths in the liver transplant group).
232
In summary – whilst this study has identified the Liver ITU population as being particularly at risk
of elevated IAP and a strong relationship between IAH and complications. It has also generated
a number of outstanding research questions (especially within the disparate cohort of patients
with “acute hepatic dysfunction”), which will require further well-controlled study if the effect of this
high incidence of raised IAP is to be more accurately explored – the data presented certainly
suggest that further study would be worthwhile.
233
Regional IAP Following Liver Transplantation
The data from these experiments have explored two of the key assumptions with regards the
measurement of intra-abdominal pressure. Firstly, as we have already seen in chapter 3, the
bladder (in the absence of known intrinsic disease) has been shown to act as a passive
diaphragm for the transmission of the pressure contained immediately outside, within the
peritoneal cavity. This finding vindicates use of the intravesical pressure as the gold-standard for
clinical investigation of IAP.
The second assumption, namely that pressure is uniform throughout the abdominal cavity, has
been widely accepted throughout the critical care community and is often acknowledged within
the introduction and discussion of publications relating to IAP without any firm evidence of its
validity. We have shown that a definite and clinically significant pressure difference exists
between the upper and lower abdominal compartments following liver transplantation (typically a
difference of 20% between compartments).
This is the first study to quantify the extent and duration of difference in compartment pressures
and is novel in the technique used for continuous pressure monitoring. This has allowed us to
demonstrate that a clinically significant difference in pressure of 4 mmHg or more can be
expected to be apparent for around 23% of the time in patients undergoing liver transplantation
and we have shown that wide variations in regional pressure (up to 16 mmHg) can exist in this
patient group. In addition, we have shown that the difference between compartmental pressures
can be manipulated by patient positioning, in that a “head-up” position seems to reliably reduce
the upper abdominal pressure. These findings also help to interpret our earlier findings and those
of the WSACS multi-centre trial into the effects of body position on IAP, in that the change in
bladder pressure observed with more erect postures does seem to be likely to be due to
mechanical change in visceral positions applying a force to the bladder. Our data has shown that
234
the increased pressure observed with this manoeuvre is not transmitted throughout the abdomen
and, in fact, upright positioning actually seems to provide a protective effect on upper abdominal
pressure.
The fact that such a manoeuvre did not result in a clinically significant increase in the lower
abdominal pressure does however suggest that this effect might be limited to those undergoing
liver transplantation, given that our own and others previous investigation of the effect of body
position does seem to have had more of an effect on the intravesical pressure.
Within this patient group however, our new data does have a definite and immediate clinical
implication. The significant inter-compartmental variation in pressure, coupled with the fact that it
is not currently possible to predict which compartment will conceal the highest pressure, does
mean that measurement of the intravesical pressure alone may result in “under staging” the
problem of raised intra-abdominal pressure, such that a dangerously high upper abdominal
pressure can occur despite a normal bladder pressure. This would therefore suggest that a low
threshold for dual compartmental pressure monitoring should be observed in this patient group.
Whilst the findings of the experiments presented in this chapter are truly novel and exciting in the
field of IAP, there are some limitations to the study design and the generalisability of the data.
Liver transplantation was purposely selected as the model intervention for this investigation as it
is reasonably standardised and mainly confined to a single abdominal compartment. It is also
fairly unique in this respect and the findings therefore may not be applicable to other surgical and
non-surgical patient groups. Transplantation also tends to carry several major risk factors for
abdominal compartment syndrome, such as large volume intravenous resuscitation, long
235
procedures and high illness severity scores and it is not clear how much these factors may also
contribute to the observed compartmental pressure discrepancies.
The observation that some patients displayed higher upper abdominal pressures whilst others
had higher lower abdominal pressure was puzzling and cannot be explained with the available
evidence. With hindsight, there are several missing variables that may have aided the
interpretation of the data. It would have been useful to know the relative liver graft to recipient
size ratios as it is quite possible that a relatively larger graft in a small recipient could be expected
to result in higher upper abdominal pressures. Also, given the assumption that changes in
pressure with body position were attributable to gravity and stress / shear forces,
anthropomorphic data such as body mass index (BMI) and thorax to limb length raitios would
have been useful to know, along with the standard illness severity scores, which are known to
influence baseline IAP.
Further experiments, with additional data fields, are therefore required in order to better
understand why the compartmental pressures seem to differ so much in this patient group and
also the significance of which of the compartments hold the higher pressure.
Similar experiments would also be required in other surgical and non-surgical (perhaps via
bladder and stomach pressures) patients in order to understand whether this is an effect limited
to post-transplant patients.
Finally – it was interesting to see that head-up positioning seemed to confer some protective
effect by lowering the upper abdominal pressure. Whilst this would seem useful at an intuitive
level and has certainly been shown to be useful from a respiratory point of view, formal
236
assessment of the hepatosplanchnic and renal circulations would be required to further
characterise this manoeuvre.
In conclusion – the research for thesis has shown that IAP, as a concept, has gained fairly
widespread acceptance and interest amongst both the surgical and anaesthetic population in the
UK, though factual knowledge and thresholds for interventions clearly need further education.
IAP can be measured accurately using a variety of techniques, each with its own set of
advantages and limitations. Our observational data has shown that IAP is a significant problem in
the context of liver intensive care and that not only do these patients carry a higher incidence of
raised IAP than those within a general ITU setting – it is also likely that their response to both the
diagnosis and treatment of raised IAP will also differ, especially in view of the identification of a
possible regional compartment syndrome.
237
Bibliography 1. Nortje J, Gupta AK: The role of tissue oxygen monitoring in patients with acute
brain injury. Br J Anaesth 2006, 97(1):95-106. 2. Tiwari A, Haq AI, Myint F, Hamilton G: Acute compartment syndromes. Br J Surg
2002, 89(4):397-412. 3. Edwards RJ, Dombrowski SM, Luciano MG, Pople IK: Chronic hydrocephalus in
adults. Brain Pathol 2004, 14(3):325-336. 4. Skau M, Brennum J, Gjerris F, Jensen R: What is new about idiopathic intracranial
hypertension? An updated review of mechanism and treatment. Cephalalgia 2006, 26(4):384-399.
5. Pritchard MH, Williams RL, Heath JP: Chronic compartment syndrome, an important cause of work-related upper limb disorder. Rheumatology (Oxford) 2005, 44(11):1442-1446.
6. Bailey J, Shapiro MJ: Abdominal compartment syndrome. Critical care (London, England) 2000, 4(1):23-29.
7. Malbrain ML: Is it wise not to think about intraabdominal hypertension in the ICU? Current opinion in critical care 2004, 10(2):132-145.
8. Sugrue M: Abdominal compartment syndrome. Current opinion in critical care 2005, 11(4):333-338.
9. Sugerman HJ: Effects of increased intra-abdominal pressure in severe obesity. Surg Clin North Am 2001, 81(5):1063-1075, vi.
10. Burch JM, Moore EE, Moore FA, Franciose R: The abdominal compartment syndrome. Surg Clin North Am 1996, 76(4):833-842.
11. Balogh Z, McKinley BA, Cox Jr CS, Allen SJ, Cocanour CS, Kozar RA, Moore EE, Miller IC, Weisbrodt NW, Moore FA: Abdominal compartment syndrome: the cause or effect of postinjury multiple organ failure. Shock 2003, 20(6):483-492.
12. Malbrain ML, Cheatham ML, Kirkpatrick A, Sugrue M, Parr M, De Waele J, Balogh Z, Leppaniemi A, Olvera C, Ivatury R et al: Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. I. Definitions. Intensive Care Med 2006, 32(11):1722-1732.
13. Emerson H: Intra-abdominal pressures. Archives of Internal Medicine 1911, 7:754 - 784.
14. Wendt E: Ueber den Einfluss des intraabdominalen Druckes auf die Absonderungsgeschwindigkeit des Harnes. Arch fur Physiol Heilkd 1867:527 - 525.
15. Barnes GE, Laine GA, Giam PY, Smith EE, Granger HJ: Cardiovascular responses to elevation of intra-abdominal hydrostatic pressure. Am J Physiol 1985, 248(2 Pt 2):R208-213.
16. Ridings PC, Bloomfield GL, Blocher CR, Sugerman HJ: Cardiopulmonary effects of raised intra-abdominal pressure before and after intravascular volume expansion. The Journal of trauma 1995, 39(6):1071-1075.
17. Shelly MP, Robinson AA, Hesford JW, Park GR: Haemodynamic effects following surgical release of increased intra-abdominal pressure. Br J Anaesth 1987, 59(6):800-805.
18. Tal R, Lask DM, Keslin J, Livne PM: Abdominal compartment syndrome: urological aspects. BJU Int 2004, 93(4):474-477.
19. Ogilvie W: The late complications of abdominal war wounds. . Lancet 1940, 2:253-256.
20. Baggot MG: Abdominal blow-out: a concept. Curr Res Anesth Analg 1951, 30(5):295-299.
238
21. Fietsam R, Jr., Villalba M, Glover JL, Clark K: Intra-abdominal compartment syndrome as a complication of ruptured abdominal aortic aneurysm repair. Am Surg 1989, 55(6):396-402.
22. Kron IL, Harman PK, Nolan SP: The measurement of intra-abdominal pressure as a criterion for abdominal re-exploration. Ann Surg 1984, 199(1):28-30.
23. Harman PK, Kron IL, McLachlan HD, Freedlender AE, Nolan SP: Elevated intra-abdominal pressure and renal function. Ann Surg 1982, 196(5):594-597.
24. Malbrain ML, Cheatham ML, Kirkpatrick A, Sugrue M, De Waele J, Ivatury R: Abdominal compartment syndrome: it's time to pay attention! Intensive care medicine 2006, 32(11):1912-1914.
25. Cobb WS, Burns JM, Kercher KW, Matthews BD, James Norton H, Todd Heniford B: Normal intraabdominal pressure in healthy adults. The Journal of surgical research 2005, 129(2):231-235.
26. Shafik A, El-Sibai O, Shafik AA, Ahmed I: Effect of straining on perineal muscles and their role in perineal support: identification of the straining-perineal reflex. The Journal of surgical research 2003, 112(2):162-167.
27. Shafik A, El-Sharkawy A, Sharaf WM: Direct measurement of intra-abdominal pressure in various conditions. Eur J Surg 1997, 163(12):883-887.
28. Sanchez NC, Tenofsky PL, Dort JM, Shen LY, Helmer SD, Smith RS: What is normal intra-abdominal pressure? Am Surg 2001, 67(3):243-248.
29. Malbrain ML, Chiumello D, Pelosi P, Wilmer A, Brienza N, Malcangi V, Bihari D, Innes R, Cohen J, Singer P et al: Prevalence of intra-abdominal hypertension in critically ill patients: a multicentre epidemiological study. Intensive Care Med 2004, 30(5):822-829.
30. Cheatham ML, Safcsak K: Intraabdominal pressure: a revised method for measurement. J Am Coll Surg 1998, 186(5):594-595.
31. Malbrain ML, Chiumello D, Pelosi P, Bihari D, Innes R, Ranieri VM, Del Turco M, Wilmer A, Brienza N, Malcangi V et al: Incidence and prognosis of intraabdominal hypertension in a mixed population of critically ill patients: a multiple-center epidemiological study. Critical care medicine 2005, 33(2):315-322.
32. Malbrain ML, Deeren D, De Potter TJ: Intra-abdominal hypertension in the critically ill: it is time to pay attention. Current opinion in critical care 2005, 11(2):156-171.
33. Vidal MG, Ruiz Weisser J, Gonzalez F, Toro MA, Loudet C, Balasini C, Canales H, Reina R, Estenssoro E: Incidence and clinical effects of intra-abdominal hypertension in critically ill patients. Critical care medicine 2008, 36(6):1823-1831.
34. Kim IB, Prowle J, Baldwin I, Bellomo R: Incidence, risk factors and outcome associations of intra-abdominal hypertension in critically ill patients. Anaesthesia and intensive care 2012, 40(1):79-89.
35. Santa-Teresa P, Munoz J, Montero I, Zurita M, Tomey M, Alvarez-Sala L, Garcia P: Incidence and prognosis of intra-abdominal hypertension in critically ill medical patients: a prospective epidemiological study. Annals of intensive care 2012, 2 Suppl 1:S3.
36. Al-Bahrani AZ, Abid GH, Holt A, McCloy RF, Benson J, Eddleston J, Ammori BJ: Clinical relevance of intra-abdominal hypertension in patients with severe acute pancreatitis. Pancreas 2008, 36(1):39-43.
37. Leppaniemi A, Johansson K, De Waele JJ: Abdominal compartment syndrome and acute pancreatitis. Acta clinica Belgica 2007(1):131-135.
38. Regueira T, Bruhn A, Hasbun P, Aguirre M, Romero C, Llanos O, Castro R, Bugedo G, Hernandez G: Intra-abdominal hypertension: incidence and association with
239
organ dysfunction during early septic shock. Journal of critical care 2008, 23(4):461-467.
39. Meldrum DR, Moore FA, Moore EE, Franciose RJ, Sauaia A, Burch JM: Prospective characterization and selective management of the abdominal compartment syndrome. American journal of surgery 1997, 174(6):667-672; discussion 672-663.
40. Ivatury RR, Porter JM, Simon RJ, Islam S, John R, Stahl WM: Intra-abdominal hypertension after life-threatening penetrating abdominal trauma: prophylaxis, incidence, and clinical relevance to gastric mucosal pH and abdominal compartment syndrome. The Journal of trauma 1998, 44(6):1016-1021; discussion 1021-1013.
41. Maxwell RA, Fabian TC, Croce MA, Davis KA: Secondary abdominal compartment syndrome: an underappreciated manifestation of severe hemorrhagic shock. The Journal of trauma 1999, 47(6):995-999.
42. Kirkpatrick AW, Brenneman FD, McLean RF, Rapanos T, Boulanger BR: Is clinical examination an accurate indicator of raised intra-abdominal pressure in critically injured patients? Canadian journal of surgery 2000, 43(3):207-211.
43. Ertel W, Oberholzer A, Platz A, Stocker R, Trentz O: Incidence and clinical pattern of the abdominal compartment syndrome after "damage-control" laparotomy in 311 patients with severe abdominal and/or pelvic trauma. Crit Care Med 2000, 28(6):1747-1753.
44. Offner PJ, de Souza AL, Moore EE, Biffl WL, Franciose RJ, Johnson JL, Burch JM: Avoidance of abdominal compartment syndrome in damage-control laparotomy after trauma. Arch Surg 2001, 136(6):676-681.
45. Raeburn CD, Moore EE, Biffl WL, Johnson JL, Meldrum DR, Offner PJ, Franciose RJ, Burch JM: The abdominal compartment syndrome is a morbid complication of postinjury damage control surgery. Am J Surg 2001, 182(6):542-546.
46. Hong JJ, Cohn SM, Perez JM, Dolich MO, Brown M, McKenney MG: Prospective study of the incidence and outcome of intra-abdominal hypertension and the abdominal compartment syndrome. Br J Surg 2002, 89(5):591-596.
47. Balogh Z, McKinley BA, Cocanour CS, Kozar RA, Valdivia A, Sailors RM, Moore FA: Supranormal trauma resuscitation causes more cases of abdominal compartment syndrome. Arch Surg 2003, 138(6):637-642; discussion 642-633.
48. Balogh Z, McKinley BA, Holcomb JB, Miller CC, Cocanour CS, Kozar RA, Valdivia A, Ware DN, Moore FA: Both primary and secondary abdominal compartment syndrome can be predicted early and are harbingers of multiple organ failure. The Journal of trauma 2003, 54(5):848-859; discussion 859-861.
49. Sugrue M, Buist MD, Hourihan F, Deane S, Bauman A, Hillman K: Prospective study of intra-abdominal hypertension and renal function after laparotomy. Br J Surg 1995, 82(2):235-238.
50. Sugrue M, Jones F, Lee A, Buist MD, Deane S, Bauman A, Hillman K: Intraabdominal pressure and gastric intramucosal pH: is there an association? World journal of surgery 1996, 20(8):988-991.
51. Sugrue M, Jones F, Deane SA, Bishop G, Bauman A, Hillman K: Intra-abdominal hypertension is an independent cause of postoperative renal impairment. Arch Surg 1999, 134(10):1082-1085.
52. Biancofiore G, Bindi ML, Romanelli AM, Boldrini A, Consani G, Bisa M, Filipponi F, Vagelli A, Mosca F: Intra-abdominal pressure monitoring in liver transplant recipients: a prospective study. Intensive care medicine 2003, 29(1):30-36.
53. Busani S, Soccorsi MC, Poma C, Girardis M: Intra-abdominal hypertension in nonelective surgery: a preliminary report. Transplant Proc 2006, 38(3):836-837.
240
54. Djavani K, Wanhainen A, Bjorck M: Intra-abdominal hypertension and abdominal compartment syndrome following surgery for ruptured abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2006, 31(6):581-584.
55. Greenhalgh DG, Warden GD: The importance of intra-abdominal pressure measurements in burned children. J Trauma 1994, 36(5):685-690.
56. Ivy ME, Atweh NA, Palmer J, Possenti PP, Pineau M, D'Aiuto M: Intra-abdominal hypertension and abdominal compartment syndrome in burn patients. J Trauma 2000, 49(3):387-391.
57. Latenser BA, Kowal-Vern A, Kimball D, Chakrin A, Dujovny N: A pilot study comparing percutaneous decompression with decompressive laparotomy for acute abdominal compartment syndrome in thermal injury. The Journal of burn care & rehabilitation 2002, 23(3):190-195.
58. Hobson KG, Young KM, Ciraulo A, Palmieri TL, Greenhalgh DG: Release of abdominal compartment syndrome improves survival in patients with burn injury. J Trauma 2002, 53(6):1129-1133; discussion 1133-1124.
59. Oda J, Yamashita K, Inoue T, Harunari N, Ode Y, Mega K, Aoki Y, Noborio M, Ueyama M: Resuscitation fluid volume and abdominal compartment syndrome in patients with major burns. Burns 2006, 32(2):151-154.
60. Sugrue M, Bauman A, Jones F, Bishop G, Flabouris A, Parr M, Stewart A, Hillman K, Deane SA: Clinical examination is an inaccurate predictor of intraabdominal pressure. World journal of surgery 2002, 26(12):1428-1431.
61. Castillo M LR, Ulrich H, Rivera G, Hanf C, Kvetan V: Clinical estimate compared to intra-abdominal pressure measurement. Poster - Society of Critical Care Medicine 1998, 27th Educational and Scientific Symposium.
62. Mieghem NV, Verbrugghe W, Daelemans R: Can abdominal perimeter be used as an accurate estimation of intra-abdominal pressure? Critical Care 2003, 7(S2):183.
63. Suominen PK, Pakarinen MP, Rautiainen P, Mattila I, Sairanen H: Comparison of direct and intravesical measurement of intraabdominal pressure in children. Journal of pediatric surgery 2006, 41(8):1381-1385.
64. Iberti TJ, Kelly KM, Gentili DR, Hirsch S, Benjamin E: A simple technique to accurately determine intra-abdominal pressure. Crit Care Med 1987, 15(12):1140-1142.
65. Iberti TJ, Lieber CE, Benjamin E: Determination of intra-abdominal pressure using a transurethral bladder catheter: clinical validation of the technique. Anesthesiology 1989, 70(1):47-50.
66. Schachtrupp A, Tons C, Fackeldey V, Hoer J, Reinges M, Schumpelick V: Evaluation of two novel methods for the direct and continuous measurement of the intra-abdominal pressure in a porcine model. Intensive care medicine 2003, 29(9):1605-1608.
67. De Waele J, Pletinckx P, Blot S, Hoste E: Saline volume in transvesical intra-abdominal pressure measurement: enough is enough. Intensive care medicine 2006, 32(3):455-459.
68. Malbrain ML: Different techniques to measure intra-abdominal pressure (IAP): time for a critical re-appraisal. Intensive care medicine 2004, 30(3):357-371.
69. Sugrue M, Buist MD, Lee A, Sanchez DJ, Hillman KM: Intra-abdominal pressure measurement using a modified nasogastric tube: description and validation of a new technique. Intensive Care Med 1994, 20(8):588-590.
70. Harrahill M: Intra-abdominal pressure monitoring. J Emerg Nurs 1998, 24(5):465-466.
241
71. Collee GG, Lomax DM, Ferguson C, Hanson GC: Bedside measurement of intra-abdominal pressure (IAP) via an indwelling naso-gastric tube: clinical validation of the technique. Intensive care medicine 1993, 19(8):478-480.
72. Cheatham ML, Malbrain ML, Kirkpatrick A, Sugrue M, Parr M, De Waele J, Balogh Z, Leppaniemi A, Olvera C, Ivatury R et al: Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. II. Recommendations. Intensive Care Med 2007.
73. Schunemann HJ, Jaeschke R, Cook DJ, Bria WF, El-Solh AA, Ernst A, Fahy BF, Gould MK, Horan KL, Krishnan JA et al: An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med 2006, 174(5):605-614.
74. Cheatham ML, Malbrain ML, Kirkpatrick A, Sugrue M, Parr M, De Waele J, Balogh Z, Leppaniemi A, Olvera C, Ivatury R et al: Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. II. Recommendations. Intensive care medicine 2007, 33(6):951-962.
75. Ivatury RR, Diebel L, Porter JM, Simon RJ: Intra-abdominal hypertension and the abdominal compartment syndrome. Surg Clin North Am 1997, 77(4):783-800.
76. Yagmurdur MC, Basaran O, Ozdemir H, Gur G, Turan M, Karakayali H, Haberal M: The impact of transient elevation of intra-abdominal pressure on liver regeneration in the rat. J Invest Surg 2004, 17(6):315-322.
77. Biancofiore G, Bindi ML, Romanelli AM, Bisa M, Boldrini A, Consani G, Filipponi F, Mosca F: Postoperative intra-abdominal pressure and renal function after liver transplantation. Arch Surg 2003, 138(7):703-706.
78. Blumgart LH, Wheatley AM, Mathie RT: Surgery of the Liver, Biliary Tract and Pancreas, vol. 1, 4 edn. New York: Saunders; 2006.
79. Lautt WW: Relationship between hepatic blood flow and overall metabolism: the hepatic arterial buffer response. Fed Proc 1983, 42(6):1662-1666.
80. Lautt WW, D'Almeida MS, McQuaker J, D'Aleo L: Impact of the hepatic arterial buffer response on splanchnic vascular responses to intravenous adenosine, isoproterenol, and glucagon. Can J Physiol Pharmacol 1988, 66(6):807-813.
81. Mathie RT, Alexander B: The role of adenosine in the hyperaemic response of the hepatic artery to portal vein occlusion (the 'buffer response'). Br J Pharmacol 1990, 100(3):626-630.
82. Klopfenstein CE, Morel DR, Clergue F, Pastor CM: Effects of abdominal CO2 insufflation and changes of position on hepatic blood flow in anesthetized pigs. Am J Physiol 1998, 275(3 Pt 2):H900-905.
83. Eleftheriadis E, Kotzampassi K: Hepatic microcirculation after continuous 7-day elevated intra-abdominal pressure in cirrhotic rats. Hepatol Res 2005, 32(2):96-100.
84. Burns P, Taylor K, Blei AT: Doppler flowmetry and portal hypertension. Gastroenterology 1987, 92(3):824-826.
85. Gorg C, Riera-Knorrenschild J, Dietrich J: Pictorial review: Colour Doppler ultrasound flow patterns in the portal venous system. Br J Radiol 2002, 75(899):919-929.
86. Lim AK, Taylor-Robinson SD, Patel N, Eckersley RJ, Goldin RD, Hamilton G, Foster GR, Thomas HC, Cosgrove DO, Blomley MJ: Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C. Gut 2005, 54(1):128-133.
87. Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE: Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology 2003, 229(2):409-414.
242
88. Scharf J, Zapletal C, Hess T, Hoffmann U, Mehrabi A, Mihm D, Hoffmann V, Brix G, Kraus T, Richter GM et al: Assessment of hepatic perfusion in pigs by pharmacokinetic analysis of dynamic MR images. J Magn Reson Imaging 1999, 9(4):568-572.
89. Matejovic M, Rokyta R, Jr., Radermacher P, Krouzecky A, Sramek V, Novak I: Effect of prone position on hepato-splanchnic hemodynamics in acute lung injury. Intensive care medicine 2002, 28(12):1750-1755.
90. Grainger SL, Keeling PW, Brown IM, Marigold JH, Thompson RP: Clearance and non-invasive determination of the hepatic extraction of indocyanine green in baboons and man. Clin Sci (Lond) 1983, 64(2):207-212.
91. Faybik P, Krenn CG, Baker A, Lahner D, Berlakovich G, Steltzer H, Hetz H: Comparison of invasive and noninvasive measurement of plasma disappearance rate of indocyanine green in patients undergoing liver transplantation: a prospective investigator-blinded study. Liver Transpl 2004, 10(8):1060-1064.
92. Sakka SG, Reinhart K, Meier-Hellmann A: Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients. Chest 2002, 122(5):1715-1720.
93. Sakka SG, Reinhart K, Wegscheider K, Meier-Hellmann A: Variability of splanchnic blood flow in patients with sepsis. Intensive care medicine 2001, 27(8):1281-1287.
94. Tsubono T, Todo S, Jabbour N, Mizoe A, Warty V, Demetris AJ, Starzl TE: Indocyanine green elimination test in orthotopic liver recipients. Hepatology 1996, 24(5):1165-1171.
95. Gottlieb ME, Stratton HH, Newell JC, Shah DM: Indocyanine green. Its use as an early indicator of hepatic dysfunction following injury in man. Arch Surg 1984, 119(3):264-268.
96. Okochi O, Kaneko T, Sugimoto H, Inoue S, Takeda S, Nakao A: ICG pulse spectrophotometry for perioperative liver function in hepatectomy. The Journal of surgical research 2002, 103(1):109-113.
97. Yokoyama Y, Alterman DM, Sarmadi AH, Baveja R, Zhang JX, Huynh T, Clemens MG: Hepatic vascular response to elevated intraperitoneal pressure in the rat. The Journal of surgical research 2002, 105(2):86-94.
98. Schemmer P, Barro-Bejarano M, Mehrabi A, Gebhard MM, Kraus T, Buchler MW, Gutt CN: Laparoscopic organ retrieval for living donor liver transplantation does not prevent graft injury. Transplant Proc 2005, 37(3):1625-1627.
99. Saggi BH, Sugerman HJ, Ivatury RR, Bloomfield GL: Abdominal compartment syndrome. The Journal of trauma 1998, 45(3):597-609.
100. Diebel LN, Wilson RF, Dulchavsky SA, Saxe J: Effect of increased intra-abdominal pressure on hepatic arterial, portal venous, and hepatic microcirculatory blood flow. The Journal of trauma 1992, 33(2):279-282; discussion 282-273.
101. Schilling MK, Redaelli C, Krahenbuhl L, Signer C, Buchler MW: Splanchnic microcirculatory changes during CO2 laparoscopy. J Am Coll Surg 1997, 184(4):378-382.
102. Gutt CN, Schmandra TC: Portal venous flow during CO(2) pneumoperitoneum in the rat. Surg Endosc 1999, 13(9):902-905.
103. Dalfino L, Malcangi V, Cinnella G, Brienza N: Abdominal hypertension and liver dysfunction in intensive care unit patients: an "on-off" phenomenon? Transplant Proc 2006, 38(3):838-840.
104. Wachsberg RH: Narrowing of the upper abdominal inferior vena cava in patients with elevated intraabdominal pressure: sonographic observations. J Ultrasound Med 2000, 19(3):217-222.
243
105. Savino JA, Cerabona T, Agarwal N, Byrne D: Manipulation of ascitic fluid pressure in cirrhotics to optimize hemodynamic and renal function. Ann Surg 1988, 208(4):504-511.
106. Sutcliffe R, Meares H, Auzinger G, al. E: Preload assessment in severe liver disease associated with intra-abdominal hypertension. Intensive care medicine 2002, 28 (Suppl 1):S177A688.
107. Huettemann E, Sakka SG, Petrat G, Schier F, Reinhart K: Left ventricular regional wall motion abnormalities during pneumoperitoneum in children. Br J Anaesth 2003, 90(6):733-736.
108. Cheatham ML, Malbrain ML: Cardiovascular implications of abdominal compartment syndrome. Acta clinica Belgica 2007(1):98-112.
109. Jardin F, Brun-Ney D, Hardy A, Aegerter P, Beauchet A, Bourdarias JP: Combined thermodilution and two-dimensional echocardiographic evaluation of right ventricular function during respiratory support with PEEP. Chest 1991, 99(1):162-168.
110. Bloomfield GL, Blocher CR, Fakhry IF, Sica DA, Sugerman HJ: Elevated intra-abdominal pressure increases plasma renin activity and aldosterone levels. J Trauma 1997, 42(6):997-1004; discussion 1004-1005.
111. Cullen DJ, Coyle JP, Teplick R, Long MC: Cardiovascular, pulmonary, and renal effects of massively increased intra-abdominal pressure in critically ill patients. Critical care medicine 1989, 17(2):118-121.
112. Kirsch AJ, Hensle TW, Chang DT, Kayton ML, Olsson CA, Sawczuk IS: Renal effects of CO2 insufflation: oliguria and acute renal dysfunction in a rat pneumoperitoneum model. Urology 1994, 43(4):453-459.
113. Ortega AE, Richman MF, Hernandez M, Peters JH, Anthone GJ, Azen S, Beart RW, Jr.: Inferior vena caval blood flow and cardiac hemodynamics during carbon dioxide pneumoperitoneum. Surg Endosc 1996, 10(9):920-924.
114. Nguyen NT, Cronan M, Braley S, Rivers R, Wolfe BM: Duplex ultrasound assessment of femoral venous flow during laparoscopic and open gastric bypass. Surg Endosc 2003, 17(2):285-290.
115. Hirvonen EA, Poikolainen EO, Paakkonen ME, Nuutinen LS: The adverse hemodynamic effects of anesthesia, head-up tilt, and carbon dioxide pneumoperitoneum during laparoscopic cholecystectomy. Surg Endosc 2000, 14(3):272-277.
116. Lee SL, Anderson JT, Kraut EJ, Wisner DH, Wolfe BM: A simplified approach to the diagnosis of elevated intra-abdominal pressure. J Trauma 2002, 52(6):1169-1172.
117. Lee SS: Cardiac dysfunction in spontaneous bacterial peritonitis: a manifestation of cirrhotic cardiomyopathy? Hepatology 2003, 38(5):1089-1091.
118. Wong F, Girgrah N, Graba J, Allidina Y, Liu P, Blendis L: The cardiac response to exercise in cirrhosis. Gut 2001, 49(2):268-275.
119. Milani A, Zaccaria R, Bombardieri G, Gasbarrini A, Pola P: Cirrhotic cardiomyopathy. Dig Liver Dis 2007, 39(6):507-515.
120. Diebel LN, Wilson RF, Tagett MG, Kline RA: End-diastolic volume. A better indicator of preload in the critically ill. Arch Surg 1992, 127(7):817-821; discussion 821-812.
121. Cheatham ML, Nelson LD, Chang MC, Safcsak K: Right ventricular end-diastolic volume index as a predictor of preload status in patients on positive end-expiratory pressure. Crit Care Med 1998, 26(11):1801-1806.
244
122. Chaney JC, Derdak S: Minimally invasive hemodynamic monitoring for the intensivist: current and emerging technology. Crit Care Med 2002, 30(10):2338-2345.
123. Wiesenack C, Prasser C, Rodig G, Keyl C: Stroke volume variation as an indicator of fluid responsiveness using pulse contour analysis in mechanically ventilated patients. Anesth Analg 2003, 96(5):1254-1257.
124. Malbrain M, Meighem Nv, Verbrugghe W, Daelemans R, Lins R: PiCCO derived parameters versus "filling pressures" in intra-abdominal hypertension. Intensive Care Med 2003, 29:S130.
125. Pelosi P, Quintel M, Malbrain ML: Effect of intra-abdominal pressure on respiratory mechanics. Acta clinica Belgica 2007(1):78-88.
126. Williams M, Simms HH: Abdominal compartment syndrome: case reports and implications for management in critically ill patients. Am Surg 1997, 63(6):555-558.
127. Oikkonen M, Tallgren M: Changes in respiratory compliance at laparoscopy: measurements using side stream spirometry. Canadian journal of anaesthesia = Journal canadien d'anesthesie 1995, 42(6):495-497.
128. Puri GD, Singh H: Ventilatory effects of laparoscopy under general anaesthesia. Br J Anaesth 1992, 68(2):211-213.
129. Donahoe M: Basic ventilator management: lung protective strategies. Surg Clin North Am 2006, 86(6):1389-1408.
130. Rezende-Neto JB, Moore EE, Melo de Andrade MV, Teixeira MM, Lisboa FA, Arantes RM, de Souza DG, da Cunha-Melo JR: Systemic inflammatory response secondary to abdominal compartment syndrome: stage for multiple organ failure. J Trauma 2002, 53(6):1121-1128.
131. Diebel LN, Dulchavsky SA, Brown WJ: Splanchnic ischemia and bacterial translocation in the abdominal compartment syndrome. The Journal of trauma 1997, 43(5):852-855.
132. De laet I, Malbrain ML, Jadoul JL, Rogiers P, Sugrue M: Renal implications of increased intra-abdominal pressure: are the kidneys the canary for abdominal hypertension? Acta clinica Belgica 2007(1):119-130.
133. Kirkpatrick AW, Colistro R, Laupland KB, Fox DL, Konkin DE, Kock V, Mayo JR, Nicolaou S: Renal arterial resistive index response to intraabdominal hypertension in a porcine model. Crit Care Med 2007, 35(1):207-213.
134. Hazebroek EJ, de Vos tot Nederveen Cappel R, Gommers D, van Gelder T, Weimar W, Steyerberg EW, Bonjer HJ, JN IJ: Antidiuretic hormone release during laparoscopic donor nephrectomy. Arch Surg 2002, 137(5):600-604; discussion 605.
135. Doty JM, Saggi BH, Blocher CR, Fakhry I, Gehr T, Sica D, Sugerman HJ: Effects of increased renal parenchymal pressure on renal function. The Journal of trauma 2000, 48(5):874-877.
136. Sugrue M, Jones F, Janjua KJ, Deane SA, Bristow P, Hillman K: Temporary abdominal closure: a prospective evaluation of its effects on renal and respiratory physiology. The Journal of trauma 1998, 45(5):914-921.
137. De Waele JJ, Hoste EA, Malbrain ML: Decompressive laparotomy for abdominal compartment syndrome--a critical analysis. Crit Care 2006, 10(2):R51.
138. Citerio G, Vascotto E, Villa F, Celotti S, Pesenti A: Induced abdominal compartment syndrome increases intracranial pressure in neurotrauma patients: a prospective study. Critical care medicine 2001, 29(7):1466-1471.
139. Bloomfield GL, Ridings PC, Blocher CR, Marmarou A, Sugerman HJ: A proposed relationship between increased intra-abdominal, intrathoracic, and intracranial pressure. Crit Care Med 1997, 25(3):496-503.
245
140. Joseph DK, Dutton RP, Aarabi B, Scalea TM: Decompressive laparotomy to treat intractable intracranial hypertension after traumatic brain injury. J Trauma 2004, 57(4):687-693; discussion 693-685.
141. De Waele JJ, Cheatham ML, Malbrain ML, Kirkpatrick AW, Sugrue M, Balogh Z, Ivatury R, De Keulenaer B, Kimball EJ: Recommendations for research from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. Acta Clin Belg 2009, 64(3):203-209.
142. Sessler CN, Gosnell MS, Grap MJ, Brophy GM, O'Neal PV, Keane KA, Tesoro EP, Elswick RK: The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. American journal of respiratory and critical care medicine 2002, 166(10):1338-1344.
143. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007, 370(9596):1453-1457.
144. Karmali S, Evans D, Laupland KB, Findlay C, Ball CG, Bergeron E, Stewart TC, Parry N, Khetarpal S, Kirkpatrick AW: To close or not to close, that is one of the questions? Perceptions of Trauma Association of Canada surgical members on the management of the open abdomen. J Trauma 2006, 60(2):287-293.
145. Kirkpatrick AW, Laupland KB, Karmali S, Bergeron E, Stewart TC, Findlay C, Parry N, Khetarpal S, Evans D: Spill your guts! Perceptions of Trauma Association of Canada member surgeons regarding the open abdomen and the abdominal compartment syndrome. J Trauma 2006, 60(2):279-286.
146. Mayberry JC, Goldman RK, Mullins RJ, Brand DM, Crass RA, Trunkey DD: Surveyed opinion of American trauma surgeons on the prevention of the abdominal compartment syndrome. The Journal of trauma 1999, 47(3):509-513; discussion 513-504.
147. Kimball EJ, Rollins MD, Mone MC, Hansen HJ, Baraghoshi GK, Johnston C, Day ES, Jackson PR, Payne M, Barton RG: Survey of intensive care physicians on the recognition and management of intra-abdominal hypertension and abdominal compartment syndrome. Crit Care Med 2006, 34(9):2340-2348.
148. Nagappan R, Ernest D, Whitfield A: Recognition and management of intra-abdominal hypertension and abdominal compartment syndrome. Crit Care Resusc 2005, 7(4):298-302.
149. Ravishankar N, Hunter J: Measurement of intra-abdominal pressure in intensive care units in the United Kingdom: a national postal questionnaire study. Br J Anaesth 2005, 94(6):763-766.
150. Tiwari A, Myint F, Hamilton G: Recognition and management of abdominal compartment syndrome in the United Kingdom. Intensive care medicine 2006, 32(6):906-909.
151. Kimball EJ, Kim W, Cheatham ML, Malbrain ML: Clinical awareness of intra-abdominal hypertension and abdominal compartment syndrome in 2007. Acta clinica Belgica 2007(1):66-73.
152. Malbrain ML, De laet I, Cheatham M: Consensus conference definitions and recommendations on intra-abdominal hypertension (IAH) and the abdominal compartment syndrome (ACS)--the long road to the final publications, how did we get there? Acta clinica Belgica 2007(1):44-59.
153. An G, West MA: Abdominal compartment syndrome: a concise clinical review. Critical care medicine 2008, 36(4):1304-1310.
246
154. Cheatham ML: Abdominal compartment syndrome. Current opinion in critical care 2009, 15(2):154-162.
155. De Laet IE, Ravyts M, Vidts W, Valk J, De Waele JJ, Malbrain ML: Current insights in intra-abdominal hypertension and abdominal compartment syndrome: open the abdomen and keep it open! Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie 2008, 393(6):833-847.
156. Malbrain ML, De laet IE: Intra-abdominal hypertension: evolving concepts. Clinics in chest medicine 2009, 30(1):45-70, viii.
157. Malbrain ML, De laet IE, De Waele JJ: IAH/ACS: the rationale for surveillance. World journal of surgery 2009, 33(6):1110-1115.
158. Scheppach W: Abdominal compartment syndrome. Best practice & research 2009, 23(1):25-33.
159. Malbrain M: Incidence of intraabdominal hypertension in the intensive care unit. Critical care medicine 2005, 33(9):2150-2153.
160. Ibis C, Altan A: The value of intra-abdominal pressure measurement in patients with acute abdomen. Asian journal of surgery / Asian Surgical Association 2009, 32(1):33-38.
161. Malbrain ML, De laet I, Van Regenmortel N, Schoonheydt K, Dits H: Can the abdominal perimeter be used as an accurate estimation of intra-abdominal pressure? Critical care medicine 2009, 37(1):316-319.
162. Kimball EJ, Mone MC, Wolfe TR, Baraghoshi GK, Alder SC: Reproducibility of bladder pressure measurements in critically ill patients. Intensive Care Med 2007, 33(7):1195-1198.
163. De Potter TJ, Dits H, Malbrain ML: Intra- and interobserver variability during in vitro validation of two novel methods for intra-abdominal pressure monitoring. Intensive care medicine 2005, 31(5):747-751.
164. Maki DG, Tambyah PA: Engineering out the risk for infection with urinary catheters. Emerg Infect Dis 2001, 7(2):342-347.
165. Risin E, Kessel B, Ashkenazi I, Lieberman N, Alfici R: A new technique of direct intra-abdominal pressure measurement: a preliminary study. Am J Surg 2006, 191(2):235-237.
166. Risin E, Kessel B, Lieberman N, Schmilovich M, Ashkenazi I, Alfici R: New technique of direct intra-abdominal pressure measurement. Asian journal of surgery / Asian Surgical Association 2006, 29(4):247-250.
167. Jakob SM, Knuesel R, Tenhunen JJ, Pradl R, Takala J: Increasing abdominal pressure with and without PEEP: effects on intra-peritoneal, intra-organ and intra-vascular pressures. BMC gastroenterology 2010, 10:70.
168. Schachtrupp A, Henzler D, Orfao S, Schaefer W, Schwab R, Becker P, Schumpelick V: Evaluation of a modified piezoresistive technique and a water-capsule technique for direct and continuous measurement of intra-abdominal pressure in a porcine model. Critical care medicine 2006, 34(3):745-750.
169. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 1(8476):307-310.
170. Wolfe T, Kimball E: Inter- and intra-observer variability does not occur with a new intra-abdominal pressure monitoring kit. ANZ J Surg 2005, 57:A1.
171. Cheatham ML, De Waele JJ, De Laet I, De Keulenaer B, Widder S, Kirkpatrick AW, Cresswell AB, Malbrain M, Bodnar Z, Mejia-Mantilla JH et al: The impact of body position on intra-abdominal pressure measurement: a multicenter analysis. Critical care medicine 2009, 37(7):2187-2190.
247
172. De Waele JJ, De Laet I, De Keulenaer B, Widder S, Kirkpatrick AW, Cresswell AB, Malbrain M, Bodnar Z, Mejia-Mantilla JH, Reis R et al: The effect of different reference transducer positions on intra-abdominal pressure measurement: a multicenter analysis. Intensive care medicine 2008, 34(7):1299-1303.
173. Fusco MA, Martin RS, Chang MC: Estimation of intra-abdominal pressure by bladder pressure measurement: validity and methodology. The Journal of trauma 2001, 50(2):297-302.
174. Drakulovic MB, Torres A, Bauer TT, Nicolas JM, Nogue S, Ferrer M: Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet 1999, 354(9193):1851-1858.
175. Vasquez DG, Berg-Copas GM, Wetta-Hall R: Influence of semi-recumbent position on intra-abdominal pressure as measured by bladder pressure. The Journal of surgical research 2007, 139(2):280-285.
176. McBeth PB, Zygun DA, Widder S, Cheatham M, Zengerink I, Glowa J, Kirkpatrick AW: Effect of patient positioning on intra-abdominal pressure monitoring. American journal of surgery 2007, 193(5):644-647; discussion 647.
177. Malbrain ML, De Laet IE, Willems A, Van Regenmortel N, Schoonheydt K, Dits H: Localised abdominal compartment syndrome: bladder-over-gastric pressure ratio (B/G ratio) as a clue to diagnosis. Acta Clin Belg 2010, 65(2):98-106.
178. Malbrain M, De Laet I: Do we need to know body anthropomorphic data whilst measuring abdominal pressure? Intensive care medicine 2010, 36(1):180 - 182.
179. Shafik A: The anterolateral abdominal wall muscles during vesical filling and evacuation: electromyographic study. Urology 2008, 71(4):621-624.
180. Hunt L, Van Luenen H, Alexandrou E, Frost SA, Davidson PM, Hillman K, D'Amours S: A comparison of fluid instillation volumes to assess intra-abdominal pressure using Kron's methods. The journal of trauma and acute care surgery 2012.
181. Malbrain ML, Deeren DH: Effect of bladder volume on measured intravesical pressure: a prospective cohort study. Critical care (London, England) 2006, 10(4):R98.
182. Chiumello D, Tallarini F, Chierichetti M, Polli F, Li Bassi G, Motta G, Azzari S, Carsenzola C, Gattinoni L: The effect of different volumes and temperatures of saline on the bladder pressure measurement in critically ill patients. Critical care (London, England) 2007, 11(4):R82.
183. Cheatham ML, Safcsak K: Is the evolving management of intra-abdominal hypertension and abdominal compartment syndrome improving survival? Critical care medicine 2010, 38(2):402-407.
184. O'Mara MS, Slater H, Goldfarb IW, Caushaj PF: A prospective, randomized evaluation of intra-abdominal pressures with crystalloid and colloid resuscitation in burn patients. The Journal of trauma 2005, 58(5):1011-1018.
185. Matuschak GM, Pinsky MR, Rogers RM: Effects of positive end-expiratory pressure on hepatic blood flow and performance. J Appl Physiol 1987, 62(4):1377-1383.
186. Inal MT, Memis D, Sezer YA, Atalay M, Karakoc A, Sut N: Effects of intra-abdominal pressure on liver function assessed with the LiMON in critically ill patients. Canadian journal of surgery 2011, 54(3):161-166.
187. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Critical care medicine 1985, 13(10):818-829.
188. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on
248
Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive care medicine 1996, 22(7):707-710.
189. Dalfino L, Tullo L, Donadio I, Malcangi V, Brienza N: Intra-abdominal hypertension and acute renal failure in critically ill patients. Intensive care medicine 2008, 34(4):707-713.
190. Cheatham ML, White MW, Sagraves SG, Johnson JL, Block EF: Abdominal perfusion pressure: a superior parameter in the assessment of intra-abdominal hypertension. The Journal of trauma 2000, 49(4):621-626; discussion 626-627.
191. D'Angelo E, Pecchiari M, Acocella F, Monaco A, Bellemare F: Effects of abdominal distension on breathing pattern and respiratory mechanics in rabbits. Respir Physiol Neurobiol 2002, 130(3):293-304.
192. Cresswell AB, Wendon JA: Hepatic function and non-invasive hepatosplanchnic monitoring in patients with abdominal hypertension. Acta clinica Belgica 2007(1):113-118.
193. McNelis J, Marini CP, Jurkiewicz A, Fields S, Caplin D, Stein D, Ritter G, Nathan I, Simms HH: Predictive factors associated with the development of abdominal compartment syndrome in the surgical intensive care unit. Arch Surg 2002, 137(2):133-136.
194. Joshi D, Saha S, Bernal W, Heaton N, Wendon J, Auzinger G: Haemodynamic response to abdominal decompression in acute Budd-Chiari syndrome. Liver Int 2011, 31(8):1171-1178.
195. Balogh Z, De Waele JJ, Kirkpatrick A, Cheatham M, D'Amours S, Malbrain M: Intra-abdominal pressure measurement and abdominal compartment syndrome: the opinion of the World Society of the Abdominal Compartment Syndrome. Critical care medicine 2007, 35(2):677-678; author reply 678-679.
196. Bongard F, Pianim N, Dubecz S, Klein SR: Adverse consequences of increased intra-abdominal pressure on bowel tissue oxygen. The Journal of trauma 1995, 39(3):519-524; discussion 524-515.
197. De laet I, Citerio G, Malbrain ML: The influence of intraabdominal hypertension on the central nervous system: current insights and clinical recommendations, is it all in the head? Acta clinica Belgica 2007(1):89-97.
198. Diebel LN, Dulchavsky SA, Wilson RF: Effect of increased intra-abdominal pressure on mesenteric arterial and intestinal mucosal blood flow. The Journal of trauma 1992, 33(1):45-48; discussion 48-49.
199. Malbrain ML, Wilmer A: The polycompartment syndrome: towards an understanding of the interactions between different compartments! Intensive care medicine 2007, 33(11):1869-1872.
200. De Keulenaer BL, De Waele JJ, Powell B, Malbrain ML: What is normal intra-abdominal pressure and how is it affected by positioning, body mass and positive end-expiratory pressure? Intensive care medicine 2009, 35(6):969-976.
201. Deeren DH, Dits H, Malbrain ML: Correlation between intra-abdominal and intracranial pressure in nontraumatic brain injury. Intensive care medicine 2005, 31(11):1577-1581.
202. Duggan JE, Drummond GB: Abdominal muscle activity and intraabdominal pressure after upper abdominal surgery. Anesth Analg 1989, 69(5):598-603.
203. Asch DA, Jedrziewski MK, Christakis NA: Response rates to mail surveys published in medical journals. Journal of clinical epidemiology 1997, 50(10):1129-1136.
204. Kellerman SE, Herold J: Physician response to surveys. A review of the literature. American journal of preventive medicine 2001, 20(1):61-67.
249
Appendix
250
Appendix 1 - Questionnaires
i. IAP Questionnaire – Surgeons
ii. IAP Questionnaire – Anaesthetists
251
Intra-abdominal Hypertension and the Abdominal Compartment Syndrome - Surgeons
Years in Consultant Practice …………… Do you participate in an emergency on-call rota? Y N Which geographical region do you work in? ………..……………… What is your main sub-speciality interest?
• Upper GI / HPB • Transplant • Coloproctology • Breast / Endocrine • Vascular • General
Is the “abdominal compartment syndrome” a real clinical entity? Y N What level (in mmHg or cm H2O) corresponds to Intra-abdominal Hypertension Abdominal Compartment Syndrome How many cases of abdominal compartment syndrome have you been involved with in the last year? What proportion of these patients were Post – op
Trauma
Medical
Is Intra-abdominal pressure measured on ITU at your institution Never
Routinely
Occasionally
If occasionally, what influences the decision to measure it? ……………………..
252
How many laparostomies have you performed in the last year?
Based on IAP alone Based on operative findings Based on clinical deterioration post-op Based on other factor? (please specify) Please indicate how the following operative findings would influence your decision to leave an abdomen open 1 = Much less likely to leave abdomen open 2 = A little less likely to leave abdomen open 3 = No more or less likely to leave abdomen open 4 = A little more likely to leave abdomen open 5 = Much more likely to leave abdomen open Gross faecal soiling Massive transfusion Multi-system trauma Acidosis High Lactate Haemodynamic instability Respiratory instability Planned 2nd look Subjectively “feels tight” Measured Intra-abd pressure Please indicate how the following post-operative factors would influence your decision to perform a laparostomy 1 = Much less likely to perform a laparostomy 2 = A little less likely to perform a laparostomy 3 = No more or less likely to perform a laparostomy 4 = A little more likely to perform a laparostomy 5 = Much more likely to perform a laparostomy Worsening acidosis Worsening lactate level Worsening cardiac Index Worsening urine output Worsening LFTs Rising creatinine Rising FiO2 Rising ventilatory pressure Many thanks for taking the time to completing this questionnaire.
253
Intra-abdominal Hypertension and the Abdominal Compartment Syndrome - Anaesthetists
Years in Consultant Practice …………… Do you participate in an emergency on-call rota? Y N Which geographical region do you work in? ………..……………… What is your main area of interest?
• Anaesthetics with intensive care • Anaesthetics but not intensive care • Intensive Care (Non-anaesthetist)
Is the “abdominal compartment syndrome” a real clinical entity? Y N What level (in mmHg) corresponds to Intra-abdominal Hypertension Abdominal Compartment Syndrome How many cases of abdominal compartment syndrome have you been involved with in the last year? What proportion of these patients were Post – op
Trauma
Medical
Is Intra-abdominal pressure measured on ITU at your institution Never
Routinely
Occasionally
If occasionally, what influences the decision to measure it? ……………………..
Is there a “surgical reluctance” to perform laparostomies at your institution?
Y N
254
How many laparostomies have you been involved with in the past year?
Based on IAP alone Based on operative findings Based on clinical deterioration post-op Based on other factor? (please specify) Please indicate how the following operative findings should influence the decision to leave an abdomen open 1 = Much less likely to leave abdomen open 2 = A little less likely to leave abdomen open 3 = No more or less likely to leave abdomen open 4 = A little more likely to leave abdomen open 5 = Much more likely to leave abdomen open Gross faecal soiling Massive transfusion Multi-system trauma Acidosis High Lactate Haemodynamic instability Respiratory instability Planned 2nd look Subjectively “feels tight” Measured Intra-abd pressure Please indicate how the following post-operative factors would influence your decision to request a laparostomy 1 = Much less likely to request a laparostomy 2 = A little less likely to request a laparostomy 3 = No more or less likely to request a laparostomy 4 = A little more likely to request a laparostomy 5 = Much more likely to request a laparostomy Worsening acidosis Worsening lactate level Worsening cardiac Index Worsening urine output Worsening LFTs Rising creatinine Rising FiO2 Rising ventilatory pressure Many thanks for taking the time to completing this questionnaire.
255
Appendix 2 – Peer-reviewed publications arising from thesis
i. Hepatic function and non-invasive hepatosplanchnic monitoring in patients with abdominal hypertension. Cresswell AB, Wendon JA. Acta Clin Belg. 2007;(1):113-8.
ii. The effect of different reference transducer positions on intra-abdominal
pressure measurement: a multicenter analysis. De Waele JJ, De Laet I, De Keulenaer B, Widder S, Kirkpatrick AW, Cresswell AB, Malbrain M, Bodnar Z, Mejia-Mantilla JH, Reis R, Parr M, Schulze R, Compano S, Cheatham M. Intensive Care Med. 2008 Jul;34(7):1299-303. Epub 2008 Apr 4.
iii. The impact of body position on intra-abdominal pressure measurement: a
multicenter analysis. Cheatham ML, De Waele JJ, De Laet I, De Keulenaer B, Widder S, Kirkpatrick AW, Cresswell AB, Malbrain M, Bodnar Z, Mejia-Mantilla JH, Reis R, Parr M, Schulze R, Puig S; World Society of the Abdominal Compartment Syndrome (WSACS) Clinical Trials Working Group. Crit Care Med. 2009 Jul;37(7):2187-90.
iv. The effect of body position on compartmental intra-abdominal pressure following
liver transplantation. Cresswell AB, Jassem W, Srinivasan P, Prachalias AA, Sizer E, Burnal W, Auzinger G, Muiesan P, Rela M, Heaton ND, Bowles MJ, Wendon JA Annals of Intensive Care. 2012 5(2):S12
256
113HEPATIC FUNCTION AND NON-INVASIVE HEPATOSPLANCHNIC MONITORING IN PATIENTS WITH ABDOMINAL HYPERTENSION
Acta Clinica Belgica, 2007; 62-Supplement 1
HEPATIC FUNCTION AND NON-INVASIVE HEPATOSPLANCHNIC MONITORING IN PATIENTS WITH ABDOMINAL HYPERTENSION
A.B. Cresswell, J.A. Wendon
Key words: Hepatic Function, Abdominal Compartment Syndrome
–––––––––––––––Institute of Liver Studies,Division of Transplantation and Cell Based Therapy, Kings College London School of Medicine, Kings College Hospital, London, UK
Address for correspondence:Dr. J.A. WendonLiver Intensive Therapy UnitInstitute of Liver StudiesKing’s College Hospital LondonSE5 9RSUnited KingdomTel: +44 203 2999000
Original article – OA 13
ABSTRACT
A better understanding of intra-abdominal hypertension with relation to the liver is vital to the management of all forms of liver pathophysi-ology. Supporting good hepatic function within the critically ill patient is important not only in maintaining synthetic function, but also in avoiding the multi-organ complications of liver dysfunc-tion.
The resulting reduction in hepato-splanchnic blood fl ow (HSBF) observed with increasing intra-abdominal pressure has been clearly documented and seen to be exaggerated in animals with established liver disease. Unfortunately the tools required to measure this, remain diffi cult to apply routinely in the clinical setting and as such goal directed therapy to specifi cally improve the hepato-splanchnic circulation remains elusive.
Given the documented effects of IAP on HSBF and the relatively high incidence of intra-abdominal hypertension and the abdominal compartment syndrome within “liver patients” as a whole, close attention to IAP and timely correction by appropri-ate medical or surgical means would appear to be essential.
INTRODUCTION
Intra-abdominal hypertension (IAH) and the ab-dominal compartment syndrome (ACS) have clearly been shown to be important contributors to morbidity and mortality within the critical care patient population (1, 2). Despite a large volume of emerging evidence concerning cardiovascular, respiratory and renal effects of elevated intra-abdominal pressure (IAP) there is a relative paucity of data relating specifi cally to liver blood fl ow and function, with most of that which is available relating to animal studies or “healthy” subjects undergoing pneumoperitoneum for elective proce-dures.
A better understanding IAH with relation to the liver is vital to the management of all forms of liver pathophysiology. Supporting good hepatic function within the critically ill patient is important not only in maintaining synthetic function, but also in avoiding the multi-organ complications of liver dysfunction.
Specifi c medical and surgical insults upon the liver are becoming increasingly common with a rising inci-dence of both alcohol-related liver disease and non-alcoholic steato-hepatitis (NASH).
257
114 HEPATIC FUNCTION AND NON-INVASIVE HEPATOSPLANCHNIC MONITORING IN PATIENTS WITH ABDOMINAL HYPERTENSION
Acta Clinica Belgica, 2007; 62-Supplement 1
Surgical treatments of liver lesions, such as meta-static carcinoma and hepatocellular carcinoma, have become increasingly more aggressive with the wide-spread use of preoperative portal vein embolisation, radiofrequency ablation and staged liver resections in order to improve operability rates. In such cases pre-and perioperative optimisation of hepatic functional reserve has become vitally important and control of IAP appears to be important for hepatic regeneration (3).
The incidence of IAH following liver transplantation (4), and specifi cally its effects on renal function (5), have been previously demonstrated, and with a shrinking donor pool optimisation of support within this group is obviously as important as ever.
Signifi cant liver trauma, whether managed opera-tively or non-operatively, may be expected to lead to an elevation of IAP and for marginally ischaemic tissues, optimisation of blood fl ow is essential.
The deleterious effects of increased IAP may be considered in terms of the hepatic circulation and the biochemical function of the hepatocyte. The basic physiology and strategies for non-invasive assessment of these parameters will be discussed below with spe-cifi c reference to the effects of raised IAP.
PHYSIOLOGY OF LIVER BLOOD FLOW
The liver as an organ is unique, in that it receives its blood supply from two main sources, the hepatic artery and portal vein and, under normal conditions, will re-ceive around one quarter of the total cardiac output, accounting for approximately 20% of total body oxygen consumption. In health, the hepatic artery supplies around 30 mls/min per 100 g of liver tissue which equates to roughly 25% of the liver blood fl ow. The portal vein supplies the remaining 75% at a rate of 70 mls/min per 100g (6), and drains blood from the entire GI tract from the level of the distal oesophagus, includ-ing the spleen and pancreas (the splanchnic circulation). Portal venous blood is obviously rich in nutrients, but also by virtue of its large fl ow rate, is responsible for a signifi cant proportion of the hepatic oxygen supply. Normal portal pressure is between 5 and 8 mmHg. Hepatic vascular outfl ow is via the three hepatic veins which converge to drain into the inferior vena cava. Normal hepatic venous pressure is around 1 to 2 mmHg.
Control of liver blood fl ow is complex and occurs at the level of the splanchnic and hepatic arterioles and the portal and hepatic venules. Autoregulation is pri-
marily achieved through alterations in the hepatic arte-rial fl ow (known as the hepatic arterial buffer response (7)). In health, it is the accumulation of adenosine (8, 9) within the liver that seems to be responsible for the regulation of this buffer response.
Control of liver blood fl ow in disease states depends on the underlying pathology and cellular and biochem-ical mechanisms vary.
MEASUREMENT OF HEPATO-SPLANCHNIC BLOOD FLOW
Techniques for measuring hepatic and splanchnic blood fl ow can be broadly divided into approaches which consider fl ow in single vessels, and those providing a more global indicator of organ perfusion. By and large, most of the techniques described are employed main-ly within the research setting and routine clinical ap-plication is relatively limited.
For the invasive measurement of single vessels, dop-pler fl owmetry is commonly employed with fl ow probes surgically placed around the vessel of interest. Amongst other applications, this technique has been success-fully used to study the effects of pneumoperitoneum on the hepatic blood fl ow in anaesthetised pigs (10). More recent advances in microtechnology have allowed the development of laser doppler fl owmetry via a single fi bre microprobe. Such probes illuminate the liver tissue with a low powered laser in order to measure movement of red cells (11) and provide a regional tissue measure-ment.
In the clinical setting, non-invasive ultrasound ex-amination of the hepatic vessels has been disappointing in quantitative terms (12). The advent of colour fl ow Doppler however, has enabled the direction of fl ow within the portal vein to be ascertained (13) and micro-bubble contrast has been employed to measure he-patic vein transit times with apparent success (14).
More recently, magnetic resonance imaging has been used to estimate hepatic blood fl ow, especially with respect to the diagnosis and grading of portal hyperten-sion (15, 16).
The most commonly employed technique for the assessment of total liver blood fl ow is an indicator clearance technique, usually employing indocyanine green. This is a tri-carbocyanine dye that is actively taken up by hepatocytes and excreted exclusively into the bile. Elimination rate can be measured invasively via an hepatic vein catheter following either a continu-ous infusion (17) or bolus administration (18) of ICG or
258
115HEPATIC FUNCTION AND NON-INVASIVE HEPATOSPLANCHNIC MONITORING IN PATIENTS WITH ABDOMINAL HYPERTENSION
Acta Clinica Belgica, 2007; 62-Supplement 1
else non-invasively via a transcutaneous saturation probe (19). The rate of elimination, or plasma disap-pearance rate (PDR) is a composite measure of both total liver blood fl ow and hepatocyte function which correlates to hepato-splanchnic blood fl ow (20) and is sensitive in detecting subtle variations (21).
Data on ICG clearance may also be combined with hepatic vein, arterial and mixed venous oxygen tensions in order to calculate hepato-splanchnic oxygen delivery (17) .The separation of fl ow and metabolism can be obtained if hepatic venous sampling is undertaken for ICG concentration. In addition, ICG has been used as a reliable indicator of liver graft function following trans-plantation (22) and as an assessment of functional re-serve after trauma (23) and prior to hepatectomy (24).
Hepatosplanchnic function may also be assessed by use of arterial ketone body ratio, this appears to be very useful in assessing functional liver mass, but cannot unfortunately as of yet be utilized as a real time bedside parameter (25). Similarly hepatospnachnic fl ow and function can be examined utilizing galactose elimination (26); cannulation of hepatic veins and regional sampling allowing separation of fl ow and uptake. Again, this is mainly utilized in a research setting and as a technique cannot provide real time results. Metabolites of ligno-caine, (MEGX) were used in the past to obtain a com-posite assessment of fl ow and metabolic function fol-lowing a bolus dose of lignocaine (27); again lack of real time functionality seem to have resulted in decreased use and potential concerns in regard of lignocaine ac-cumulation in repeated testing, especially pertinent in the context of signifi cant liver dysfunction.
For the sake of completeness, two other invasive techniques for the measurement of global liver blood fl ow are worthy of mention, however their use is lim-ited exclusively to the experimental setting. Fluorescent microscopy involves visualising individual sinusoids within the liver substance and measuring the fl ow rate of injected contrast agent (28). Coloured microspheres have also been used to quantify global blood fl ow, however their used requires sacrifi ce of the experimen-tal subjects and digestion of the liver tissue, in order to count the individual spheres (29).
INTRA-ABDOMINAL PRESSURE AND THE HEPATO-SPLANCHNIC CIRCULATION
Elevated IAP has been associated with deterioration in renal and gut function which is likely, at least in part, to be due to reduced organ perfusion. For example an
IAP of 20 mmHg can be expected to reduce glomerular fi ltration rate by up to 25% (30), and mesenteric blood fl ow by 40 to 70% (31).
With specifi c reference to the hepatic circulation and function, clinical studies are clearly lacking. The data that is available clearly suggests that rising IAP signifi -cantly impairs hepatic blood fl ow, however a clear link between this reduction and subsequent organ dysfunc-tion has not been positively demonstrated.
In a relatively small animal study, in which IAP was raised incrementally to 10, 20, 30 and 40 mmHg in fi ve pigs, the effect on hepatic artery and portal vein blood fl ow was measured using doppler fl owmetry and the hepatic microvascular fl ow measured using laser doppler fl owmetry. At 20 mmHg arterial fl ow was found to be reduced to 45% of baseline, portal venous fl ow to 65% and microvascular fl ow to 71% (31), despite mainte-nance of the baseline mean arterial blood pressure by means of fl uid infusion.
Similar results have been found in rats, where the calculated blood fl ow for the spleen, stomach and total intestine (measured by a microsphere injection tech-nique) was reduced in a near linear fashion in the face of increasing IAP, although hepatic arterial fl ow was seen to be preserved at an IAP of 20 mmHg. An obser-vation that the authors attributed to the hepatic arte-rial buffer response (28). Similarly it was found that a pneumoperitoneum of 8 mmHg maintained for 90 minutes resulted in microcirculatory dysfunction (meas-ured by fl uorescent microscopy) and a signifi cant rise in transaminases (29).
In a further rat study, the effects of continuously raised IAP was compared in healthy rats and in those with induced cirrhosis. As before, increased IAP was found to impair liver microcirculation (assessed by laser doppler fl owmetry), however the deterioration was signifi cantly worse within the cirrhotic group. The au-thors also observed increased levels of alkaline phos-phatase, alanine aminotransferase and bilirubin concen-trations, although these changes did not reach signifi cance (11). The study does however, suggest that patients with pre-existing liver disease may be more susceptible to the effects of raised intra-abdominal pressure.
Impaired hepatic blood fl ow has been demonstrated in studies considering subjects undergoing pneumoper-itoneum for laparoscopy. In one human study of 18 patients undergoing laparoscopy for cholecystectomy or appendicectomy signifi cant impairment of blood fl ow to the stomach, jejunum, colon and liver was observed by laser doppler fl owmetry. Liver blood fl ow was reduced
259
116 HEPATIC FUNCTION AND NON-INVASIVE HEPATOSPLANCHNIC MONITORING IN PATIENTS WITH ABDOMINAL HYPERTENSION
Acta Clinica Belgica, 2007; 62-Supplement 1
by 39% following increase of the pneumoperitoneum from 10 mmHg to 15 mmHg (32). In an equivalent study utilising a rat model, portal vein fl ow measured by dop-pler fl owmetry was similarly seemed to reduce in a linear fashion with increasing IAP (33).
Only one study has specifi cally considered the infl u-ence of IAP on hepatocyte metabolism and this consid-ered 53 rabbits at intra-abdominal pressures of 20 mmHg and 30 mmHg. Hepatic blood fl ow was measured using the ICG disappearance rate and was found to be signifi cantly impaired at both 20 and 30 mmHg. He-patic mitochondrial redox status was also evaluated and found to be unaffected at 20 mmHg. At 30 mmHg however, the mitochondrial redox status was signifi -cantly decreased with a corresponding reduction in tissue energy level. This has been the only study to consider isolated hepatocyte function in the face of raised IAP, but unfortunately the results have not since been replicated and cannot, justifi ably, be generalised to a human population.
The effect of reduced hepato-splanchnic blood fl ow on mucosal pH has been clearly demonstrated in hu-mans. One prospective study of 73 patients undergoing major abdominal surgery demonstrated a signifi cant association between raised IAP and abnormal mucosal pH, with pressures greater than 20 mmHg being associ-ated with an 11 fold increase in abnormal pHi (< 7.32) (34). Moreover an improvement in pHi has been dem-onstrated following abdominal decompression (35).
From a clinical point of view, although we can clearly demonstrate that increasing IAP does deleteri-ously effect hepato-splanchnic bloodflow and gut mucosal pH, we are not yet at a stage to say at what level either IAP or the resulting reduction in blood fl ow, will result in a signifi cant deterioration in liver func-tion.
INTRA-ABDOMINAL PRESSURE IN ACUTE LIVER FAILURE
Very little work has been published looking specifi -cally at the effects of raised IAP in acute liver failure, although the effects of IAH on the hepatic microcircu-lation have been shown to be exaggerated in cirrhotic subjects (11). A recent study, which was designed to consider the association between abdominal hyperten-sion and liver dysfunction, found a correlation between IAP and degree of hyper-bilirubinaemia but no strict association between IAP and liver dysfunction (36). This study however, set a threshold for IAH at 10 mmHg and
recruited very few patients with an IAP > 15 mmHg (the mean IAP was 10.7 mmHg.
Interim analysis of our own unpublished data, has shown that raised IAP is an extremely common fi nding in patients with acute liver failure and a better inde-pendent predictor of length of ITU stay than other contemporary scoring systems. 95% of patients were found to have IAH (> 12 mmHg) and 60% the ACS (> 20 mmHg).
In this subgroup of physiologically unstable patients, high intra-abdominal pressures can be expected to exacerbate the other specific pathophysiological changes in associated organ systems. Namely, worsen-ing the raised intracranial pressure and renal, respira-tory and cardiac dysfunction which usually accompany acute liver failure. The observed compressive effect of high IAP on the inferior vena cava (37) may lead to signifi cant problems with hepatic outfl ow resulting in further hepatic congestion.
Patients with large volume ascites are unusual in the general course of ACS, in that the relatively minor in-tervention of paracentesis can be associated with a signifi cant increase in cardiac index, stroke volume and renal function (38). In such patients, with high intra-abdominal pressures and evidence of deteriorating or-gan function, paracentesis should therefore be consid-ered early. Paradoxically, it is these patients who may tolerate high IAP the best, due to some degree of chronic IAH. Individual pressure measurements should therefore be interpreted in conjunction with the overall clinical picture.
Of particular importance in the subgroup of acute liver failure patients with decompensated cirrhosis, is the association of right atrial dysfunction. This can make the use of conventional indicators of volume loading such as central venous pressure (CVP) or pulmonary artery wedge pressure (PAWP) unreliable. In this sub-group of patients, as well as those with other causes of acute liver failure, we have found that intrathoracic blood volume index (ITBVI) provided the best correla-tion with stroke volume and cardiac index (39) and that ICG clearance may also provide a useful adjunct in the assessment of volume status.
INTRA-ABDOMINAL PRESSURE IN LIVER TRANSPLANT RECIPIENTS
Several facets of liver transplantation place recipi-ents at risk of development of high intra-abdominal pressures. Firstly it is not unusual for the transplanted
260
117HEPATIC FUNCTION AND NON-INVASIVE HEPATOSPLANCHNIC MONITORING IN PATIENTS WITH ABDOMINAL HYPERTENSION
Acta Clinica Belgica, 2007; 62-Supplement 1
graft to be an imperfect size match, often with a greater volume than the native liver. This is particu-larly true of the shrunken cirrhotic liver. Liver transplan-tation is, by defi nition, a major and lengthy abdominal surgery and the required disruption to mesenteric out-fl ow will inevitably produce some visceral oedema, which can be exacerbated if there is any impairment of fl ow at the portal vein anastomosis. Finally, blood loss is unavoidable and large volume transfusion is not unusual, even for elective procedures.
In the only prospective study of IAP in liver transplant recipients (beyond individual case reports) the incidence of IAH (defi ned as > 25 mmHg) was 31.5%(4). In our own unpublished data, using cut-offs of 12 and 20 mmHg for IAH and ACS, we found an incidence of 60% and 25% respectively.
In the published study a signifi cant difference in IAP was noted in individuals subsequently developing acute renal failure and IAH was associated with a relative risk for acute renal failure of 9.8 (5).
The evidence to date would suggest that liver trans-plant recipients are at signifi cant risk of developing raised abdominal pressure and that the operating sur-geon should have a low threshold for the use of pro-phylactic temporary abdominal closures. Measurement of IAP in the postoperative period should be manda-tory and in due course, strategies to predict individual risk may aid in identifi cation of particular patients re-quiring more intensive observations.
INTRA-ABDOMINAL PRESSURE AND HEPATOPANCREATOBILIARY SURGERY
There are no data relating to the incidence of raised IAP following major hepatic or pancreatic resections. Interim analysis of our own unpublished data, suggest that 72% of patients developed IAH (> 12 mmHg) and that the ACS (> 20 mmHg) can be expected in 24%. The problem is therefore signifi cant and merits further re-search, especially as raised IAP has been shown to be associated with impaired liver regeneration following animal studies of hepatectomy (3).
CONCLUSIONS
The resulting reduction in hepato-splanchnic blood fl ow (HSBF) observed with increasing IAP has been clearly documented and seen to be exaggerated in animals with established liver disease. Unfortunately
the tools required to measure this, remain diffi cult to apply routinely in the clinical setting and as such goal directed therapy to specifi cally improve the hepato-splanchnic circulation remains elusive.
Given the documented effects of IAP on HSBF and the relatively high incidence of IAH and the ACS within “liver patients” as a whole, close attention to IAP and timely correction by appropriate medical or surgical means would appear to be essential.
REFERENCES
1. Ivatury RR, Diebel L, Porter JM, Simon RJ. Intra-abdominal hy-pertension and the abdominal compartment syndrome. Surg Clin North Am. 1997; 77: 783-800.
2. Malbrain ML. Is it wise not to think about intraabdominal hy-pertension in the ICU? Curr Opin Crit Care. 2004; 10: 132-45.
3. Yagmurdur MC, Basaran O, Ozdemir H, et al. The impact of transient elevation of intra-abdominal pressure on liver regen-eration in the rat. J Invest Surg. 2004; 17: 315-22.
4. Biancofi ore G, Bindi ML, Romanelli AM, et al. Intra-abdominal pressure monitoring in liver transplant recipients: a prospective study. Intensive Care Med. 2003; 29: 30-6.
5. Biancofi ore G, Bindi ML, Romanelli AM, et al. Postoperative intra-abdominal pressure and renal function after liver transplanta-tion. Arch Surg. 2003; 138: 703-6.
6. Blumgart LH, Wheatley AM, Mathie RT. Surgery of the Liver, Biliary Tract and Pancreas. 4 ed. New York: Saunders; 2006.
7. Lautt WW. Relationship between hepatic blood fl ow and overall metabolism: the hepatic arterial buffer response. Fed Proc. 1983; 42: 1662-6.
8. Lautt WW, D’Almeida MS, McQuaker J, D’Aleo L. Impact of the hepatic arterial buffer response on splanchnic vascular re-sponses to intravenous adenosine, isoproterenol, and gluca-gon. Can J Physiol Pharmacol. 1988; 66: 807-13.
9. Mathie RT, Alexander B. The role of adenosine in the hyperaemic response of the hepatic artery to portal vein occlusion (the ‘buffer response’). Br J Pharmacol. 1990; 100: 626-30.
10. Klopfenstein CE, Morel DR, Clergue F, Pastor CM. Effects of ab-dominal CO2 insuffl ation and changes of position on hepatic blood fl ow in anesthetized pigs. Am J Physiol. 1998; 275: H900-5.
11. Eleftheriadis E, Kotzampassi K. Hepatic microcirculation after continuous 7-day elevated intra- abdominal pressure in cir-rhotic rats. Hepatol Res. 2005; 32: 96-100.
12. Burns P, Taylor K, Blei AT. Doppler fl owmetry and portal hyper-tension. Gastroenterology. 1987; 92: 824-6.
13. Gorg C, Riera-Knorrenschild J, Dietrich J. Pictorial review: Colour Doppler ultrasound fl ow patterns in the portal venous system. Br J Radiol. 2002; 75: 919-29.
14. Lim AK, Taylor-Robinson SD, Patel N, et al. Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C. Gut. 2005; 54: 128-33.
15. Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE. Hepatic fl ow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology. 2003; 229: 409-14.
261
118 HEPATIC FUNCTION AND NON-INVASIVE HEPATOSPLANCHNIC MONITORING IN PATIENTS WITH ABDOMINAL HYPERTENSION
Acta Clinica Belgica, 2007; 62-Supplement 1
16. Scharf J, Zapletal C, Hess T, et al. Assessment of hepatic perfusion in pigs by pharmacokinetic analysis of dynamic MR images. J Magn Reson Imaging. 1999; 9: 568-72.
17. Matejovic M, Rokyta R, Jr., Radermacher P, Krouzecky A, Sramek V, Novak I. Effect of prone position on hepato-splanchnic he-modynamics in acute lung injury. Intensive Care Med. 2002; 28: 1750-5.
18. Grainger SL, Keeling PW, Brown IM, Marigold JH, Thompson RP. Clearance and non-invasive determination of the hepatic extrac-tion of indocyanine green in baboons and man. Clin Sci (Lond). 1983; 64: 207-12.
19. Faybik P, Krenn CG, Baker A, et al. Comparison of invasive and noninvasive measurement of plasma disappearance rate of in-docyanine green in patients undergoing liver transplantation: a prospective investigator-blinded study. Liver Transpl. 2004; 10: 1060-4.
20. Sakka SG, Reinhart K, Meier-Hellmann A. Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients. Chest. 2002; 122: 1715-20.
21. Sakka SG, Reinhart K, Wegscheider K, Meier-Hellmann A. Variabil-ity of splanchnic blood fl ow in patients with sepsis. Intensive Care Med. 2001; 27: 1281-7.
22. Tsubono T, Todo S, Jabbour N, et al. Indocyanine green elimina-tion test in orthotopic liver recipients. Hepatology. 1996; 24: 1165-71.
23. Gottlieb ME, Stratton HH, Newell JC, Shah DM. Indocyanine green. Its use as an early indicator of hepatic dysfunction fol-lowing injury in man. Arch Surg. 1984; 119: 264-8.
24. Okochi O, Kaneko T, Sugimoto H, Inoue S, Takeda S, Nakao A. ICG pulse spectrophotometry for perioperative liver function in hepatectomy. J Surg Res. 2002; 103: 109-13.
25. Nakatani T, Spolter L, Kobayashi K. Arterial ketone body ratio as a parameter of hepatic mitochondrial redox state during and after hemorrhagic shock. World J Surg. 1995; 19: 592-6.
26. Gao L, Ramzan I, Baker AB. Potential use of pharmacological markers to quantitatively assess liver function during liver transplantation surgery. Anaesth Intensive Care. 2000; 28: 375-85.
27. Oellerich M, Armstrong VW. The MEGX test: a tool for the real-time assessment of hepatic function. Ther Drug Monit. 2001; 23: 81-92.
28. Yokoyama Y, Alterman DM, Sarmadi AH, et al. Hepatic vascular response to elevated intraperitoneal pressure in the rat. J Surg Res. 2002; 105: 86-94.
29. Schemmer P, Barro-Bejarano M, Mehrabi A, et al. Laparoscopic organ retrieval for living donor liver transplantation does not prevent graft injury. Transplant Proc. 2005; 37: 1625-7.
30. Saggi BH, Sugerman HJ, Ivatury RR, Bloomfi eld GL. Abdominal compartment syndrome. J Trauma. 1998; 45: 597-609.
31. Diebel LN, Wilson RF, Dulchavsky SA, Saxe J. Effect of increased intra-abdominal pressure on hepatic arterial, portal venous, and hepatic microcirculatory blood fl ow. J Trauma. 1992; 33: 279-82; discussion 282-3.
32. Schilling MK, Redaelli C, Krahenbuhl L, Signer C, Buchler MW. Splanchnic microcirculatory changes during CO2 laparoscopy. J Am Coll Surg. 1997; 184: 378-82.
33. Gutt CN, Schmandra TC. Portal venous fl ow during CO(2) pneu-moperitoneum in the rat. Surg Endosc. 1999; 13: 902-5.
34. Sugrue M, Jones F, Lee A, et al. Intraabdominal pressure and gastric intramucosal pH: is there an association? World J Surg. 1996; 20: 988-91.
35. Ivatury RR, Porter JM, Simon RJ, Islam S, John R, Stahl WM. Intra-abdominal hypertension after life-threatening penetrating abdominal trauma: prophylaxis, incidence, and clinical r e l e -vance to gastric mucosal pH and abdominal compartment syndrome. J Trauma. 1998; 44: 1016-21; discussion 1021-3.
36. Dalfi no L, Malcangi V, Cinnella G, Brienza N. Abdominal hyper-tension and liver dysfunction in intensive care unit patients: an “on-off” phenomenon? Transplant Proc. 2006; 38: 838-40.
37. Wachsberg RH. Narrowing of the upper abdominal inferior vena cava in patients with elevated intraabdominal pressure: sono-graphic observations. J Ultrasound Med. 2000; 19: 217-22.
38. Savino JA, Cerabona T, Agarwal N, Byrne D. Manipulation of ascitic fl uid pressure in cirrhotics to optimize hemodynamic and renal function. Ann Surg. 1988; 208: 504-11.
39. Sutcliffe R, Meares H, Auzinger G, al. E. Preload assessment in severe liver disease associated with intra-abdominal hyperten-sion. Intensive Care Medicine. 2002; 28 (Suppl 1): S177A688.
262
Intensive Care Med (2008) 34:1299–1303DOI 10.1007/s00134-008-1098-4 BRIEF REPORT
Jan J. De WaeleInneke De laetBart De KeulenaerSandy WidderAndrew W. KirkpatrickAdrian B. CresswellManu MalbrainZsolt BodnarJorge H. Mejia-MantillaRichard ReisMichael ParrRobert SchulzeSonia CompanoMichael Cheatham
The effect of different reference transducerpositions on intra-abdominal pressuremeasurement: a multicenter analysis
Received: 19 November 2007Accepted: 27 February 2008Published online: 4 April 2008© Springer-Verlag 2008
This study was performed on behalf of theClinical Trials Working Group of the WorldSociety for Abdominal CompartmentSyndrome. It was presented at the 2007World Congress on the AbdominalCompartment Syndrome, Antwerp,Belgium.
J. J. De Waele (�)Ghent University Hospital, SurgicalIntensive Care Unit,De Pintelaan 185, 9000 Gent, Belgiume-mail: [email protected].: +32-9-2402775Fax: +32-9-2404995
I. De laetZiekenhuis Netwerk Antwerpen, CampusStuivenberg, Intensive Care Unit,Antwerpen, Belgium
B. De KeulenaerFremantle Hospital, Intensive Care Unit,Alma Street, Fremantle, Australia
S. WidderUniversity of Calgary,Department of Surgery,Calgary, Canada
A. W. KirkpatrickFoothills Medical Centre, Departmentsof Critical Care Medicine and Surgery,Calgary, Canada
A. B. CresswellLiver Transplant Surgical Service and LiverITU Institute of Liver Studies King’sCollege Hospital,London, UK
M. MalbrainZiekenhuis Netwerk Antwerpen, CampusStuivenberg, Intensive Care Unit,Antwerpen, Belgium
Z. BodnarKenézy Teaching Hospital,Department of Surgery,Debrecen, Hungary
J. H. Mejia-MantillaUniversidad del Valle, Anesthesiaand Intensive Care,Cali, Colombia
R. ReisBratislava University,Department of Surgery,Bratislava, Slovakia
M. ParrLiverpool Hospital, Intensive Care Unit,Sydney, Australia
R. SchulzeSUNY Downstate/Kings County Hospital,Department of Surgery,Brooklyn NY, USA
S. CompanoHospital del Mar,Barcelona, Spain
M. CheathamOrlando Regional Medical Center,Department of Surgical Education,Orlando FL, USA
Abstract Objective: To investigatethe effect of different reference trans-ducer positions on intra-abdominalpressure (IAP) measurement. Threereference levels were studied: thesymphysis pubis; the phlebostaticaxis; and the midaxillary line at thelevel of the iliac crest. Design:Prospective cohort study. Setting:The intensive care units of par-ticipating hospitals Patients andparticipants: One hundred thirty-two critically ill patients at risk forintra-abdominal hypertension (IAH).Interventions: In each patient, threesets of IAP measurements were ob-tained in the supine position, usingthe different reference levels. TheIAP measurements obtained atthe different reference levels werecompared using a paired t-test andBland–Altman statistics were calcu-lated. Measurements and results:IAPphlebostatic (9.9 ± 4.67 mmHg) andIAPpubis (8.4 ± 4.60 mmHg) weresignificantly lower that IAPmidax(12.2 ± 4.66 mmHg; p < 0.0001for both comparisons). The biasbetween the IAPmidax and IAPpubiswas 3.8 mmHg (95% CI 3.5–4.1) and2.3 mmHg (95% CI 1.9–2.6) betweenthe IAPmidax and the IAPphlebostatic .The precision was 3.03 and 3.40,respectively. Conclusions: In the
263
1300
supine position, IAPmidax is higherthan both IAPphlebostatic and IAPpubis,differences found to be clinicallysignificant; therefore, the symphysispubis or phlebostatic axis reference
lines are not interchangeable with themidaxillary level.
Keywords Intra-abdominal pressure ·Intra-abdominal hypertension · Ab-
dominal compartment syndrome ·Surgery · Trauma · Critically illpatients · Intensive care
Introduction
Intra-abdominal hypertension (IAH) and abdominal com-partment syndrome (ACS) are significant causes of mor-bidity and mortality in the critically ill [1]. Several authorshave shown clinical examination to be unreliable for de-tecting the presence of elevated intra-abdominal pressure(IAP) [2, 3], and serial IAP measurements are widely ac-knowledged to be essential to both the diagnosis and treat-ment of IAH/ACS [4–6]. Current consensus recommenda-tions, published by the World Society for the AbdominalCompartment Syndrome (WSACS), suggest that IAP bemeasured using the intravesicular technique with the pa-tient in supine position and the transducer zeroed at thelevel of the midaxillary line [7].
Before this consensus was reached, the symphysis pu-bis was often used as a reference level; however, the exactlocalization of the “symphysis pubis” is subject to interpre-tation, which may lead to observer-dependent variability inIAP measurement. To overcome this problem, the WSACSconsensus definitions suggested the use of the midaxillaryline at the level of the iliac crest as a reference point, asthis bony structure is easier to palpate, even in obese pa-tients. The effect of this change in reference line on blad-der pressure measurement was never formally investigated,however, and the possible utility of other reference lines,including that standard used for all other pressure-relatedphysiologic measurements in the intensive care unit (thephlebostatic axis), has not been studied.
The aim of this analysis was thus to determine the dif-ference between transvesical IAP values when using differ-ent reference lines [symphysis pubis (IAPpubis) and phle-bostatic axis (IAPphlebostatic) compared with the midaxil-lary line at the iliac crest (IAPmidax)] with the patient inthe supine position.
Fig. 1 Localization of thedifferent reference levels used.(From the World Society for theAbdominal CompartmentSyndrome)
Patients and methods
The WSACS Clinical Trials Group initiated a prospective,multicenter trial which was approved by the institutionalreview board/ethics committee at each study site. Thestudy recruited patients between November 2005 andApril 2006. The inclusion criteria selected patients agedmore than 18 years, who were sedated and mechanicallyventilated, and demonstrated at least one risk factorfor intra-abdominal hypertension as proposed by theWSACS [7]. Patients were excluded if unable to toleratechanges in body position.
Before the first measurement, three reference levelswere identified with the patient in the supine position: thesymphysis pubis reference level at the anterior border ofthe symphysis pubis; the phlebostatic axis (or mid-chestreference level) at one half of the patient’s anteroposteriordiameter below the sternal angle; and the midaxillaryreference level at the midaxillary line (Fig. 1). Thesereference points were clearly marked to be used for allstudy measurements.
In each patient, three sets of IAP measurements wereperformed at least 4 h apart. The IAP was measured us-ing the transvesical technique after instillation of 20 ml ofsaline using an AbViser device (Wolfe-Tory Medical, SaltLake City, Utah) and expressed in milligrams of mercury(mmHg) and obtained in relaxed patients at end expira-tion. The order of measurement was also varied through-out these three sets of measurements. The transducer waszeroed prior to every single IAP measurement.
Statistical analysis was performed using Medcalc(Medcalc, Mariakerke, Belgium). The IAP measurementsobtained at the different transducer levels were comparedusing a paired t-test. Additionally, the IAP measurementsobtained at the different reference levels were compared
264
1301
using Bland–Altman statistics [8] (bias with 95% confi-dence interval, precision, i.e., the standard deviation of thebias, and the lower and upper limits of agreement), and theSpearman rank correlation coefficients were calculated.Data are reported as mean ± SD.
We considered the difference to be clinically non-significant if the bias did not exceed 1 mmHg (eitherpositive or negative) and the precision was not higher than2 mmHg, as proposed by the WSACS [9].
Results
One hundred and thirty-two (132) patients were en-rolled from 12 sites (across Europe and North America),which resulted in 396 IAP measurement sets. Forty-threepercent of the patients were admitted with a medicaldiagnosis, 39% with a surgical diagnosis, and 18% weretrauma patients. At the moment of inclusion in the study,APACHE II was 21 ± 11, SAPS II was 44 ± 18, and
Fig. 2 Bland–Altman plots of the difference between IAPmidax andIAPpubis (a) and between IAPmidax and IAPphlebostatic (b)
SOFA was 10 ± 7. The IAP ranged from 2 to 29 mmHg(mean 12.2 mmHg). In 50.8% of the measurements, IAPwas above 12 mmHg, the threshold for IAH, and in 6.4%,IAP was above 20 mmHg (which is defined as abdominalcompartment syndrome according to the WSACS con-sensus definitions, if accompanied by new or progressiveorgan dysfunction [7]) IAPphlebostatic (9.9 ± 4.67 mmHg)and IAPpubis (8.4 ± 4.60 mmHg) were significantly lowerthan IAPmidax (12.2 ± 4.66 mmHg; p < 0.0001 for bothcomparisons).
In the supine position, the bias between the IAPmidaxand IAPpubis was 3.8 mmHg (95% CI 3.5–4.1; lower andupper limits of agreement –2.16 and 9.71, respectively)and 2.3 mmHg (95% CI 1.9–2.6) between the IAPmidaxand the IAPphlebostatic (lower and upper limits of agreement–4.36 and 8.98, respectively). The precision was 3.03 and3.40, respectively. Overall, the bias was not differentacross the range of IAP values (Fig. 2).
The Spearman rank correlation coefficient betweenIAPmidax and IAPpubis and between IAPmidax andIAPphlebostatic was 0.74 and 0.70, respectively.
Discussion
In this study, IAPmidax was higher than both IAPphlebostaticand IAPpubis in the supine position; the correlation betweenIAPmidax and the IAPpubis was slightly better than betweenIAPmidax and the IAPphlebostatic . As the bias and precisionexceeded the predefined values, we considered the differ-ence to be clinically significant, and therefore, the IAPpubisand IAPphlebostatic should not be used as alternatives for theIAPmidax.
Although transvesical measurement is advocated asthe standard technique for intermittent IAP measurementby the WSACS [7], and it is the most widely usedtechnique [10], there are still some controversial issuessurrounding it, such as which reference line should be usedfor transvesical IAP measurement, or what instillationvolume should be used [11]. The WSACS consensus defi-nitions state that intra-vesical pressure should be measuredin completely supine position with the transducer zeroedat the level of the midaxillary line.
Before the 2004 consensus definition, the symphysispubis was recommended as a reference line, but in dailypractice, the exact localization of the symphysis pubis wasfound to be subject to interpretation due to differences inpatient body habitus, which leads to observer-dependentvariability in IAP measurement. The WSACS consensusdefinitions attempted to resolve this by suggesting the useof the midaxillary line as a reference level, as the midaxil-lary line is easier to identify in critically ill patients; how-ever, the effect of this change in reference level on IAPmeasurement was never formally investigated.
In addition, the possible value of other reference levels,such as the reference level used for all other pressure-
265
1302
related physiologic measurements in the intensive careunit, i.e., the level of the right atrium or phlebostaticaxis, has not been studied. Since the phlebostatic axis isdefined as a horizontal line (in supine position) halfwaybetween the anterior and posterior surface of the thoraxat the sternal angle, the phlebostatic axis level and themidaxillary level were expected to be located at approx-imately the same level in supine position. Utilization ofa single reference point for all manometric measurementsin critically ill patients would have benefits in simplifyingthe care of these patients and in the training of nursingand medical care providers. Furthermore, utilizing thephlebostatic axis offers the promise of a reference pointthat might be independent of the angle of the bed, whichis a serious concern to the adoption of continuous IAPmeasurement techniques [12].
The IAPphlebostatic was found to be considerably lowerthan IAPmidax. There are two possible explanations forthis phenomenon: either the intra-vesical pressure itselfchanged during the time between measurements; or thephlebostatic level used was localized higher (or moreanterior) than the midaxillary position in the patientsstudied. A true change in IAP is unlikely since both meas-urements were performed consecutively and in varyingorder; therefore, the second explanation is more likely.It is important to keep in mind that the phlebostatic axisrepresents the mid-chest reference point and the referencepoint for hemodynamic pressure monitoring because theleft ventricle, aorta, and pulmonary artery, as well as thetip of catheters for central venous pressure monitoring,are located at this level [13]. It is therefore not surprising,as was confirmed by the results of this study, that itcannot be used as a substitute for the midaxillary levelor the mid-abdomen level. Also, it might be difficult toidentify the mid-chest reference point reliably in criticallyill patients, since many patients are placed on specialair-cushioned mattresses and the outermost posterior edgeof the thorax is impossible to identify without changingbody position.
The IAPmidax and IAPpubis correlated slightly better,although there was a still a clinically significant differ-ence between both values. The IAPmidax was higher than
IAPpubis, which suggests that the midaxillary referencelevel was located lower (or more posterior) than the pubisreference level, which seems to be anatomically correct;however, the very large limits of agreement suggest thatthe distance between both reference levels may alsobe dependent on individual anatomical characteristicsor confusion over the theoretical localization of thesymphysis pubis point, as some clinicians use the bonysymphysis pubis and others use the overlying skin or fatpad.
From a theoretical point of view, the only correct ref-erence level to use is the mid-bladder level, i.e., the levelof the tip of the Foley catheter; however this level cannotbe identified at the bedside in clinical practice. Any sur-rogate level should ideally be easy to localize, reliably andindependently of body position. This study compared threepossible estimates of the mid-bladder level, starting fromthe midaxillary level used in the consensus definition ofthe WSACS and adding two alternatives: the phlebostaticaxis, which is already frequently used as a reference pointin ICU patients; and the symphysis pubis which was usedin the past and never formally abandoned; however, meas-urements at both levels proved to correlate poorly withmeasurement at the mid-axillary level.
Conclusion
In conclusion, there is a clinically significant differencebetween IAP measured with the reference line at differentlevels in supine position. The IAPmidax was higher thanboth IAPpubis and IAPphlebostatic . The results of this studysuggest that there may be considerable variation in de-termining the exact location of both the phlebostatic axisand the symphysis pubis, and that patient factors affectthe localization of these reference levels. As such, neitherone can satisfactorily replace the mid-axillary referencepoint advocated by the WSACS for transvesical IAPmeasurement.
Acknowledgements. This work was supported by an unrestrictedgrant from Wolfe-Tory Medical.
References
1. Malbrain ML, Chiumello D, Pelosi P,Bihari D, Innes R, Ranieri VM, delTurco M, Wilmer A, Brienza N,Malcangi V, Cohen J, Japiassu A, DeKeulenaer BL, Daelemans R, Jacquet L,Laterre PF, Frank G, de Souza P,Cesana B, Gattinoni L (2005) Incidenceand prognosis of intraabdominal hy-pertension in a mixed population ofcritically ill patients: a multiple-centerepidemiological study. Crit Care Med33:315–322
2. Kirkpatrick AW, Brenneman FD,McLean RF, Rapanos T, Boulanger BR(2000) Is clinical examination an accu-rate indicator of raised intra-abdominalpressure in critically injured patients?Can J Surg 43:207–211
3. Sugrue M, Bauman A, Jones F,Bishop G, Flabouris A, Parr M, Stew-art A, Hillman K, Deane SA (2002)Clinical examination is an inaccuratepredictor of intraabdominal pressure.World J Surg 26:1428–1431
4. De Waele JJ, De laet I, Malbrain ML(2007) Rational intraabdominal pres-sure monitoring: How to do it? ActaClin Belg Suppl 16–25
5. Kirkpatrick AW, Balogh Z, Ball CG,Ahmed N, Chun R, McBeth P, Kirby A,Zygun DA (2006) The secondaryabdominal compartment syndrome:Iatrogenic or unavoidable? J Am CollSurg 202:668–679
266
1303
6. Kirkpatrick AW, De Waele JJ, Ball CG,Ranson K, Widder S, Laupland KB(2007) The secondary and recurrentabdominal compartment syndrome.Acta Clin Belg 1(Suppl):60–65
7. Malbrain ML, Cheatham ML, Kirk-patrick A, Sugrue M, Parr M,De Waele J, Balogh Z, Leppaniemi A,Olvera C, Ivatury R, D’Amours S,Wendon J, Hillman K, Johansson K,Kolkman K, Wilmer A (2006) Resultsfrom the International Conference ofExperts on Intra-abdominal Hyper-tension and Abdominal CompartmentSyndrome. I. Definitions. IntensiveCare Med 32:1722–1732
8. Bland JM, Altman DG (1986) Statis-tical methods for assessing agreementbetween two methods of clinicalmeasurement. Lancet 1:307–310
9. Malbrain ML, De laet I, Cheatham M(2007) Consensus conference def-initions and recommendations onintra-abdominal hypertension (IAH)and the abdominal compartment syn-drome (ACS): the long road to the finalpublications, how did we get there?Acta Clin Belg 1(Suppl):44–59
10. Malbrain ML (2004) Different tech-niques to measure intra-abdominalpressure (IAP): time for a criticalre-appraisal. Intensive Care Med30:357–371
11. De Waele J, Pletinckx P, Blot S, Hoste E(2006) Saline volume in transvesicalintra-abdominal pressure measurement:enough is enough. Intensive Care Med32:455–459
12. McBeth PB, Zygun DA, Widder S,Cheatham M, Zengerink I, Glowa J,Kirkpatrick AW (2007) Effect of patientpositioning on intra-abdominal pressuremonitoring. Am J Surg 193:644–647
13. Darovic GO, Vanriper S, Vanriper J(1995) Fluid-filled monitoring systems.In: Darovic GO (ed) Hemodynamicmonitoring. Saunders, Philadelphia,pp 149–175
267
The impact of body position on intra-abdominal pressuremeasurement: A multicenter analysis*
Michael L. Cheatham, MD; Jan J. De Waele, MD, PhD; Inneke De Laet, MD; Bart De Keulenaer, MD;Sandy Widder, MD, FRCSC; Andrew W. Kirkpatrick, MD; Adrian B. Cresswell, MD;Manu Malbrain, MD, PhD; Zsolt Bodnar, MD; Jorge H. Mejia-Mantilla, MD; Richard Reis, MD;Michael Parr, MD; Robert Schulze, MD; Sonia Puig, MD; for the World Society of the Abdominal CompartmentSyndrome (WSACS) Clinical Trials Working Group
Elevated intra-abdominal pres-sure (IAP) is a frequent causeof morbidity and mortalityamong the critically ill (1–5).
Increased recognition of its prevalence,combined with recent advances in thediagnosis and management of intra-abdominal hypertension (IAH) and ab-
dominal compartment syndrome (ACS),has resulted in significantly improved pa-tient survival (4, 5). Serial IAP measure-ments are essential to the diagnosis andmanagement of IAH/ACS because clinicalexamination has a sensitivity of only 40%to 60% for detecting the presence of ele-vated IAP (6, 7). The World Society of the
Abdominal Compartment Syndrome(WSACS) has recently published evi-dence-based medicine consensus guide-lines for the measurement of IAP andtreatment of IAH/ACS (1, 2).
IAP has traditionally been measured us-ing the intravesicular or “bladder” tech-nique with the transducer zeroed at thesymphysis pubis (8, 9). The location of thiszero reference point, however, is subject tointerpretation, potentially leading to bothIAP measurement errors and inappropriatetherapy. A point located along the mid-axillary line at the iliac crest is more con-sistently identifiable, anatomically constantduring head of bed elevation, and physio-logically representative of the true locationof the urinary catheter tip within the blad-der (2, 9).
Head of bed elevation is widely recom-mended to reduce the incidence of venti-lator-associated pneumonia (10, 11). Tworecent clinical trials, however, have dem-onstrated that IAP measurements in-crease significantly as the patient’s headof bed is raised (12, 13). As a result, su-pine IAP measurements may underesti-
Objective: Elevated intra-abdominal pressure (IAP) is a frequentcause of morbidity and mortality among the critically ill. IAP is mostcommonly measured using the intravesicular or “bladder” technique.The impact of changes in body position on the accuracy of IAPmeasurements, such as head of bed elevation to reduce the risk ofventilator-associated pneumonia, remains unclear.
Design: Prospective, cohort study.Setting: Twelve international intensive care units.Patients: One hundred thirty-two critically ill medical and
surgical patients at risk for intra-abdominal hypertension andabdominal compartment syndrome.
Interventions: Triplicate intravesicular pressure measurementswere performed at least 4 hours apart with the patient in thesupine, 15°, and 30° head of bed elevated positions. The zeroreference point was the mid-axillary line at the iliac crest.
Measurements and Main Results: Mean IAP values at eachhead of bed position were significantly different (p < 0.0001). Thebias between IAPsupine and IAP15° was 1.5 mm Hg (1.3–1.7). Thebias between IAPsupine and IAP30° was 3.7 mm Hg (3.4–4.0).
Conclusions: Head of bed elevation results in clinically signif-icant increases in measured IAP. Consistent body positioningfrom one IAP measurement to the next is necessary to allowconsistent trending of IAP for accurate clinical decision making.Studies that involve IAP measurements should describe the pa-tient’s body position so that these values may be properly inter-preted. (Crit Care Med 2009; 37:2187–2190)
KEY WORDS: intra-abdominal pressure; intra-abdominal hyper-tension; abdominal compartment syndrome; intravesicular pres-sure; intensive care; monitoring
*See also p. 2310.From the Department of Surgical Education (MLC),
Orlando Regional Medical Center, Orlando, FL; SurgicalIntensive Care Unit (JJDW), Ghent University Hospital,Ghent, Belgium; Intensive Care Unit (IDL), ZiekenhuisNetwerk Antwerpen, Campus Stuivenberg, Antwerpen,Belgium; Intensive Care Unit (BDK), Fremantle Hospital,Alma Street, Fremantle, Australia; Department of Sur-gery (SW), University of Calgary, Calgary, Alberta, Can-ada; Departments of Critical Care Medicine and Sur-gery (AWK), Foothills Medical Centre, Calgary, Canada;Liver Transplant Surgical Service and Liver ITU Insti-tute of Liver Studies King’s College Hospital (ABC),London, United Kingdom; Intensive Care Unit (MM),Ziekenhuis Netwerk Antwerpen, Campus Stuivenberg,Antwerpen, Belgium; Department of Surgery (ZB), Ken-ezy Teaching Hospital, Debrecen, Hungary; Anesthesiaand Intensive Care (JHM-M), Universidad del Valle,Cali, Colombia; Department of Surgery (RR), BratislavaUniversity, Bratislava, Slovakia; Intensive Care Unit(MP), Liverpool Hospital, Sydney, Australia; Depart-
ment of Surgery (RS), SUNY Downstate/Kings CountyHospital, Brooklyn, NY; and Hospital del Mar (SP),Barcelona, Spain.
Supported, in part, by an unrestricted grant fromWolfe-Tory Medical.
Dr. Malbrain has consulted for and has stockownership with Pulsion Medical Systems. Dr. Malbrainhas received patent support from Pulsion Medical Sys-tems. He has also received royalties from HoltechMedical. The remaining authors have not disclosed anypotential conflicts of interest.
Presented, in part, at the 2007 World Congress onthe Abdominal Compartment Syndrome, Antwerp, Bel-gium.
For information regarding this article, E-mail:[email protected]
Copyright © 2009 by the Society of Critical CareMedicine and Lippincott Williams & Wilkins
DOI: 10.1097/CCM.0b013e3181a021fa
2187Crit Care Med 2009 Vol. 37, No. 7
268
mate true IAP if the patient’s head of bedis elevated between measurements. Thefirst of these studies, however, used asaline instillation volume of 50 mL,which exceeds the currently recom-mended volume and could potentiallyhave resulted in erroneously high IAPmeasurements (12). This study also didnot report the zero reference point used.The second study used a continuous IAPtechnique that is not widely used and forwhich the residual fluid volume withinthe bladder cannot be standardized (13).As a result of these concerns and theimportance of accurately determiningIAP, a multicenter trial was performed todetermine the clinical impact of threedifferent body positions (supine, 15°, and30° head of bed elevation) on intravesicu-lar pressure measured using a standard-ized, reproducible approach (2).
MATERIALS AND METHODS
Study Design. The WSACS Clinical TrialsWorking Group initiated a prospective, inter-ventional cohort study to test the hypothesisthat head of bed elevation significantly in-creases IAP over that measured in the supineposition. The study was designed with 80%power to detect a minimum difference be-tween IAP measurements of 2 mm Hg with atwo-tailed alpha of 0.05. A sample size of 150patients (including a 20% increase for incom-plete data, protocol violations, and patientdropout) was calculated. Study sites were re-cruited from the membership of the WSACSand provided with the study protocol. Patientscreening and enrollment were initiated afterapproval by the institutional review board orethics committee at each study site.
Patient Selection. Patients were enrolledfrom the intensive care units of each study sitebetween November 2005 and April 2006. Pa-
tients were included in the study if they wereaged �18 years, sedated (per study-site proto-col) and on mechanical ventilation, and dem-onstrated at least one risk factor for IAH orACS (Table 1). Either written informed con-sent or a waiver of informed consent, as de-termined by each study site’s institutional re-view board or ethics committee, was alsorequired. Patients were excluded if they wereunable to tolerate changes in body position(because of spinal precautions, intracranialhypertension, hemodynamic instability, etc)or intravesicular pressure measurements werecontraindicated (such as recent bladder sur-gery or injury).
Treatment Protocol. After patient enroll-ment, a point corresponding to the mid-axillary line at the level of the iliac crest wasclearly marked on the patient’s skin to serve asthe zero reference point for all the subsequentIAP measurements. To limit the occurrence ofinaccurate IAP measurements secondary toactive abdominal wall contraction and in-creased work of breathing, patients were se-dated according to the WSACS consensus rec-ommendations during measurements to aRichmond Agitation Sedation Score of �4 (2).IAP was measured using the intravesiculartechnique (AbViser, Wolfe-Tory Medical, SaltLake City, UT) with a standard instillationvolume of 20 mL per the WSACS consensusrecommendations. The intravesicular pres-sure monitoring kits were provided free ofcharge by the manufacturer to standardize theIAP measurement technique among all thestudy sites. The pressure transducer was con-nected to the electronic monitoring equip-ment available in the intensive care unit ofeach study site. Three sets of IAP measure-ments at each body position (supine, 15°, and30° head of bed elevation) were performed atleast 4 hours apart. The order of body positionduring IAP determination was varied witheach set of measurements. The pressure trans-ducer was zeroed at the marked point in themid-axillary line before each IAP measure-
ment. IAP was measured in mm Hg, at endexpiration, in the absence of active abdominalmuscle contraction, and after waiting at least30 seconds to allow for bladder detrusor mus-cle relaxation. The instilled saline was allowedto drain completely from the patient’s bladderbefore performing the next IAP measurement.
Data Collection. At the time of enrollment,information on patient demographics, includingage, sex, weight, height, admission at diagnosis/mechanism of injury, and presence of IAH riskfactors, were collected. Severity of illness duringthe 24-hour period before the first IAP measure-ment was documented through calculation ofthe Acute Physiology and Chronic Health Eval-uation score (version II), Simplified Acute Phys-iology score (version 2), and Sequential OrganFailure Assessment scores. For each set of mea-surements, IAPsupine, IAP15°, IAP30°, mean arte-rial pressure, positive end-expiratory pressure,peak inspiratory pressure, mean airway pressure,and Richmond Agitation Sedation Score wererecorded. At the conclusion of the study, thecause of IAH or ACS, if present, as well asthe occurrence of aspiration during the studyperiod was determined by the primary inves-tigator at each site. IAP, IAH, and ACS weredefined according to the WSACS consensusdefinitions statement (Table 2) (1). Patientsurvival to intensive care unit discharge wasrecorded. All study data were initially enteredonto a case report form on paper and subse-quently entered as deidentified patient datainto an online, secure (128-bit encryption)database maintained on the WSACS Web site.
Statistical Analysis. Data are reported asmean with 95% confidence interval. Repeated-measures analysis of variance was performedto determine statistical significance betweenIAP groups with paired Student’s t tests forpost hoc analysis. Bland and Altman analysiswas performed to identify the bias and limitsof agreement among the three body positions.The WSACS recommends that a bias of �1mm Hg and limits of agreement of �4 to � 4are necessary for two IAP techniques to beconsidered equivalent (14). All p values aretwo sided, with a threshold alpha of 0.05 usedto assign significance.
RESULTS
Patient enrollment occurred from Au-gust 1, 2006 to December 31, 2006. At theconclusion of the study period, 132 hadbeen enrolled from 12 international studysites. A total of 392 IAP measurements wereperformed with four patients who were un-able to tolerate the third set of measure-ments due to their critical illness. Therewere no other protocol violations or pa-tients with incomplete data. As a result, thecalculated sample size for study enrollmentwas exceeded. Patient demographics andseverity of illness are presented in Table 3.The prevalence of IAH (46%) and ACS
Table 1. Risks factors for intra-abdominal hypertension or abdominal compartment syndrome
Acidosis (pH below 7.2)Hypothermia (core temperature below 33°C)Polytransfusion (�10 units of packed red cells/24 hrs)Coagulopathy (platelet count below 55,000/mm3 or a prothrombin time below 50% or an activated
partial thromboplastin time more than two times normal or an international standardized ratio�1.5)
Sepsis (as defined by the American–European Consensus Conference definitions)BacteremiaLiver dysfunction with ascitesMechanical ventilationUse of PEEP or the presence of auto-PEEPPneumoniaAbdominal surgery, especially with tight abdominal closuresMassive fluid resuscitation (�5 L of colloid or crystalloid/24 hrs)Gastroparesis/gastric distention/ileusHemoperitoneumPneumoperitoneum
PEEP, positive end-expiratory pressure.
2188 Crit Care Med 2009 Vol. 37, No. 7
269
(15%) are consistent with previously pub-lished trials (2, 3, 5). The risk factors forIAH that justified patient enrollment arelisted in Table 4. No patient developed as-piration as a result of being placed supineduring the study. During the study mea-surements, mean arterial pressure was 83
mm Hg (81.5–84.1), peak inspiratory pres-sure was 24 cm H2O (23.4–25.0), meanairway pressure was 13 cm H2O (12.4–13.3), and positive end-expiratory pressurewas 8 cm H2O (7.4–8.0). The mean Rich-mond Agitation Sedation Score was �3.8(�3.9 to �3.7) confirming appropriate se-dation to minimize the potential for erro-neous IAP measurements secondary to ab-dominal wall contraction. Eighty-eightpercent of patients had a closed abdomenduring their IAP measurements. Of the12% of patients with an open abdomen,56% required abdominal decompressionfor ACS, whereas the remaining 44% re-quired an open abdomen following eitherdamage control laparotomy for trauma orintestinal perforation. Twenty-four percentof the study patients died due to the follow-ing reasons: multiple system organ failure,44%; ACS, 22%; hemorrhage, 18%; andsepsis, 16%.
The triplicate IAP measurements foreach body position were compared usingrepeated-measures analysis of variance(Table 5). Both IAP15° and IAP30° weresignificantly increased compared withIAPsupine (p � 0.0001). The bias betweenIAPsupine and IAP15° was 1.5 mm Hg (1.3–1.7) with limits of agreement of �2.8 to5.8. The bias between IAPsupine and IAP30°
was 3.7 mm Hg (3.4–4.0) with limits ofagreement of �2.2 to 9.6.
When those patients with marked IAH(IAP �20 mm Hg) were considered, onlyIAP30° remained significantly increasedcompared with IAPsupine (p � 0.01) (Table5). The bias between IAPsupine and IAP15°
was �0.2 mm Hg (�1.2 to 0.8), withlimits of agreement of �5.8 to 5.4. Thebias between IAPsupine and IAP30° was 2.7mm Hg (1.3–4.2), with limits of agree-ment of �5.4 to 10.8.
DISCUSSION
The importance of serial IAP measure-ments in the assessment and resuscitationof critically ill patients has been increas-ingly recognized over the past decade (1–9).
Given the significant associated morbidityand mortality, IAP should be monitored inany patient who demonstrates risk factorsfor IAH/ACS (Table 1) (1, 2, 5). IAP is botha diagnostic measurement, given the inac-curacy of clinical examination in detectingthe presence of IAH, and a therapeuticmeasurement, because IAP-guided resusci-tation correlates with improved survival(5). As IAP measurement techniques haveevolved, several key questions have arisenincluding the optimal intravesicular salineinstillation volume, the proper zero refer-ence position for transducer placement(symphysis pubis, mid-axillary, or phlebo-static axis), and the proper body position forIAP measurements. Although previousstudies have provided answers to the firsttwo questions, this study addresses this lastand very important question (2, 9).
Head of bed elevation is commonlyused to reduce the risk of aspiration andincidence of ventilator-associated pneu-monia (10, 11). This study confirms thateven mild head of bed elevation signifi-cantly increases measured IAP above thatdetermined in the supine position. Thesepositional differences, although seem-ingly small, are both statistically andclinically significant, and could poten-tially lead to alterations in clinical ther-apy. They emphasize the importance ofconsistent body positioning from mea-surement to measurement to allow accu-rate trending of IAP for clinical decisionmaking. Furthermore, patient body posi-tion during IAP measurement should al-ways be documented both clinically andin future studies so that IAP values maybe properly interpreted and compared.
The abdominal cavity is widely consid-ered to be homogeneous and primarily flu-idic in character, behaving as a unit accord-ing to Pascal’s Law such that IAP is thesame throughout. As a result, IAP shouldremain constant regardless of changes inbody position. Three factors determine IAP:gravity, visceral shear deformation, and vis-ceral compression. In the supine position,the effects of gravity and visceral shearshould be minimal such that visceral com-pression correlates directly with intrave-sicular pressure. With head of bed eleva-tion, however, gravity and an increasedhydraulic column of fluid compressing thebladder may well play a significant role inintravesicular pressure measurements ac-cording to the formula
P2 � P1 � �� � g�h2 � h1�
where P is the hydrostatic pressure, � (rho),the density of the fluid, g, the sea level
Table 2. Definitions (1)
Parameter Definition
IAP The pressure concealed within the abdominal cavityNormal IAP is approximately 5–7 mm Hg in critically ill adults
IAH A sustained or repeated pathologic elevation of IAP �12 mm HgACS A sustained IAP �20 mm Hg (with or without an APP �60 mm Hg) that is
associated with new organ dysfunction or failure
IAP, intra-abdominal pressure; IAH, intra-abdominal hypertension; ACS, abdominal compartmentsyndrome; APP, abdominal perfusion pressure.
Table 3. Patient demographics
Patients 132Age (yrs) 59 � 18Male gender (%) 71Body mass index (kg/m2) 27 � 6Etiology of critical illness (%)
Medical 43Surgical 39Trauma 18
Severity of illness scoresAPACHE II 21 � 9SAPS 2 45 � 18SOFA 10 � 6
Intra-abdominalhypertension (%)
46
Abdominal compartmentsyndrome (%)
15
Abdominal decompression (%) 14Pulmonary aspiration (%) 0Survival to intensive care
unit discharge (%)76
APACHE II, Acute Physiology and ChronicHealth Evaluation score, version II; SAPS 2, Sim-plified Acute Physiology score, version 2; SOFA,Sequential Organ Failure Assessment score.
Table 4. Risk factors for intra-abdominal hyper-tension/abdominal compartment syndrome
Mechanical ventilation (%) 100Positive end-expiratory pressure (%) 100Recent abdominal surgery (%) 37Sepsis (%) 34Fluid resuscitation (�5 L/24 hrs) (%) 30Liver dysfunction (%) 30Acidosis (%) 24Coagulopathy (%) 20Pneumonia (%) 18Polytransfusion (%) 14Hypothermia (%) 10Gastroparesis/ileus (%) 10Hemothorax (%) 7Bacteremia (%) 6Pneumothorax (%) 1
Total exceeds 100% because of the presenceof multiple risk factors.
2189Crit Care Med 2009 Vol. 37, No. 7
270
acceleration due to Earth’s gravity, and h,the height of bed elevation for two differentbody positions (such as 30° vs. supine).
This study confirms, in a larger patientpopulation, the findings of previous studiesdemonstrating that changes in body posi-tion do alter IAP measurements and sug-gests that the abdominal cavity is hetero-geneous in nature. However, the reasonthat changes in body position significantlyalter measured IAP remains unclear. Onepossible explanation is that head of bedelevation results in visceral compression ofthe bladder, due to gravity, resulting inelevated intravesicular pressure measure-ments compared with what would be re-corded if the patients were supine. As evi-dent from this study, however, the impactof head of bed elevation appears to be lesspronounced in patients with higher gradesof IAH where the edematous viscera aremore fixed and less likely to gravitationallycompress the bladder. A more probable ex-planation is that head of bed elevation in-creases visceral compression between therigid thorax and pelvis resulting in a trueelevation in IAP. Anecdotal experiencedemonstrates a significant increase in bothintravesicular and intragastric pressurewith head of bed elevation suggesting thatgravity alone is insufficient to explain thedifferences encountered in this study (15).
The seminal studies defining the “criti-cal IAP” at which organ dysfunction andfailure begins to occur, and on which thedefinitions for IAH and ACS are based, wereall performed with patients in the supineposition. Additional research is necessary tomore fully characterize the nature of theabdominal cavity and document whetherhead of bed elevation results in uniformelevations in IAP throughout all quadrantsof the abdomen. Until studies are availabledefining new benchmarks for critical IAPvalues at various head of bed elevations, webelieve that IAP measurements should beperformed in the supine position to bothstandardize the measurement techniquefor consistent serial IAP monitoring and toremove the issue of whether IAP measure-
ments at 15° and 30° head of bed elevationare accurate or a measurement artifact. It isalso crucial for clinicians to recognize thatsupine intravesicular pressures may under-estimate the true IAP if head of bed eleva-tion is used between measurements to re-duce ventilator-associated pneumonia.
CONCLUSIONS
Head of bed elevation results in clini-cally significant increases in measured IAP.Until the implications and clinical accuracyof nonsupine IAP measurements are betterdefined, IAP measurements should be per-formed in the supine position. Future IAH/ACS research should include documenta-tion of the patient’s body position duringIAP measurement so that these values maybe properly interpreted.
ACKNOWLEDGMENTS
We like to extend our sincere apprecia-tion to the following individuals for theirassistance in this study: Karen Safcsak, RN,Orlando Regional Medical Center, Orlando,FL; Veerle Bosschem, RN, Dieter Debergh,RN, Ghent University Hospital, Ghent, Bel-gium; Ian Jenkins, FJFICM, Bruce Powell,MD, Fremantle Hospital, Fremantle, Aus-tralia; Crystal Wilson, RN, Linda Knox, RN,Foothills Medical Centre, Calgary, AB, Can-ada; Julia Wendon, FRCP, Matthew Bowles,BSc, MS, FRCS, King’s College Hospital,London, United Kingdom; Carlos Ordonez,MD, Fundacion Valle del Lili, Cali, Colom-bia; Peter Labas, MD, PhD, Anna Vdovia-kova, RN, Olina Kubisova, RN, ComeniusUniversity, Bratislava, Slovakia; Ali Ibra-him, MBChB, FRCA, Sharon Micallef, RN,Liverpool Hospital, Sydney, Australia; andAntonia Vazquez, MD, Luís Grande, MD,PhD, Hospital del Mar, Barcelona, Spain.
REFERENCES
1. Malbrain ML, Cheatham ML, Kirkpatrick A,et al: Results from the International Confer-ence of Experts on Intra-abdominal Hyper-tension and Abdominal Compartment Syn-
drome. I. Definitions. Intensive Care Med2006; 32:1722–1732
2. Cheatham ML, Malbrain ML, Kirkpatrick A,et al: Results from the International Confer-ence of Experts on Intra-abdominal Hyper-tension and Abdominal Compartment Syn-drome. II. Recommendations. Intensive CareMed 2007; 33:951–962
3. Malbrain ML, Chiumello D, Pelosi P, et al: Prev-alence of intra-abdominal hypertension in criti-cally ill patients: A multicentre epidemiologicalstudy. Intensive Care Med 2004; 30:822–829
4. Cheatham ML, Safcsak K: Is the evolvingmanagement of IAH/ACS improving sur-vival? Acta Clin Belg 2007; 62(Suppl 1):268
5. Kimball EJ, Kim W, Cheatham ML, et al:Clinical awareness of intra-abdominal hyper-tension and abdominal compartment syn-drome in 2007. Acta Clin Belg 2007;62(Suppl 1):66–73
6. Sugrue M, Bauman A, Jones F, et al: Clinicalexamination is an inaccurate predictor of in-traabdominal pressure. World J Surg 2002;26:1428–1431
7. Kirkpatrick AW, Brenneman FD, McLean RF,et al: Is clinical examination an accurate indi-cator of raised intra-abdominal pressure incritically injured patients? Can J Surg 2000;43:207–211
8. Malbrain ML, Jones F: Intra-abdominal pres-sure measurement techniques. In: Abdomi-nal Compartment Syndrome. Ivatury RR,Cheatham ML, Malbrain ML, et al (Eds). Lan-des Biomedical, Georgetown, 2006
9. De Waele JJ, Cheatham ML, De laet I, et al:The effect of different reference transducerpositions on intra-abdominal pressure mea-surement: A multicenter analysis. IntensiveCare Med 2008; 34:1299–1303
10. Kollef MH: Ventilator-associated pneumonia:A multivariate analysis. JAMA 1993; 70:1965–1970
11. Drakulovic MB, Torres A, Bauer TT, et al:Supine body position as a risk factor fornosocomial pneumonia in mechanically ven-tilated patients: A randomized trial. Lancet1999; 354:1851–1858
12. Vasquez DG, Berg-Copas GM, Wetta-Hall R:Influence of semi-recumbent position on in-tra-abdominal pressure as measured by blad-der pressure. J Surg Res 2007; 139:280–285
13. McBeth PB, Zygun DA, Widder S, et al: Effect ofpatient positioning on intra-abdominal pressuremonitoring. Am J Surg 2007; 193:644–647
14. Malbrain ML, De laet I, Cheatham ML: Con-sensus conference definitions and recom-mendations on intra-abdominal hyperten-sion (IAH) and the abdominal compartmentsyndrome (ACS)—The long road to the finalpublications, how did we get there? Acta ClinBelg 2007; 62(Suppl 1); 44–59
15. Vianne D, De laet I, Vermeiren G, et al: Effectof different body positions on intra-abdomi-nal pressure estimated with 3 different meth-ods via the bladder and stomach. Acta ClinBelg 2007; 62(Suppl 1):257
Table 5. Intra-abdominal pressures by body position
All measurements IAP �20 mm Hg
Patients (n) 132 32IAPsupine 12.1 mm Hg (11.7–12.6) 22.5 mm Hg (21.6–23.4)IAP15° 13.6 mm Hg (13.2–14.1) 22.3 mm Hg (21.3–23.3)IAP30° 15.8 mm Hg (15.3–16.4) 25.2 mm Hg (23.7–26.8)
IAP, intra-abdominal pressure.
2190 Crit Care Med 2009 Vol. 37, No. 7
271
RESEARCH Open Access
The effect of body position on compartmentalintra-abdominal pressure following livertransplantationAdrian B Cresswell, Wayel Jassem, Parthi Srinivasan, Andreas A Prachalias, Elizabeth Sizer, William Burnal,Georg Auzinger, Paolo Muiesan, Nigel D Heaton, Matthew J Bowles, Julia A Wendon*
Abstract
Background: Current assumptions rely on intra-abdominal pressure (IAP) being uniform across the abdominalcavity. The abdominal contents are, however, a heterogeneous mix of solid, liquid and gas, and pressuretransmission may not be uniform. The current study examines the upper and lower IAP following livertransplantation.
Methods: IAP was measured directly via intra-peritoneal catheters placed at the liver and outside the bladder.Compartmental pressure data were recorded at 10-min intervals for up to 72 h following surgery, and the effect ofintermittent posture change on compartmental pressures was also studied. Pelvic intra-peritoneal pressure wascompared to intra-bladder pressure measured via a FoleyManometer.
Results: A significant variation in upper and lower IAP of 18% was observed with a range of differences of 0 to 16mmHg. A sustained difference in inter-compartmental pressure of 4 mmHg or more was present for 23% of thestudy time. Head-up positioning at 30° provided a protective effect on upper intra-abdominal pressure, resulting ina significant reduction in all patients. There was excellent agreement between intra-bladder and pelvic pressure.
Conclusions: A clinically significant variation in inter-compartmental pressure exists following liver transplantation,which can be manipulated by changes to body position. The existence of regional pressure differences suggeststhat IAP monitoring at the bladder alone may under-diagnose intra-abdominal hypertension and abdominalcompartment syndrome in these patients. The upper and lower abdomen may need to be considered as separateentities in certain conditions.
IntroductionInterest in the measurement of intra-abdominal pressure(IAP) has grown steadily over the last decade and hasbeen shown to be a significant problem within the gen-eral intensive care unit (ICU) population [1,2], with thedeleterious effects of elevated IAP having been welldescribed in numerous clinical studies and reviews[3-15]. The culmination of the recent increase in inter-est in this condition has been the creation, by an inter-national panel of experts (The World Society onAbdominal Compartment Syndrome, WSACS, http://
www.wsacs.org), of a consensus document for defini-tions [16] and suggested management guidelines [17].Underpinning these recommendations, however, is a
requirement for accurate and reproducible measurementof IAP with several studies having shown that there is norole for clinical estimation of IAP, either by palpation ormeasurement of abdominal perimeter [18-20].Numerous techniques for the measurement of IAP by
both direct and indirect methods have been described,with indirect approaches utilizing measurement of thepressure concealed within a hollow intra-abdominal viscusmost usually the urinary bladder (intra-bladder pressure,IBP) [21] or stomach (intra-gastric pressure, IGP) [22].Direct methods for measuring IAP have been employedexclusively in the experimental setting whereby the IAP is
* Correspondence: [email protected] Transplant Surgical Service and Liver Intensive Care Unit, Kings CollegeLondon, Institute of Liver Studies, King’s College Hospital, Denmark Hill, SE59RS, London, UK
Cresswell et al. Annals of Intensive Care 2012, 2(Suppl 1):S12http://www.annalsofintensivecare.com/content/2/S1/S12
© 2012 Cresswell et al.; licensee Springer This is an open access article distributed under the terms of the Creative CommonsAttribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction inany medium, provided the original work is properly cited.
272
transduced directly from the peritoneal cavity via a cathe-ter containing a continuous column of fluid [23], a bal-loon-tipped catheter [24] or via a laparoscopic gasinsufflation system [25]. The application of such techni-ques is clearly limited by their invasiveness, and no advan-tage over indirect measurements has been demonstratedin terms of accuracy.On the face of the available data, therefore, a non-inva-
sive technique such as the IBP or IGP method would seemmore attractive for routine clinical use. This, however,relies on two unproven assumptions regarding the trans-mission of pressure throughout the abdomen. The firstassumption is that the bladder wall will act as a passivediaphragm for the transmission of pressure, and the sec-ond is that IAP is transmitted uniformly throughout theabdominal cavity such that the measured pressure at anyone position will be reflected elsewhere in the cavity.The second assumption relies on the contents of the
intra-abdominal cavity, transmitting pressure as a singlecompartment, which, given the heterogeneous mix of con-tents, may not hold true. Such a regional variation in post-operative patients would have important implications bothfor the post-operative screening of IAP following surgeryand for the potential of a localised effect on the regionalorgan systems that may not be manifested by the measure-ment of the relatively remote IBP. This concept would besynonymous with the poly-compartment syndrome whichhas previously been suggested to affect the head, thorax,abdomen [26] and extremities.It has been shown that IAP can be influenced by body
position with an increase in bladder pressure of up to 7.5mmHg with a 45° positioning angle [27]. However, theeffect of body position on the individual intra-abdominalcompartment has not previously been described.Liver transplantation was chosen for the study as a
major intervention that has been shown to be associatedwith a significant incidence of intra-abdominal hyperten-sion (IAH) in both our own unpublished data and in stu-dies from other institutions [28]. The surgical procedureitself is relatively standardised and confined to a singleintra-abdominal compartment, which makes comparisonsbetween individual subjects easier and logically suggeststhat the chances of identifying a regional pressure phe-nomenon would be highest.The two primary aims of the current study were to
compare the IBP to that immediately outside within theintra-peritoneal pelvis and to establish whether there areany regional variations in IAP between the upper andlower abdominal compartments (upper intra-abdominalpressure, UIAP and lower intra-abdominal pressure,LIAP) following liver transplantation. A secondary end-point was to examine the effect, if any, of body positionon the compartmental pressures.
MethodsFollowing approval of the study design by the localResearch Ethics and Research & Development Commit-tees, a total of 20 patients undergoing elective orthotopictransplantation were recruited, all of whom gave informedconsent to take part in this study. All patients receivedcadaveric whole grafts and had not undergone liver trans-plantation previously. Data were collected during the sub-jects’ stay on a 15-bed dedicated Liver Intensive Care Unitwith aspects of post-operative care such as the administra-tion of intra-venous fluids and the use of vaso-activeagents, guided by established unit protocol. All subjectswere nursed in a 30° head of bed position to minimise riskof respiratory complications with the exception of shortperiods of being laid flat in order to measure supine IAP.All were calm and comfortable at the time of measure-ment (Richmond agitation-sedation scale of 0).For each patient, UIAP and LIAP were measured
directly via catheters placed under the left lobe of thetransplanted organ and in the pelvis at the time ofoperation (Minivac Drain, Unomedical, Worcestershire,UK). These catheters were connected, via a fluid columnto an electronic pressure transducer with numeric andpressure trace displayed on the ICU monitor (FukudaDenshi Co., Ltd, Tokyo, Japan). These catheters wereused solely for measurement of IAP and not for drai-nage. Standard closed surgical drains were placed in theusual position to prevent accumulation of body fluids.The electronic transducers were fixed to the patient by
sutures at a point corresponding to the internal positionof the catheter tips on the upper and lower abdominalwall. A position that was found to correspond to thezero-reference point as suggested by the WSACS, of themid-axillary line at the iliac crest when supine. Thetransducers were flushed and zeroed twice daily andafter each patient position change. The measured deadspace of the catheter was < 2 ml, and thus, a 4-ml flushwith normal saline, from a sterile closed system, ensureda continuous column of fluid between the intra-perito-neal catheter tip and the transducer which was main-tained between flushes by continuous low volumeirrigation. The quality of the pressure waveform waschecked hourly by the ‘rapid oscillation test [21]’,whereby rapid and repeated palpation of the abdominalwall at the level of the intra-peritoneal catheter tip wasvisible in real time on the ICU monitor’s pressure trace(Figure 1).Compartmental IAP was transduced continuously via
this equipment, and the monitoring system recordedpaired measurement of UIAP and LIAP at 10-min inter-val. The catheters were left in place for a maximum of72 h or until the point of discharge from the LiverIntensive Care Unit, whichever came sooner.
Cresswell et al. Annals of Intensive Care 2012, 2(Suppl 1):S12http://www.annalsofintensivecare.com/content/2/S1/S12
Page 2 of 10
273
Each patient was re-positioned to lie supine at 6-hourintervals (four times per day) in order to measure thesupine compartmental pressures. The transducers were‘re-zeroed’ following each position change, and the pres-sure was allowed to equilibrate for 5 min prior to mak-ing each of these recordings.In addition to the direct pressure measurements, IBP
was also recorded at 6-h intervals with the patient bothin a 30° head up and supine positions using a Foley-Manometer system (Holtech medical Company, Charlot-tenlund, Denmark), as shown in Figure 2.
Statistical analysisThe data were recorded in a Microsoft Excel Spread-sheet (Microsoft, WA, USA) and analysed using SPSSv15 (Chicago, IL, USA) in accordance with the recom-mendations for data analysis published by the WSACS[29]. Data obtained at 6-hourly intervals (IBP, LIAP andUIAP at supine and 30° head of bed angles) were com-pared by means of a Bland and Altman analysis [30].The coefficient of variance of IAP was defined as thestandard deviation of IAP divided by the mean IAP. Per-centage error of the measurement was defined as twicethe precision divided by the mean IAP. The normalityof distribution of the continuous pressure recordingswas tested using a Kolmogorov-Smirnov test, and beingparametric and normally distributed, means were com-pared using a paired t test.Following professional statistical advice and in order to
perform both within and between individual comparisonsof the difference in compartmental pressures in subjectswith differing baseline IAP, the difference between the
two compartmental recordings was converted to a per-centage of the mean of both compartments (Difference ÷(mean of UIAP + LIAP) × 100). This eliminated the effectof the underlying baseline IAP and inter-individual varia-tions. For the same reason, the trend in compartmentalpressure over time was expressed as the difference ineach subsequent pressure recording over the initial IAP.The differences in compartmental pressures over timewere normally distributed and, therefore, compared bylinear regression. For the purpose of reporting, a differ-ence of 4 mmHg or greater between the compartmentswas considered to be clinically significant.
ResultsComparison of direct and indirect measurement of lowerintra-abdominal pressureThere was no clinically relevant difference between themean measurements made via the pelvic transducer andthe foley manometer. The Bland and Altman plot(Figure 3a, b, c) confirmed excellent agreement betweenthe two measures in all body positions, with a calculatedbias and precision of -0.06 and 0.6 when supine and0.006 and 0.5 at 30°. Full details of the two measure-ments are given in Table 1.
Compartmental pressure measurementsA total of 169 synchronous measurements of IBP, LIAPand UIAP were made to obtain compartmental pressurewith subjects in a supine and 30° head of bed position at6-h intervals. In contrast to the excellent agreementbetween IBP and LIAP, comparisons of both IBP andUIAP, and LIAP and UIAP revealed very poor agreement
Figure 1 Equipment set-up to transduce LIAP and UIAP along with FoleyManometer for measurement of IBP.
Cresswell et al. Annals of Intensive Care 2012, 2(Suppl 1):S12http://www.annalsofintensivecare.com/content/2/S1/S12
Page 3 of 10
274
with a high measured bias, precision and percentageerror (Table 1 and Figure 4a, b). Parameters for thesecomparisons fell well outside the thresholds for agree-ment stated by the WSACS [29].The mean UIAP when supine was 11.7 mmHg, which
was reduced to 9.6 mmHg with 30° head of bed positioning(p < 0.001). Mean LIAP was 9.2 mmHg when supine andincreased to 9.6 mmHg with 30° head of bed (p < 0.001).The increase in UIAP with a move to a supine position
was observed in all patients, irrespective of which com-partment contained the higher pressure. The observedmagnitude of change in mean UIAP was not differentbetween subjects exhibiting a raised IAP (> 12 mmHg)and those with a normal IAP (2.4 and 1.8 mmHg change,respectively; p = 0.5). Similarly, although there was a sug-gestion that subjects with higher upper than lower com-partmental pressures exhibited a larger change in UIAPwhen moving to a supine position (2.4 and 1.1 mmHgchange, respectively), this difference was not statisticallysignificant (p = 0.9).
Continuous pressure measurementsA total of 5,980 automated-paired pressure measurementsof direct LIAP and UIAP were recorded with an average
of 299 per patient (range 212 to 461). Of the 20 subjects,12 revealed a higher mean pressure within the UIAP thanthe LIAP compartment, with the greatest mean pressuredifference for an individual being 5.3 mmHg.When analysed as a whole and as sub-groups with
either higher UIAP or higher LIAP, the differencebetween the compartmental pressures was highly statisti-cally significant (p < 0.001, p < 0.001 and p < 0.004,respectively). The range of differences between compart-mental pressures in the two groups also differed withthose exhibiting a higher UIAP having a broader range (0to 16 mmHg) than those with a higher LIAP (0 to 12mmHg). The mean pressures observed in each compart-ment for the subjects as a whole and for the two sub-groups are displayed in Table 2.The mean difference between the two compartments
was similar, whether it was the upper or lower compart-ment that contained the higher pressure. Expressed as apercentage of the mean of the two compartments, thisequated to a clinically significant 23.4% difference whenUIAP was highest, and 23.6% when LIAP was highest.Individual analysis of each subject’s data confirmed
the significant difference (p < 0.001) between compart-ments for all but two patients. In two individuals, the
Figure 2 Technique for using FoleyManometer for the measurement of intra-abdominal pressure. IBP marked by arrow.
Cresswell et al. Annals of Intensive Care 2012, 2(Suppl 1):S12http://www.annalsofintensivecare.com/content/2/S1/S12
Page 4 of 10
275
(a)
(b)
(c)
Figure 3 Bland and Altman plots comparing intra-bladder pressure (IBP) and lower intra-abdominal pressure (LIAP). (a) Bland andAltman plot to compare IBP and LIAP with a supine body position and a head of bed position of 30°. (b) Bland and Altman plot to compareIBP and LIAP with a supine body position.(c) Bland and Altman plot to compare IBP and LIAP with a head of bed position of 30°. Lower level ofagreement (LLA) and upper level of agreement (ULA) marked by dotted lines.
Cresswell et al. Annals of Intensive Care 2012, 2(Suppl 1):S12http://www.annalsofintensivecare.com/content/2/S1/S12
Page 5 of 10
276
compartmental pressures did not differ significantly (p =0.349 and 0.122, respectively); however, the mean IAPsfor both patients and in both compartments fell withinnormal safe limits (7.1 and 7.3 mmHg, and 11.4 and12.0 mmHg, respectively).Nine subjects displayed a continuous pressure > 12
mmHg in one or other compartment for greater than 1h. Of these, five had higher mean UIAP, and four hadhigher LIAP. There was no difference between the meandifference in compartmental pressures in subjects with asustained pressure of > 12 mmHg compared to thosewithout (2.3 and 2.1 mmHg, respectively; p = 0.772).In the higher UIAP group, a clinically significant dif-
ference of 4 mmHg or more between compartmentalpressures was observed during an average of 23% of thestudy period. This proportion was higher in the higherLIAP group at 37% of the study duration; however,these differences were not statistically significant (p =0.666). The direction of change in compartmental IAPover time correlated positively such that an overallupward trend in UIAP was accompanied by an upwardtrend in LIAP (r2 = 0.582, p < 0.001, n = 5,960).
DiscussionThe recognition and treatment of IAH and the abdom-inal compartment syndrome (ACS) are clearly reliant onan accurate and reliable system for the measurement ofIAP. The technique for IBP measurement has under-gone much refinement over the last decade [21] and hasnow been presented, by an international panel ofexperts, as the gold standard for intra-abdominal pres-sure measurement [17]. In addition to the effects ofgravity and sheer stress [31], the value of bladder pres-sure relies on two key assumptions which have beenwidely accepted without direct evidence of their validity.The first assumption is that the bladder wall will act as
a passive diaphragm to the transmission of pressure, andtherefore, the pressure measured within the urinary blad-der will accurately reflect the pressure immediately
outside within the peritoneal cavity. Several studies, inboth animal and human models, have shown good agree-ment between directly and indirectly measured intra-abdominal pressure [22,23,32,33]. All of these studies,however, have measured direct IAP at a site distant tothe urinary bladder and followed artificial elevation ofIAP by means of either saline or gas insufflation, or byinsertion of a mechanical prosthesis. Our data is the firstto directly compare the pressure measured at the intra-vesical and intra-peritoneal sides of the bladder wall andconfirms that the pressure measured within the urinarybladder demonstrates excellent agreement with the pres-sure to be measured within the pelvic peritoneal cavity.The second assumption relates to the mechanical
properties of the peritoneal contents. It has been sug-gested that the abdominal contents are primarily fluid incomposition and, therefore, that pressure transmissioncan be expected to follow Pascal’s law such that mea-surement of the IAP at any point will reflect the pres-sure contained within the entire abdominal cavity [21].In reality, however, the abdominal contents remain aheterogeneous mix of solid, liquid and gaseous compo-nents with the exact composition influenced by severaldisease processes such as paralytic ileus, visceraloedema, or the presence of ascites. Pressure transmis-sion characteristics are, therefore, likely to be rathermore complex.
Regional IAPThe implications of a regional ACS are profound withthe gold-standard technique for pressure measurementoccurring at the lowest point in the abdominal cavity,whilst the organs that have been shown to be most sus-ceptible to raised IAP all lie in the upper abdomen.Separate studies have all clearly shown the deleteriouseffects of raised IAP on the splanchnic circulation[11-13,34,35], cardiac [8,36], respiratory [9,37,38], renal[5,32,39] and neurological [40,41] functions in bothhuman and animal models.
Table 1 Comparison of IBP, LIAP and UIAP
Comparisons Number Mean IAP Range IAP COVA IAP ra p Bias Precision LLA ULA % Error
IBP vs LIAP All 338 9.43 0.0 to 19.0 43.6 0.99 < 0.001 0.03 0.59 -1.14 1.18 13
Supine 169 9.23 0.5 to 18.0 43.7 0.99 < 0.001 0.06 0.62 -1.16 1.28 13
30° HOB 169 9.63 0.0 to 19.0 43.6 0.99 < 0.001 -0.01 0.55 -1.07 1.09 11
IBP vs UIAP All 338 10.07 1.5 to 19.5 39.7 0.66 < 0.001 -1.25 3.63 -8.36 5.86 72
Supine 169 10.49 2.5 to 19.5 38.9 0.70 < 0.001 -2.46 3.52 -9.36 4.44 67
30° HOB 169 9.65 1.5 to 18.5 39.9 0.68 < 0.001 -0.05 3.34 -6.60 6.5 69
LIAP vs UIAP All 338 10.06 1.5 to 19.5 39.8 0.66 < 0.001 -1.28 3.63 -7.31 4.75 72
Supine 169 10.46 2.5 to 19.5 39.3 0.70 < 0.001 -2.51 3.47 -9.31 4.29 66
30° HOB 169 9.66 1.5 to 18.0 40.1 0.68 < 0.001 -0.05 3.36 -6.64 6.54 70
The patient positioned supine and in a 30° head of bed angle. IBP, intra-bladder pressure; LIAP, lower intra-abdominal pressure; UIAP, upper intra-abdominalpressure; HOB, head of bed, IAP, intra-abdominal pressure; COVA; coefficient of variance; LLA, Lower level of agreement; ULA, Upper level of agreement. ar =Pearson product-moment correlation coefficient.
Cresswell et al. Annals of Intensive Care 2012, 2(Suppl 1):S12http://www.annalsofintensivecare.com/content/2/S1/S12
Page 6 of 10
277
The possibility of a regional variation between theupper and lower IAP was identified, but not explored indetail in 1994 [22]. In this study, IGP was measured in
nine patients undergoing laparoscopic cholecystectomyat a variety of different insufflation pressures. The studywas designed to validate the measurement of IGP
(a)
(b)
Figure 4 Intra-bladder pressure (IBP) and upper intra-abdominal pressure (UIAP), and lower intra-abdominal pressure (LIAP) and UIAP.(a) Bland and Altman plot to compare IBP and UIAP with a supine body position and a head of bed position of 30°. (b) Bland and Altman plotto compare LIAP and UIAP with a supine body position and a head of bed position of 30°. LLA and ULA marked by dotted lines.
Cresswell et al. Annals of Intensive Care 2012, 2(Suppl 1):S12http://www.annalsofintensivecare.com/content/2/S1/S12
Page 7 of 10
278
against the pneumoperitoneum but also showed thatIGP could also be up to 4 mmHg higher or 3 mmHglower than the measured IBP. A further small study hasidentified differences in gastric and bladder pressure intwo patients within a general ICU population [42] andsuggested that such a variation could provide clues as toany underlying pathophysiological process.Our study is the largest to compare the two compart-
mental pressures within a clinical setting, without artifi-cial manipulation of IAP. In keeping with the abovestudy, we showed a significant difference between com-partmental pressures but with a much broader andmore clinically significant range of variation of up to 16mmHg and a mean difference between the compart-ments of around 20% which equates to a maximal inter-compartmental mean difference of 5.3 mmHg.Clearly, such a magnitude of variation, coupled with
the observation that compartmental pressures were seento vary by 4 mmHg or more for an average of 23% ofthe time, means that relying on the measurement of onecompartmental pressure only may lead to a significantlyelevated pressure in the other compartment beingmissed. The positive relationship that we have demon-strated between compartmental pressures should man-date separate measurement of UIAP in patients inwhom the IBP is adopting an upward trend.It was interesting to observe that the range of varia-
tion in inter-compartmental pressure was greater inthose patients concealing a higher UIAP, and this maybe related to the previous data which suggest that upperabdominal incisions result in measurable changes toabdominal wall contractile properties which may contri-bute to the generation of a locally raised IAP [43].
Body position and regional IAPPrevious clinical studies have considered the influence ofpatient positioning on IAP. In the largest [44], a multi-centre study of 132 ventilated patients, the mean differ-ence between supine and 30° IBP was 3.7 mmHg with a
range of 3.4 to 4.0 mmHg. The largest reported differ-ence in positional pressures was seen in a study of 37patients at a range of bed positions between 0 and 45°[27]. It was found that IBP increased with head-up tiltwith a mean increase of 5 mmHg at 30°, and 7.4 mmHgat 45°.Our data have also demonstrated a statistically signifi-
cant increase in the IBP with head-up positioning to30°. This was, however, a far smaller increase of just0.43 mmHg rather than the 5 mmHg seen in the abovestudy. This would lend support to the theory that LIAPwill increase as the result of a more upright posture[33]. The most likely explanation for this is that an erectposture leads to an increase in the hydrostatic weightexerted by the abdominal organs and body habituspressing downwards on the bladder much in the samemanner as increasing the height of a standing column offluid would increase the measurable pressure at the bot-tom of the column.A more interesting observation in our own data, how-
ever, is the fact that despite accurate re-zeroing of apatient mounted transducer UIAP was significantlyincreased in the supine position compared to a 30°head-up tilt. The reason for this observation remainsunclear but may be related to the re-positioning of themore mobile hollow abdominal viscera along with boththeir fluid contents and any free intra-peritoneal fluidwith a more upright posture. This observation wouldsuggest that a simple change in posture could provide aclinically significant improvement in the UIAP, which inturn, may improve hepatic, renal and splanchnic bloodflow. Such positive effects on organ perfusion wouldneed to be demonstrated by further specific studies;however, it does raise the possibility that a head-upposition may be advantageous for reasons other thansimple ventilatory mechanics. It is also particularlyencouraging to note that a larger reduction in UIAP canbe expected in those patients with a higher upper, ratherthan lower, baseline intra-abdominal pressure. The lack
Table 2 Mean continuous pressures observed in each compartment, split according to highest average compartmentpressure
Subject group Meancompartmental IAP
(mmHg, SD)
Mean difference between compartments (SD) Mean percentage difference between compartmentsa
UIAP LIAP
Higher 10.5 8.3 2.2 23.4%
UIAP (4.6) (4.5) (2.4)
Higher 8.6 10.9 2.3 23.6%
LIAP (3.8) (5.6) (3.2)
Overall 9.7 9.5 0.3 3.1%
(4.2) (4.6) (4.1)
UIAP, upper intra-abdominal pressure; LIAP, lower intra-abdominal pressure; SD, Standard Deviation. aMean percentage difference between compartments =mean difference between compartments/(mean UIAP + mean LIAP/2) × 100.
Cresswell et al. Annals of Intensive Care 2012, 2(Suppl 1):S12http://www.annalsofintensivecare.com/content/2/S1/S12
Page 8 of 10
279
of collection of other body anthropomorphic data tofurther examine these two groups is accepted to be anunfortunate limitation of the study.
Clinical applicationThe fact that it was impossible to predict which of thetwo compartments would conceal the higher pressuresuggests that, for this subgroup of patients, dual com-partmental pressure monitoring may be required basedupon the clinical condition of the patient. It remainsunclear, however, whether the observed variation ininter-compartmental pressure is specific to the procedureof liver transplantation, or whether the findings could begeneralised to all upper abdominal surgery, local inflam-matory conditions such as severe acute pancreatitis, orindeed the measurement of IAP in general. It is also ashortcoming that various anthropomorphic data anddetails of illness severity scores were not collected, asthese have been shown to impact on baseline IAP.Further study with a larger sample size will be
required to elucidate the relationship between the loca-tion of the higher compartmental pressure, the magni-tude of variation in compartmental pressure and theduration for which there is a significant differencebetween compartments with clinical outcome. Such astudy, with higher numbers, may be facilitated by therecent introduction of a commercially available non-invasive device for the measurement of IGP (CiMON,Pulsion Medical Systems, Munich, Germany). It wouldalso be extremely interesting to measure the retroperito-neal compartmental pressure within the upper abdomenwhich very much contains the ‘anatomical terminus’ forthe arrival and departure of the abdominal blood supply,as well as the kidneys themselves.
ConclusionIt remains to be seen and further research is certainlyrequired to discover whether the observed effects arespecific to patients undergoing liver transplantation andto define any effects on clinical outcome. The currentdata do, however, demonstrate a significant variation inregional IAP within the study group. It may be well thatwe need to consider regional IAP in more detail andconsider the different abdominal compartments, includ-ing the retroperitoneum, as more distinct entities, andpatient positioning may prove a useful utility for opti-mising compartmental pressures and perfusion.
ConsentWritten informed consent was obtained from the patientfor publication of this case report and accompanyingimages. A copy of the written consent is available forreview by the Editor-in-Chief of this journal.
AbbreviationsACS: abdominal compartment syndrome; IAH: intra-abdominal hypertension;IAP: intra-abdominal pressure; IBP: intra-bladder pressure; ICU: intensive careunit; IGP: intra-gastric pressure; LIAP: lower intra-abdominal pressure; UIAP:upper intra-abdominal pressure; WSACS: World Society on AbdominalCompartment Syndrome.
AcknowledgementsThis article has been published as part of Annals of Intensive Care Volume 2Supplement 1, 2012: Diagnosis and management of intra-abdominalhypertension and abdominal compartment syndrome. The full contents ofthe supplement are available online at http://www.annalsofintensivecare.com/supplements/2/S1.Figure 2 is reproduced with the kind permission of Mr. Bo Holte, Holtech,Charlottenlund, Denmark. The authors wish to thank Pulsion MedicalSystems who have sponsored the processing fees for this article.
Authors’ contributionsABC conceived of the idea, designed the study, arranged ethical approval,conducted the study, collected the data, analysed the data and wrote themanuscript. JAW and MJB reviewed the study design, assisted with analysisand reviewed the manuscript. WJ, PS, AAP, ES, WB, GA, PM, MR and NDHassisted in the insertion and the day-to-day care of the experimentalpressure catheters.
Authors’ informationABC is now a hepatopancreatobiliary (HPB) surgeon at the BasingstokeHepatobiliary Unit, UK. WJ, PS, AAP, MR and NDH are HPB and livertransplant surgeons at King’s College Hospital, UK. JAW, ES, WB and GA areliver intensivists at King’s College Hospital, UK. MJB is an HPB surgeon atDerriford Hospital, UK but undertook this work whilst a HPB and transplantsurgeon at Kings College Hospital.
Competing interestsDr Julia Wendon is a member of the medical advisory board of PulsionMedical Systems, who have sponsored the processing fees of thissubmission. The authors declare that they have no other conflicts ofinterests.
Published: 5 July 2012
References1. Malbrain ML, Chiumello D, Pelosi P, Bihari D, Innes R, Ranieri VM, Del
Turco M, Wilmer A, Brienza N, Malcangi V, Cohen J, Japiassu A, DeKeulenaer BL, Daelemans R, Jacquet L, Laterre PF, Frank G, de Souza P,Cesana B, Gattinoni L: Incidence and prognosis of intraabdominalhypertension in a mixed population of critically ill patients: a multiple-center epidemiological study. Crit Care Med 2005, 33:315-322.
2. Malbrain ML, Chiumello D, Pelosi P, Wilmer A, Brienza N, Malcangi V,Bihari D, Innes R, Cohen J, Singer P, Japiassu A, Kurtop E, De Keulenaer BL,Daelemans R, Del Turco M, Cosimini P, Ranieri M, Jacquet L, Laterre PF,Gattinoni L: Prevalence of intra-abdominal hypertension in critically illpatients: a multicentre epidemiological study. Intensive Care Med 2004,30:822-829.
3. Malbrain ML, Deeren D, De Potter TJ: Intra-abdominal hypertension in thecritically ill: it is time to pay attention. Curr Opin Crit Care 2005,11:156-171.
4. Balogh Z, De Waele JJ, Kirkpatrick A, Cheatham M, D’Amours S, Malbrain M:Intra-abdominal pressure measurement and abdominal compartmentsyndrome: the opinion of the World Society of the AbdominalCompartment Syndrome. Crit Care Med 2007, 35:677-678, author reply 678-679.
5. Biancofiore G, Bindi ML, Romanelli AM, Bisa M, Boldrini A, Consani G,Filipponi F, Mosca F: Postoperative intra-abdominal pressure and renalfunction after liver transplantation. Arch Surg 2003, 138:703-706.
6. Bloomfield GL, Blocher CR, Fakhry IF, Sica DA, Sugerman HJ: Elevated intra-abdominal pressure increases plasma renin activity and aldosteronelevels. J Trauma 1997, 42:997-1004, discussion 1004-1005.
7. Bongard F, Pianim N, Dubecz S, Klein SR: Adverse consequences ofincreased intra-abdominal pressure on bowel tissue oxygen. J Trauma1995, 39:519-524, discussion 524-515.
Cresswell et al. Annals of Intensive Care 2012, 2(Suppl 1):S12http://www.annalsofintensivecare.com/content/2/S1/S12
Page 9 of 10
280
8. Cheatham ML, Malbrain ML: Cardiovascular implications of abdominalcompartment syndrome. Acta Clin Belg Suppl 2007, 1:98-112.
9. D’Angelo E, Pecchiari M, Acocella F, Monaco A, Bellemare F: Effects ofabdominal distension on breathing pattern and respiratory mechanics inrabbits. Respir Physiol Neurobiol 2002, 130:293-304.
10. De laet I, Malbrain ML, Jadoul JL, Rogiers P, Sugrue M: Renal implicationsof increased intra-abdominal pressure: are the kidneys the canary forabdominal hypertension? Acta Clin Belg Suppl 2007, 1:119-130.
11. Diebel LN, Dulchavsky SA, Wilson RF: Effect of increased intra-abdominalpressure on mesenteric arterial and intestinal mucosal blood flow. JTrauma 1992, 33:45-48, discussion 48-49.
12. Diebel LN, Wilson RF, Dulchavsky SA, Saxe J: Effect of increased intra-abdominal pressure on hepatic arterial, portal venous, and hepaticmicrocirculatory blood flow. J Trauma 1992, 33:279-282, discussion 282-273.
13. Eleftheriadis E, Kotzampassi K: Hepatic microcirculation after continuous7-day elevated intra-abdominal pressure in cirrhotic rats. Hepatol Res2005, 32:96-100.
14. Ivatury RR, Diebel L, Porter JM, Simon RJ: Intra-abdominal hypertensionand the abdominal compartment syndrome. Surg Clin North Am 1997,77:783-800.
15. Malbrain ML, Cheatham ML, Kirkpatrick A, Sugrue M, De Waele J, Ivatury R:Abdominal compartment syndrome: it’s time to pay attention! IntensiveCare Med 2006, 32:1912-1914.
16. Malbrain ML, Cheatham ML, Kirkpatrick A, Sugrue M, Parr M, De Waele J,Balogh Z, Leppaniemi A, Olvera C, Ivatury R, D’Amours S, Wendon J,Hillman K, Johansson K, Kolkman K, Wilmer A: Results from theInternational Conference of Experts on Intra-abdominal Hypertensionand Abdominal Compartment Syndrome. I. Definitions. Intensive CareMed 2006, 32:1722-1732.
17. Cheatham ML, Malbrain ML, Kirkpatrick A, Sugrue M, Parr M, De Waele J,Balogh Z, Leppaniemi A, Olvera C, Ivatury R, D’Amours S, Wendon J,Hillman K, Johansson K, Kolkman K, Wilmer A: Results from theInternational Conference of Experts on Intra-abdominal Hypertensionand Abdominal Compartment Syndrome. II. Recommendations. IntensiveCare Med 2007.
18. Malbrain ML, De laet I, Van Regenmortel N, Schoonheydt K, Dits H: Can theabdominal perimeter be used as an accurate estimation of intra-abdominal pressure? Crit Care Med 2009, 37:316-319.
19. Kirkpatrick AW, Brenneman FD, McLean RF, Rapanos T, Boulanger BR: Isclinical examination an accurate indicator of raised intra-abdominalpressure in critically injured patients? Can J Surg 2000, 43:207-211.
20. Sugrue M, Bauman A, Jones F, Bishop G, Flabouris A, Parr M, Stewart A,Hillman K, Deane SA: Clinical examination is an inaccurate predictor ofintraabdominal pressure. World J Surg 2002, 26:1428-1431.
21. Malbrain ML: Different techniques to measure intra-abdominal pressure(IAP): time for a critical re-appraisal. Intensive Care Med 2004, 30:357-371.
22. Sugrue M, Buist MD, Lee A, Sanchez DJ, Hillman KM: Intra-abdominalpressure measurement using a modified nasogastric tube: descriptionand validation of a new technique. Intensive Care Med 1994, 20:588-590.
23. Risin E, Kessel B, Ashkenazi I, Lieberman N, Alfici R: A new technique ofdirect intra-abdominal pressure measurement: a preliminary study. Am JSurg 2006, 191:235-237.
24. Schachtrupp A, Henzler D, Orfao S, Schaefer W, Schwab R, Becker P,Schumpelick V: Evaluation of a modified piezoresistive technique and awater-capsule technique for direct and continuous measurement ofintra-abdominal pressure in a porcine model. Crit Care Med 2006,34:745-750.
25. Risin E, Kessel B, Lieberman N, Schmilovich M, Ashkenazi I, Alfici R: Newtechnique of direct intra-abdominal pressure measurement. Asian J Surg2006, 29:247-250.
26. Malbrain ML, Wilmer A: The polycompartment syndrome: towards anunderstanding of the interactions between different compartments!Intensive Care Med 2007, 33:1869-1872.
27. McBeth PB, Zygun DA, Widder S, Cheatham M, Zengerink I, Glowa J,Kirkpatrick AW: Effect of patient positioning on intra-abdominal pressuremonitoring. Am J Surg 2007, 193:644-647, discussion 647.
28. Biancofiore G, Bindi ML, Romanelli AM, Boldrini A, Consani G, Bisa M,Filipponi F, Vagelli A, Mosca F: Intra-abdominal pressure monitoring inliver transplant recipients: a prospective study. Intensive Care Med 2003,29:30-36.
29. De Waele JJ, Cheatham ML, Malbrain ML, Kirkpatrick AW, Sugrue M,Balogh Z, Ivatury R, De Keulenaer B, Kimball EJ: Recommendations forresearch from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. ActaClin Belg 2009, 64:203-209.
30. Bland JM, Altman DG: Statistical methods for assessing agreementbetween two methods of clinical measurement. Lancet 1986, 1:307-310.
31. De Keulenaer BL, De Waele JJ, Powell B, Malbrain ML: What is normalintra-abdominal pressure and how is it affected by positioning, bodymass and positive end-expiratory pressure? Intensive Care Med 2009,35:969-976.
32. Kirkpatrick AW, Colistro R, Laupland KB, Fox DL, Konkin DE, Kock V, Mayo JR,Nicolaou S: Renal arterial resistive index response to intraabdominalhypertension in a porcine model. Crit Care Med 2007, 35:207-213.
33. Shafik A, El-Sharkawy A, Sharaf WM: Direct measurement of intra-abdominal pressure in various conditions. Eur J Surg 1997, 163:883-887.
34. Diebel LN, Dulchavsky SA, Brown WJ: Splanchnic ischemia and bacterialtranslocation in the abdominal compartment syndrome. J Trauma 1997,43:852-855.
35. Sugrue M, Jones F, Lee A, Buist MD, Deane S, Bauman A, Hillman K:Intraabdominal pressure and gastric intramucosal pH: is there anassociation? World J Surg 1996, 20:988-991.
36. Cullen DJ, Coyle JP, Teplick R, Long MC: Cardiovascular, pulmonary, andrenal effects of massively increased intra-abdominal pressure in criticallyill patients. Crit Care Med 1989, 17:118-121.
37. Oikkonen M, Tallgren M: Changes in respiratory compliance atlaparoscopy: measurements using side stream spirometry. Can J Anaesth1995, 42:495-497.
38. Pelosi P, Quintel M, Malbrain ML: Effect of intra-abdominal pressure onrespiratory mechanics. Acta Clin Belg Suppl 2007, 1:78-88.
39. Doty JM, Saggi BH, Blocher CR, Fakhry I, Gehr T, Sica D, Sugerman HJ:Effects of increased renal parenchymal pressure on renal function. JTrauma 2000, 48:874-877.
40. De laet I, Citerio G, Malbrain ML: The influence of intraabdominalhypertension on the central nervous system: current insights andclinical recommendations, is it all in the head? Acta Clin Belg Suppl 2007,1:89-97.
41. Deeren DH, Dits H, Malbrain ML: Correlation between intra-abdominaland intracranial pressure in nontraumatic brain injury. Intensive Care Med2005, 31:1577-1581.
42. Malbrain ML, De Laet IE, Willems A, Van Regenmortel N, Schoonheydt K,Dits H: Localised abdominal compartment syndrome: bladder-over-gastric pressure ratio (B/G ratio) as a clue to diagnosis. Acta Clin Belg2010, 65:98-106.
43. Duggan JE, Drummond GB: Abdominal muscle activity andintraabdominal pressure after upper abdominal surgery. Anesth Analg1989, 69:598-603.
44. Cheatham ML, De Waele JJ, De Laet I, De Keulenaer B, Widder S,Kirkpatrick AW, Cresswell AB, Malbrain M, Bodnar Z, Mejia-Mantilla JH,Reis R, Parr M, Schulze R, Puig S, World Society of the AbdominalCompartment Syndrome (WSACS) Clinical Trials Working Group: Theimpact of body position on intra-abdominal pressure measurement: amulticenter analysis. Crit Care Med 2009, 37:2187-2190.
doi:10.1186/2110-5820-2-S1-S12Cite this article as: Cresswell et al.: The effect of body position oncompartmental intra-abdominal pressure following liver transplantation.Annals of Intensive Care 2012 2(Suppl 1):S12.
Cresswell et al. Annals of Intensive Care 2012, 2(Suppl 1):S12http://www.annalsofintensivecare.com/content/2/S1/S12
Page 10 of 10
281